data_2pdz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2pdz _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.436 0.636 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.448 ' CB ' HG11 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -155.18 168.03 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.409 -0.807 . . . . 0.0 110.692 -179.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.55 121.12 13.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.468 -0.77 . . . . 0.0 109.197 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 44' ' ' ALA . 64.3 t -131.94 139.48 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.931 -1.105 . . . . 0.0 111.05 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.8 m -119.14 116.47 26.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.459 -0.776 . . . . 0.0 109.683 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 78' ' ' VAL . 90.9 t -103.83 111.57 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 110.207 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.86 . . . . 0.0 109.916 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.993 0.425 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.446 ' CA ' HD23 ' A' ' 37' ' ' LEU . . . 56.0 87.0 0.02 OUTLIER Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.432 HD13 ' CD1' ' A' ' 45' ' ' LEU . 3.3 tt -176.32 118.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.223 -1.163 . . . . 0.0 110.345 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -112.94 101.09 9.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.561 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.485 ' CD1' ' CG2' ' A' ' 68' ' ' VAL . 28.4 pt -78.31 151.06 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.95 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.6 tttt -137.83 122.22 18.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.452 -0.78 . . . . 0.0 110.209 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.08 -153.05 24.16 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 160.44 133.85 1.56 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.427 ' CZ ' ' O ' ' A' ' 60' ' ' SER . 0.2 OUTLIER -60.12 -15.43 23.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.424 -1.045 . . . . 0.0 110.617 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.68 7.07 15.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.719 -1.238 . . . . 0.0 110.487 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.53 23.76 2.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.085 -1.009 . . . . 0.0 109.749 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm 53.88 64.87 1.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.883 . . . . 0.0 110.213 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.451 ' CE ' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.51 117.84 5.2 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 110.236 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.451 ' HD2' ' CE ' ' A' ' 26' ' ' MET . 48.3 Cg_endo -69.54 54.34 1.09 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 O-C-N 123.425 1.224 . . . . 0.0 111.653 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.495 HD11 HG22 ' A' ' 28' ' ' ILE . 16.3 mm 42.33 88.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 O-C-N 121.268 -0.895 . . . . 0.0 110.304 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 49' ' ' ASP . 31.8 tp -100.89 125.72 47.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.843 -1.16 . . . . 0.0 111.888 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 57.4 mt -61.82 136.26 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.588 -0.695 . . . . 0.0 110.188 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.3 t -121.98 -11.4 8.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 110.686 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 106.78 3.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.956 -1.09 . . . . 0.0 110.703 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.444 ' CG2' ' HB2' ' A' ' 40' ' ' ASP . 11.8 mm -95.6 94.74 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 109.45 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.536 ' CE1' ' CD1' ' B' ' 6' ' ' LEU . 88.3 m-85 -54.27 141.55 29.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.841 . . . . 0.0 110.26 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -86.42 171.57 11.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 110.805 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.58 30.89 73.13 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.446 HD23 ' CA ' ' A' ' 15' ' ' GLY . 0.7 OUTLIER -138.28 162.61 33.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -1.196 . . . . 0.0 110.78 -179.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.436 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . . . -46.5 -64.08 0.85 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.514 -0.741 . . . . 0.0 111.63 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 45' ' ' LEU . . . -48.6 -53.75 17.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.96 -1.087 . . . . 0.0 111.385 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.444 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 16.3 t70 -77.3 -9.26 58.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.86 -1.15 . . . . 0.0 111.891 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.436 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -107.41 10.95 29.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.67 -1.268 . . . . 0.0 110.746 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.4 t -106.82 15.62 25.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.017 -1.052 . . . . 0.0 110.512 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 47.74 55.31 8.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.117 -0.989 . . . . 0.0 110.991 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.486 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -176.64 -47.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.083 -1.011 . . . . 0.0 110.524 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.432 ' CD1' HD13 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -67.93 82.44 0.21 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.973 -1.079 . . . . 0.0 109.154 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.588 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.91 150.01 32.39 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.548 -0.72 . . . . 0.0 109.835 -179.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.431 ' N ' HG13 ' A' ' 33' ' ' ILE . 96.2 t -50.24 167.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.97 -1.081 . . . . 0.0 110.253 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.88 30.21 68.35 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.475 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 36.5 m-20 -114.06 99.57 7.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.485 -1.009 . . . . 0.0 110.968 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . . . -78.43 107.11 10.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 109.518 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 51' ' ' ILE . 61.2 mt -77.46 134.33 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 110.939 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.431 ' CD2' ' O ' ' A' ' 50' ' ' ALA . 4.0 mm? -120.9 7.3 10.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.488 -0.757 . . . . 0.0 110.003 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 4.8 t -175.76 131.92 0.26 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.148 -0.97 . . . . 0.0 109.871 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.464 HG23 ' CB ' ' A' ' 70' ' ' ALA . 2.0 m -123.9 113.96 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.302 -0.873 . . . . 0.0 109.721 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.6 34.29 20.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.292 -0.88 . . . . 0.0 110.283 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.99 21.02 51.8 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 53' ' ' SER . 3.3 tm-20 -109.51 84.9 2.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.064 -1.257 . . . . 0.0 110.417 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -44.56 97.88 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.432 -0.793 . . . . 0.0 110.947 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.436 ' CD1' HG21 ' A' ' 54' ' ' VAL . 37.3 mt -79.09 -8.78 59.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.473 -0.767 . . . . 0.0 110.877 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.427 ' O ' ' CZ ' ' A' ' 22' ' ' ARG . 21.7 p -47.01 -36.19 7.58 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.212 -0.93 . . . . 0.0 110.611 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -106.85 29.86 6.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.752 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.423 ' HB2' ' CB ' ' A' ' 66' ' ' GLU . . . -119.72 153.65 35.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.355 -0.841 . . . . 0.0 110.133 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.402 ' HA ' ' CB ' ' A' ' 22' ' ' ARG . 2.9 p -86.32 171.56 11.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.303 -0.873 . . . . 0.0 110.071 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.49 ' CD2' HG22 ' A' ' 68' ' ' VAL . 6.2 t60 -55.29 -24.65 29.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 109.777 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -77.14 -38.24 52.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.014 . . . . 0.0 109.761 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.423 ' CB ' ' HB2' ' A' ' 62' ' ' ALA . 4.1 mm-40 -67.94 -25.89 65.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.832 . . . . 0.0 110.166 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.417 ' HA ' ' CD2' ' A' ' 59' ' ' LEU . . . -81.87 -38.82 24.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 110.416 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.49 HG22 ' CD2' ' A' ' 64' ' ' HIS . 8.2 t -73.26 -27.38 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.068 -1.02 . . . . 0.0 109.334 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -65.09 -38.16 89.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.363 -0.835 . . . . 0.0 109.767 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.464 ' CB ' HG23 ' A' ' 54' ' ' VAL . . . -70.26 -48.53 56.45 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.15 -0.969 . . . . 0.0 108.726 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.431 ' HA ' ' CG2' ' A' ' 74' ' ' THR . 82.7 mt -59.62 -22.49 61.92 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.661 -0.649 . . . . 0.0 109.674 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -80.11 -45.11 18.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.654 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 5.5 tttt -112.74 59.79 0.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.38 -0.825 . . . . 0.0 109.719 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.431 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 47.3 p -78.08 174.2 11.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 110.248 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.88 -169.48 29.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -52.11 23.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.017 -1.284 . . . . 0.0 110.448 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 1.8 pt-20 -107.74 117.24 33.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.902 . . . . 0.0 109.778 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.422 HG13 ' CD1' ' A' ' 80' ' ' LEU . 45.8 t -83.11 78.56 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.938 -1.101 . . . . 0.0 110.781 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.8 t -68.53 112.53 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.101 -0.999 . . . . 0.0 108.329 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.422 ' CD1' HG13 ' A' ' 78' ' ' VAL . 4.4 mp -119.94 115.79 24.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.993 -1.067 . . . . 0.0 111.87 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -73.56 128.63 36.02 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.448 HG11 ' CB ' ' A' ' 2' ' ' ARG . 2.5 p -127.23 150.27 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.044 -1.035 . . . . 0.0 112.15 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -115.58 85.04 2.2 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.588 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -51.56 130.65 28.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.468 -0.77 . . . . 0.0 111.119 -177.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.4 mtt -115.47 51.74 0.92 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.765 . . . . 0.0 109.451 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.338 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.404 ' HB3' ' ND1' ' A' ' 64' ' ' HIS . 10.6 tttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.174 0.511 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -121.49 94.34 4.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.154 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.409 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -91.28 -169.52 2.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.394 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.536 ' CD1' ' CE1' ' A' ' 34' ' ' PHE . 5.1 tp -157.77 94.83 1.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.82 . . . . 0.0 109.883 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.088 179.778 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.499 0.666 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.444 ' CG ' HG11 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -158.77 146.51 17.9 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.548 -0.72 . . . . 0.0 109.736 -179.421 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.405 ' N ' ' HG3' ' A' ' 2' ' ' ARG . 0.4 OUTLIER -124.28 129.33 50.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.057 -1.027 . . . . 0.0 110.307 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' A' ' 44' ' ' ALA . 93.5 t -128.79 127.53 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.384 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.6 m -114.69 132.57 56.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.737 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.4 t -122.69 109.96 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 110.304 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 109.549 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.435 ' CD2' ' HB3' ' A' ' 39' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.067 0.461 . . . . 0.0 110.367 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.467 ' N ' ' CD2' ' A' ' 37' ' ' LEU . . . 56.21 90.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.414 HD13 ' CD2' ' A' ' 45' ' ' LEU . 1.1 tt -176.33 120.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.203 -1.175 . . . . 0.0 110.525 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.485 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 1.3 m -112.46 106.25 14.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.186 -0.947 . . . . 0.0 109.404 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.487 ' CD1' ' CG2' ' A' ' 68' ' ' VAL . 12.3 pt -82.58 156.64 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.426 -0.796 . . . . 0.0 111.501 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.431 ' CD ' ' CB ' ' A' ' 31' ' ' SER . 10.4 mtpt -136.44 156.92 47.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.578 -0.702 . . . . 0.0 109.833 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 123.05 -156.49 17.44 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.68 133.98 1.57 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.419 ' CB ' ' HA ' ' A' ' 63' ' ' THR . 1.9 tpm_? -60.71 -15.39 28.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -1.15 . . . . 0.0 110.62 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.412 ' OE2' ' ND2' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -82.03 5.51 19.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.649 -1.282 . . . . 0.0 110.342 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.412 ' ND2' ' OE2' ' A' ' 23' ' ' GLU . 0.7 OUTLIER -140.9 25.75 2.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.091 -1.006 . . . . 0.0 109.446 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.29 90.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 0.0 109.875 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.442 ' CE ' ' HB2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -170.03 127.01 0.76 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.305 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 57.0 Cg_endo -75.88 45.5 1.51 Allowed 'Trans proline' 0 N--CA 1.494 1.541 0 O-C-N 123.371 1.195 . . . . 0.0 111.717 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.458 HD11 HG22 ' A' ' 28' ' ' ILE . 27.0 mm 47.51 90.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 120.789 -1.194 . . . . 0.0 109.848 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.466 HD13 ' N ' ' A' ' 49' ' ' ASP . 36.6 tp -103.15 125.05 49.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.812 -1.18 . . . . 0.0 112.051 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 60.9 mt -58.78 139.39 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.568 -0.707 . . . . 0.0 109.85 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.431 ' CB ' ' CD ' ' A' ' 19' ' ' LYS . 33.3 t -124.6 -10.5 7.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 110.969 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.411 ' CB ' ' NZ ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -154.81 100.4 2.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.905 -1.122 . . . . 0.0 110.843 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.43 ' CG2' ' HB2' ' A' ' 40' ' ' ASP . 13.7 mm -86.39 101.26 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.212 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.485 ' CE1' ' OG ' ' A' ' 17' ' ' SER . 3.3 m-85 -59.36 135.56 57.69 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.604 -0.685 . . . . 0.0 109.698 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 169.47 15.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.117 -0.989 . . . . 0.0 110.851 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.48 30.29 77.15 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER -138.28 162.1 35.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.112 -1.228 . . . . 0.0 110.955 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -46.22 -69.06 0.14 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.628 -0.67 . . . . 0.0 111.694 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.435 ' HB3' ' CD2' ' A' ' 14' ' ' LEU . . . -45.01 -39.25 5.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.472 -0.767 . . . . 0.0 111.575 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.43 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 16.5 t70 -93.61 10.62 31.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.057 -1.027 . . . . 0.0 110.758 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -115.44 3.72 14.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.925 -1.109 . . . . 0.0 110.773 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.1 t -108.22 15.16 24.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.93 -1.106 . . . . 0.0 110.893 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.12 60.98 3.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.084 -1.01 . . . . 0.0 110.926 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.481 ' O ' ' CE2' ' A' ' 46' ' ' PHE . . . -175.15 -50.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.2 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.447 HD22 ' CD1' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -70.31 86.83 0.6 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.959 -1.088 . . . . 0.0 108.705 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.603 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -115.96 153.33 31.81 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.825 -0.547 . . . . 0.0 110.029 -179.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.414 HG21 HG12 ' A' ' 33' ' ' ILE . 32.5 t -48.12 165.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 120.899 -1.126 . . . . 0.0 110.151 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.77 31.69 67.33 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.466 ' N ' HD13 ' A' ' 29' ' ' LEU . 44.9 m-20 -116.58 100.28 7.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -1.041 . . . . 0.0 110.997 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . . . -79.1 108.88 12.93 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.858 . . . . 0.0 109.831 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.423 HG23 ' CG1' ' A' ' 54' ' ' VAL . 55.2 mt -75.4 139.94 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.329 -0.857 . . . . 0.0 110.824 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -125.05 4.63 7.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.255 -0.903 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 176.96 103.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.832 -1.168 . . . . 0.0 109.75 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.487 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 20.5 m -92.49 121.04 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.223 -0.923 . . . . 0.0 110.602 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 59.41 34.16 22.62 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.168 -0.958 . . . . 0.0 110.809 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.99 19.89 62.12 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.8 mt-10 -110.23 91.83 3.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.941 -1.329 . . . . 0.0 109.91 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -41.44 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.574 0.702 . . . . 0.0 111.488 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.442 ' CD1' ' HB2' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -90.39 14.01 14.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.489 -0.757 . . . . 0.0 110.399 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.6 t -68.88 -49.54 57.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 110.724 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.36 18.58 5.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.061 -1.024 . . . . 0.0 110.523 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.442 ' HB2' ' CD1' ' A' ' 59' ' ' LEU . . . -104.21 158.41 16.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -0.927 . . . . 0.0 110.233 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.419 ' HA ' ' CB ' ' A' ' 22' ' ' ARG . 12.4 p -90.15 176.23 6.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 110.071 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.5 ' CD2' HG22 ' A' ' 68' ' ' VAL . 4.5 t60 -58.64 -26.01 63.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.072 -1.018 . . . . 0.0 109.556 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.45 -30.28 59.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.089 -1.007 . . . . 0.0 109.709 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -75.62 -27.03 58.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.838 . . . . 0.0 109.952 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.432 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -80.09 -36.68 35.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.368 -0.832 . . . . 0.0 110.502 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.5 HG22 ' CD2' ' A' ' 64' ' ' HIS . 17.5 t -75.5 -32.71 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.047 -1.033 . . . . 0.0 109.549 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -60.97 -38.32 85.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 109.879 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.487 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -70.98 -50.58 32.77 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.177 -0.952 . . . . 0.0 108.788 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.452 ' HA ' ' CG2' ' A' ' 74' ' ' THR . 86.7 mt -58.56 -23.59 58.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.619 -0.676 . . . . 0.0 110.01 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -80.69 -36.78 31.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.124 -0.985 . . . . 0.0 109.941 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -119.43 58.21 0.88 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.111 -0.993 . . . . 0.0 109.871 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.452 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 39.4 p -80.96 -170.65 2.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.904 . . . . 0.0 110.003 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.53 -175.05 15.33 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -49.04 -59.88 3.25 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.056 -1.261 . . . . 0.0 110.298 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -88.4 95.44 10.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 109.582 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -79.86 78.74 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 110.66 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.0 t -68.66 116.32 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.083 -1.01 . . . . 0.0 108.352 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 mp -121.06 100.8 7.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.978 -1.076 . . . . 0.0 111.743 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -64.13 128.89 37.8 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.444 HG11 ' CG ' ' A' ' 2' ' ' ARG . 2.2 p -131.9 143.93 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 111.799 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -106.67 88.34 2.74 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.603 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -56.0 111.24 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.456 -0.778 . . . . 0.0 111.165 -177.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 mtt -89.21 53.43 2.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 109.198 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.149 -179.535 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.465 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 15.3 tttp . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.157 0.503 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -121.13 90.84 3.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.991 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.417 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -79.9 -161.72 0.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 0.0 110.461 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.48 HD12 ' CZ ' ' A' ' 34' ' ' PHE . 22.1 tp -171.14 99.88 0.21 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 109.935 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 92.5 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.255 180.0 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.351 0.596 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.453 ' CB ' HG11 ' A' ' 82' ' ' VAL . 1.7 mtp85 -157.05 167.74 29.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.68 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -138.66 119.01 13.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.497 -0.752 . . . . 0.0 109.189 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 44' ' ' ALA . 83.2 t -127.63 126.15 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.969 -1.082 . . . . 0.0 110.655 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.5 m -117.29 114.39 23.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.446 -0.784 . . . . 0.0 109.441 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.441 ' CG2' HD13 ' A' ' 45' ' ' LEU . 98.4 t -102.8 111.04 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.946 . . . . 0.0 109.964 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.436 -0.79 . . . . 0.0 110.044 -179.847 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.451 ' CD2' ' HB3' ' A' ' 39' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.173 0.511 . . . . 0.0 110.277 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.437 ' CA ' HD23 ' A' ' 37' ' ' LEU . . . 63.86 81.65 0.1 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 tt -176.42 117.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.326 -1.102 . . . . 0.0 110.325 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' B' ' 5' ' ' SER . 0.7 OUTLIER -111.8 119.57 39.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.186 -0.946 . . . . 0.0 109.577 179.231 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.487 ' CD1' ' CG2' ' A' ' 68' ' ' VAL . 8.8 pt -95.6 148.98 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.98 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HG2' ' CA ' ' B' ' 4' ' ' GLU . 0.2 OUTLIER -132.67 134.72 45.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.812 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 142.17 -159.98 27.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.32 136.84 2.12 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -16.1 21.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -1.133 . . . . 0.0 110.598 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.43 -12.38 60.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.826 -1.171 . . . . 0.0 110.233 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.14 27.54 8.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.088 -1.007 . . . . 0.0 110.185 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.69 49.68 19.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.126 -0.984 . . . . 0.0 110.043 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.425 ' CA ' ' HE1' ' A' ' 26' ' ' MET . 0.0 OUTLIER -125.33 122.56 25.11 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 110.365 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.451 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 55.5 Cg_endo -72.66 50.86 1.77 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 O-C-N 123.422 1.222 . . . . 0.0 111.735 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.434 ' CG2' HD11 ' A' ' 18' ' ' ILE . 25.4 mm 43.37 88.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 O-C-N 121.053 -1.029 . . . . 0.0 110.706 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 50' ' ' ALA . 5.6 mt -97.74 132.51 43.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.857 -1.152 . . . . 0.0 111.608 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.437 HG23 ' CD1' ' A' ' 33' ' ' ILE . 56.9 mt -69.2 138.21 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.284 -0.885 . . . . 0.0 108.952 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.6 t -119.83 -24.73 6.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.94 -1.1 . . . . 0.0 110.931 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.43 108.3 5.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.016 -1.053 . . . . 0.0 110.666 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.458 HG21 HD11 ' A' ' 33' ' ' ILE . 15.9 mm -94.24 98.44 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.429 -0.794 . . . . 0.0 109.166 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.537 ' CE1' ' CD2' ' B' ' 6' ' ' LEU . 92.0 m-85 -57.9 130.83 48.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.608 -0.683 . . . . 0.0 110.362 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.423 ' O ' ' CD1' ' A' ' 37' ' ' LEU . 7.3 pttt -76.83 171.68 14.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.402 -0.811 . . . . 0.0 110.95 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.57 30.57 65.53 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 34' ' ' PHE . 0.5 OUTLIER -138.47 161.96 35.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.076 -1.249 . . . . 0.0 110.903 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.432 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . . . -48.24 -66.73 0.35 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.579 -0.701 . . . . 0.0 111.592 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.451 ' HB3' ' CD2' ' A' ' 14' ' ' LEU . . . -47.57 -33.03 6.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 112.199 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.449 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 5.4 t70 -95.77 -19.91 19.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.719 -1.238 . . . . 0.0 111.302 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.432 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -93.78 14.86 17.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.905 -1.122 . . . . 0.0 110.725 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 t -107.74 14.07 25.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.013 -1.055 . . . . 0.0 110.843 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 44.79 46.91 8.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.188 -0.945 . . . . 0.0 111.284 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.488 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -165.62 -51.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 110.515 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.451 HD11 ' CB ' ' A' ' 39' ' ' ALA . 2.8 mt -70.61 83.07 0.6 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.839 -1.163 . . . . 0.0 108.504 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.591 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -110.29 155.07 22.58 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.361 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.439 ' N ' HG13 ' A' ' 33' ' ' ILE . 90.6 t -51.02 167.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.813 -1.179 . . . . 0.0 110.29 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.409 ' N ' HG13 ' A' ' 47' ' ' VAL . . . 67.84 32.36 77.49 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.472 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 32.6 m-20 -114.05 104.44 12.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.484 -1.009 . . . . 0.0 110.431 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.451 ' CB ' ' HG2' ' A' ' 27' ' ' PRO . . . -80.56 105.69 12.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.328 -0.857 . . . . 0.0 109.627 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 54.7 mt -76.62 135.97 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.405 -0.809 . . . . 0.0 111.07 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.425 ' N ' HD21 ' A' ' 52' ' ' LEU . 4.4 mm? -120.55 8.21 10.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.488 -0.757 . . . . 0.0 110.214 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 26.0 t -178.68 135.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.103 -0.998 . . . . 0.0 109.704 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.485 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 1.5 m -129.24 114.83 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.309 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.414 ' ND2' ' HB ' ' A' ' 74' ' ' THR . 2.9 m-80 58.75 31.15 20.9 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.262 -0.899 . . . . 0.0 110.76 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.83 21.07 34.72 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.3 mm-40 -112.41 88.03 2.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.041 -1.27 . . . . 0.0 110.164 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -46.64 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.276 -0.89 . . . . 0.0 111.004 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 57' ' ' GLU . 79.8 mt -81.7 -11.92 58.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.563 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 t -48.16 -32.41 6.96 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.231 -0.918 . . . . 0.0 110.06 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.9 t -112.06 22.62 14.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.343 -0.848 . . . . 0.0 109.451 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 66' ' ' GLU . . . -113.11 152.57 29.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.425 -0.797 . . . . 0.0 110.143 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 p -86.9 169.94 12.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 110.053 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.544 ' CD2' ' CD ' ' B' ' 3' ' ' LYS . 3.3 t60 -54.0 -25.74 22.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.929 . . . . 0.0 109.789 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -77.44 -36.26 53.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.062 -1.024 . . . . 0.0 110.034 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.428 ' CB ' ' HB3' ' A' ' 62' ' ' ALA . 46.4 mm-40 -73.11 -23.04 60.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.934 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.36 -38.25 24.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 110.417 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.496 HG22 ' CD2' ' A' ' 64' ' ' HIS . 14.1 t -72.44 -29.21 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.154 -0.966 . . . . 0.0 109.184 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -61.37 -37.2 82.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.335 -0.853 . . . . 0.0 109.813 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.485 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -71.54 -50.31 32.4 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.171 -0.956 . . . . 0.0 108.81 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.421 ' HA ' ' CG2' ' A' ' 74' ' ' THR . 86.7 mt -57.68 -23.67 52.75 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.543 -0.723 . . . . 0.0 109.443 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -78.56 -34.91 46.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.678 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -130.79 54.17 1.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.343 -0.848 . . . . 0.0 109.684 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.421 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 66.2 p -57.81 -84.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.855 . . . . 0.0 110.502 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.12 -170.74 32.7 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -47.23 -35.69 7.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.147 -1.208 . . . . 0.0 110.665 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -132.96 130.39 39.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.223 -0.923 . . . . 0.0 109.705 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.413 ' CG1' HD23 ' A' ' 80' ' ' LEU . 99.4 t -94.64 81.59 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.072 -1.018 . . . . 0.0 111.196 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.21 116.74 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.413 HD23 ' CG1' ' A' ' 78' ' ' VAL . 3.8 mp -124.54 108.49 12.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.959 -1.088 . . . . 0.0 112.108 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.26 129.15 38.56 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.453 HG11 ' CB ' ' A' ' 2' ' ' ARG . 2.8 p -129.02 145.38 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.855 -1.153 . . . . 0.0 112.602 -177.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -111.51 83.77 1.83 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.591 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -49.31 119.39 3.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.469 -0.77 . . . . 0.0 111.645 -177.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.8 mmt -101.21 47.32 0.91 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.6 tptt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.318 -179.449 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.544 ' CD ' ' CD2' ' A' ' 64' ' ' HIS . 12.0 mttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.319 0.58 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . 0.439 ' CA ' ' HG2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER 54.92 49.71 17.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.015 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.423 ' O ' ' CB ' ' A' ' 17' ' ' SER . 26.5 t -54.24 -175.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 110.526 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.537 ' CD2' ' CE1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -149.95 73.31 1.16 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.375 -0.828 . . . . 0.0 110.381 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.168 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.272 0.558 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.449 ' CB ' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -155.19 162.4 40.95 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.217 -0.927 . . . . 0.0 110.506 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.93 109.92 6.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.438 -0.789 . . . . 0.0 109.295 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.441 ' CG1' ' HB2' ' A' ' 44' ' ' ALA . 89.6 t -115.49 152.87 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.029 -1.045 . . . . 0.0 110.846 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.6 m -132.79 114.94 14.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 109.564 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.409 ' HB ' ' HB ' ' A' ' 78' ' ' VAL . 86.2 t -102.82 118.67 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.086 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.1 mtm180 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.934 179.999 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.023 0.44 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.431 ' CA ' HD23 ' A' ' 37' ' ' LEU . . . 57.88 90.17 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 tt -176.78 118.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.204 -1.174 . . . . 0.0 110.226 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' B' ' 5' ' ' SER . 1.1 t -112.4 100.24 8.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.182 -0.949 . . . . 0.0 109.783 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.478 ' CD1' ' CG2' ' A' ' 68' ' ' VAL . 9.8 pt -77.63 150.48 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 110.693 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -136.18 123.24 21.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 110.103 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.75 -140.44 8.69 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.432 ' CA ' ' HB2' ' A' ' 64' ' ' HIS . . . 138.99 148.11 5.22 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -14.11 24.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -1.08 . . . . 0.0 110.844 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -9.08 57.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.921 -1.112 . . . . 0.0 110.559 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -130.32 26.28 5.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.043 -1.036 . . . . 0.0 110.12 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.5 mttp 54.72 40.88 32.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.312 -0.868 . . . . 0.0 110.157 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.459 ' CE ' ' HD2' ' A' ' 27' ' ' PRO . 6.2 mmm -120.88 124.77 27.33 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.377 -0.827 . . . . 0.0 110.034 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.459 ' HD2' ' CE ' ' A' ' 26' ' ' MET . 49.6 Cg_endo -70.21 52.66 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 O-C-N 123.348 1.183 . . . . 0.0 111.745 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.444 ' CG2' HD11 ' A' ' 18' ' ' ILE . 18.0 mm 43.53 89.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.084 -1.01 . . . . 0.0 110.096 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.469 HD13 ' N ' ' A' ' 49' ' ' ASP . 32.7 tp -102.41 126.78 49.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.886 -1.134 . . . . 0.0 112.072 -178.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 56.7 mt -62.08 135.81 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.463 -0.773 . . . . 0.0 109.633 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.4 t -121.91 -18.49 7.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 110.963 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.89 106.48 4.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.002 -1.061 . . . . 0.0 110.702 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.451 ' CG2' ' HB2' ' A' ' 40' ' ' ASP . 16.8 mm -94.77 109.78 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 0.0 109.265 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.528 ' CZ ' ' CD1' ' B' ' 6' ' ' LEU . 88.6 m-85 -71.54 128.15 34.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -73.83 173.08 10.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -0.939 . . . . 0.0 110.666 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.23 29.65 69.13 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -138.26 159.42 42.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -1.163 . . . . 0.0 110.941 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -44.44 -62.42 1.18 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.628 -0.67 . . . . 0.0 111.604 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 45' ' ' LEU . . . -47.82 -57.76 5.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.179 -0.95 . . . . 0.0 110.99 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.451 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 12.8 t70 -75.47 0.51 16.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.998 -1.064 . . . . 0.0 111.332 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -104.66 -2.44 25.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.75 -1.219 . . . . 0.0 110.865 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.2 t -98.67 14.82 27.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.842 -1.161 . . . . 0.0 110.662 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 47.62 49.31 16.38 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.11 -0.993 . . . . 0.0 110.649 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.478 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -169.11 -43.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 110.206 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.438 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -68.17 80.1 0.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 108.83 179.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.586 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.23 153.67 26.75 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.594 -0.692 . . . . 0.0 110.043 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.426 ' N ' HG13 ' A' ' 33' ' ' ILE . 96.1 t -52.66 168.35 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.075 -1.015 . . . . 0.0 110.362 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 30.28 68.33 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.483 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 45.6 m-20 -114.92 99.9 7.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -1.036 . . . . 0.0 111.059 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . . . -79.07 107.58 11.93 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.092 -1.005 . . . . 0.0 109.718 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.444 HG23 ' CG1' ' A' ' 54' ' ' VAL . 52.2 mt -76.49 138.66 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.441 -0.787 . . . . 0.0 110.683 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.423 ' CD2' ' O ' ' A' ' 50' ' ' ALA . 3.9 mm? -127.35 7.23 6.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.153 -0.967 . . . . 0.0 110.82 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 176.08 99.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.87 -1.144 . . . . 0.0 109.765 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.483 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 23.1 m -91.1 121.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.138 -0.976 . . . . 0.0 110.36 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' A' ' 79' ' ' VAL . 3.8 m120 60.37 36.29 20.45 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.096 -1.002 . . . . 0.0 110.274 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.3 11.42 85.34 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.2 tp10 -96.79 92.34 6.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.882 -1.363 . . . . 0.0 109.429 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -40.89 103.96 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.562 0.696 . . . . 0.0 111.31 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.455 HD13 ' CB ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -92.99 -13.53 28.6 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.61 -0.681 . . . . 0.0 110.499 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.2 p -54.9 -37.64 66.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.004 . . . . 0.0 110.135 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 m -96.96 23.42 7.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -0.935 . . . . 0.0 110.264 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.448 ' CB ' HD11 ' A' ' 59' ' ' LEU . . . -117.59 155.43 29.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 110.171 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.9 p -85.54 172.6 10.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.314 -0.866 . . . . 0.0 110.18 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.54 ' CE1' ' CB ' ' B' ' 3' ' ' LYS . 4.0 t60 -53.62 -25.74 18.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.107 -0.996 . . . . 0.0 109.786 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -75.87 -40.91 53.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.017 -1.052 . . . . 0.0 109.27 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -65.25 -22.43 66.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.527 -0.733 . . . . 0.0 109.87 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.455 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -83.98 -40.58 18.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.298 -0.877 . . . . 0.0 110.658 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.504 HG22 ' CD2' ' A' ' 64' ' ' HIS . 9.4 t -74.49 -28.37 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.205 -0.935 . . . . 0.0 109.26 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -65.54 -37.88 88.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.342 -0.849 . . . . 0.0 110.093 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.483 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -70.06 -37.28 75.46 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.12 -0.988 . . . . 0.0 109.125 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.8 mt -73.81 -19.95 60.6 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.648 -0.658 . . . . 0.0 109.808 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -80.88 -45.0 17.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.904 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -106.22 30.83 5.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.366 -0.834 . . . . 0.0 109.99 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.436 HG22 ' CG1' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -65.64 142.66 57.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.845 . . . . 0.0 109.972 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.86 -179.98 40.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -49.9 -50.92 44.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.363 -1.081 . . . . 0.0 110.688 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -88.86 92.87 9.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.908 -1.12 . . . . 0.0 109.133 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.445 ' CG1' HD12 ' A' ' 80' ' ' LEU . 78.3 t -83.06 78.63 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.189 -0.944 . . . . 0.0 110.903 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.466 ' N ' ' ND2' ' A' ' 55' ' ' ASN . 11.0 t -66.44 124.01 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.445 HD12 ' CG1' ' A' ' 78' ' ' VAL . 2.3 mp -124.21 106.14 10.07 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.901 -1.125 . . . . 0.0 111.749 -178.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.2 121.59 16.53 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.449 HG11 ' CB ' ' A' ' 2' ' ' ARG . 2.6 p -127.05 147.95 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.069 -1.02 . . . . 0.0 112.683 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -112.45 88.2 2.76 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.586 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -56.28 126.68 27.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 111.157 -177.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.0 mmt -105.89 54.89 0.69 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.344 -0.847 . . . . 0.0 109.226 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.5 tttt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.224 -179.527 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.54 ' CB ' ' CE1' ' A' ' 64' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.234 0.54 . . . . 0.0 110.178 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 54.29 62.31 2.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -0.862 . . . . 0.0 109.858 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 17' ' ' SER . 3.5 t -73.59 -156.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.241 -0.912 . . . . 0.0 110.62 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.528 ' CD1' ' CZ ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -167.07 89.25 0.34 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.317 -0.864 . . . . 0.0 110.515 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.066 -1.021 . . . . 0.0 110.082 179.738 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 15.5 mtm-85 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.468 0.652 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.458 ' CB ' HG11 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -148.21 164.36 34.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.397 -0.815 . . . . 0.0 110.195 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.43 117.51 18.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 109.461 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.454 ' CG1' ' HB2' ' A' ' 44' ' ' ALA . 53.3 t -129.63 126.95 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.05 -1.031 . . . . 0.0 110.521 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.1 m -119.79 130.81 55.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.364 -0.835 . . . . 0.0 109.674 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.2 t -117.21 111.1 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.783 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.016 -179.864 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 39' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.207 0.527 . . . . 0.0 110.283 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 37' ' ' LEU . . . 65.23 76.19 0.34 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.423 HD13 ' CD2' ' A' ' 45' ' ' LEU . 4.2 tt -166.24 117.18 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -1.055 . . . . 0.0 109.698 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' ' 32' ' ' LYS . 1.2 t -107.29 92.31 4.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.09 -1.006 . . . . 0.0 109.933 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.452 ' CD1' HG21 ' A' ' 68' ' ' VAL . 45.2 pt -69.04 146.67 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.199 -0.938 . . . . 0.0 110.886 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' CB ' ' HB2' ' A' ' 31' ' ' SER . 21.5 tttt -135.41 117.32 15.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.495 -0.753 . . . . 0.0 109.728 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.06 -155.37 26.44 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.92 135.66 2.03 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -14.47 29.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -1.12 . . . . 0.0 110.698 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.7 2.2 34.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.838 -1.164 . . . . 0.0 110.23 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -138.35 26.77 2.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.517 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.07 74.15 0.38 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.0 109.965 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.442 ' HE2' ' CD1' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -161.82 120.43 1.42 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 110.649 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 53.6 Cg_endo -72.63 52.85 2.14 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 O-C-N 123.508 1.267 . . . . 0.0 111.408 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.4 mm 43.45 87.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 120.998 -1.064 . . . . 0.0 110.666 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.442 ' CD1' ' HE2' ' A' ' 26' ' ' MET . 6.0 mt -97.33 132.32 43.18 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.672 -1.268 . . . . 0.0 111.663 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.476 HG23 HD11 ' A' ' 30' ' ' ILE . 57.4 mt -65.64 137.17 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.248 -0.907 . . . . 0.0 108.628 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.436 ' HB2' ' CB ' ' A' ' 19' ' ' LYS . 3.1 t -119.73 -29.58 4.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.046 -1.034 . . . . 0.0 110.715 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -133.45 101.43 5.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 110.601 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.44 ' CD1' HG23 ' A' ' 30' ' ' ILE . 10.2 mm -87.69 106.11 15.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.482 ' CE1' HD11 ' B' ' 6' ' ' LEU . 5.3 m-85 -59.24 123.1 15.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.509 -0.745 . . . . 0.0 110.219 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.417 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -75.21 146.18 41.4 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.228 -0.92 . . . . 0.0 110.563 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.74 0.75 81.84 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.447 ' CB ' ' HA3' ' A' ' 15' ' ' GLY . 4.0 mm? -100.7 163.07 12.5 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.942 -1.328 . . . . 0.0 110.26 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -47.09 -55.5 8.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.364 -0.835 . . . . 0.0 110.775 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.489 ' CB ' ' CD2' ' A' ' 45' ' ' LEU . . . -51.38 -47.67 62.8 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.363 -0.835 . . . . 0.0 111.024 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.432 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 13.8 t70 -86.72 3.43 44.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.157 -0.964 . . . . 0.0 111.267 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -103.58 4.56 35.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.815 -1.178 . . . . 0.0 110.783 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.9 t -107.66 14.65 25.44 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.854 -1.154 . . . . 0.0 110.712 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 45.4 56.79 5.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.263 -0.898 . . . . 0.0 111.068 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.492 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . . . -170.57 -48.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.109 -0.994 . . . . 0.0 110.315 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.489 ' CD2' ' CB ' ' A' ' 39' ' ' ALA . 3.5 tp -70.45 84.58 0.59 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.831 -1.168 . . . . 0.0 108.489 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -111.04 147.44 34.77 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.758 -0.589 . . . . 0.0 110.039 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.412 ' N ' HG13 ' A' ' 33' ' ' ILE . 52.0 t -47.35 147.47 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.274 -0.891 . . . . 0.0 110.3 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.32 26.85 26.99 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.421 -1.872 . . . . 0.0 108.421 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.478 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 58.2 m-20 -110.26 106.82 16.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.524 -0.986 . . . . 0.0 110.384 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.455 ' CB ' ' HG2' ' A' ' 27' ' ' PRO . . . -84.41 108.95 17.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.938 . . . . 0.0 109.593 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.461 HD11 HG22 ' A' ' 51' ' ' ILE . 63.8 mt -76.57 136.31 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 111.042 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.431 ' N ' HD21 ' A' ' 52' ' ' LEU . 4.2 mm? -124.63 15.5 8.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.476 -0.765 . . . . 0.0 109.886 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 4.6 t 176.81 135.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 108.967 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.479 HG23 ' CB ' ' A' ' 70' ' ' ALA . 1.2 m -128.68 118.15 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.041 -1.037 . . . . 0.0 110.497 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 54.72 37.91 29.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.332 -0.855 . . . . 0.0 110.554 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.75 26.93 40.07 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 53' ' ' SER . 47.7 mt-10 -118.93 93.19 4.01 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.081 -1.247 . . . . 0.0 110.173 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -44.96 111.79 0.36 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.448 -0.783 . . . . 0.0 110.93 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.454 HD11 ' CB ' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -101.48 17.18 23.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.508 -0.745 . . . . 0.0 110.658 -179.385 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 t -66.3 -50.37 63.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 0.0 110.29 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.28 36.62 1.57 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.066 -1.021 . . . . 0.0 110.48 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.454 ' CB ' HD11 ' A' ' 59' ' ' LEU . . . -116.46 149.44 39.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.957 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.8 p -83.09 171.58 13.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 0.0 110.418 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.489 ' CD2' HG22 ' A' ' 68' ' ' VAL . 8.7 t60 -56.61 -23.45 41.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.231 -0.918 . . . . 0.0 109.91 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.91 -42.83 31.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 109.447 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -65.65 -21.16 66.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.349 -0.844 . . . . 0.0 109.784 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.449 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -84.5 -45.41 12.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.371 -0.831 . . . . 0.0 110.53 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.489 HG22 ' CD2' ' A' ' 64' ' ' HIS . 6.0 t -67.03 -31.48 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.124 -0.985 . . . . 0.0 109.186 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -42.04 82.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.401 -0.812 . . . . 0.0 109.444 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 54' ' ' VAL . . . -67.93 -46.0 72.74 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.115 -0.991 . . . . 0.0 108.741 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.444 ' HB3' ' CG1' ' B' ' 7' ' ' VAL . 3.8 mm? -52.88 -29.79 30.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.672 -0.643 . . . . 0.0 109.697 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HG2' HG12 ' B' ' 7' ' ' VAL . 7.8 mttm -82.19 -40.15 22.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.242 -0.911 . . . . 0.0 110.24 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -110.59 34.66 3.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 110.117 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.435 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 21.3 p -51.97 -79.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 0.0 110.309 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.39 -176.99 25.96 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -50.59 -41.04 54.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.206 -1.173 . . . . 0.0 110.169 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 3.7 pt-20 -117.61 112.64 20.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.852 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.426 HG11 ' CD2' ' A' ' 80' ' ' LEU . 53.1 t -84.94 83.66 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.076 -1.015 . . . . 0.0 110.407 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.1 t -76.1 116.68 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.426 ' CD2' HG11 ' A' ' 78' ' ' VAL . 14.8 mt -125.06 116.45 22.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.842 -1.161 . . . . 0.0 111.523 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -74.19 122.57 22.99 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.458 HG11 ' CB ' ' A' ' 2' ' ' ARG . 3.1 p -119.21 144.63 27.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.543 -177.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -110.15 90.06 3.2 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.58 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -55.21 125.12 19.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.448 -0.783 . . . . 0.0 111.067 -177.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.4 mmm -116.3 51.91 0.95 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.462 -0.774 . . . . 0.0 109.41 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.7 pttt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.256 -179.605 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.469 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 14.9 tttt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.211 0.529 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -112.68 97.88 6.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.215 -0.928 . . . . 0.0 110.02 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 33.1 m -103.99 133.07 49.57 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.201 -0.937 . . . . 0.0 110.398 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.482 HD11 ' CE1' ' A' ' 34' ' ' PHE . 41.0 tp -105.92 108.35 19.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -0.863 . . . . 0.0 110.207 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 71' ' ' LEU . 40.2 t . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.053 -1.029 . . . . 0.0 110.203 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.304 0.573 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.46 ' CB ' HG11 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -147.85 158.72 44.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.537 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.7 115.26 16.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.215 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.461 ' CG1' ' CB ' ' A' ' 44' ' ' ALA . 37.9 t -132.0 139.32 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.07 -1.018 . . . . 0.0 110.689 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.8 m -128.26 126.54 41.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.311 -0.868 . . . . 0.0 110.271 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.431 HG21 ' CG2' ' A' ' 42' ' ' THR . 98.2 t -106.07 126.37 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.047 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 110.203 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.118 0.485 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.458 ' HA3' ' CG ' ' A' ' 37' ' ' LEU . . . 64.86 87.53 0.05 OUTLIER Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.426 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -178.8 121.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.113 -1.227 . . . . 0.0 110.28 -178.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.49 109.78 21.55 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.464 ' CD1' HG21 ' A' ' 68' ' ' VAL . 27.5 pt -92.05 143.08 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -0.89 . . . . 0.0 111.171 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.69 170.14 11.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.57 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.09 -143.28 15.91 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.438 ' CA ' ' HB2' ' A' ' 64' ' ' HIS . . . 138.43 143.04 4.41 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -14.56 20.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -1.116 . . . . 0.0 110.99 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.14 -20.35 64.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.934 -1.104 . . . . 0.0 110.106 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.73 24.33 7.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 109.726 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.2 tttt 55.58 82.59 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.41 -0.806 . . . . 0.0 110.218 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.456 ' HE1' ' N ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -159.12 127.89 3.03 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 109.879 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.456 ' N ' ' HE1' ' A' ' 26' ' ' MET . 52.9 Cg_endo -70.28 50.61 0.96 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 O-C-N 123.321 1.169 . . . . 0.0 112.376 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.425 ' N ' ' HE3' ' A' ' 26' ' ' MET . 21.0 mm 38.88 88.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.549 0 O-C-N 121.201 -0.937 . . . . 0.0 111.189 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 50' ' ' ALA . 6.1 mt -96.66 133.23 41.44 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.88 -1.138 . . . . 0.0 111.765 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 67.8 mt -65.74 144.25 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 108.806 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.3 t -123.85 -23.88 4.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.925 -1.11 . . . . 0.0 111.252 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.06 95.26 2.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.97 -1.081 . . . . 0.0 111.04 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.444 ' CG2' ' HB2' ' A' ' 40' ' ' ASP . 10.7 mm -77.47 100.24 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.36 -0.837 . . . . 0.0 108.831 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.534 ' CZ ' ' CD1' ' B' ' 6' ' ' LEU . 17.2 m-85 -49.76 137.17 16.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.637 -0.664 . . . . 0.0 110.644 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.426 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 0.9 OUTLIER -79.29 159.0 27.41 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.177 -0.952 . . . . 0.0 110.487 -179.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.58 21.37 27.97 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.458 ' CG ' ' HA3' ' A' ' 15' ' ' GLY . 2.1 mm? -111.09 167.9 9.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -1.191 . . . . 0.0 109.865 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.84 -66.89 0.31 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.139 -0.975 . . . . 0.0 111.164 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 45' ' ' LEU . . . -47.62 -47.25 29.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.253 -0.905 . . . . 0.0 111.108 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.444 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 4.8 t70 -71.88 -11.76 60.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.097 -1.002 . . . . 0.0 110.861 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -105.48 15.87 26.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.828 -1.17 . . . . 0.0 110.547 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.431 ' CG2' HG21 ' A' ' 6' ' ' VAL . 48.3 p -106.06 12.81 29.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.027 -1.045 . . . . 0.0 110.73 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 48.24 44.88 20.0 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.056 -1.027 . . . . 0.0 110.538 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.488 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -174.72 -43.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.551 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.429 ' CB ' ' O ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -66.83 83.37 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.81 -1.181 . . . . 0.0 109.049 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.585 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -114.24 151.39 32.9 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.579 -0.7 . . . . 0.0 110.094 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.426 ' N ' HG13 ' A' ' 33' ' ' ILE . 24.5 t -47.66 169.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.21 -0.931 . . . . 0.0 110.35 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.46 33.77 85.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.423 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 28.4 m-20 -115.16 106.23 13.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.432 -1.04 . . . . 0.0 110.177 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' N ' HD22 ' A' ' 29' ' ' LEU . . . -83.76 108.78 17.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.212 -0.93 . . . . 0.0 110.383 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.426 ' CG2' HG11 ' A' ' 54' ' ' VAL . 60.1 mt -77.67 134.79 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.413 -0.805 . . . . 0.0 110.379 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.451 ' CD1' ' HB2' ' A' ' 27' ' ' PRO . 10.0 mp -126.6 10.14 7.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.877 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 176.31 96.97 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.983 -1.073 . . . . 0.0 110.013 179.06 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.476 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 33.7 m -86.99 118.32 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.858 . . . . 0.0 110.508 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 55.49 33.96 22.07 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.362 -0.836 . . . . 0.0 111.089 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.11 -11.4 72.03 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.555 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 53' ' ' SER . 0.3 OUTLIER -77.53 90.23 3.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.787 -1.42 . . . . 0.0 109.593 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -41.97 106.51 0.06 Allowed 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.557 0.694 . . . . 0.0 111.075 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.446 HD13 ' CB ' ' A' ' 67' ' ' ALA . 0.4 OUTLIER -98.9 -10.32 22.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.546 -0.722 . . . . 0.0 110.92 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.2 p -52.65 -36.53 57.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.02 -1.05 . . . . 0.0 110.296 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 m -113.57 49.34 0.98 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.167 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.429 ' CB ' HD11 ' A' ' 59' ' ' LEU . . . -130.74 149.2 52.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.236 -0.915 . . . . 0.0 110.303 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.9 p -72.41 163.01 28.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.369 -0.832 . . . . 0.0 109.882 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.503 ' CE1' ' CG ' ' B' ' 3' ' ' LYS . 7.7 t60 -54.48 -25.16 23.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.004 -1.06 . . . . 0.0 109.729 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -75.17 -43.93 49.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.063 -1.023 . . . . 0.0 108.796 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -28.83 68.52 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.502 -0.749 . . . . 0.0 109.419 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.446 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -77.51 -49.49 14.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.688 -0.633 . . . . 0.0 110.881 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.475 HG22 ' CD2' ' A' ' 64' ' ' HIS . 3.0 t -66.56 -30.54 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 119.206 -0.998 . . . . 0.0 108.927 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.58 -36.61 71.93 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.308 -0.87 . . . . 0.0 109.202 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.476 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -72.49 -35.76 68.24 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.245 -0.909 . . . . 0.0 109.302 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.446 ' HB3' ' CG1' ' B' ' 7' ' ' VAL . 4.1 mm? -69.18 -29.08 66.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.698 -0.626 . . . . 0.0 109.918 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -79.1 -37.85 37.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.212 -0.93 . . . . 0.0 109.87 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -104.33 33.52 3.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.423 -0.798 . . . . 0.0 109.591 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.438 HG23 ' CG1' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -73.39 138.09 45.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.403 -0.811 . . . . 0.0 110.188 -179.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.99 -178.46 52.4 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -53.31 -62.98 1.3 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -1.126 . . . . 0.0 110.366 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -73.59 90.59 1.78 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.209 -0.932 . . . . 0.0 109.223 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.438 ' CG1' HG23 ' A' ' 74' ' ' THR . 99.2 t -84.33 83.29 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 110.92 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.426 ' O ' ' CD2' ' A' ' 80' ' ' LEU . 9.0 t -74.98 124.92 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.426 ' CD1' HG13 ' A' ' 78' ' ' VAL . 13.0 mt -130.25 118.67 21.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.744 -1.223 . . . . 0.0 111.71 -178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -76.59 121.47 23.24 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.46 HG11 ' CB ' ' A' ' 2' ' ' ARG . 2.7 p -120.28 149.31 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 0.0 112.447 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.418 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -114.54 86.49 2.44 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.611 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.585 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -55.09 118.17 4.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.414 -0.804 . . . . 0.0 111.475 -177.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 mmt -95.98 51.01 1.21 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.319 -0.863 . . . . 0.0 108.769 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.8 tttt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.302 -179.402 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.503 ' CG ' ' CE1' ' A' ' 64' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.376 0.608 . . . . 0.0 110.523 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -58.5 96.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.468 -0.77 . . . . 0.0 110.593 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.401 ' OG ' ' NE2' ' A' ' 64' ' ' HIS . 8.2 m -84.22 -162.15 0.63 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.217 -0.927 . . . . 0.0 110.01 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.534 ' CD1' ' CZ ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -161.6 86.3 0.65 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.068 -1.02 . . . . 0.0 110.326 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 71' ' ' LEU . 39.1 t . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.05 -1.031 . . . . 0.0 109.979 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.53 0.681 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.44 ' CB ' HG11 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -158.78 143.47 15.9 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.483 -0.761 . . . . 0.0 109.614 -179.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.9 ptt-85 -122.28 136.56 54.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.121 -0.987 . . . . 0.0 110.115 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.425 HG12 ' CB ' ' A' ' 44' ' ' ALA . 46.6 t -139.31 134.26 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.103 -0.998 . . . . 0.0 110.538 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.7 m -118.04 125.22 49.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.393 -0.817 . . . . 0.0 110.08 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 78' ' ' VAL . 83.2 t -118.39 129.14 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.353 -0.842 . . . . 0.0 109.185 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.6 mtm-85 . . . . . 0 C--N 1.301 -1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.912 -179.427 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.434 ' CD2' ' HB3' ' A' ' 39' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.033 0.444 . . . . 0.0 110.382 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.44 ' CA ' ' HB2' ' A' ' 34' ' ' PHE . . . 56.48 90.47 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.478 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 0.7 OUTLIER -175.04 123.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.175 -1.191 . . . . 0.0 110.826 -178.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.423 ' HB3' ' CB ' ' A' ' 32' ' ' LYS . 29.7 t -111.07 125.04 53.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 109.403 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 30' ' ' ILE . 42.4 pt -105.0 150.66 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.135 -0.978 . . . . 0.0 110.883 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -133.9 158.97 42.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.377 -0.827 . . . . 0.0 109.848 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.1 -159.86 13.85 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.83 148.25 5.4 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.437 ' CB ' ' HA ' ' A' ' 63' ' ' THR . 10.5 ttp85 -60.46 -14.94 22.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -1.085 . . . . 0.0 110.809 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.63 -19.8 54.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.897 -1.127 . . . . 0.0 110.021 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -111.34 23.08 14.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.266 -0.896 . . . . 0.0 109.932 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 tptp 54.49 54.88 8.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.323 -0.86 . . . . 0.0 110.355 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.454 ' CE ' ' HD2' ' A' ' 27' ' ' PRO . 4.9 mmm -138.05 125.66 13.79 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.218 -0.926 . . . . 0.0 110.233 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.454 ' HD2' ' CE ' ' A' ' 26' ' ' MET . 48.3 Cg_endo -69.53 52.33 0.91 Allowed 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.104 1.203 . . . . 0.0 111.882 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.0 mm 42.96 90.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 121.116 -0.99 . . . . 0.0 110.285 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.448 HD13 ' N ' ' A' ' 49' ' ' ASP . 30.4 tp -98.9 124.97 44.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.887 -1.133 . . . . 0.0 111.785 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 56.2 mt -57.27 142.31 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.47 -0.769 . . . . 0.0 109.671 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.3 -25.9 4.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.136 -0.977 . . . . 0.0 110.904 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' CB ' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -141.11 105.59 4.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.02 -1.05 . . . . 0.0 110.628 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 33' ' ' ILE . 15.9 mm -90.38 115.71 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 109.085 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.523 ' CE1' ' CD2' ' B' ' 6' ' ' LEU . 17.2 m-85 -75.99 136.75 39.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.443 -0.785 . . . . 0.0 109.774 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.68 167.59 18.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.152 -0.968 . . . . 0.0 110.855 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.88 29.01 74.19 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.454 ' CD1' ' HB3' ' A' ' 34' ' ' PHE . 0.5 OUTLIER -137.47 160.23 39.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -1.157 . . . . 0.0 110.834 -179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -44.11 -69.63 0.13 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.495 -0.753 . . . . 0.0 111.935 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.434 ' HB3' ' CD2' ' A' ' 14' ' ' LEU . . . -45.55 -47.65 14.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.482 -0.761 . . . . 0.0 111.532 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.436 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 13.7 t70 -85.18 4.84 32.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.959 -1.088 . . . . 0.0 110.892 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -106.11 -3.14 21.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.822 -1.174 . . . . 0.0 110.835 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 t -99.82 14.71 29.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.922 -1.111 . . . . 0.0 110.643 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 47.43 39.24 8.87 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.043 -1.035 . . . . 0.0 110.904 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.487 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -152.28 -46.38 0.1 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.152 -0.967 . . . . 0.0 110.428 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.478 ' CD2' ' CD1' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -71.69 85.62 0.91 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.781 -1.2 . . . . 0.0 108.649 179.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.602 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.82 156.12 23.44 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.655 -179.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.432 ' N ' HG13 ' A' ' 33' ' ' ILE . 89.3 t -52.04 163.37 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.659 -1.275 . . . . 0.0 109.575 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.59 26.17 66.0 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.481 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 59.5 m-20 -112.94 101.24 9.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.506 -0.996 . . . . 0.0 110.57 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.444 ' CA ' HD11 ' A' ' 29' ' ' LEU . . . -79.4 110.0 14.29 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.369 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.9 mt -78.28 138.81 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.426 -0.796 . . . . 0.0 110.325 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.432 ' CD1' ' HB2' ' A' ' 27' ' ' PRO . 3.3 mp -135.34 15.35 3.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.591 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 14.6 t 175.59 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.409 -0.807 . . . . 0.0 109.267 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.491 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 33.8 m -100.68 122.23 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.253 -0.904 . . . . 0.0 110.96 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 57.43 28.24 15.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.442 -0.786 . . . . 0.0 111.466 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.26 22.46 32.14 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.585 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 53' ' ' SER . 9.1 mt-10 -115.72 93.22 4.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.97 -1.312 . . . . 0.0 109.539 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.42 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.62 0.724 . . . . 0.0 111.438 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.458 HD13 ' CB ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -87.61 -12.65 44.99 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.607 -0.683 . . . . 0.0 110.622 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.3 m -53.09 -31.8 43.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.994 -1.066 . . . . 0.0 110.442 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.61 33.25 3.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.194 -0.941 . . . . 0.0 110.475 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.436 ' CB ' HD11 ' A' ' 59' ' ' LEU . . . -124.7 144.94 49.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 0.0 110.203 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.437 ' HA ' ' CB ' ' A' ' 22' ' ' ARG . 51.1 p -76.9 166.19 23.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 109.835 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.478 ' CD2' ' O ' ' A' ' 64' ' ' HIS . 6.6 t60 -51.59 -25.04 6.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.056 -1.028 . . . . 0.0 110.071 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.69 -44.0 35.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.117 -0.989 . . . . 0.0 109.057 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.59 -22.34 66.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.387 -0.821 . . . . 0.0 109.499 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.458 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -80.6 -46.91 14.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.388 -0.82 . . . . 0.0 110.44 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.469 HG22 ' CD2' ' A' ' 64' ' ' HIS . 10.4 t -64.73 -29.82 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.99 -31.01 69.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.351 -0.843 . . . . 0.0 109.468 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.491 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -74.25 -33.31 63.27 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.276 -0.89 . . . . 0.0 109.679 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.438 ' HB3' ' CG1' ' B' ' 7' ' ' VAL . 4.4 mm? -72.02 -26.38 62.19 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.537 -0.727 . . . . 0.0 109.782 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.4 -41.36 24.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.251 -0.906 . . . . 0.0 109.939 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -93.63 23.21 4.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.678 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.477 ' CG2' ' CG2' ' A' ' 78' ' ' VAL . 74.4 m -54.83 129.86 38.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.394 -0.816 . . . . 0.0 110.16 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.79 176.91 46.32 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.82 -46.03 50.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -1.146 . . . . 0.0 110.517 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -90.94 106.15 18.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.026 -1.047 . . . . 0.0 109.092 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.477 ' CG2' ' CG2' ' A' ' 74' ' ' THR . 20.3 t -97.5 82.0 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.132 -0.98 . . . . 0.0 111.15 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.8 t -78.64 108.2 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 mp -114.82 112.22 22.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.78 -1.2 . . . . 0.0 112.529 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -74.89 124.48 26.96 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.44 HG11 ' CB ' ' A' ' 2' ' ' ARG . 2.2 p -127.53 147.6 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.949 -1.095 . . . . 0.0 111.768 -177.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -107.75 87.4 2.49 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.602 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -59.51 114.08 2.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.505 -0.747 . . . . 0.0 110.788 -177.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 mmm -93.62 59.95 2.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.883 . . . . 0.0 109.756 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.0 tttt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.285 -179.81 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.459 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 8.9 tttt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.236 0.541 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -117.88 86.23 2.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 110.196 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.04 -169.44 2.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.209 -0.932 . . . . 0.0 110.258 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.523 ' CD2' ' CE1' ' A' ' 34' ' ' PHE . 2.5 tm? -160.51 106.75 1.5 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 110.122 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 71' ' ' LEU . 61.6 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.163 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 121.225 0.536 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.447 ' CB ' HG11 ' A' ' 82' ' ' VAL . 1.6 tpt180 -167.6 143.92 4.17 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.321 -0.862 . . . . 0.0 109.74 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -119.98 136.75 54.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.09 -1.006 . . . . 0.0 110.29 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.438 ' CG1' ' HB2' ' A' ' 44' ' ' ALA . 54.9 t -142.75 159.6 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.968 . . . . 0.0 110.528 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.0 m -146.73 143.38 28.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.356 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.7 t -130.28 118.03 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.334 -0.854 . . . . 0.0 109.804 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.851 179.734 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.179 0.514 . . . . 0.0 110.51 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.458 ' HA3' ' HG ' ' A' ' 37' ' ' LEU . . . 66.6 91.71 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.437 ' CD1' HD12 ' A' ' 30' ' ' ILE . 2.2 tt -179.15 119.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.094 -1.239 . . . . 0.0 110.56 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.427 ' HB3' ' HB3' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -105.71 91.48 3.77 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.24 -0.913 . . . . 0.0 109.177 178.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 30' ' ' ILE . 25.2 pt -69.16 155.35 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 111.131 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.11 175.2 9.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.089 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.61 -154.97 19.36 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 157.57 134.53 1.76 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.452 ' CB ' ' HA ' ' A' ' 63' ' ' THR . 7.2 ttp85 -60.07 -15.47 23.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.4 -1.059 . . . . 0.0 110.762 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.61 -15.15 61.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.856 -1.152 . . . . 0.0 109.813 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.93 22.15 11.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.16 -0.962 . . . . 0.0 109.663 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.67 58.16 5.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.888 . . . . 0.0 109.842 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.447 ' HE1' ' N ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -138.7 132.59 16.35 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.935 -179.454 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.447 ' N ' ' HE1' ' A' ' 26' ' ' MET . 46.3 Cg_endo -68.83 132.31 24.57 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 N-CA-C 108.332 -1.449 . . . . 0.0 108.332 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.458 HG13 ' CB ' ' A' ' 67' ' ' ALA . 17.4 mm -48.77 97.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.055 -1.028 . . . . 0.0 109.591 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 39.9 tp -101.24 128.73 47.23 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.438 -0.789 . . . . 0.0 112.149 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 64.0 mt -63.91 139.23 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.601 -0.687 . . . . 0.0 110.18 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.2 t -121.83 -25.3 5.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 110.641 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -137.25 108.83 6.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.088 -1.007 . . . . 0.0 110.501 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG13 ' N ' ' A' ' 47' ' ' VAL . 10.5 mm -94.64 105.55 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.13 -0.981 . . . . 0.0 108.853 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.516 ' CZ ' ' CD1' ' B' ' 6' ' ' LEU . 4.2 m-85 -56.75 134.41 54.9 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.274 0.559 . . . . 0.0 110.495 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -80.76 158.64 25.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.184 -0.947 . . . . 0.0 110.36 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.49 19.29 47.31 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.458 ' HG ' ' HA3' ' A' ' 15' ' ' GLY . 2.4 mm? -109.91 167.48 10.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.18 -1.188 . . . . 0.0 109.698 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.53 -65.84 0.54 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.013 -1.054 . . . . 0.0 110.96 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.436 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . -47.58 -37.7 12.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.309 -0.869 . . . . 0.0 111.284 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.431 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 9.3 t70 -86.62 -6.78 58.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.038 -1.039 . . . . 0.0 111.047 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -97.85 -1.86 42.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.825 -1.172 . . . . 0.0 110.911 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.6 t -97.81 13.61 29.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.839 -1.163 . . . . 0.0 110.708 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 45.52 59.18 3.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.316 -0.865 . . . . 0.0 111.141 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.484 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -174.1 -49.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.153 -0.967 . . . . 0.0 110.128 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.437 ' CD2' HD12 ' A' ' 30' ' ' ILE . 1.7 mt -70.95 84.02 0.68 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.933 -1.104 . . . . 0.0 108.303 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.597 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -111.0 153.13 25.99 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.879 -0.513 . . . . 0.0 110.083 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.435 ' N ' HG13 ' A' ' 33' ' ' ILE . 91.7 t -50.26 152.26 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.833 -1.167 . . . . 0.0 109.767 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.79 26.06 39.46 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.544 -1.823 . . . . 0.0 108.544 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.486 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 67.6 m-20 -111.53 100.08 8.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.396 -1.061 . . . . 0.0 110.627 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . . . -77.9 110.38 12.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.095 -1.003 . . . . 0.0 110.67 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 61.6 mt -79.29 134.64 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 110.232 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -125.64 10.95 7.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.258 -0.902 . . . . 0.0 110.439 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 175.99 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.031 -1.043 . . . . 0.0 109.765 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.443 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 27.5 m -76.24 126.46 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.365 -0.834 . . . . 0.0 110.847 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 79' ' ' VAL . 19.0 p30 37.19 40.45 0.18 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.57 -7.18 63.37 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.565 -1.302 . . . . 0.0 111.142 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.432 ' CB ' HG21 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -89.81 91.9 8.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.671 -1.488 . . . . 0.0 109.848 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -44.33 112.16 0.38 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.381 0.61 . . . . 0.0 110.888 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.449 HD13 ' CB ' ' A' ' 67' ' ' ALA . 0.9 OUTLIER -101.8 -5.97 24.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.323 -0.86 . . . . 0.0 110.962 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.5 m -55.36 -32.65 62.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.875 -1.141 . . . . 0.0 110.287 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.3 m -113.13 35.64 3.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.092 -1.005 . . . . 0.0 110.345 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.433 ' CB ' ' CD1' ' A' ' 59' ' ' LEU . . . -121.5 152.8 38.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.178 -0.951 . . . . 0.0 110.193 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.452 ' HA ' ' CB ' ' A' ' 22' ' ' ARG . 18.0 p -81.79 165.13 21.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.857 . . . . 0.0 109.87 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' A' ' 64' ' ' HIS . 6.1 t60 -52.55 -26.15 12.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.014 -1.054 . . . . 0.0 109.903 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.63 -45.73 51.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.052 -1.03 . . . . 0.0 108.923 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -61.26 -23.01 65.35 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.597 -0.689 . . . . 0.0 109.4 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.458 ' CB ' HG13 ' A' ' 28' ' ' ILE . . . -80.42 -47.22 14.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.788 . . . . 0.0 110.319 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.457 HG21 ' CD1' ' A' ' 18' ' ' ILE . 2.6 t -66.3 -33.07 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.481 -0.888 . . . . 0.0 108.773 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -56.25 -41.23 75.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.415 -0.803 . . . . 0.0 109.131 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.443 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -70.91 -26.35 63.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.439 -0.788 . . . . 0.0 109.35 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.432 ' HB3' ' CG1' ' B' ' 7' ' ' VAL . 3.5 mm? -80.6 -34.57 35.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.628 -0.67 . . . . 0.0 110.082 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -75.93 -33.87 59.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.064 -1.023 . . . . 0.0 110.125 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -112.07 36.27 3.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.631 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.425 ' CG2' HG23 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -71.42 137.65 48.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.391 -0.818 . . . . 0.0 110.077 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.18 -177.95 34.44 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -55.45 -76.61 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -1.158 . . . . 0.0 110.022 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -63.91 101.56 0.39 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.095 -1.003 . . . . 0.0 109.466 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.432 HG11 ' CD2' ' A' ' 80' ' ' LEU . 94.5 t -96.61 82.78 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 111.32 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 55' ' ' ASN . 35.0 t -80.26 113.73 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.432 ' CD2' HG11 ' A' ' 78' ' ' VAL . 13.0 mt -117.42 125.03 50.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.956 -1.09 . . . . 0.0 111.917 -177.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.78 125.39 29.28 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.447 HG11 ' CB ' ' A' ' 2' ' ' ARG . 1.8 p -126.03 147.94 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.993 -1.067 . . . . 0.0 111.749 -177.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.2 85.79 2.18 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.597 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -55.62 118.58 4.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.433 -0.792 . . . . 0.0 110.957 -177.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.9 mmm -96.76 49.58 1.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.184 -0.948 . . . . 0.0 109.401 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.8 tptt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.236 -179.669 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.43 ' HB3' ' ND1' ' A' ' 64' ' ' HIS . 32.2 tttt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.282 0.563 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 3.4 tt0 -153.87 138.31 16.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 110.032 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.403 ' CB ' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -126.59 -163.37 1.23 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.192 -0.942 . . . . 0.0 110.419 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 34' ' ' PHE . 1.4 tp -159.16 56.57 0.41 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.321 -0.862 . . . . 0.0 110.187 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 71' ' ' LEU . 53.4 t . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.048 -1.032 . . . . 0.0 110.255 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.408 ' O ' ' CG ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.317 0.58 . . . . 0.0 110.257 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.442 ' CB ' HG11 ' A' ' 82' ' ' VAL . 3.9 mtp85 -161.94 170.54 19.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 110.408 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' A' ' 3' ' ' ARG . 0.5 OUTLIER -138.88 116.7 11.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.408 -0.808 . . . . 0.0 109.206 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.442 ' CG1' ' HB2' ' A' ' 44' ' ' ALA . 65.7 t -121.24 136.85 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.992 -1.067 . . . . 0.0 110.841 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.8 m -125.08 126.26 45.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.371 -0.83 . . . . 0.0 109.881 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.404 ' CG2' HD13 ' A' ' 45' ' ' LEU . 89.3 t -121.79 115.35 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.138 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.127 -0.983 . . . . 0.0 109.871 179.872 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.442 ' CD2' ' HB1' ' A' ' 39' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.048 0.451 . . . . 0.0 110.534 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.438 ' CA ' HD23 ' A' ' 37' ' ' LEU . . . 60.61 82.49 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 tt -173.11 120.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.427 -1.043 . . . . 0.0 110.341 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.481 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -112.08 119.38 38.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 109.543 179.152 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' ILE . 21.2 pt -100.72 151.66 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.236 -0.915 . . . . 0.0 111.266 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 pttt -131.04 160.74 33.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 109.643 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.59 -163.78 12.13 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.51 141.0 3.02 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -60.15 -15.59 25.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -1.091 . . . . 0.0 110.695 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -71.93 -16.86 62.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.886 -1.134 . . . . 0.0 109.796 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -125.66 24.18 7.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.246 -0.908 . . . . 0.0 109.706 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.19 92.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.336 -0.852 . . . . 0.0 110.259 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.483 ' HE1' ' N ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -170.92 128.25 0.71 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.904 . . . . 0.0 110.208 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.483 ' N ' ' HE1' ' A' ' 26' ' ' MET . 55.9 Cg_endo -72.82 46.51 1.07 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 O-C-N 123.448 1.236 . . . . 0.0 112.19 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.43 HG22 ' CB ' ' A' ' 67' ' ' ALA . 12.9 mm 44.33 90.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 120.797 -1.189 . . . . 0.0 110.756 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.448 ' CB ' ' HE3' ' A' ' 26' ' ' MET . 5.4 mt -97.28 132.84 42.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.799 -1.188 . . . . 0.0 111.613 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.473 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 54.8 mt -67.63 136.99 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.868 . . . . 0.0 108.854 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.1 -16.27 8.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.955 -1.091 . . . . 0.0 110.997 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.95 100.47 3.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.995 -1.065 . . . . 0.0 110.682 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.437 ' CG2' ' HB2' ' A' ' 40' ' ' ASP . 16.7 mm -86.83 94.12 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.417 -0.802 . . . . 0.0 108.894 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.485 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 4.3 m-30 -52.69 137.04 32.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.475 -0.765 . . . . 0.0 110.0 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -83.75 171.55 13.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.896 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.49 32.4 73.02 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -140.44 162.94 34.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.132 -1.216 . . . . 0.0 111.088 -179.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.43 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . . . -50.04 -56.59 10.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.523 -0.735 . . . . 0.0 111.461 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB1' ' CD2' ' A' ' 14' ' ' LEU . . . -55.67 -35.51 66.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.245 -0.909 . . . . 0.0 112.092 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.437 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 22.0 t70 -95.74 -3.11 46.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.916 -1.115 . . . . 0.0 111.474 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.43 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 1.4 pp0? -110.34 16.98 21.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.728 -1.233 . . . . 0.0 110.354 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.4 t -108.47 14.72 24.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.945 . . . . 0.0 110.777 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 45.5 54.38 7.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.197 -0.94 . . . . 0.0 111.343 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.484 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . . . -175.72 -50.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.127 -0.983 . . . . 0.0 110.445 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.473 ' CD2' ' CD1' ' A' ' 30' ' ' ILE . 1.4 mt -70.51 84.56 0.6 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.871 -1.143 . . . . 0.0 108.92 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.592 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -112.88 152.28 29.46 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.56 -179.399 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.407 ' N ' HG13 ' A' ' 33' ' ' ILE . 60.3 t -47.74 168.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.028 -1.045 . . . . 0.0 110.607 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.8 37.22 92.15 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.477 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 27.8 m-20 -120.89 107.61 12.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.256 -1.143 . . . . 0.0 110.483 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' N ' HD22 ' A' ' 29' ' ' LEU . . . -84.57 105.12 15.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.835 . . . . 0.0 110.147 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.0 mt -71.03 135.95 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.363 -0.835 . . . . 0.0 110.854 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.473 ' CD1' ' HB2' ' A' ' 27' ' ' PRO . 6.5 mp -125.63 6.97 7.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.391 -0.818 . . . . 0.0 110.96 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 176.1 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.97 -1.082 . . . . 0.0 109.978 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.491 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 17.5 m -96.53 119.22 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.134 -0.979 . . . . 0.0 110.865 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 45.8 m-80 57.06 33.52 23.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.53 -0.731 . . . . 0.0 111.573 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.82 12.05 61.07 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.944 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 53' ' ' SER . 10.1 mt-10 -105.46 90.5 3.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.7 -1.47 . . . . 0.0 109.741 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.33 102.01 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.479 0.656 . . . . 0.0 110.977 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.471 ' CD1' ' CB ' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -94.8 -14.04 25.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.429 -0.794 . . . . 0.0 110.703 -179.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.5 p -50.01 -32.62 15.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.004 -1.06 . . . . 0.0 110.437 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 t -107.75 31.41 5.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 109.987 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.471 ' CB ' ' CD1' ' A' ' 59' ' ' LEU . . . -122.43 163.66 19.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.378 -0.826 . . . . 0.0 110.346 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -85.12 165.07 17.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.399 -0.813 . . . . 0.0 110.375 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.554 ' CD2' ' CD ' ' B' ' 3' ' ' LYS . 3.4 t60 -53.72 -26.17 21.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 109.831 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -73.75 -36.58 65.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.081 -1.012 . . . . 0.0 109.335 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.419 ' CB ' ' HB2' ' A' ' 62' ' ' ALA . 1.3 mm-40 -68.86 -22.96 64.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.588 -0.695 . . . . 0.0 109.724 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.458 ' CA ' HD13 ' A' ' 59' ' ' LEU . . . -82.83 -41.05 19.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.299 -0.876 . . . . 0.0 110.545 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.442 HG21 ' CD1' ' A' ' 18' ' ' ILE . 2.9 t -72.85 -32.86 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.152 -0.968 . . . . 0.0 109.372 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -59.65 -38.1 80.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.371 -0.831 . . . . 0.0 109.952 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.491 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -70.45 -53.1 17.73 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.152 -0.967 . . . . 0.0 108.81 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.447 ' HA ' ' CG2' ' A' ' 74' ' ' THR . 96.4 mt -56.78 -22.43 35.89 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.709 -0.619 . . . . 0.0 109.485 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -79.52 -40.42 29.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.859 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 1.5 ttmt -119.11 59.54 0.83 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.405 -0.809 . . . . 0.0 109.869 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.447 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 66.4 p -78.06 -175.04 3.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.324 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.06 -171.46 20.13 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -48.57 -48.37 38.92 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.101 -1.235 . . . . 0.0 110.455 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 12.4 pt-20 -108.73 119.88 40.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.328 -0.857 . . . . 0.0 109.863 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.446 HG11 ' CD2' ' A' ' 80' ' ' LEU . 85.6 t -89.42 82.02 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.176 -0.952 . . . . 0.0 110.721 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.27 107.11 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.446 ' CD2' HG11 ' A' ' 78' ' ' VAL . 14.1 mt -113.34 115.77 28.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.805 -1.184 . . . . 0.0 111.576 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.407 ' CB ' ' OG ' ' A' ' 53' ' ' SER . 5.9 tp10 -67.79 124.59 23.75 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.442 HG11 ' CB ' ' A' ' 2' ' ' ARG . 2.4 p -121.74 141.53 41.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.003 -1.06 . . . . 0.0 112.199 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -107.41 81.3 1.51 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.592 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -50.52 122.19 6.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.576 -0.703 . . . . 0.0 111.191 -178.002 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.405 ' HG3' ' CD2' ' A' ' 29' ' ' LEU . 6.3 mmt -96.39 49.0 1.1 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.281 -0.887 . . . . 0.0 109.023 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.874 -1.06 . . . . 0.0 110.295 -179.512 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.554 ' CD ' ' CD2' ' A' ' 64' ' ' HIS . 1.6 mttm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.32 0.581 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 54.19 41.45 32.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 109.679 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.407 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . 1.3 m -57.28 -169.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.359 -0.838 . . . . 0.0 110.783 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.485 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 39.2 tp -156.71 117.58 3.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.387 -0.821 . . . . 0.0 110.086 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 66.2 t . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.157 179.749 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.44 0.638 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.44 ' HG2' ' CG1' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -161.91 146.61 12.83 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.461 -0.774 . . . . 0.0 109.586 -179.306 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.408 ' N ' ' HG3' ' A' ' 2' ' ' ARG . 1.6 mpp_? -120.59 126.57 50.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 109.927 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.454 ' CG2' HG12 ' A' ' 82' ' ' VAL . 54.5 t -121.51 153.87 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 110.549 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 84.8 m -139.16 109.69 6.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.514 -0.741 . . . . 0.0 109.513 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 78' ' ' VAL . 56.6 t -100.53 125.19 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 0.0 109.813 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.9 mtt-85 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.933 . . . . 0.0 110.29 -179.58 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.431 ' CD2' ' HB3' ' A' ' 39' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.119 0.485 . . . . 0.0 110.464 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.451 ' N ' ' CD2' ' A' ' 37' ' ' LEU . . . 56.9 86.72 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.417 ' CD1' HD22 ' A' ' 45' ' ' LEU . 6.2 tt -174.34 115.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.107 -1.231 . . . . 0.0 110.534 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.22 98.18 7.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.937 . . . . 0.0 109.728 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.476 HG13 ' CE1' ' A' ' 64' ' ' HIS . 44.7 pt -74.55 146.93 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 110.615 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -132.97 116.14 16.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.462 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.11 -160.38 30.78 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.17 134.47 1.65 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -14.85 23.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.465 -1.021 . . . . 0.0 110.807 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.29 5.53 22.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.984 -1.073 . . . . 0.0 110.138 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -140.94 25.65 2.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.093 -1.004 . . . . 0.0 109.463 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 54.75 83.23 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.333 -0.855 . . . . 0.0 109.62 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.452 ' HE2' ' HB2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -169.11 126.92 0.85 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.254 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.417 ' N ' ' HE1' ' A' ' 26' ' ' MET . 56.0 Cg_endo -76.76 45.66 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.459 1.241 . . . . 0.0 111.972 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.42 ' N ' ' HE3' ' A' ' 26' ' ' MET . 19.9 mm 45.07 89.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 O-C-N 120.869 -1.144 . . . . 0.0 110.218 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.477 HD13 ' N ' ' A' ' 49' ' ' ASP . 36.6 tp -103.7 127.58 51.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.853 -1.155 . . . . 0.0 111.751 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 61.8 mt -62.05 136.2 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.464 -0.772 . . . . 0.0 109.734 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 t -120.5 -18.59 7.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.218 -0.926 . . . . 0.0 110.734 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.5 104.77 4.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.972 -1.08 . . . . 0.0 110.517 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.448 ' CG2' ' HB2' ' A' ' 40' ' ' ASP . 10.8 mm -92.56 99.51 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.146 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.541 ' CE1' ' CD2' ' B' ' 6' ' ' LEU . 94.7 m-85 -59.64 136.34 57.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.488 -0.758 . . . . 0.0 110.271 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -80.37 174.49 11.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 110.649 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.77 28.33 62.91 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -136.54 160.45 38.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.106 -1.232 . . . . 0.0 110.726 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.433 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . . . -48.43 -57.71 5.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 111.502 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.481 ' CB ' ' CD2' ' A' ' 45' ' ' LEU . . . -52.04 -45.79 64.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 111.808 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.448 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 7.3 t70 -85.01 -17.29 38.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.913 -1.117 . . . . 0.0 111.623 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.433 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 1.5 pp0? -99.42 13.2 34.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.797 -1.189 . . . . 0.0 110.851 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.0 t -107.84 14.83 25.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.997 -1.064 . . . . 0.0 110.775 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 45.39 49.71 10.32 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.252 -0.905 . . . . 0.0 111.079 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.499 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -167.43 -55.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.585 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.481 ' CD2' ' CB ' ' A' ' 39' ' ' ALA . 2.4 tp -69.43 84.03 0.4 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.853 -1.154 . . . . 0.0 108.683 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.602 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.58 152.55 28.76 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.86 -0.525 . . . . 0.0 109.665 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.416 ' N ' HG13 ' A' ' 33' ' ' ILE . 65.7 t -49.26 153.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.919 -1.113 . . . . 0.0 110.035 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.76 24.08 50.84 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.487 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 69.4 m-20 -109.69 100.38 9.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.398 -1.06 . . . . 0.0 110.675 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . . . -78.28 102.23 7.55 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.152 -0.968 . . . . 0.0 110.022 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 81' ' ' GLU . 69.4 mt -71.03 138.03 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.428 -0.795 . . . . 0.0 110.702 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 83.0 mt -136.32 9.83 3.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.287 -0.883 . . . . 0.0 111.269 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.417 ' OG ' ' CB ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER 179.09 92.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.922 -1.111 . . . . 0.0 109.832 179.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.482 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 33.1 m -91.51 121.04 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.287 -0.883 . . . . 0.0 110.156 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 55.69 36.42 27.19 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.495 -0.753 . . . . 0.0 110.838 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.99 -7.35 78.08 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.743 -1.218 . . . . 0.0 110.388 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -78.63 93.81 4.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.741 -1.447 . . . . 0.0 109.513 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.71 102.87 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.525 0.678 . . . . 0.0 111.021 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.436 HD13 ' CB ' ' A' ' 67' ' ' ALA . 0.5 OUTLIER -91.0 -4.89 56.07 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.5 -0.75 . . . . 0.0 110.556 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 t -58.54 -43.16 89.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 110.242 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.2 m -102.27 35.25 2.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 110.343 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.426 ' CB ' HD11 ' A' ' 59' ' ' LEU . . . -119.29 145.39 46.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 110.274 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.2 p -78.23 168.6 19.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.911 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.527 ' CE1' ' HB3' ' B' ' 3' ' ' LYS . 7.7 t60 -54.51 -24.04 18.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.01 -1.056 . . . . 0.0 109.871 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.25 -43.39 42.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.12 -0.987 . . . . 0.0 109.12 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -65.61 -21.49 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.586 -0.696 . . . . 0.0 109.648 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.436 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -83.54 -47.5 11.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 110.583 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.466 HG22 ' CD2' ' A' ' 64' ' ' HIS . 7.8 t -62.8 -27.14 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.126 -0.983 . . . . 0.0 108.797 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -39.4 81.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.425 -0.797 . . . . 0.0 109.202 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.482 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -62.8 -44.35 96.39 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.355 -0.84 . . . . 0.0 108.849 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.449 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 3.8 mm? -69.7 -23.39 63.42 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -84.27 -42.04 16.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.977 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -100.79 24.33 9.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.0 109.89 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.38 154.23 36.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.916 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.54 -172.01 20.6 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -48.95 -62.32 1.59 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.061 -1.258 . . . . 0.0 110.389 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -83.62 115.92 22.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.083 -1.011 . . . . 0.0 108.639 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.451 ' CG1' ' CD2' ' A' ' 80' ' ' LEU . 71.5 t -109.39 89.85 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.072 -1.018 . . . . 0.0 111.154 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.7 t -76.96 123.46 33.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.451 ' CD2' ' CG1' ' A' ' 78' ' ' VAL . 15.5 mt -128.09 109.33 11.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.822 -1.174 . . . . 0.0 111.64 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.417 ' CB ' ' OG ' ' A' ' 53' ' ' SER . 13.6 tp10 -66.29 129.63 40.47 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.454 HG12 ' CG2' ' A' ' 4' ' ' VAL . 2.4 p -132.68 146.7 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.873 -1.142 . . . . 0.0 112.119 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -107.7 85.09 2.06 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.602 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -55.51 123.53 14.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.741 . . . . 0.0 110.99 -177.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.1 mmt -99.47 51.63 0.94 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.375 -0.828 . . . . 0.0 109.866 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.268 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.527 ' HB3' ' CE1' ' A' ' 64' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.185 0.517 . . . . 0.0 110.355 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 54.6 68.89 0.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.883 . . . . 0.0 110.361 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 39.8 t -66.21 -153.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.097 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.541 ' CD2' ' CE1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -175.81 66.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.115 -0.991 . . . . 0.0 110.328 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.439 ' CG1' ' HB3' ' A' ' 71' ' ' LEU . 46.6 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.236 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.312 0.577 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.446 ' CB ' HG11 ' A' ' 82' ' ' VAL . 1.6 mtp85 -157.15 165.42 36.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.319 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -140.97 112.53 7.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.409 -0.807 . . . . 0.0 109.229 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.445 ' CG2' ' HB2' ' A' ' 44' ' ' ALA . 37.5 t -124.56 152.85 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.039 -1.038 . . . . 0.0 110.529 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.3 m -139.99 143.57 36.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.365 -0.835 . . . . 0.0 110.124 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.5 t -130.75 109.7 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.919 . . . . 0.0 109.849 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.436 ' HD3' ' N ' ' A' ' 7' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 110.159 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.408 ' CD2' HG23 ' A' ' 16' ' ' ILE . 1.4 tt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.28 0.562 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.446 ' HA3' ' HG ' ' A' ' 37' ' ' LEU . . . 70.94 79.93 0.35 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.436 HD11 ' CD1' ' A' ' 45' ' ' LEU . 2.7 tt -176.58 117.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.314 -1.109 . . . . 0.0 109.876 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.1 t -108.69 114.56 28.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.29 -0.881 . . . . 0.0 110.263 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 30' ' ' ILE . 27.2 pt -88.06 153.84 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 110.637 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' B' ' 3' ' ' LYS . 16.4 ttpp -142.83 118.47 10.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.272 -0.893 . . . . 0.0 110.054 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.55 -161.07 32.87 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 169.12 131.95 1.38 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -60.31 -15.34 24.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -1.191 . . . . 0.0 110.71 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.95 -14.02 58.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.94 -1.1 . . . . 0.0 109.977 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.87 24.0 11.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.809 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.1 tttt 54.67 78.81 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.995 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.442 ' HE2' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -161.95 120.77 1.42 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 110.409 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.45 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 50.6 Cg_endo -71.35 52.45 1.55 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 O-C-N 123.514 1.271 . . . . 0.0 111.966 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.427 ' N ' ' HE3' ' A' ' 26' ' ' MET . 6.9 mm 42.57 89.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.09 -1.006 . . . . 0.0 110.574 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 50' ' ' ALA . 6.0 mt -98.66 132.69 43.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.768 -1.208 . . . . 0.0 111.975 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 49.1 mt -66.52 133.53 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.306 -0.872 . . . . 0.0 108.815 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 t -116.79 -16.53 10.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.066 -1.021 . . . . 0.0 110.888 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.02 106.63 4.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.998 -1.064 . . . . 0.0 111.143 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 33' ' ' ILE . 12.2 mm -93.32 115.16 31.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.261 -0.899 . . . . 0.0 108.601 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.486 ' CZ ' HD23 ' B' ' 6' ' ' LEU . 10.0 m-85 -66.82 134.39 52.02 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.405 -0.809 . . . . 0.0 109.988 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.81 151.88 30.05 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.259 -0.9 . . . . 0.0 110.821 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.16 16.5 60.13 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.446 ' HG ' ' HA3' ' A' ' 15' ' ' GLY . 3.2 mm? -105.4 165.3 11.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -1.164 . . . . 0.0 110.298 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -48.42 -63.73 1.0 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.22 -0.925 . . . . 0.0 111.036 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.427 ' O ' ' CG2' ' A' ' 42' ' ' THR . . . -50.45 -53.0 32.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 110.721 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.439 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 24.1 t70 -73.09 -4.93 35.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.026 -1.046 . . . . 0.0 111.152 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -97.01 3.54 51.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.773 -1.205 . . . . 0.0 110.899 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.427 ' CG2' ' O ' ' A' ' 39' ' ' ALA . 7.2 t -107.68 15.17 24.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.805 -1.184 . . . . 0.0 110.781 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 47.31 56.95 6.27 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.12 -0.988 . . . . 0.0 110.954 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.488 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -173.74 -44.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 110.245 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.436 ' CD1' HD11 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -69.09 81.94 0.33 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.975 -1.078 . . . . 0.0 108.687 179.208 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.587 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.21 149.32 32.44 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.601 -0.687 . . . . 0.0 110.231 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.438 ' N ' HG13 ' A' ' 33' ' ' ILE . 84.5 t -49.89 169.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.124 -0.985 . . . . 0.0 110.404 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.61 32.96 75.35 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.479 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 27.6 m-20 -117.95 108.57 15.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.559 -0.965 . . . . 0.0 110.423 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.45 ' CB ' ' HG2' ' A' ' 27' ' ' PRO . . . -85.8 104.69 15.71 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.442 HG22 ' CG1' ' A' ' 54' ' ' VAL . 30.7 mt -70.36 134.05 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.356 -0.84 . . . . 0.0 110.136 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.44 ' CD1' ' HB2' ' A' ' 27' ' ' PRO . 2.4 mp -132.25 17.69 4.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 110.368 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 174.58 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.214 -0.929 . . . . 0.0 109.967 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.469 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 21.2 m -91.08 127.0 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.107 -0.996 . . . . 0.0 109.846 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.3 m120 57.72 38.64 27.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 0.0 110.013 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.83 29.87 70.74 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 53' ' ' SER . 7.4 tt0 -115.81 91.8 3.71 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -1.108 . . . . 0.0 109.579 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' HA ' ' OG ' ' A' ' 53' ' ' SER . 10.3 m-20 -37.91 102.04 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.691 0.758 . . . . 0.0 112.071 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.444 HD11 ' CB ' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -91.48 -13.63 31.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.648 -0.658 . . . . 0.0 110.483 179.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.1 m -53.52 -37.14 62.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.014 -1.054 . . . . 0.0 110.182 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.9 m -96.86 25.88 4.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 110.035 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.444 ' CB ' HD11 ' A' ' 59' ' ' LEU . . . -120.18 157.54 28.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 110.233 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 22' ' ' ARG . 32.0 p -88.95 164.96 14.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 110.081 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.529 ' CD2' ' HD2' ' B' ' 3' ' ' LYS . 2.1 t60 -52.0 -25.76 9.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.953 . . . . 0.0 109.578 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -73.13 -40.19 65.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.096 -1.003 . . . . 0.0 109.082 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -71.06 -25.57 62.69 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.441 -0.787 . . . . 0.0 109.452 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.441 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -76.35 -42.2 45.62 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.445 -0.784 . . . . 0.0 110.0 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.488 HG22 ' CD2' ' A' ' 64' ' ' HIS . 6.3 t -70.47 -30.63 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.189 -0.944 . . . . 0.0 109.08 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -58.87 -40.27 83.87 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.375 -0.828 . . . . 0.0 109.16 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.469 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -68.68 -46.75 68.23 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.355 -0.841 . . . . 0.0 108.814 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.459 ' N ' HD21 ' A' ' 71' ' ' LEU . 3.0 mm? -56.75 -30.13 63.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.681 -0.637 . . . . 0.0 109.63 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.3 -41.52 22.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.1 -1.0 . . . . 0.0 109.983 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -106.58 55.17 0.67 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.667 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 70' ' ' ALA . 33.2 p -79.11 149.14 32.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.323 -0.861 . . . . 0.0 109.657 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.04 -177.63 45.88 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -50.94 47.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.253 -1.145 . . . . 0.0 110.122 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -98.35 94.18 6.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -0.87 . . . . 0.0 109.423 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.8 t -63.72 78.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 111.085 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 77' ' ' GLU . 12.8 t -75.81 123.7 32.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.405 ' CD2' ' O ' ' A' ' 79' ' ' VAL . 13.0 mt -128.98 117.62 21.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.747 -1.22 . . . . 0.0 111.465 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -73.78 125.21 27.61 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.446 HG11 ' CB ' ' A' ' 2' ' ' ARG . 3.0 p -125.72 145.48 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.052 -1.03 . . . . 0.0 112.206 -177.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.53 86.41 2.36 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.587 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -52.91 129.46 30.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.572 -0.705 . . . . 0.0 110.959 -178.121 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.4 mmt -101.29 46.66 0.93 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.292 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.284 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.529 ' HD2' ' CD2' ' A' ' 64' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.29 0.566 . . . . 0.0 110.59 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.8 mt-10 -109.37 -158.89 0.66 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.455 -0.778 . . . . 0.0 109.048 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.85 -48.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.83 -1.169 . . . . 0.0 110.806 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.486 HD23 ' CZ ' ' A' ' 34' ' ' PHE . 13.0 tp 54.6 92.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 109.936 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.028 179.82 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.271 0.558 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.534 ' HD2' ' CD2' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -122.52 147.35 46.47 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.272 -0.892 . . . . 0.0 109.032 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -105.24 106.49 17.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.054 -1.029 . . . . 0.0 110.058 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.424 ' CG1' HD21 ' A' ' 45' ' ' LEU . 61.1 t -107.48 128.86 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.948 . . . . 0.0 110.266 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.0 m -115.28 111.23 20.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 110.125 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.0 t -97.09 118.54 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.846 . . . . 0.0 109.823 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.232 -0.917 . . . . 0.0 110.288 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.213 0.53 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.476 ' CA ' ' HB2' ' A' ' 34' ' ' PHE . . . 58.27 87.46 0.02 OUTLIER Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.6 tt -176.51 117.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.184 -1.186 . . . . 0.0 110.404 -178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.2 t -106.94 117.82 35.06 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.295 -0.878 . . . . 0.0 109.619 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.498 HG13 ' CE1' ' A' ' 64' ' ' HIS . 43.7 pt -94.85 150.26 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 110.817 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -138.49 120.26 15.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 110.183 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.18 -153.43 24.61 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 157.19 134.13 1.71 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -14.77 22.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.374 -1.074 . . . . 0.0 110.547 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' OE2' ' ND2' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -80.32 1.88 26.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.949 -1.094 . . . . 0.0 110.469 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.414 ' ND2' ' OE2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -138.07 26.17 2.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.973 -1.08 . . . . 0.0 109.795 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 54.47 66.99 1.08 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 110.113 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.459 ' CE ' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -149.86 115.89 3.52 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.436 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.459 ' HD2' ' CE ' ' A' ' 26' ' ' MET . 49.2 Cg_endo -68.2 55.38 0.76 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.321 1.347 . . . . 0.0 111.793 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 64' ' ' HIS . 16.0 mm 41.66 88.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 121.286 -0.884 . . . . 0.0 110.446 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 34.3 tp -101.88 126.66 48.83 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.831 -1.168 . . . . 0.0 112.121 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 55.6 mt -64.41 140.88 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.686 -0.634 . . . . 0.0 109.953 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.6 t -128.68 4.14 5.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 110.718 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.416 ' CE ' ' OE2' ' B' ' 4' ' ' GLU . 1.9 ttmt -165.03 99.89 0.75 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.818 -1.176 . . . . 0.0 110.263 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.432 HG13 ' N ' ' A' ' 47' ' ' VAL . 14.4 mm -89.64 111.88 23.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.32 -0.862 . . . . 0.0 109.318 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.487 ' CE1' HD12 ' B' ' 6' ' ' LEU . 16.2 m-85 -74.3 126.83 31.51 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.47 -0.769 . . . . 0.0 109.984 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -75.62 170.54 15.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.312 -0.867 . . . . 0.0 110.548 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.52 26.19 71.77 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.447 ' CD1' ' HB3' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -138.99 159.55 41.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -1.19 . . . . 0.0 110.918 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -42.72 -66.36 0.37 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.648 -0.658 . . . . 0.0 112.128 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 45' ' ' LEU . . . -45.83 -59.3 2.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.316 -0.865 . . . . 0.0 111.354 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.401 ' HB2' HG21 ' A' ' 33' ' ' ILE . 39.7 t0 -71.97 -4.19 27.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.904 -1.123 . . . . 0.0 111.114 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -107.78 11.82 27.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.555 -1.341 . . . . 0.0 110.726 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 t -108.42 15.73 23.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.956 -1.09 . . . . 0.0 110.708 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 47.86 51.08 14.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.07 -1.019 . . . . 0.0 110.846 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.48 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -172.73 -45.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -0.918 . . . . 0.0 110.017 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.436 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -67.26 81.49 0.14 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.017 -1.052 . . . . 0.0 109.344 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -113.21 152.7 29.42 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.479 -0.763 . . . . 0.0 109.978 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.432 ' N ' HG13 ' A' ' 33' ' ' ILE . 86.4 t -50.94 163.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.783 -1.198 . . . . 0.0 109.98 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.0 28.5 62.36 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.449 ' N ' HD13 ' A' ' 29' ' ' LEU . 46.3 m-20 -109.81 98.15 7.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.387 -1.066 . . . . 0.0 110.705 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . . . -75.4 92.61 2.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 0.0 110.282 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 51.6 mt -64.13 136.72 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.386 -0.821 . . . . 0.0 110.191 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.448 ' CD2' ' HB3' ' A' ' 27' ' ' PRO . 10.5 mt -136.11 19.82 3.21 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.375 -0.828 . . . . 0.0 109.591 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.444 ' HB3' ' CB ' ' A' ' 81' ' ' GLU . 22.6 t 177.72 126.46 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.594 -0.691 . . . . 0.0 109.351 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.463 HG23 ' CB ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -124.81 116.68 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 58.58 31.95 21.62 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.481 -0.762 . . . . 0.0 110.643 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.44 23.92 32.61 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 53' ' ' SER . 4.9 tt0 -115.4 88.23 2.83 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.026 -1.279 . . . . 0.0 110.079 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -44.62 101.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.504 -0.748 . . . . 0.0 111.28 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.438 ' CD1' HG21 ' A' ' 54' ' ' VAL . 70.5 mt -81.3 -13.04 58.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 110.358 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 t -48.5 -33.45 9.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.16 -0.963 . . . . 0.0 110.284 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.43 27.97 7.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.353 -0.842 . . . . 0.0 109.591 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.81 149.07 46.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.407 -0.808 . . . . 0.0 110.493 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 p -79.86 166.43 21.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.312 -0.868 . . . . 0.0 109.812 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.498 ' CE1' HG13 ' A' ' 18' ' ' ILE . 2.4 t60 -55.48 -31.83 62.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.082 -1.011 . . . . 0.0 109.854 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.66 -32.43 65.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.824 -1.173 . . . . 0.0 109.547 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -72.65 -28.39 62.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.55 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.08 -41.72 41.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.757 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.46 HG21 ' CD1' ' A' ' 18' ' ' ILE . 7.3 t -63.79 -26.96 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.544 -0.862 . . . . 0.0 108.98 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -36.58 81.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.522 -0.736 . . . . 0.0 109.549 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.463 ' CB ' HG23 ' A' ' 54' ' ' VAL . . . -72.36 -39.89 67.73 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.169 -0.957 . . . . 0.0 109.262 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.428 ' N ' HD21 ' A' ' 71' ' ' LEU . 4.0 mm? -60.64 -29.92 69.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.368 -0.832 . . . . 0.0 108.918 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -84.75 -36.77 21.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.853 . . . . 0.0 110.118 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -106.05 27.34 8.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.974 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -67.29 166.58 14.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.133 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.19 -176.01 21.4 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -51.78 -63.1 1.24 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.204 -1.174 . . . . 0.0 110.4 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -81.8 88.02 6.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.206 -0.934 . . . . 0.0 109.915 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.428 HG13 ' CG ' ' A' ' 80' ' ' LEU . 53.9 t -80.4 90.35 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.932 . . . . 0.0 110.644 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 t -80.68 117.3 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.433 HD21 ' CG1' ' A' ' 54' ' ' VAL . 17.3 mt -122.5 116.02 23.2 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.409 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.444 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 0.8 OUTLIER -74.0 133.51 42.98 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.655 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.498 ' CG1' ' HB2' ' A' ' 2' ' ' ARG . 4.0 p -129.99 153.68 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.95 -1.093 . . . . 0.0 112.519 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.424 ' N ' HG21 ' A' ' 82' ' ' VAL . 2.6 mtpt -115.53 81.55 1.61 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -47.96 121.13 3.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.457 -0.777 . . . . 0.0 111.334 -177.668 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.3 mtt -116.15 52.21 0.92 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.48 -0.762 . . . . 0.0 109.311 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.396 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.48 ' HG2' ' CD2' ' A' ' 64' ' ' HIS . 6.9 tttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.167 0.508 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . 0.416 ' OE2' ' CE ' ' A' ' 32' ' ' LYS . 1.2 tt0 -113.71 70.31 0.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 109.938 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.6 -176.42 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.265 -0.897 . . . . 0.0 110.73 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.487 HD12 ' CE1' ' A' ' 34' ' ' PHE . 21.8 tp -160.15 90.64 0.91 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.443 -0.785 . . . . 0.0 109.855 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' A' ' 71' ' ' LEU . 93.1 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.122 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.267 0.556 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.487 ' HD2' ' CD2' ' A' ' 84' ' ' TYR . 1.1 ttm-85 -152.83 172.65 16.41 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 0.0 109.939 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.84 135.44 14.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.916 . . . . 0.0 109.349 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.448 ' CG2' ' HB2' ' A' ' 44' ' ' ALA . 66.6 t -142.19 137.67 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.05 -1.031 . . . . 0.0 110.997 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.9 m -121.08 114.08 20.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.522 -0.736 . . . . 0.0 109.304 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.421 ' HB ' ' HB ' ' A' ' 78' ' ' VAL . 83.1 t -105.53 119.51 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.123 -0.986 . . . . 0.0 110.826 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.396 -0.815 . . . . 0.0 109.74 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.088 0.47 . . . . 0.0 110.505 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.454 ' N ' ' CD2' ' A' ' 37' ' ' LEU . . . 57.84 89.78 0.01 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.48 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 0.9 OUTLIER -174.92 120.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.237 -1.155 . . . . 0.0 110.316 -179.043 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.416 ' HB3' ' CB ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -110.56 93.62 4.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.253 -0.904 . . . . 0.0 109.755 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.46 ' CD1' HG21 ' A' ' 68' ' ' VAL . 28.9 pt -73.62 148.67 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.378 -0.826 . . . . 0.0 110.557 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -136.88 144.46 43.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.01 . . . . 0.0 110.183 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 136.85 -158.34 24.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 165.89 133.24 1.48 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.432 ' CB ' ' HA ' ' A' ' 63' ' ' THR . 1.9 ttp85 -59.53 -15.64 19.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -1.13 . . . . 0.0 110.64 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -14.2 60.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.946 -1.096 . . . . 0.0 109.922 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.02 24.36 10.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.189 -0.944 . . . . 0.0 109.704 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.39 73.21 0.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 110.166 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.434 ' HE1' ' N ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -150.4 123.96 4.4 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.93 . . . . 0.0 110.317 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.443 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 54.8 Cg_endo -73.04 50.23 1.78 Allowed 'Trans proline' 0 N--CA 1.493 1.448 0 O-C-N 123.35 1.184 . . . . 0.0 111.752 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.0 mm 43.06 89.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.498 0 O-C-N 121.101 -0.999 . . . . 0.0 110.656 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 50' ' ' ALA . 6.1 mt -96.57 132.87 41.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.88 -1.137 . . . . 0.0 111.723 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 30' ' ' ILE . 52.3 mt -67.49 135.55 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.7 t -116.29 -36.04 4.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.062 -1.024 . . . . 0.0 110.815 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.416 ' CB ' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -129.06 105.04 7.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.056 -1.028 . . . . 0.0 110.82 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.434 ' CD1' HG23 ' A' ' 30' ' ' ILE . 10.1 mm -90.45 97.2 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.198 -0.939 . . . . 0.0 109.139 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.535 ' CZ ' ' CD1' ' B' ' 6' ' ' LEU . 96.3 m-85 -61.89 133.86 55.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.476 -0.765 . . . . 0.0 110.529 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -79.06 175.91 10.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.829 . . . . 0.0 110.432 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.61 25.08 60.51 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -134.88 159.42 41.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.144 . . . . 0.0 110.386 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -47.54 -59.06 3.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.382 -0.824 . . . . 0.0 111.17 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.4 -44.55 34.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.279 -0.888 . . . . 0.0 111.334 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.426 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 16.4 t70 -95.87 11.13 34.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 111.092 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -107.12 -4.74 18.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.823 -1.173 . . . . 0.0 110.588 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 t -105.56 14.44 28.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.827 -1.171 . . . . 0.0 110.704 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 46.21 53.85 8.97 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.23 -0.919 . . . . 0.0 110.951 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.489 ' O ' ' CE2' ' A' ' 46' ' ' PHE . . . -160.74 -48.43 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.239 -0.913 . . . . 0.0 110.036 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.48 ' CD2' ' CD1' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -72.64 87.63 1.24 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.843 -1.161 . . . . 0.0 108.0 178.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.589 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -113.2 149.57 33.53 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.133 0.492 . . . . 0.0 110.175 -178.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.413 ' N ' HG13 ' A' ' 33' ' ' ILE . 56.3 t -47.19 154.2 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.048 -1.032 . . . . 0.0 110.331 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.18 28.74 43.68 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.485 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 62.3 m-20 -113.43 103.38 11.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.438 -1.036 . . . . 0.0 110.435 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.447 ' N ' HD22 ' A' ' 29' ' ' LEU . . . -80.29 108.28 13.77 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.186 -0.946 . . . . 0.0 109.295 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.446 HD12 HG22 ' A' ' 51' ' ' ILE . 51.4 mt -75.4 134.55 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 111.085 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.432 ' N ' HD21 ' A' ' 52' ' ' LEU . 4.5 mm? -119.58 14.04 12.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.505 -0.747 . . . . 0.0 109.81 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 1.3 t 178.02 146.33 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 108.997 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.48 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 2.6 m -138.72 125.28 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.985 -1.072 . . . . 0.0 111.186 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.445 ' ND2' ' HA ' ' A' ' 78' ' ' VAL . 6.3 m120 59.12 16.08 4.55 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.411 -0.806 . . . . 0.0 111.233 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.9 24.98 7.02 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.481 ' O ' ' CB ' ' A' ' 53' ' ' SER . 2.4 mm-40 -116.26 166.14 12.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -1.163 . . . . 0.0 108.686 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.16 119.57 39.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.058 -1.026 . . . . 0.0 110.062 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.446 HD13 ' CB ' ' A' ' 67' ' ' ALA . 2.0 mm? -101.1 -9.52 21.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 110.693 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -51.64 -28.87 15.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.972 -1.08 . . . . 0.0 110.483 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.9 m -120.65 46.76 1.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.37 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.427 ' CB ' HD11 ' A' ' 59' ' ' LEU . . . -135.57 157.2 47.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 110.207 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.432 ' HA ' ' CB ' ' A' ' 22' ' ' ARG . 33.7 p -87.94 167.79 13.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.398 -0.814 . . . . 0.0 110.34 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.491 ' CD2' HG22 ' A' ' 68' ' ' VAL . 6.1 t60 -53.69 -24.51 14.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.181 -0.95 . . . . 0.0 109.622 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.37 -39.99 52.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 109.455 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -68.32 -25.87 65.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.482 -0.761 . . . . 0.0 109.623 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.446 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -79.33 -44.32 21.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.345 -0.847 . . . . 0.0 110.38 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.491 HG22 ' CD2' ' A' ' 64' ' ' HIS . 4.0 t -69.06 -30.49 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.064 -1.022 . . . . 0.0 108.745 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.65 -38.07 71.64 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.484 -0.76 . . . . 0.0 109.236 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.48 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -74.02 -25.87 60.11 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.402 -0.811 . . . . 0.0 109.478 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.443 ' HB3' ' CG1' ' B' ' 7' ' ' VAL . 3.6 mm? -75.18 -27.86 59.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.408 -0.808 . . . . 0.0 109.893 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -76.61 -42.5 42.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.907 . . . . 0.0 110.162 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -95.16 22.23 6.96 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.246 -0.909 . . . . 0.0 109.965 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.484 ' CG2' ' CG2' ' A' ' 78' ' ' VAL . 60.2 m -52.91 132.51 37.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 110.518 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.39 178.29 51.65 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -52.99 -32.76 48.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.209 -1.171 . . . . 0.0 110.34 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.427 ' N ' ' HG3' ' A' ' 76' ' ' LYS . 9.3 tt0 -101.81 109.0 20.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 108.983 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.484 ' CG2' ' CG2' ' A' ' 74' ' ' THR . 22.0 t -97.0 82.41 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 0.0 111.052 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.422 ' CG2' ' OE2' ' A' ' 77' ' ' GLU . 3.3 t -78.2 108.48 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.446 ' CD1' HG13 ' A' ' 78' ' ' VAL . 5.7 mp -118.73 109.09 15.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.025 -1.047 . . . . 0.0 112.508 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -71.04 137.9 49.39 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.448 ' CG1' ' HB3' ' A' ' 2' ' ' ARG . 2.2 p -139.22 145.64 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.81 -1.181 . . . . 0.0 112.093 -177.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.75 88.57 2.79 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.589 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -55.62 114.78 2.0 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.463 -0.773 . . . . 0.0 111.151 -177.671 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.4 mtt -100.38 50.93 0.89 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 108.992 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.197 -179.406 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 tttt . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.188 0.518 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 47.2 tt0 -153.66 106.46 2.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.322 -0.861 . . . . 0.0 110.065 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 70.3 m -109.01 131.29 55.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.143 -0.973 . . . . 0.0 110.206 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.535 ' CD1' ' CZ ' ' A' ' 34' ' ' PHE . 0.5 OUTLIER -100.13 96.81 7.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -0.836 . . . . 0.0 110.751 -179.601 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 71' ' ' LEU . 44.5 t . . . . . 0 N--CA 1.492 1.667 0 O-C-N 120.919 -1.113 . . . . 0.0 110.133 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.442 0.639 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.445 ' CB ' HG11 ' A' ' 82' ' ' VAL . 1.7 mtp85 -153.51 168.17 27.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.409 -0.807 . . . . 0.0 110.187 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -135.57 118.83 16.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 0.0 109.384 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 44' ' ' ALA . 60.3 t -124.04 128.85 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.004 -1.06 . . . . 0.0 110.691 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.7 m -118.26 118.8 32.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.453 -0.78 . . . . 0.0 109.768 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.445 ' CG2' HD11 ' A' ' 45' ' ' LEU . 89.7 t -113.73 108.08 24.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.63 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.7 mtm105 . . . . . 0 C--N 1.299 -1.606 0 O-C-N 121.524 -0.735 . . . . 0.0 110.048 -179.481 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.43 ' CD2' ' HB3' ' A' ' 39' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.971 0.415 . . . . 0.0 110.756 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.462 ' N ' ' CD2' ' A' ' 37' ' ' LEU . . . 58.21 83.39 0.05 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.4 tt -175.16 117.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.218 -1.166 . . . . 0.0 110.002 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' B' ' 6' ' ' LEU . 1.2 t -108.44 106.52 16.66 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.131 -0.981 . . . . 0.0 110.089 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.465 ' CD1' HG21 ' A' ' 68' ' ' VAL . 20.4 pt -83.65 145.85 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.406 -0.809 . . . . 0.0 110.275 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.447 ' CG ' ' HB2' ' A' ' 31' ' ' SER . 3.2 ptmt -128.61 153.19 47.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.974 -1.079 . . . . 0.0 109.066 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 127.89 -157.65 21.14 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.274 -1.441 . . . . 0.0 110.338 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 162.22 134.68 1.68 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -16.66 16.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -1.08 . . . . 0.0 110.603 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -14.74 60.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.736 -1.227 . . . . 0.0 110.246 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.3 28.14 7.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.976 . . . . 0.0 110.006 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt 52.48 81.76 0.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.218 -0.926 . . . . 0.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.431 ' HE3' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -160.23 122.46 1.82 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.185 -0.947 . . . . 0.0 110.336 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.441 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 54.3 Cg_endo -72.38 50.95 1.69 Allowed 'Trans proline' 0 N--CA 1.494 1.554 0 O-C-N 123.42 1.221 . . . . 0.0 111.773 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.434 HG22 ' CB ' ' A' ' 67' ' ' ALA . 17.6 mm 42.36 87.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 121.108 -0.995 . . . . 0.0 110.746 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 50' ' ' ALA . 5.9 mt -95.28 134.58 37.89 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.822 -1.174 . . . . 0.0 111.849 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.471 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 59.5 mt -66.95 138.03 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.218 -0.926 . . . . 0.0 108.831 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.447 ' HB2' ' CG ' ' A' ' 19' ' ' LYS . 47.4 t -120.37 -26.29 5.45 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.975 -1.078 . . . . 0.0 110.941 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.84 105.5 5.59 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.069 -1.019 . . . . 0.0 111.019 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.453 HD11 HG21 ' A' ' 33' ' ' ILE . 15.3 mm -90.71 96.97 6.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.53 ' CE1' ' CD2' ' B' ' 6' ' ' LEU . 95.9 m-85 -62.34 134.79 56.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.605 -0.685 . . . . 0.0 110.625 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.17 176.1 9.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.421 -0.8 . . . . 0.0 110.528 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.55 28.62 51.81 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.462 ' CD2' ' N ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -136.42 162.69 32.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -1.162 . . . . 0.0 110.65 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.8 -55.21 24.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.582 -0.699 . . . . 0.0 111.916 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.43 ' HB3' ' CD2' ' A' ' 14' ' ' LEU . . . -56.37 -37.01 69.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.115 -0.99 . . . . 0.0 112.126 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.414 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 17.6 t70 -92.77 -6.23 49.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.807 -1.183 . . . . 0.0 111.615 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.82 15.7 25.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.807 -1.183 . . . . 0.0 110.525 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.9 t -108.91 14.56 24.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.101 -1.0 . . . . 0.0 110.812 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 45.22 48.41 10.11 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.199 -0.938 . . . . 0.0 111.419 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.493 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . . . -169.15 -46.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 0.0 110.471 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.471 ' CD2' ' CD1' ' A' ' 30' ' ' ILE . 2.2 mt -71.66 84.83 0.89 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.812 -1.18 . . . . 0.0 108.568 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.595 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -111.13 151.22 28.39 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.739 -179.198 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.451 ' N ' HG13 ' A' ' 33' ' ' ILE . 98.3 t -50.36 159.14 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.851 -1.156 . . . . 0.0 110.008 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.56 31.11 51.6 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 42.2 m-20 -114.25 104.77 12.42 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.542 -0.975 . . . . 0.0 110.354 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.446 ' N ' HD22 ' A' ' 29' ' ' LEU . . . -82.86 110.58 17.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.151 -0.968 . . . . 0.0 109.761 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 51' ' ' ILE . 71.9 mt -77.28 136.89 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.87 . . . . 0.0 110.891 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.438 ' CD2' ' N ' ' A' ' 52' ' ' LEU . 4.4 mm? -120.43 -0.44 10.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.464 -0.772 . . . . 0.0 110.844 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 2.5 p -178.79 103.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.875 -1.141 . . . . 0.0 109.819 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.503 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 17.1 m -92.46 121.38 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.167 -0.958 . . . . 0.0 110.351 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 57.65 34.2 24.21 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.135 -0.978 . . . . 0.0 110.917 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.96 17.62 67.08 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 53' ' ' SER . 4.8 tt0 -105.01 91.24 3.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.019 -1.283 . . . . 0.0 109.805 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -43.49 99.52 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.523 0.678 . . . . 0.0 111.135 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.468 ' CD1' ' CB ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -92.54 24.88 3.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -0.796 . . . . 0.0 110.292 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 61' ' ' SER . 52.6 p -73.92 -58.71 3.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.147 -0.971 . . . . 0.0 110.397 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.425 ' N ' ' OG ' ' A' ' 60' ' ' SER . 0.8 OUTLIER -80.47 -19.21 46.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 110.096 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.468 ' CB ' ' CD1' ' A' ' 59' ' ' LEU . . . -57.54 167.54 1.01 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.36 -0.837 . . . . 0.0 110.589 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.5 p -100.72 -166.76 1.35 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.398 -0.814 . . . . 0.0 108.98 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.49 ' CE1' ' HG3' ' B' ' 3' ' ' LYS . 7.3 t60 -75.18 -23.6 57.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.006 -1.059 . . . . 0.0 109.981 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.01 -34.76 61.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.961 . . . . 0.0 109.663 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -72.55 -25.55 61.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 109.849 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.451 ' CA ' HD13 ' A' ' 59' ' ' LEU . . . -78.91 -38.88 36.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 110.205 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' A' ' 18' ' ' ILE . 2.9 t -75.03 -37.86 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.216 -0.928 . . . . 0.0 108.806 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -55.47 -38.89 69.69 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.443 -0.786 . . . . 0.0 109.965 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.503 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -70.53 -49.4 48.54 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.112 -0.992 . . . . 0.0 109.107 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.436 ' HA ' ' CG2' ' A' ' 74' ' ' THR . 79.1 mt -61.1 -23.94 65.86 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.656 -0.653 . . . . 0.0 109.666 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -76.11 -37.17 58.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.084 -1.01 . . . . 0.0 109.082 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 17.0 ttmt -121.72 51.07 1.35 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.436 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 58.8 p -52.44 -85.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 110.615 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.432 ' N ' ' OG1' ' A' ' 74' ' ' THR . . . 147.99 -172.81 28.22 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.412 ' CG ' ' N ' ' A' ' 77' ' ' GLU . 3.7 pttt -49.08 -40.28 31.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.247 -1.149 . . . . 0.0 110.441 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 76' ' ' LYS . 25.8 pt-20 -128.58 129.94 46.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.326 -0.859 . . . . 0.0 109.672 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.45 HG13 ' CD1' ' A' ' 80' ' ' LEU . 45.2 t -96.8 79.63 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.036 -1.04 . . . . 0.0 111.12 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.1 t -73.43 112.09 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.45 ' CD1' HG13 ' A' ' 78' ' ' VAL . 4.8 mp -120.34 110.14 16.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.915 -1.116 . . . . 0.0 111.943 -177.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.412 ' CB ' ' OG ' ' A' ' 53' ' ' SER . 1.1 tp10 -69.32 122.7 19.42 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.445 HG11 ' CB ' ' A' ' 2' ' ' ARG . 2.4 p -118.31 146.35 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.092 -1.005 . . . . 0.0 112.19 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -113.18 82.42 1.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.595 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -50.11 127.11 16.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.529 -0.732 . . . . 0.0 111.211 -177.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.3 mtt -121.87 53.78 1.19 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.421 -0.8 . . . . 0.0 109.518 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.484 ' HD2' ' CE2' ' A' ' 84' ' ' TYR . 6.3 mtpp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.287 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.49 ' HG3' ' CE1' ' A' ' 64' ' ' HIS . 3.1 ptmt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.048 0.451 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 19.9 mt-10 -48.82 126.54 12.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.17 -0.956 . . . . 0.0 110.251 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.43 -24.65 10.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.97 -1.081 . . . . 0.0 111.138 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.53 ' CD2' ' CE1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER 59.06 96.75 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.099 -1.001 . . . . 0.0 110.592 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.046 -1.034 . . . . 0.0 110.071 179.516 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.259 0.552 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.443 ' CB ' HG11 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -163.59 147.3 10.33 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.21 -0.931 . . . . 0.0 109.728 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.417 ' N ' ' HG3' ' A' ' 2' ' ' ARG . 21.5 ptt180 -125.53 136.65 53.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.112 -0.992 . . . . 0.0 110.041 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.428 HG22 ' CG1' ' A' ' 82' ' ' VAL . 46.6 t -140.42 157.06 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.102 -0.999 . . . . 0.0 110.567 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.1 m -144.24 125.69 14.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 110.212 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.409 ' HB ' ' HB ' ' A' ' 78' ' ' VAL . 87.7 t -117.75 114.4 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.649 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 -179.675 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.131 0.491 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.473 ' HA3' ' CG ' ' A' ' 37' ' ' LEU . . . 63.38 83.94 0.07 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 tt -176.43 120.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -1.175 . . . . 0.0 109.921 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.488 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -111.53 106.1 14.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.89 . . . . 0.0 109.469 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 30' ' ' ILE . 22.0 pt -82.41 156.54 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.449 -0.782 . . . . 0.0 111.522 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' CB ' ' HB2' ' A' ' 31' ' ' SER . 7.9 ttmm -139.73 119.98 13.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.493 -0.755 . . . . 0.0 109.772 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.71 -159.46 28.09 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.43 ' CA ' ' HB2' ' A' ' 64' ' ' HIS . . . 156.88 140.27 2.91 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.88 -14.64 23.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -1.084 . . . . 0.0 110.713 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -72.73 -19.12 61.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.893 -1.129 . . . . 0.0 110.006 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -123.38 28.22 7.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 109.879 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.24 83.91 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.392 -0.817 . . . . 0.0 110.166 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.445 ' HE3' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -167.39 123.13 0.87 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.29 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.441 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 55.2 Cg_endo -71.61 52.32 1.63 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 O-C-N 123.39 1.205 . . . . 0.0 111.729 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.438 HG22 HD11 ' A' ' 28' ' ' ILE . 13.9 mm 42.39 88.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 O-C-N 121.093 -1.005 . . . . 0.0 110.817 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 50' ' ' ALA . 6.0 mt -97.39 131.6 43.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.757 -1.214 . . . . 0.0 111.89 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.472 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 39.6 mt -67.18 132.22 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.284 -0.885 . . . . 0.0 108.74 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.438 ' HB2' ' CB ' ' A' ' 19' ' ' LYS . 6.9 t -119.51 -10.4 9.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.167 -0.958 . . . . 0.0 111.092 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.38 99.4 2.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.987 -1.071 . . . . 0.0 110.707 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.438 ' CG2' ' HB2' ' A' ' 40' ' ' ASP . 13.4 mm -89.58 95.92 5.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.318 -0.864 . . . . 0.0 108.682 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.49 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 4.8 m-30 -45.02 137.45 4.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.818 -0.551 . . . . 0.0 110.85 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -79.98 158.42 26.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.279 -0.888 . . . . 0.0 110.479 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.27 22.31 29.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.473 ' CG ' ' HA3' ' A' ' 15' ' ' GLY . 1.9 mm? -112.01 168.82 9.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -1.111 . . . . 0.0 109.718 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.1 -70.46 0.11 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.135 -0.978 . . . . 0.0 111.174 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.423 ' HA ' HD11 ' A' ' 45' ' ' LEU . . . -47.1 -24.66 0.7 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.332 -0.855 . . . . 0.0 111.671 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 4.8 t70 -93.91 -31.81 14.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.888 -1.133 . . . . 0.0 110.456 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -87.13 12.0 12.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.062 -1.024 . . . . 0.0 110.491 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.3 p -98.88 6.62 46.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.053 -1.029 . . . . 0.0 110.815 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 49.98 53.83 12.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.864 -1.147 . . . . 0.0 110.818 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.489 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -177.13 -52.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.134 -0.979 . . . . 0.0 110.547 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.472 ' CD2' ' CD1' ' A' ' 30' ' ' ILE . 2.6 mt -69.56 85.96 0.45 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.874 -1.141 . . . . 0.0 108.808 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.606 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -112.59 151.38 30.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.942 -0.474 . . . . 0.0 109.801 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.419 ' N ' HG13 ' A' ' 33' ' ' ILE . 53.7 t -49.1 162.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 120.903 -1.123 . . . . 0.0 110.127 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.07 32.18 58.86 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.786 -1.725 . . . . 0.0 108.786 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.484 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 54.2 m-20 -116.96 104.8 11.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.603 -0.939 . . . . 0.0 110.173 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.45 ' N ' HD22 ' A' ' 29' ' ' LEU . . . -81.94 97.04 7.88 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 110.158 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.422 HD12 HG22 ' A' ' 51' ' ' ILE . 51.4 mt -62.1 135.07 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 0.0 110.155 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.3 mt -132.53 14.0 4.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.465 -0.772 . . . . 0.0 110.217 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 178.96 96.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.505 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.481 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 14.5 m -95.46 126.48 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.216 -0.927 . . . . 0.0 110.452 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.2 m120 59.28 24.4 12.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.382 -0.824 . . . . 0.0 110.609 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.6 30.78 17.62 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.1 mm-40 -123.07 95.58 4.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.134 -1.215 . . . . 0.0 109.647 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.6 97.55 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.561 0.696 . . . . 0.0 111.356 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.48 ' CD1' ' CB ' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -80.58 -8.12 59.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.54 -0.725 . . . . 0.0 110.548 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.8 p -54.36 -36.7 64.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.011 -1.055 . . . . 0.0 110.152 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t -95.39 22.33 7.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 110.108 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.48 ' CB ' ' CD1' ' A' ' 59' ' ' LEU . . . -118.76 161.48 20.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 110.281 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.1 p -91.08 -170.71 2.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 109.926 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.498 ' CE1' ' O ' ' B' ' 3' ' ' LYS . 10.2 t60 -69.07 -23.57 64.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.031 -1.043 . . . . 0.0 109.806 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -77.42 -39.73 45.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.617 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.3 -24.72 67.36 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.424 -0.797 . . . . 0.0 109.953 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.443 ' CA ' HD13 ' A' ' 59' ' ' LEU . . . -82.83 -41.11 19.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.175 -0.953 . . . . 0.0 110.587 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.496 HG22 ' CD2' ' A' ' 64' ' ' HIS . 5.4 t -73.45 -28.45 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.141 -0.974 . . . . 0.0 109.398 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -40.33 93.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -0.801 . . . . 0.0 109.81 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.481 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -68.47 -49.3 60.85 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.209 -0.932 . . . . 0.0 108.976 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.407 ' HA ' ' CG2' ' A' ' 74' ' ' THR . 82.4 mt -58.51 -23.35 57.85 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.641 -0.662 . . . . 0.0 109.362 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -77.54 -40.12 43.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 109.624 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.11 64.82 0.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.403 -0.811 . . . . 0.0 109.364 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.407 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 30.4 p -82.23 174.4 11.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.375 -0.828 . . . . 0.0 109.933 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.17 -175.03 34.61 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.67 -37.88 19.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.148 -1.207 . . . . 0.0 110.544 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 4.2 pt-20 -117.76 101.9 8.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.397 -0.814 . . . . 0.0 109.894 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.409 ' HB ' ' HB ' ' A' ' 6' ' ' VAL . 59.9 t -67.28 73.5 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.0 110.795 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.0 t -69.53 106.47 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.0 119.79 38.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.884 -1.135 . . . . 0.0 112.235 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -73.34 133.39 43.82 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.443 HG11 ' CB ' ' A' ' 2' ' ' ARG . 2.2 p -135.16 144.35 34.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.837 -1.164 . . . . 0.0 111.741 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.51 86.57 2.33 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.606 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -54.33 122.86 11.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.472 -0.768 . . . . 0.0 110.662 -177.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -111.78 52.3 0.76 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.636 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.3 pttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.27 -179.762 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.498 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 56.3 tttt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.128 0.489 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.54 87.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.431 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.431 ' N ' ' O ' ' B' ' 3' ' ' LYS . 0.4 OUTLIER -90.86 -163.54 1.04 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 109.865 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.49 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 30.5 tp -163.27 121.49 1.98 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 109.995 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.435 ' CG2' ' CG1' ' A' ' 68' ' ' VAL . 83.1 t . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.082 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.436 0.636 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.448 ' CB ' HG11 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -155.18 168.03 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.409 -0.807 . . . . 0.0 110.692 -179.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.55 121.12 13.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.468 -0.77 . . . . 0.0 109.197 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 44' ' ' ALA . 64.3 t -131.94 139.48 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.931 -1.105 . . . . 0.0 111.05 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.8 m -119.14 116.47 26.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.459 -0.776 . . . . 0.0 109.683 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 78' ' ' VAL . 90.9 t -103.83 111.57 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 110.207 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.88 131.15 42.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.86 . . . . 0.0 109.916 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -61.46 -151.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.369 -0.832 . . . . 0.0 110.387 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 55.63 -171.21 0.07 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.248 -0.907 . . . . 0.0 110.225 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 12' ' ' GLY . 6.9 m-20 58.48 113.28 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.594 -0.691 . . . . 0.0 110.583 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 67.26 -62.02 0.33 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.353 -0.842 . . . . 0.0 110.595 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 10' ' ' ASP . . . 125.46 -74.9 0.41 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.56 160.87 10.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.4 -16.2 22.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -1.186 . . . . 0.0 110.666 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.446 ' CA ' HD23 ' A' ' 37' ' ' LEU . . . 56.0 87.0 0.02 OUTLIER Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.432 HD13 ' CD1' ' A' ' 45' ' ' LEU . 3.3 tt -176.32 118.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.223 -1.163 . . . . 0.0 110.345 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -112.94 101.09 9.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.561 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.485 ' CD1' ' CG2' ' A' ' 68' ' ' VAL . 28.4 pt -78.31 151.06 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.95 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.6 tttt -137.83 122.22 18.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.452 -0.78 . . . . 0.0 110.209 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.08 -153.05 24.16 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 160.44 133.85 1.56 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.427 ' CZ ' ' O ' ' A' ' 60' ' ' SER . 0.2 OUTLIER -60.12 -15.43 23.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.424 -1.045 . . . . 0.0 110.617 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.68 7.07 15.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.719 -1.238 . . . . 0.0 110.487 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.53 23.76 2.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.085 -1.009 . . . . 0.0 109.749 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm 53.88 64.87 1.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.883 . . . . 0.0 110.213 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.451 ' CE ' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.51 117.84 5.2 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 110.236 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.451 ' HD2' ' CE ' ' A' ' 26' ' ' MET . 48.3 Cg_endo -69.54 54.34 1.09 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 O-C-N 123.425 1.224 . . . . 0.0 111.653 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.495 HD11 HG22 ' A' ' 28' ' ' ILE . 16.3 mm 42.33 88.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 O-C-N 121.268 -0.895 . . . . 0.0 110.304 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 49' ' ' ASP . 31.8 tp -100.89 125.72 47.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.843 -1.16 . . . . 0.0 111.888 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 57.4 mt -61.82 136.26 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.588 -0.695 . . . . 0.0 110.188 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.3 t -121.98 -11.4 8.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 110.686 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 106.78 3.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.956 -1.09 . . . . 0.0 110.703 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.444 ' CG2' ' HB2' ' A' ' 40' ' ' ASP . 11.8 mm -95.6 94.74 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 109.45 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.536 ' CE1' ' CD1' ' B' ' 6' ' ' LEU . 88.3 m-85 -54.27 141.55 29.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.841 . . . . 0.0 110.26 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -86.42 171.57 11.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 110.805 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.58 30.89 73.13 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.446 HD23 ' CA ' ' A' ' 15' ' ' GLY . 0.7 OUTLIER -138.28 162.61 33.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -1.196 . . . . 0.0 110.78 -179.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.436 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . . . -46.5 -64.08 0.85 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.514 -0.741 . . . . 0.0 111.63 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 45' ' ' LEU . . . -48.6 -53.75 17.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.96 -1.087 . . . . 0.0 111.385 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.444 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 16.3 t70 -77.3 -9.26 58.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.86 -1.15 . . . . 0.0 111.891 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.436 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -107.41 10.95 29.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.67 -1.268 . . . . 0.0 110.746 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.4 t -106.82 15.62 25.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.017 -1.052 . . . . 0.0 110.512 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 47.74 55.31 8.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.117 -0.989 . . . . 0.0 110.991 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.486 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -176.64 -47.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.083 -1.011 . . . . 0.0 110.524 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.432 ' CD1' HD13 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -67.93 82.44 0.21 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.973 -1.079 . . . . 0.0 109.154 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.588 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.91 150.01 32.39 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.548 -0.72 . . . . 0.0 109.835 -179.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.431 ' N ' HG13 ' A' ' 33' ' ' ILE . 96.2 t -50.24 167.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.97 -1.081 . . . . 0.0 110.253 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.88 30.21 68.35 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.475 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 36.5 m-20 -114.06 99.57 7.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.485 -1.009 . . . . 0.0 110.968 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . . . -78.43 107.11 10.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 109.518 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 51' ' ' ILE . 61.2 mt -77.46 134.33 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 110.939 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.431 ' CD2' ' O ' ' A' ' 50' ' ' ALA . 4.0 mm? -120.9 7.3 10.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.488 -0.757 . . . . 0.0 110.003 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 4.8 t -175.76 131.92 0.26 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.148 -0.97 . . . . 0.0 109.871 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.464 HG23 ' CB ' ' A' ' 70' ' ' ALA . 2.0 m -123.9 113.96 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.302 -0.873 . . . . 0.0 109.721 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.6 34.29 20.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.292 -0.88 . . . . 0.0 110.283 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.99 21.02 51.8 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 53' ' ' SER . 3.3 tm-20 -109.51 84.9 2.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.064 -1.257 . . . . 0.0 110.417 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -44.56 97.88 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.432 -0.793 . . . . 0.0 110.947 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.436 ' CD1' HG21 ' A' ' 54' ' ' VAL . 37.3 mt -79.09 -8.78 59.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.473 -0.767 . . . . 0.0 110.877 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.427 ' O ' ' CZ ' ' A' ' 22' ' ' ARG . 21.7 p -47.01 -36.19 7.58 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.212 -0.93 . . . . 0.0 110.611 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -106.85 29.86 6.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.752 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.423 ' HB2' ' CB ' ' A' ' 66' ' ' GLU . . . -119.72 153.65 35.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.355 -0.841 . . . . 0.0 110.133 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.402 ' HA ' ' CB ' ' A' ' 22' ' ' ARG . 2.9 p -86.32 171.56 11.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.303 -0.873 . . . . 0.0 110.071 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.49 ' CD2' HG22 ' A' ' 68' ' ' VAL . 6.2 t60 -55.29 -24.65 29.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 109.777 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -77.14 -38.24 52.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.014 . . . . 0.0 109.761 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.423 ' CB ' ' HB2' ' A' ' 62' ' ' ALA . 4.1 mm-40 -67.94 -25.89 65.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.832 . . . . 0.0 110.166 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.417 ' HA ' ' CD2' ' A' ' 59' ' ' LEU . . . -81.87 -38.82 24.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 110.416 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.49 HG22 ' CD2' ' A' ' 64' ' ' HIS . 8.2 t -73.26 -27.38 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.068 -1.02 . . . . 0.0 109.334 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -65.09 -38.16 89.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.363 -0.835 . . . . 0.0 109.767 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.464 ' CB ' HG23 ' A' ' 54' ' ' VAL . . . -70.26 -48.53 56.45 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.15 -0.969 . . . . 0.0 108.726 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.431 ' HA ' ' CG2' ' A' ' 74' ' ' THR . 82.7 mt -59.62 -22.49 61.92 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.661 -0.649 . . . . 0.0 109.674 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -80.11 -45.11 18.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.654 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 5.5 tttt -112.74 59.79 0.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.38 -0.825 . . . . 0.0 109.719 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.431 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 47.3 p -78.08 174.2 11.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 110.248 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.88 -169.48 29.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -52.11 23.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.017 -1.284 . . . . 0.0 110.448 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 1.8 pt-20 -107.74 117.24 33.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.902 . . . . 0.0 109.778 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.422 HG13 ' CD1' ' A' ' 80' ' ' LEU . 45.8 t -83.11 78.56 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.938 -1.101 . . . . 0.0 110.781 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.8 t -68.53 112.53 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.101 -0.999 . . . . 0.0 108.329 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.422 ' CD1' HG13 ' A' ' 78' ' ' VAL . 4.4 mp -119.94 115.79 24.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.993 -1.067 . . . . 0.0 111.87 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -73.56 128.63 36.02 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.448 HG11 ' CB ' ' A' ' 2' ' ' ARG . 2.5 p -127.23 150.27 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.044 -1.035 . . . . 0.0 112.15 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -115.58 85.04 2.2 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.588 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -51.56 130.65 28.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.468 -0.77 . . . . 0.0 111.119 -177.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.4 mtt -115.47 51.74 0.92 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.765 . . . . 0.0 109.451 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.338 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.404 ' HB3' ' ND1' ' A' ' 64' ' ' HIS . 10.6 tttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.174 0.511 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -121.49 94.34 4.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.154 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.409 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -91.28 -169.52 2.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.394 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.536 ' CD1' ' CE1' ' A' ' 34' ' ' PHE . 5.1 tp -157.77 94.83 1.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.82 . . . . 0.0 109.883 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.088 179.778 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.499 0.666 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.444 ' CG ' HG11 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -158.77 146.51 17.9 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.548 -0.72 . . . . 0.0 109.736 -179.421 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.405 ' N ' ' HG3' ' A' ' 2' ' ' ARG . 0.4 OUTLIER -124.28 129.33 50.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.057 -1.027 . . . . 0.0 110.307 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' A' ' 44' ' ' ALA . 93.5 t -128.79 127.53 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.384 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.6 m -114.69 132.57 56.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.737 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.4 t -122.69 109.96 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 110.304 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.12 78.12 0.95 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 109.549 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.49 155.92 0.32 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.314 -0.866 . . . . 0.0 110.786 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.84 -168.27 1.69 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.87 . . . . 0.0 110.199 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.7 -43.64 88.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 110.229 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.8 121.66 1.31 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 110.172 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.0 -78.23 0.04 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.75 165.57 21.15 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.435 ' CD2' ' HB3' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -109.83 -23.07 11.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -1.194 . . . . 0.0 110.367 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.467 ' N ' ' CD2' ' A' ' 37' ' ' LEU . . . 56.21 90.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.414 HD13 ' CD2' ' A' ' 45' ' ' LEU . 1.1 tt -176.33 120.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.203 -1.175 . . . . 0.0 110.525 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.485 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 1.3 m -112.46 106.25 14.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.186 -0.947 . . . . 0.0 109.404 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.487 ' CD1' ' CG2' ' A' ' 68' ' ' VAL . 12.3 pt -82.58 156.64 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.426 -0.796 . . . . 0.0 111.501 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.431 ' CD ' ' CB ' ' A' ' 31' ' ' SER . 10.4 mtpt -136.44 156.92 47.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.578 -0.702 . . . . 0.0 109.833 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 123.05 -156.49 17.44 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.68 133.98 1.57 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.419 ' CB ' ' HA ' ' A' ' 63' ' ' THR . 1.9 tpm_? -60.71 -15.39 28.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -1.15 . . . . 0.0 110.62 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.412 ' OE2' ' ND2' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -82.03 5.51 19.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.649 -1.282 . . . . 0.0 110.342 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.412 ' ND2' ' OE2' ' A' ' 23' ' ' GLU . 0.7 OUTLIER -140.9 25.75 2.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.091 -1.006 . . . . 0.0 109.446 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.29 90.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 0.0 109.875 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.442 ' CE ' ' HB2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -170.03 127.01 0.76 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.305 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 57.0 Cg_endo -75.88 45.5 1.51 Allowed 'Trans proline' 0 N--CA 1.494 1.541 0 O-C-N 123.371 1.195 . . . . 0.0 111.717 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.458 HD11 HG22 ' A' ' 28' ' ' ILE . 27.0 mm 47.51 90.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 120.789 -1.194 . . . . 0.0 109.848 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.466 HD13 ' N ' ' A' ' 49' ' ' ASP . 36.6 tp -103.15 125.05 49.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.812 -1.18 . . . . 0.0 112.051 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 60.9 mt -58.78 139.39 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.568 -0.707 . . . . 0.0 109.85 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.431 ' CB ' ' CD ' ' A' ' 19' ' ' LYS . 33.3 t -124.6 -10.5 7.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 110.969 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' CB ' ' NZ ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -154.81 100.4 2.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.905 -1.122 . . . . 0.0 110.843 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.43 ' CG2' ' HB2' ' A' ' 40' ' ' ASP . 13.7 mm -86.39 101.26 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.212 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.485 ' CE1' ' OG ' ' A' ' 17' ' ' SER . 3.3 m-85 -59.36 135.56 57.69 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.604 -0.685 . . . . 0.0 109.698 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 169.47 15.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.117 -0.989 . . . . 0.0 110.851 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.48 30.29 77.15 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER -138.28 162.1 35.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.112 -1.228 . . . . 0.0 110.955 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -46.22 -69.06 0.14 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.628 -0.67 . . . . 0.0 111.694 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.435 ' HB3' ' CD2' ' A' ' 14' ' ' LEU . . . -45.01 -39.25 5.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.472 -0.767 . . . . 0.0 111.575 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.43 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 16.5 t70 -93.61 10.62 31.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.057 -1.027 . . . . 0.0 110.758 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -115.44 3.72 14.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.925 -1.109 . . . . 0.0 110.773 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.1 t -108.22 15.16 24.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.93 -1.106 . . . . 0.0 110.893 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.12 60.98 3.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.084 -1.01 . . . . 0.0 110.926 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.481 ' O ' ' CE2' ' A' ' 46' ' ' PHE . . . -175.15 -50.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.2 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.447 HD22 ' CD1' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -70.31 86.83 0.6 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.959 -1.088 . . . . 0.0 108.705 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.603 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -115.96 153.33 31.81 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.825 -0.547 . . . . 0.0 110.029 -179.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.414 HG21 HG12 ' A' ' 33' ' ' ILE . 32.5 t -48.12 165.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 120.899 -1.126 . . . . 0.0 110.151 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.77 31.69 67.33 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.466 ' N ' HD13 ' A' ' 29' ' ' LEU . 44.9 m-20 -116.58 100.28 7.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -1.041 . . . . 0.0 110.997 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . . . -79.1 108.88 12.93 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.858 . . . . 0.0 109.831 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.423 HG23 ' CG1' ' A' ' 54' ' ' VAL . 55.2 mt -75.4 139.94 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.329 -0.857 . . . . 0.0 110.824 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -125.05 4.63 7.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.255 -0.903 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 176.96 103.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.832 -1.168 . . . . 0.0 109.75 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.487 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 20.5 m -92.49 121.04 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.223 -0.923 . . . . 0.0 110.602 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 59.41 34.16 22.62 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.168 -0.958 . . . . 0.0 110.809 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.99 19.89 62.12 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.8 mt-10 -110.23 91.83 3.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.941 -1.329 . . . . 0.0 109.91 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -41.44 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.574 0.702 . . . . 0.0 111.488 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.442 ' CD1' ' HB2' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -90.39 14.01 14.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.489 -0.757 . . . . 0.0 110.399 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.6 t -68.88 -49.54 57.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 110.724 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.36 18.58 5.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.061 -1.024 . . . . 0.0 110.523 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.442 ' HB2' ' CD1' ' A' ' 59' ' ' LEU . . . -104.21 158.41 16.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -0.927 . . . . 0.0 110.233 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.419 ' HA ' ' CB ' ' A' ' 22' ' ' ARG . 12.4 p -90.15 176.23 6.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 110.071 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.5 ' CD2' HG22 ' A' ' 68' ' ' VAL . 4.5 t60 -58.64 -26.01 63.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.072 -1.018 . . . . 0.0 109.556 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.45 -30.28 59.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.089 -1.007 . . . . 0.0 109.709 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -75.62 -27.03 58.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.838 . . . . 0.0 109.952 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.432 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -80.09 -36.68 35.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.368 -0.832 . . . . 0.0 110.502 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.5 HG22 ' CD2' ' A' ' 64' ' ' HIS . 17.5 t -75.5 -32.71 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.047 -1.033 . . . . 0.0 109.549 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -60.97 -38.32 85.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 109.879 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.487 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -70.98 -50.58 32.77 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.177 -0.952 . . . . 0.0 108.788 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.452 ' HA ' ' CG2' ' A' ' 74' ' ' THR . 86.7 mt -58.56 -23.59 58.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.619 -0.676 . . . . 0.0 110.01 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -80.69 -36.78 31.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.124 -0.985 . . . . 0.0 109.941 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -119.43 58.21 0.88 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.111 -0.993 . . . . 0.0 109.871 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.452 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 39.4 p -80.96 -170.65 2.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.904 . . . . 0.0 110.003 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.53 -175.05 15.33 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -49.04 -59.88 3.25 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.056 -1.261 . . . . 0.0 110.298 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -88.4 95.44 10.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 109.582 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -79.86 78.74 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 110.66 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.0 t -68.66 116.32 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.083 -1.01 . . . . 0.0 108.352 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 mp -121.06 100.8 7.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.978 -1.076 . . . . 0.0 111.743 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -64.13 128.89 37.8 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.444 HG11 ' CG ' ' A' ' 2' ' ' ARG . 2.2 p -131.9 143.93 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 111.799 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -106.67 88.34 2.74 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.603 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -56.0 111.24 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.456 -0.778 . . . . 0.0 111.165 -177.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 mtt -89.21 53.43 2.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 109.198 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.149 -179.535 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.465 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 15.3 tttp . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.157 0.503 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -121.13 90.84 3.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.991 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.417 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -79.9 -161.72 0.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 0.0 110.461 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.48 HD12 ' CZ ' ' A' ' 34' ' ' PHE . 22.1 tp -171.14 99.88 0.21 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 109.935 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 92.5 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.255 180.0 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.351 0.596 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.453 ' CB ' HG11 ' A' ' 82' ' ' VAL . 1.7 mtp85 -157.05 167.74 29.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.68 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -138.66 119.01 13.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.497 -0.752 . . . . 0.0 109.189 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 44' ' ' ALA . 83.2 t -127.63 126.15 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.969 -1.082 . . . . 0.0 110.655 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.5 m -117.29 114.39 23.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.446 -0.784 . . . . 0.0 109.441 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.441 ' CG2' HD13 ' A' ' 45' ' ' LEU . 98.4 t -102.8 111.04 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.946 . . . . 0.0 109.964 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -71.72 123.68 23.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.436 -0.79 . . . . 0.0 110.044 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -67.61 -70.72 0.24 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 110.2 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 64.39 -70.61 0.08 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.636 -0.665 . . . . 0.0 110.39 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 8' ' ' LYS . 15.9 m-20 -163.17 117.01 1.62 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.062 -1.024 . . . . 0.0 109.882 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -174.87 126.09 0.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.834 . . . . 0.0 110.015 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -50.91 -64.07 4.04 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.3 -168.1 15.46 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.451 ' CD2' ' HB3' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -113.39 -17.84 12.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.409 -1.053 . . . . 0.0 110.277 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' CA ' HD23 ' A' ' 37' ' ' LEU . . . 63.86 81.65 0.1 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 tt -176.42 117.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.326 -1.102 . . . . 0.0 110.325 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' B' ' 5' ' ' SER . 0.7 OUTLIER -111.8 119.57 39.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.186 -0.946 . . . . 0.0 109.577 179.231 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.487 ' CD1' ' CG2' ' A' ' 68' ' ' VAL . 8.8 pt -95.6 148.98 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.98 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HG2' ' CA ' ' B' ' 4' ' ' GLU . 0.2 OUTLIER -132.67 134.72 45.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.812 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 142.17 -159.98 27.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.32 136.84 2.12 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -16.1 21.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -1.133 . . . . 0.0 110.598 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.43 -12.38 60.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.826 -1.171 . . . . 0.0 110.233 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.14 27.54 8.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.088 -1.007 . . . . 0.0 110.185 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.69 49.68 19.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.126 -0.984 . . . . 0.0 110.043 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.425 ' CA ' ' HE1' ' A' ' 26' ' ' MET . 0.0 OUTLIER -125.33 122.56 25.11 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 110.365 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.451 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 55.5 Cg_endo -72.66 50.86 1.77 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 O-C-N 123.422 1.222 . . . . 0.0 111.735 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.434 ' CG2' HD11 ' A' ' 18' ' ' ILE . 25.4 mm 43.37 88.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 O-C-N 121.053 -1.029 . . . . 0.0 110.706 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 50' ' ' ALA . 5.6 mt -97.74 132.51 43.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.857 -1.152 . . . . 0.0 111.608 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.437 HG23 ' CD1' ' A' ' 33' ' ' ILE . 56.9 mt -69.2 138.21 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.284 -0.885 . . . . 0.0 108.952 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.6 t -119.83 -24.73 6.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.94 -1.1 . . . . 0.0 110.931 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.43 108.3 5.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.016 -1.053 . . . . 0.0 110.666 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.458 HG21 HD11 ' A' ' 33' ' ' ILE . 15.9 mm -94.24 98.44 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.429 -0.794 . . . . 0.0 109.166 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.537 ' CE1' ' CD2' ' B' ' 6' ' ' LEU . 92.0 m-85 -57.9 130.83 48.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.608 -0.683 . . . . 0.0 110.362 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' O ' ' CD1' ' A' ' 37' ' ' LEU . 7.3 pttt -76.83 171.68 14.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.402 -0.811 . . . . 0.0 110.95 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.57 30.57 65.53 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 34' ' ' PHE . 0.5 OUTLIER -138.47 161.96 35.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.076 -1.249 . . . . 0.0 110.903 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.432 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . . . -48.24 -66.73 0.35 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.579 -0.701 . . . . 0.0 111.592 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.451 ' HB3' ' CD2' ' A' ' 14' ' ' LEU . . . -47.57 -33.03 6.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 112.199 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.449 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 5.4 t70 -95.77 -19.91 19.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.719 -1.238 . . . . 0.0 111.302 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.432 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -93.78 14.86 17.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.905 -1.122 . . . . 0.0 110.725 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 t -107.74 14.07 25.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.013 -1.055 . . . . 0.0 110.843 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 44.79 46.91 8.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.188 -0.945 . . . . 0.0 111.284 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.488 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -165.62 -51.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 110.515 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.451 HD11 ' CB ' ' A' ' 39' ' ' ALA . 2.8 mt -70.61 83.07 0.6 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.839 -1.163 . . . . 0.0 108.504 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.591 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -110.29 155.07 22.58 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.361 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.439 ' N ' HG13 ' A' ' 33' ' ' ILE . 90.6 t -51.02 167.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.813 -1.179 . . . . 0.0 110.29 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.409 ' N ' HG13 ' A' ' 47' ' ' VAL . . . 67.84 32.36 77.49 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.472 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 32.6 m-20 -114.05 104.44 12.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.484 -1.009 . . . . 0.0 110.431 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.451 ' CB ' ' HG2' ' A' ' 27' ' ' PRO . . . -80.56 105.69 12.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.328 -0.857 . . . . 0.0 109.627 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 54.7 mt -76.62 135.97 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.405 -0.809 . . . . 0.0 111.07 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.425 ' N ' HD21 ' A' ' 52' ' ' LEU . 4.4 mm? -120.55 8.21 10.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.488 -0.757 . . . . 0.0 110.214 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 26.0 t -178.68 135.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.103 -0.998 . . . . 0.0 109.704 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.485 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 1.5 m -129.24 114.83 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.309 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.414 ' ND2' ' HB ' ' A' ' 74' ' ' THR . 2.9 m-80 58.75 31.15 20.9 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.262 -0.899 . . . . 0.0 110.76 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.83 21.07 34.72 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.3 mm-40 -112.41 88.03 2.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.041 -1.27 . . . . 0.0 110.164 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -46.64 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.276 -0.89 . . . . 0.0 111.004 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 57' ' ' GLU . 79.8 mt -81.7 -11.92 58.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.563 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 t -48.16 -32.41 6.96 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.231 -0.918 . . . . 0.0 110.06 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.9 t -112.06 22.62 14.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.343 -0.848 . . . . 0.0 109.451 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 66' ' ' GLU . . . -113.11 152.57 29.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.425 -0.797 . . . . 0.0 110.143 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 p -86.9 169.94 12.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 110.053 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.544 ' CD2' ' CD ' ' B' ' 3' ' ' LYS . 3.3 t60 -54.0 -25.74 22.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.929 . . . . 0.0 109.789 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -77.44 -36.26 53.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.062 -1.024 . . . . 0.0 110.034 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.428 ' CB ' ' HB3' ' A' ' 62' ' ' ALA . 46.4 mm-40 -73.11 -23.04 60.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.934 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.36 -38.25 24.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 110.417 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.496 HG22 ' CD2' ' A' ' 64' ' ' HIS . 14.1 t -72.44 -29.21 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.154 -0.966 . . . . 0.0 109.184 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -61.37 -37.2 82.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.335 -0.853 . . . . 0.0 109.813 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.485 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -71.54 -50.31 32.4 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.171 -0.956 . . . . 0.0 108.81 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.421 ' HA ' ' CG2' ' A' ' 74' ' ' THR . 86.7 mt -57.68 -23.67 52.75 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.543 -0.723 . . . . 0.0 109.443 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -78.56 -34.91 46.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.678 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -130.79 54.17 1.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.343 -0.848 . . . . 0.0 109.684 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.421 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 66.2 p -57.81 -84.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.855 . . . . 0.0 110.502 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.12 -170.74 32.7 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -47.23 -35.69 7.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.147 -1.208 . . . . 0.0 110.665 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -132.96 130.39 39.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.223 -0.923 . . . . 0.0 109.705 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.413 ' CG1' HD23 ' A' ' 80' ' ' LEU . 99.4 t -94.64 81.59 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.072 -1.018 . . . . 0.0 111.196 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.21 116.74 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.413 HD23 ' CG1' ' A' ' 78' ' ' VAL . 3.8 mp -124.54 108.49 12.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.959 -1.088 . . . . 0.0 112.108 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.26 129.15 38.56 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.453 HG11 ' CB ' ' A' ' 2' ' ' ARG . 2.8 p -129.02 145.38 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.855 -1.153 . . . . 0.0 112.602 -177.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -111.51 83.77 1.83 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.591 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -49.31 119.39 3.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.469 -0.77 . . . . 0.0 111.645 -177.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.8 mmt -101.21 47.32 0.91 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.6 tptt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.318 -179.449 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.544 ' CD ' ' CD2' ' A' ' 64' ' ' HIS . 12.0 mttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.319 0.58 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.439 ' CA ' ' HG2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER 54.92 49.71 17.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.015 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.423 ' O ' ' CB ' ' A' ' 17' ' ' SER . 26.5 t -54.24 -175.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 110.526 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.537 ' CD2' ' CE1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -149.95 73.31 1.16 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.375 -0.828 . . . . 0.0 110.381 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.168 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.272 0.558 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.449 ' CB ' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -155.19 162.4 40.95 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.217 -0.927 . . . . 0.0 110.506 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.93 109.92 6.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.438 -0.789 . . . . 0.0 109.295 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.441 ' CG1' ' HB2' ' A' ' 44' ' ' ALA . 89.6 t -115.49 152.87 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.029 -1.045 . . . . 0.0 110.846 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.6 m -132.79 114.94 14.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 109.564 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.409 ' HB ' ' HB ' ' A' ' 78' ' ' VAL . 86.2 t -102.82 118.67 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.086 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.1 mtm180 -88.05 87.81 7.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.934 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -49.4 112.32 0.62 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.298 -0.877 . . . . 0.0 110.637 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.87 50.55 1.42 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.35 -0.844 . . . . 0.0 109.907 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.35 26.22 10.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.37 -0.831 . . . . 0.0 109.968 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.95 59.34 0.7 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.369 -0.832 . . . . 0.0 110.511 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.61 36.74 32.33 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.38 -149.13 18.21 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.72 -18.92 10.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -1.154 . . . . 0.0 110.717 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.431 ' CA ' HD23 ' A' ' 37' ' ' LEU . . . 57.88 90.17 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 tt -176.78 118.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.204 -1.174 . . . . 0.0 110.226 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' B' ' 5' ' ' SER . 1.1 t -112.4 100.24 8.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.182 -0.949 . . . . 0.0 109.783 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.478 ' CD1' ' CG2' ' A' ' 68' ' ' VAL . 9.8 pt -77.63 150.48 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 110.693 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -136.18 123.24 21.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 110.103 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.75 -140.44 8.69 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.432 ' CA ' ' HB2' ' A' ' 64' ' ' HIS . . . 138.99 148.11 5.22 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -14.11 24.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -1.08 . . . . 0.0 110.844 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -9.08 57.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.921 -1.112 . . . . 0.0 110.559 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -130.32 26.28 5.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.043 -1.036 . . . . 0.0 110.12 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.5 mttp 54.72 40.88 32.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.312 -0.868 . . . . 0.0 110.157 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.459 ' CE ' ' HD2' ' A' ' 27' ' ' PRO . 6.2 mmm -120.88 124.77 27.33 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.377 -0.827 . . . . 0.0 110.034 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.459 ' HD2' ' CE ' ' A' ' 26' ' ' MET . 49.6 Cg_endo -70.21 52.66 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 O-C-N 123.348 1.183 . . . . 0.0 111.745 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.444 ' CG2' HD11 ' A' ' 18' ' ' ILE . 18.0 mm 43.53 89.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.084 -1.01 . . . . 0.0 110.096 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.469 HD13 ' N ' ' A' ' 49' ' ' ASP . 32.7 tp -102.41 126.78 49.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.886 -1.134 . . . . 0.0 112.072 -178.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 56.7 mt -62.08 135.81 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.463 -0.773 . . . . 0.0 109.633 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.4 t -121.91 -18.49 7.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 110.963 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.89 106.48 4.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.002 -1.061 . . . . 0.0 110.702 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.451 ' CG2' ' HB2' ' A' ' 40' ' ' ASP . 16.8 mm -94.77 109.78 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 0.0 109.265 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.528 ' CZ ' ' CD1' ' B' ' 6' ' ' LEU . 88.6 m-85 -71.54 128.15 34.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -73.83 173.08 10.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -0.939 . . . . 0.0 110.666 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.23 29.65 69.13 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -138.26 159.42 42.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -1.163 . . . . 0.0 110.941 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -44.44 -62.42 1.18 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.628 -0.67 . . . . 0.0 111.604 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 45' ' ' LEU . . . -47.82 -57.76 5.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.179 -0.95 . . . . 0.0 110.99 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.451 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 12.8 t70 -75.47 0.51 16.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.998 -1.064 . . . . 0.0 111.332 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -104.66 -2.44 25.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.75 -1.219 . . . . 0.0 110.865 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.2 t -98.67 14.82 27.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.842 -1.161 . . . . 0.0 110.662 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 47.62 49.31 16.38 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.11 -0.993 . . . . 0.0 110.649 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.478 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -169.11 -43.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 110.206 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.438 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -68.17 80.1 0.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 108.83 179.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.586 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.23 153.67 26.75 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.594 -0.692 . . . . 0.0 110.043 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.426 ' N ' HG13 ' A' ' 33' ' ' ILE . 96.1 t -52.66 168.35 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.075 -1.015 . . . . 0.0 110.362 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 30.28 68.33 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.483 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 45.6 m-20 -114.92 99.9 7.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -1.036 . . . . 0.0 111.059 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . . . -79.07 107.58 11.93 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.092 -1.005 . . . . 0.0 109.718 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.444 HG23 ' CG1' ' A' ' 54' ' ' VAL . 52.2 mt -76.49 138.66 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.441 -0.787 . . . . 0.0 110.683 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.423 ' CD2' ' O ' ' A' ' 50' ' ' ALA . 3.9 mm? -127.35 7.23 6.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.153 -0.967 . . . . 0.0 110.82 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 176.08 99.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.87 -1.144 . . . . 0.0 109.765 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.483 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 23.1 m -91.1 121.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.138 -0.976 . . . . 0.0 110.36 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' A' ' 79' ' ' VAL . 3.8 m120 60.37 36.29 20.45 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.096 -1.002 . . . . 0.0 110.274 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.3 11.42 85.34 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.2 tp10 -96.79 92.34 6.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.882 -1.363 . . . . 0.0 109.429 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -40.89 103.96 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.562 0.696 . . . . 0.0 111.31 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.455 HD13 ' CB ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -92.99 -13.53 28.6 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.61 -0.681 . . . . 0.0 110.499 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.2 p -54.9 -37.64 66.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.004 . . . . 0.0 110.135 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 m -96.96 23.42 7.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -0.935 . . . . 0.0 110.264 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.448 ' CB ' HD11 ' A' ' 59' ' ' LEU . . . -117.59 155.43 29.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 110.171 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.9 p -85.54 172.6 10.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.314 -0.866 . . . . 0.0 110.18 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.54 ' CE1' ' CB ' ' B' ' 3' ' ' LYS . 4.0 t60 -53.62 -25.74 18.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.107 -0.996 . . . . 0.0 109.786 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -75.87 -40.91 53.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.017 -1.052 . . . . 0.0 109.27 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -65.25 -22.43 66.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.527 -0.733 . . . . 0.0 109.87 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.455 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -83.98 -40.58 18.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.298 -0.877 . . . . 0.0 110.658 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.504 HG22 ' CD2' ' A' ' 64' ' ' HIS . 9.4 t -74.49 -28.37 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.205 -0.935 . . . . 0.0 109.26 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -65.54 -37.88 88.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.342 -0.849 . . . . 0.0 110.093 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.483 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -70.06 -37.28 75.46 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.12 -0.988 . . . . 0.0 109.125 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.8 mt -73.81 -19.95 60.6 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.648 -0.658 . . . . 0.0 109.808 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -80.88 -45.0 17.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.904 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -106.22 30.83 5.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.366 -0.834 . . . . 0.0 109.99 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.436 HG22 ' CG1' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -65.64 142.66 57.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.845 . . . . 0.0 109.972 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.86 -179.98 40.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -49.9 -50.92 44.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.363 -1.081 . . . . 0.0 110.688 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -88.86 92.87 9.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.908 -1.12 . . . . 0.0 109.133 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.445 ' CG1' HD12 ' A' ' 80' ' ' LEU . 78.3 t -83.06 78.63 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.189 -0.944 . . . . 0.0 110.903 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.466 ' N ' ' ND2' ' A' ' 55' ' ' ASN . 11.0 t -66.44 124.01 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.445 HD12 ' CG1' ' A' ' 78' ' ' VAL . 2.3 mp -124.21 106.14 10.07 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.901 -1.125 . . . . 0.0 111.749 -178.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.2 121.59 16.53 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.449 HG11 ' CB ' ' A' ' 2' ' ' ARG . 2.6 p -127.05 147.95 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.069 -1.02 . . . . 0.0 112.683 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -112.45 88.2 2.76 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.586 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -56.28 126.68 27.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 111.157 -177.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.0 mmt -105.89 54.89 0.69 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.344 -0.847 . . . . 0.0 109.226 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.5 tttt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.224 -179.527 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.54 ' CB ' ' CE1' ' A' ' 64' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.234 0.54 . . . . 0.0 110.178 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 54.29 62.31 2.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -0.862 . . . . 0.0 109.858 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 17' ' ' SER . 3.5 t -73.59 -156.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.241 -0.912 . . . . 0.0 110.62 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.528 ' CD1' ' CZ ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -167.07 89.25 0.34 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.317 -0.864 . . . . 0.0 110.515 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.066 -1.021 . . . . 0.0 110.082 179.738 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 15.5 mtm-85 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.468 0.652 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.458 ' CB ' HG11 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -148.21 164.36 34.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.397 -0.815 . . . . 0.0 110.195 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.43 117.51 18.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 109.461 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.454 ' CG1' ' HB2' ' A' ' 44' ' ' ALA . 53.3 t -129.63 126.95 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.05 -1.031 . . . . 0.0 110.521 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.1 m -119.79 130.81 55.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.364 -0.835 . . . . 0.0 109.674 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.2 t -117.21 111.1 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.783 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -72.3 94.46 1.6 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.016 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -61.21 100.18 0.12 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.384 -0.823 . . . . 0.0 110.43 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.37 32.42 2.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 110.156 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 56.91 108.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.527 -0.733 . . . . 0.0 110.595 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -175.34 80.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 110.217 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.31 -62.43 1.81 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.15 -151.77 10.54 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -102.7 -19.63 14.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -1.175 . . . . 0.0 110.283 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 37' ' ' LEU . . . 65.23 76.19 0.34 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.423 HD13 ' CD2' ' A' ' 45' ' ' LEU . 4.2 tt -166.24 117.18 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -1.055 . . . . 0.0 109.698 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' ' 32' ' ' LYS . 1.2 t -107.29 92.31 4.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.09 -1.006 . . . . 0.0 109.933 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.452 ' CD1' HG21 ' A' ' 68' ' ' VAL . 45.2 pt -69.04 146.67 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.199 -0.938 . . . . 0.0 110.886 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' CB ' ' HB2' ' A' ' 31' ' ' SER . 21.5 tttt -135.41 117.32 15.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.495 -0.753 . . . . 0.0 109.728 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.06 -155.37 26.44 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.92 135.66 2.03 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -14.47 29.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -1.12 . . . . 0.0 110.698 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.7 2.2 34.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.838 -1.164 . . . . 0.0 110.23 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -138.35 26.77 2.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.517 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.07 74.15 0.38 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.0 109.965 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.442 ' HE2' ' CD1' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -161.82 120.43 1.42 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 110.649 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 53.6 Cg_endo -72.63 52.85 2.14 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 O-C-N 123.508 1.267 . . . . 0.0 111.408 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.4 mm 43.45 87.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 120.998 -1.064 . . . . 0.0 110.666 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.442 ' CD1' ' HE2' ' A' ' 26' ' ' MET . 6.0 mt -97.33 132.32 43.18 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.672 -1.268 . . . . 0.0 111.663 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.476 HG23 HD11 ' A' ' 30' ' ' ILE . 57.4 mt -65.64 137.17 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.248 -0.907 . . . . 0.0 108.628 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.436 ' HB2' ' CB ' ' A' ' 19' ' ' LYS . 3.1 t -119.73 -29.58 4.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.046 -1.034 . . . . 0.0 110.715 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -133.45 101.43 5.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 110.601 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.44 ' CD1' HG23 ' A' ' 30' ' ' ILE . 10.2 mm -87.69 106.11 15.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.482 ' CE1' HD11 ' B' ' 6' ' ' LEU . 5.3 m-85 -59.24 123.1 15.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.509 -0.745 . . . . 0.0 110.219 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.417 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -75.21 146.18 41.4 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.228 -0.92 . . . . 0.0 110.563 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.74 0.75 81.84 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.447 ' CB ' ' HA3' ' A' ' 15' ' ' GLY . 4.0 mm? -100.7 163.07 12.5 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.942 -1.328 . . . . 0.0 110.26 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -47.09 -55.5 8.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.364 -0.835 . . . . 0.0 110.775 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.489 ' CB ' ' CD2' ' A' ' 45' ' ' LEU . . . -51.38 -47.67 62.8 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.363 -0.835 . . . . 0.0 111.024 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.432 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 13.8 t70 -86.72 3.43 44.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.157 -0.964 . . . . 0.0 111.267 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -103.58 4.56 35.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.815 -1.178 . . . . 0.0 110.783 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.9 t -107.66 14.65 25.44 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.854 -1.154 . . . . 0.0 110.712 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 45.4 56.79 5.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.263 -0.898 . . . . 0.0 111.068 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.492 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . . . -170.57 -48.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.109 -0.994 . . . . 0.0 110.315 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.489 ' CD2' ' CB ' ' A' ' 39' ' ' ALA . 3.5 tp -70.45 84.58 0.59 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.831 -1.168 . . . . 0.0 108.489 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -111.04 147.44 34.77 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.758 -0.589 . . . . 0.0 110.039 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.412 ' N ' HG13 ' A' ' 33' ' ' ILE . 52.0 t -47.35 147.47 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.274 -0.891 . . . . 0.0 110.3 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.32 26.85 26.99 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.421 -1.872 . . . . 0.0 108.421 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.478 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 58.2 m-20 -110.26 106.82 16.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.524 -0.986 . . . . 0.0 110.384 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.455 ' CB ' ' HG2' ' A' ' 27' ' ' PRO . . . -84.41 108.95 17.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.938 . . . . 0.0 109.593 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.461 HD11 HG22 ' A' ' 51' ' ' ILE . 63.8 mt -76.57 136.31 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 111.042 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.431 ' N ' HD21 ' A' ' 52' ' ' LEU . 4.2 mm? -124.63 15.5 8.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.476 -0.765 . . . . 0.0 109.886 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 4.6 t 176.81 135.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 108.967 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.479 HG23 ' CB ' ' A' ' 70' ' ' ALA . 1.2 m -128.68 118.15 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.041 -1.037 . . . . 0.0 110.497 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 54.72 37.91 29.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.332 -0.855 . . . . 0.0 110.554 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.75 26.93 40.07 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 53' ' ' SER . 47.7 mt-10 -118.93 93.19 4.01 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.081 -1.247 . . . . 0.0 110.173 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -44.96 111.79 0.36 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.448 -0.783 . . . . 0.0 110.93 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.454 HD11 ' CB ' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -101.48 17.18 23.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.508 -0.745 . . . . 0.0 110.658 -179.385 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 t -66.3 -50.37 63.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 0.0 110.29 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.28 36.62 1.57 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.066 -1.021 . . . . 0.0 110.48 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.454 ' CB ' HD11 ' A' ' 59' ' ' LEU . . . -116.46 149.44 39.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.957 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.8 p -83.09 171.58 13.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 0.0 110.418 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.489 ' CD2' HG22 ' A' ' 68' ' ' VAL . 8.7 t60 -56.61 -23.45 41.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.231 -0.918 . . . . 0.0 109.91 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.91 -42.83 31.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 109.447 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -65.65 -21.16 66.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.349 -0.844 . . . . 0.0 109.784 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.449 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -84.5 -45.41 12.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.371 -0.831 . . . . 0.0 110.53 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.489 HG22 ' CD2' ' A' ' 64' ' ' HIS . 6.0 t -67.03 -31.48 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.124 -0.985 . . . . 0.0 109.186 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -42.04 82.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.401 -0.812 . . . . 0.0 109.444 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 54' ' ' VAL . . . -67.93 -46.0 72.74 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.115 -0.991 . . . . 0.0 108.741 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.444 ' HB3' ' CG1' ' B' ' 7' ' ' VAL . 3.8 mm? -52.88 -29.79 30.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.672 -0.643 . . . . 0.0 109.697 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HG2' HG12 ' B' ' 7' ' ' VAL . 7.8 mttm -82.19 -40.15 22.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.242 -0.911 . . . . 0.0 110.24 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -110.59 34.66 3.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 110.117 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.435 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 21.3 p -51.97 -79.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 0.0 110.309 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.39 -176.99 25.96 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -50.59 -41.04 54.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.206 -1.173 . . . . 0.0 110.169 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 3.7 pt-20 -117.61 112.64 20.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.852 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.426 HG11 ' CD2' ' A' ' 80' ' ' LEU . 53.1 t -84.94 83.66 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.076 -1.015 . . . . 0.0 110.407 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.1 t -76.1 116.68 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.426 ' CD2' HG11 ' A' ' 78' ' ' VAL . 14.8 mt -125.06 116.45 22.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.842 -1.161 . . . . 0.0 111.523 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -74.19 122.57 22.99 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.458 HG11 ' CB ' ' A' ' 2' ' ' ARG . 3.1 p -119.21 144.63 27.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.543 -177.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -110.15 90.06 3.2 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.58 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -55.21 125.12 19.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.448 -0.783 . . . . 0.0 111.067 -177.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.4 mmm -116.3 51.91 0.95 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.462 -0.774 . . . . 0.0 109.41 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.7 pttt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.256 -179.605 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.469 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 14.9 tttt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.211 0.529 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -112.68 97.88 6.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.215 -0.928 . . . . 0.0 110.02 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 33.1 m -103.99 133.07 49.57 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.201 -0.937 . . . . 0.0 110.398 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.482 HD11 ' CE1' ' A' ' 34' ' ' PHE . 41.0 tp -105.92 108.35 19.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -0.863 . . . . 0.0 110.207 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 71' ' ' LEU . 40.2 t . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.053 -1.029 . . . . 0.0 110.203 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.304 0.573 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.46 ' CB ' HG11 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -147.85 158.72 44.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.537 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.7 115.26 16.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.215 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.461 ' CG1' ' CB ' ' A' ' 44' ' ' ALA . 37.9 t -132.0 139.32 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.07 -1.018 . . . . 0.0 110.689 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.8 m -128.26 126.54 41.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.311 -0.868 . . . . 0.0 110.271 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.431 HG21 ' CG2' ' A' ' 42' ' ' THR . 98.2 t -106.07 126.37 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.047 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.89 85.03 2.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 110.203 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.21 166.69 21.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 110.155 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.41 63.73 1.46 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.943 . . . . 0.0 110.366 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 52.84 23.01 2.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.435 -0.791 . . . . 0.0 110.396 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.13 -58.73 6.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.235 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.15 -73.38 0.08 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.36 143.88 15.18 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.23 -17.39 62.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -1.105 . . . . 0.0 110.726 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.458 ' HA3' ' CG ' ' A' ' 37' ' ' LEU . . . 64.86 87.53 0.05 OUTLIER Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.426 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -178.8 121.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.113 -1.227 . . . . 0.0 110.28 -178.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.49 109.78 21.55 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.464 ' CD1' HG21 ' A' ' 68' ' ' VAL . 27.5 pt -92.05 143.08 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -0.89 . . . . 0.0 111.171 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.69 170.14 11.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.57 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.09 -143.28 15.91 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.438 ' CA ' ' HB2' ' A' ' 64' ' ' HIS . . . 138.43 143.04 4.41 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -14.56 20.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -1.116 . . . . 0.0 110.99 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.14 -20.35 64.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.934 -1.104 . . . . 0.0 110.106 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.73 24.33 7.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 109.726 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.2 tttt 55.58 82.59 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.41 -0.806 . . . . 0.0 110.218 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.456 ' HE1' ' N ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -159.12 127.89 3.03 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 109.879 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.456 ' N ' ' HE1' ' A' ' 26' ' ' MET . 52.9 Cg_endo -70.28 50.61 0.96 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 O-C-N 123.321 1.169 . . . . 0.0 112.376 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.425 ' N ' ' HE3' ' A' ' 26' ' ' MET . 21.0 mm 38.88 88.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.549 0 O-C-N 121.201 -0.937 . . . . 0.0 111.189 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 50' ' ' ALA . 6.1 mt -96.66 133.23 41.44 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.88 -1.138 . . . . 0.0 111.765 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 67.8 mt -65.74 144.25 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 108.806 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.3 t -123.85 -23.88 4.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.925 -1.11 . . . . 0.0 111.252 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.06 95.26 2.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.97 -1.081 . . . . 0.0 111.04 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.444 ' CG2' ' HB2' ' A' ' 40' ' ' ASP . 10.7 mm -77.47 100.24 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.36 -0.837 . . . . 0.0 108.831 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.534 ' CZ ' ' CD1' ' B' ' 6' ' ' LEU . 17.2 m-85 -49.76 137.17 16.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.637 -0.664 . . . . 0.0 110.644 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.426 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 0.9 OUTLIER -79.29 159.0 27.41 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.177 -0.952 . . . . 0.0 110.487 -179.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.58 21.37 27.97 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.458 ' CG ' ' HA3' ' A' ' 15' ' ' GLY . 2.1 mm? -111.09 167.9 9.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -1.191 . . . . 0.0 109.865 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.84 -66.89 0.31 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.139 -0.975 . . . . 0.0 111.164 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 45' ' ' LEU . . . -47.62 -47.25 29.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.253 -0.905 . . . . 0.0 111.108 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.444 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 4.8 t70 -71.88 -11.76 60.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.097 -1.002 . . . . 0.0 110.861 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -105.48 15.87 26.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.828 -1.17 . . . . 0.0 110.547 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.431 ' CG2' HG21 ' A' ' 6' ' ' VAL . 48.3 p -106.06 12.81 29.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.027 -1.045 . . . . 0.0 110.73 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 48.24 44.88 20.0 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.056 -1.027 . . . . 0.0 110.538 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.488 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -174.72 -43.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.551 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.429 ' CB ' ' O ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -66.83 83.37 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.81 -1.181 . . . . 0.0 109.049 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.585 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -114.24 151.39 32.9 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.579 -0.7 . . . . 0.0 110.094 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.426 ' N ' HG13 ' A' ' 33' ' ' ILE . 24.5 t -47.66 169.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.21 -0.931 . . . . 0.0 110.35 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.46 33.77 85.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.423 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 28.4 m-20 -115.16 106.23 13.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.432 -1.04 . . . . 0.0 110.177 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' N ' HD22 ' A' ' 29' ' ' LEU . . . -83.76 108.78 17.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.212 -0.93 . . . . 0.0 110.383 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.426 ' CG2' HG11 ' A' ' 54' ' ' VAL . 60.1 mt -77.67 134.79 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.413 -0.805 . . . . 0.0 110.379 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.451 ' CD1' ' HB2' ' A' ' 27' ' ' PRO . 10.0 mp -126.6 10.14 7.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.877 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 176.31 96.97 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.983 -1.073 . . . . 0.0 110.013 179.06 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.476 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 33.7 m -86.99 118.32 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.858 . . . . 0.0 110.508 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 55.49 33.96 22.07 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.362 -0.836 . . . . 0.0 111.089 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.11 -11.4 72.03 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.555 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 53' ' ' SER . 0.3 OUTLIER -77.53 90.23 3.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.787 -1.42 . . . . 0.0 109.593 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -41.97 106.51 0.06 Allowed 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.557 0.694 . . . . 0.0 111.075 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.446 HD13 ' CB ' ' A' ' 67' ' ' ALA . 0.4 OUTLIER -98.9 -10.32 22.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.546 -0.722 . . . . 0.0 110.92 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.2 p -52.65 -36.53 57.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.02 -1.05 . . . . 0.0 110.296 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 m -113.57 49.34 0.98 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.167 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.429 ' CB ' HD11 ' A' ' 59' ' ' LEU . . . -130.74 149.2 52.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.236 -0.915 . . . . 0.0 110.303 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.9 p -72.41 163.01 28.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.369 -0.832 . . . . 0.0 109.882 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.503 ' CE1' ' CG ' ' B' ' 3' ' ' LYS . 7.7 t60 -54.48 -25.16 23.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.004 -1.06 . . . . 0.0 109.729 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -75.17 -43.93 49.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.063 -1.023 . . . . 0.0 108.796 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -28.83 68.52 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.502 -0.749 . . . . 0.0 109.419 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.446 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -77.51 -49.49 14.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.688 -0.633 . . . . 0.0 110.881 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.475 HG22 ' CD2' ' A' ' 64' ' ' HIS . 3.0 t -66.56 -30.54 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 119.206 -0.998 . . . . 0.0 108.927 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.58 -36.61 71.93 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.308 -0.87 . . . . 0.0 109.202 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.476 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -72.49 -35.76 68.24 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.245 -0.909 . . . . 0.0 109.302 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.446 ' HB3' ' CG1' ' B' ' 7' ' ' VAL . 4.1 mm? -69.18 -29.08 66.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.698 -0.626 . . . . 0.0 109.918 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -79.1 -37.85 37.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.212 -0.93 . . . . 0.0 109.87 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -104.33 33.52 3.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.423 -0.798 . . . . 0.0 109.591 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.438 HG23 ' CG1' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -73.39 138.09 45.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.403 -0.811 . . . . 0.0 110.188 -179.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.99 -178.46 52.4 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -53.31 -62.98 1.3 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -1.126 . . . . 0.0 110.366 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -73.59 90.59 1.78 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.209 -0.932 . . . . 0.0 109.223 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.438 ' CG1' HG23 ' A' ' 74' ' ' THR . 99.2 t -84.33 83.29 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 110.92 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.426 ' O ' ' CD2' ' A' ' 80' ' ' LEU . 9.0 t -74.98 124.92 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.426 ' CD1' HG13 ' A' ' 78' ' ' VAL . 13.0 mt -130.25 118.67 21.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.744 -1.223 . . . . 0.0 111.71 -178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -76.59 121.47 23.24 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.46 HG11 ' CB ' ' A' ' 2' ' ' ARG . 2.7 p -120.28 149.31 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 0.0 112.447 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.418 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -114.54 86.49 2.44 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.611 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.585 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -55.09 118.17 4.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.414 -0.804 . . . . 0.0 111.475 -177.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 mmt -95.98 51.01 1.21 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.319 -0.863 . . . . 0.0 108.769 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.8 tttt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.302 -179.402 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.503 ' CG ' ' CE1' ' A' ' 64' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.376 0.608 . . . . 0.0 110.523 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -58.5 96.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.468 -0.77 . . . . 0.0 110.593 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.401 ' OG ' ' NE2' ' A' ' 64' ' ' HIS . 8.2 m -84.22 -162.15 0.63 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.217 -0.927 . . . . 0.0 110.01 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.534 ' CD1' ' CZ ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -161.6 86.3 0.65 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.068 -1.02 . . . . 0.0 110.326 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 71' ' ' LEU . 39.1 t . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.05 -1.031 . . . . 0.0 109.979 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.53 0.681 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.44 ' CB ' HG11 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -158.78 143.47 15.9 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.483 -0.761 . . . . 0.0 109.614 -179.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.9 ptt-85 -122.28 136.56 54.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.121 -0.987 . . . . 0.0 110.115 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.425 HG12 ' CB ' ' A' ' 44' ' ' ALA . 46.6 t -139.31 134.26 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.103 -0.998 . . . . 0.0 110.538 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.7 m -118.04 125.22 49.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.393 -0.817 . . . . 0.0 110.08 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 78' ' ' VAL . 83.2 t -118.39 129.14 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.353 -0.842 . . . . 0.0 109.185 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.6 mtm-85 -96.61 85.47 3.87 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.912 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -83.96 176.5 8.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 110.392 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.9 -156.78 0.59 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.891 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -51.13 -53.12 37.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.027 -1.045 . . . . 0.0 110.317 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.45 70.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.27 -0.894 . . . . 0.0 110.293 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.18 33.73 6.08 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.86 143.73 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.434 ' CD2' ' HB3' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -109.82 -16.81 13.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -1.15 . . . . 0.0 110.382 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.44 ' CA ' ' HB2' ' A' ' 34' ' ' PHE . . . 56.48 90.47 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.478 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 0.7 OUTLIER -175.04 123.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.175 -1.191 . . . . 0.0 110.826 -178.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.423 ' HB3' ' CB ' ' A' ' 32' ' ' LYS . 29.7 t -111.07 125.04 53.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 109.403 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 30' ' ' ILE . 42.4 pt -105.0 150.66 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.135 -0.978 . . . . 0.0 110.883 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -133.9 158.97 42.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.377 -0.827 . . . . 0.0 109.848 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.1 -159.86 13.85 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.83 148.25 5.4 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.437 ' CB ' ' HA ' ' A' ' 63' ' ' THR . 10.5 ttp85 -60.46 -14.94 22.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -1.085 . . . . 0.0 110.809 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.63 -19.8 54.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.897 -1.127 . . . . 0.0 110.021 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -111.34 23.08 14.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.266 -0.896 . . . . 0.0 109.932 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 tptp 54.49 54.88 8.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.323 -0.86 . . . . 0.0 110.355 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.454 ' CE ' ' HD2' ' A' ' 27' ' ' PRO . 4.9 mmm -138.05 125.66 13.79 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.218 -0.926 . . . . 0.0 110.233 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.454 ' HD2' ' CE ' ' A' ' 26' ' ' MET . 48.3 Cg_endo -69.53 52.33 0.91 Allowed 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.104 1.203 . . . . 0.0 111.882 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.0 mm 42.96 90.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 121.116 -0.99 . . . . 0.0 110.285 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.448 HD13 ' N ' ' A' ' 49' ' ' ASP . 30.4 tp -98.9 124.97 44.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.887 -1.133 . . . . 0.0 111.785 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 56.2 mt -57.27 142.31 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.47 -0.769 . . . . 0.0 109.671 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.3 -25.9 4.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.136 -0.977 . . . . 0.0 110.904 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' CB ' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -141.11 105.59 4.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.02 -1.05 . . . . 0.0 110.628 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 33' ' ' ILE . 15.9 mm -90.38 115.71 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 109.085 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.523 ' CE1' ' CD2' ' B' ' 6' ' ' LEU . 17.2 m-85 -75.99 136.75 39.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.443 -0.785 . . . . 0.0 109.774 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.68 167.59 18.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.152 -0.968 . . . . 0.0 110.855 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.88 29.01 74.19 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.454 ' CD1' ' HB3' ' A' ' 34' ' ' PHE . 0.5 OUTLIER -137.47 160.23 39.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -1.157 . . . . 0.0 110.834 -179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -44.11 -69.63 0.13 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.495 -0.753 . . . . 0.0 111.935 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.434 ' HB3' ' CD2' ' A' ' 14' ' ' LEU . . . -45.55 -47.65 14.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.482 -0.761 . . . . 0.0 111.532 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.436 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 13.7 t70 -85.18 4.84 32.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.959 -1.088 . . . . 0.0 110.892 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -106.11 -3.14 21.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.822 -1.174 . . . . 0.0 110.835 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 t -99.82 14.71 29.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.922 -1.111 . . . . 0.0 110.643 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 47.43 39.24 8.87 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.043 -1.035 . . . . 0.0 110.904 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.487 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -152.28 -46.38 0.1 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.152 -0.967 . . . . 0.0 110.428 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.478 ' CD2' ' CD1' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -71.69 85.62 0.91 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.781 -1.2 . . . . 0.0 108.649 179.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.602 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.82 156.12 23.44 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.655 -179.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.432 ' N ' HG13 ' A' ' 33' ' ' ILE . 89.3 t -52.04 163.37 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.659 -1.275 . . . . 0.0 109.575 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.59 26.17 66.0 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.481 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 59.5 m-20 -112.94 101.24 9.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.506 -0.996 . . . . 0.0 110.57 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.444 ' CA ' HD11 ' A' ' 29' ' ' LEU . . . -79.4 110.0 14.29 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.369 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.9 mt -78.28 138.81 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.426 -0.796 . . . . 0.0 110.325 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.432 ' CD1' ' HB2' ' A' ' 27' ' ' PRO . 3.3 mp -135.34 15.35 3.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.591 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 14.6 t 175.59 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.409 -0.807 . . . . 0.0 109.267 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.491 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 33.8 m -100.68 122.23 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.253 -0.904 . . . . 0.0 110.96 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 57.43 28.24 15.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.442 -0.786 . . . . 0.0 111.466 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.26 22.46 32.14 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.585 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 53' ' ' SER . 9.1 mt-10 -115.72 93.22 4.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.97 -1.312 . . . . 0.0 109.539 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.42 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.62 0.724 . . . . 0.0 111.438 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.458 HD13 ' CB ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -87.61 -12.65 44.99 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.607 -0.683 . . . . 0.0 110.622 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.3 m -53.09 -31.8 43.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.994 -1.066 . . . . 0.0 110.442 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.61 33.25 3.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.194 -0.941 . . . . 0.0 110.475 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.436 ' CB ' HD11 ' A' ' 59' ' ' LEU . . . -124.7 144.94 49.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 0.0 110.203 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.437 ' HA ' ' CB ' ' A' ' 22' ' ' ARG . 51.1 p -76.9 166.19 23.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 109.835 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.478 ' CD2' ' O ' ' A' ' 64' ' ' HIS . 6.6 t60 -51.59 -25.04 6.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.056 -1.028 . . . . 0.0 110.071 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.69 -44.0 35.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.117 -0.989 . . . . 0.0 109.057 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.59 -22.34 66.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.387 -0.821 . . . . 0.0 109.499 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.458 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -80.6 -46.91 14.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.388 -0.82 . . . . 0.0 110.44 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.469 HG22 ' CD2' ' A' ' 64' ' ' HIS . 10.4 t -64.73 -29.82 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.99 -31.01 69.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.351 -0.843 . . . . 0.0 109.468 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.491 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -74.25 -33.31 63.27 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.276 -0.89 . . . . 0.0 109.679 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.438 ' HB3' ' CG1' ' B' ' 7' ' ' VAL . 4.4 mm? -72.02 -26.38 62.19 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.537 -0.727 . . . . 0.0 109.782 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.4 -41.36 24.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.251 -0.906 . . . . 0.0 109.939 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -93.63 23.21 4.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.678 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.477 ' CG2' ' CG2' ' A' ' 78' ' ' VAL . 74.4 m -54.83 129.86 38.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.394 -0.816 . . . . 0.0 110.16 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.79 176.91 46.32 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.82 -46.03 50.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -1.146 . . . . 0.0 110.517 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -90.94 106.15 18.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.026 -1.047 . . . . 0.0 109.092 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.477 ' CG2' ' CG2' ' A' ' 74' ' ' THR . 20.3 t -97.5 82.0 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.132 -0.98 . . . . 0.0 111.15 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.8 t -78.64 108.2 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 mp -114.82 112.22 22.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.78 -1.2 . . . . 0.0 112.529 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -74.89 124.48 26.96 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.44 HG11 ' CB ' ' A' ' 2' ' ' ARG . 2.2 p -127.53 147.6 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.949 -1.095 . . . . 0.0 111.768 -177.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -107.75 87.4 2.49 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.602 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -59.51 114.08 2.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.505 -0.747 . . . . 0.0 110.788 -177.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 mmm -93.62 59.95 2.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.883 . . . . 0.0 109.756 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.0 tttt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.285 -179.81 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.459 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 8.9 tttt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.236 0.541 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -117.88 86.23 2.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 110.196 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.04 -169.44 2.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.209 -0.932 . . . . 0.0 110.258 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.523 ' CD2' ' CE1' ' A' ' 34' ' ' PHE . 2.5 tm? -160.51 106.75 1.5 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 110.122 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 71' ' ' LEU . 61.6 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.163 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 121.225 0.536 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.447 ' CB ' HG11 ' A' ' 82' ' ' VAL . 1.6 tpt180 -167.6 143.92 4.17 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.321 -0.862 . . . . 0.0 109.74 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -119.98 136.75 54.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.09 -1.006 . . . . 0.0 110.29 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.438 ' CG1' ' HB2' ' A' ' 44' ' ' ALA . 54.9 t -142.75 159.6 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.968 . . . . 0.0 110.528 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.0 m -146.73 143.38 28.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.356 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.7 t -130.28 118.03 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.334 -0.854 . . . . 0.0 109.804 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -92.01 95.91 10.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.851 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt -49.76 119.15 3.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.318 -0.864 . . . . 0.0 110.722 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.81 118.68 24.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.839 . . . . 0.0 109.912 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.78 21.47 3.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.908 . . . . 0.0 110.285 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.32 98.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.291 -0.881 . . . . 0.0 110.432 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.13 -84.69 0.25 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.25 -178.18 22.34 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.67 -32.92 3.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.233 -1.157 . . . . 0.0 110.51 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.458 ' HA3' ' HG ' ' A' ' 37' ' ' LEU . . . 66.6 91.71 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.437 ' CD1' HD12 ' A' ' 30' ' ' ILE . 2.2 tt -179.15 119.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.094 -1.239 . . . . 0.0 110.56 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.427 ' HB3' ' HB3' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -105.71 91.48 3.77 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.24 -0.913 . . . . 0.0 109.177 178.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 30' ' ' ILE . 25.2 pt -69.16 155.35 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 111.131 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.11 175.2 9.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.089 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.61 -154.97 19.36 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 157.57 134.53 1.76 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' CB ' ' HA ' ' A' ' 63' ' ' THR . 7.2 ttp85 -60.07 -15.47 23.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.4 -1.059 . . . . 0.0 110.762 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.61 -15.15 61.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.856 -1.152 . . . . 0.0 109.813 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.93 22.15 11.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.16 -0.962 . . . . 0.0 109.663 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.67 58.16 5.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.888 . . . . 0.0 109.842 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.447 ' HE1' ' N ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -138.7 132.59 16.35 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.935 -179.454 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.447 ' N ' ' HE1' ' A' ' 26' ' ' MET . 46.3 Cg_endo -68.83 132.31 24.57 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 N-CA-C 108.332 -1.449 . . . . 0.0 108.332 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.458 HG13 ' CB ' ' A' ' 67' ' ' ALA . 17.4 mm -48.77 97.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.055 -1.028 . . . . 0.0 109.591 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 39.9 tp -101.24 128.73 47.23 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.438 -0.789 . . . . 0.0 112.149 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 64.0 mt -63.91 139.23 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.601 -0.687 . . . . 0.0 110.18 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.2 t -121.83 -25.3 5.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 110.641 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -137.25 108.83 6.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.088 -1.007 . . . . 0.0 110.501 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG13 ' N ' ' A' ' 47' ' ' VAL . 10.5 mm -94.64 105.55 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.13 -0.981 . . . . 0.0 108.853 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.516 ' CZ ' ' CD1' ' B' ' 6' ' ' LEU . 4.2 m-85 -56.75 134.41 54.9 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.274 0.559 . . . . 0.0 110.495 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -80.76 158.64 25.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.184 -0.947 . . . . 0.0 110.36 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.49 19.29 47.31 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.458 ' HG ' ' HA3' ' A' ' 15' ' ' GLY . 2.4 mm? -109.91 167.48 10.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.18 -1.188 . . . . 0.0 109.698 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.53 -65.84 0.54 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.013 -1.054 . . . . 0.0 110.96 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.436 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . -47.58 -37.7 12.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.309 -0.869 . . . . 0.0 111.284 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.431 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 9.3 t70 -86.62 -6.78 58.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.038 -1.039 . . . . 0.0 111.047 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -97.85 -1.86 42.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.825 -1.172 . . . . 0.0 110.911 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.6 t -97.81 13.61 29.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.839 -1.163 . . . . 0.0 110.708 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 45.52 59.18 3.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.316 -0.865 . . . . 0.0 111.141 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.484 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -174.1 -49.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.153 -0.967 . . . . 0.0 110.128 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.437 ' CD2' HD12 ' A' ' 30' ' ' ILE . 1.7 mt -70.95 84.02 0.68 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.933 -1.104 . . . . 0.0 108.303 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.597 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -111.0 153.13 25.99 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.879 -0.513 . . . . 0.0 110.083 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.435 ' N ' HG13 ' A' ' 33' ' ' ILE . 91.7 t -50.26 152.26 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.833 -1.167 . . . . 0.0 109.767 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.79 26.06 39.46 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.544 -1.823 . . . . 0.0 108.544 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.486 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 67.6 m-20 -111.53 100.08 8.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.396 -1.061 . . . . 0.0 110.627 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . . . -77.9 110.38 12.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.095 -1.003 . . . . 0.0 110.67 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 61.6 mt -79.29 134.64 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 110.232 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -125.64 10.95 7.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.258 -0.902 . . . . 0.0 110.439 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 175.99 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.031 -1.043 . . . . 0.0 109.765 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.443 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 27.5 m -76.24 126.46 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.365 -0.834 . . . . 0.0 110.847 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 79' ' ' VAL . 19.0 p30 37.19 40.45 0.18 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.57 -7.18 63.37 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.565 -1.302 . . . . 0.0 111.142 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.432 ' CB ' HG21 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -89.81 91.9 8.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.671 -1.488 . . . . 0.0 109.848 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -44.33 112.16 0.38 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.381 0.61 . . . . 0.0 110.888 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.449 HD13 ' CB ' ' A' ' 67' ' ' ALA . 0.9 OUTLIER -101.8 -5.97 24.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.323 -0.86 . . . . 0.0 110.962 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.5 m -55.36 -32.65 62.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.875 -1.141 . . . . 0.0 110.287 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.3 m -113.13 35.64 3.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.092 -1.005 . . . . 0.0 110.345 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.433 ' CB ' ' CD1' ' A' ' 59' ' ' LEU . . . -121.5 152.8 38.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.178 -0.951 . . . . 0.0 110.193 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.452 ' HA ' ' CB ' ' A' ' 22' ' ' ARG . 18.0 p -81.79 165.13 21.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.857 . . . . 0.0 109.87 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' A' ' 64' ' ' HIS . 6.1 t60 -52.55 -26.15 12.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.014 -1.054 . . . . 0.0 109.903 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.63 -45.73 51.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.052 -1.03 . . . . 0.0 108.923 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -61.26 -23.01 65.35 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.597 -0.689 . . . . 0.0 109.4 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.458 ' CB ' HG13 ' A' ' 28' ' ' ILE . . . -80.42 -47.22 14.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.788 . . . . 0.0 110.319 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.457 HG21 ' CD1' ' A' ' 18' ' ' ILE . 2.6 t -66.3 -33.07 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.481 -0.888 . . . . 0.0 108.773 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -56.25 -41.23 75.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.415 -0.803 . . . . 0.0 109.131 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.443 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -70.91 -26.35 63.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.439 -0.788 . . . . 0.0 109.35 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.432 ' HB3' ' CG1' ' B' ' 7' ' ' VAL . 3.5 mm? -80.6 -34.57 35.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.628 -0.67 . . . . 0.0 110.082 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -75.93 -33.87 59.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.064 -1.023 . . . . 0.0 110.125 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -112.07 36.27 3.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.631 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.425 ' CG2' HG23 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -71.42 137.65 48.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.391 -0.818 . . . . 0.0 110.077 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.18 -177.95 34.44 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -55.45 -76.61 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -1.158 . . . . 0.0 110.022 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -63.91 101.56 0.39 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.095 -1.003 . . . . 0.0 109.466 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.432 HG11 ' CD2' ' A' ' 80' ' ' LEU . 94.5 t -96.61 82.78 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 111.32 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 55' ' ' ASN . 35.0 t -80.26 113.73 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.432 ' CD2' HG11 ' A' ' 78' ' ' VAL . 13.0 mt -117.42 125.03 50.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.956 -1.09 . . . . 0.0 111.917 -177.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.78 125.39 29.28 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.447 HG11 ' CB ' ' A' ' 2' ' ' ARG . 1.8 p -126.03 147.94 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.993 -1.067 . . . . 0.0 111.749 -177.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.2 85.79 2.18 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.597 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -55.62 118.58 4.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.433 -0.792 . . . . 0.0 110.957 -177.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.9 mmm -96.76 49.58 1.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.184 -0.948 . . . . 0.0 109.401 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.8 tptt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.236 -179.669 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.43 ' HB3' ' ND1' ' A' ' 64' ' ' HIS . 32.2 tttt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.282 0.563 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 3.4 tt0 -153.87 138.31 16.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 110.032 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.403 ' CB ' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -126.59 -163.37 1.23 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.192 -0.942 . . . . 0.0 110.419 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 34' ' ' PHE . 1.4 tp -159.16 56.57 0.41 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.321 -0.862 . . . . 0.0 110.187 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 71' ' ' LEU . 53.4 t . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.048 -1.032 . . . . 0.0 110.255 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.408 ' O ' ' CG ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.317 0.58 . . . . 0.0 110.257 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.442 ' CB ' HG11 ' A' ' 82' ' ' VAL . 3.9 mtp85 -161.94 170.54 19.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 110.408 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' A' ' 3' ' ' ARG . 0.5 OUTLIER -138.88 116.7 11.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.408 -0.808 . . . . 0.0 109.206 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.442 ' CG1' ' HB2' ' A' ' 44' ' ' ALA . 65.7 t -121.24 136.85 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.992 -1.067 . . . . 0.0 110.841 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.8 m -125.08 126.26 45.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.371 -0.83 . . . . 0.0 109.881 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.404 ' CG2' HD13 ' A' ' 45' ' ' LEU . 89.3 t -121.79 115.35 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.138 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -87.7 114.87 24.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.127 -0.983 . . . . 0.0 109.871 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -115.51 79.37 1.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 110.662 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.34 -58.32 7.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.903 . . . . 0.0 110.078 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.09 -23.28 65.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 110.252 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.28 46.61 26.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.24 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.85 75.2 0.22 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.18 138.79 0.35 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.442 ' CD2' ' HB1' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -102.03 -14.61 17.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -1.116 . . . . 0.0 110.534 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.438 ' CA ' HD23 ' A' ' 37' ' ' LEU . . . 60.61 82.49 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 tt -173.11 120.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.427 -1.043 . . . . 0.0 110.341 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.481 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -112.08 119.38 38.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 109.543 179.152 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' ILE . 21.2 pt -100.72 151.66 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.236 -0.915 . . . . 0.0 111.266 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 pttt -131.04 160.74 33.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 109.643 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.59 -163.78 12.13 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.51 141.0 3.02 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -60.15 -15.59 25.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -1.091 . . . . 0.0 110.695 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -71.93 -16.86 62.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.886 -1.134 . . . . 0.0 109.796 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -125.66 24.18 7.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.246 -0.908 . . . . 0.0 109.706 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.19 92.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.336 -0.852 . . . . 0.0 110.259 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.483 ' HE1' ' N ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -170.92 128.25 0.71 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.904 . . . . 0.0 110.208 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.483 ' N ' ' HE1' ' A' ' 26' ' ' MET . 55.9 Cg_endo -72.82 46.51 1.07 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 O-C-N 123.448 1.236 . . . . 0.0 112.19 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.43 HG22 ' CB ' ' A' ' 67' ' ' ALA . 12.9 mm 44.33 90.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 120.797 -1.189 . . . . 0.0 110.756 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.448 ' CB ' ' HE3' ' A' ' 26' ' ' MET . 5.4 mt -97.28 132.84 42.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.799 -1.188 . . . . 0.0 111.613 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.473 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 54.8 mt -67.63 136.99 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.868 . . . . 0.0 108.854 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.1 -16.27 8.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.955 -1.091 . . . . 0.0 110.997 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.95 100.47 3.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.995 -1.065 . . . . 0.0 110.682 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.437 ' CG2' ' HB2' ' A' ' 40' ' ' ASP . 16.7 mm -86.83 94.12 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.417 -0.802 . . . . 0.0 108.894 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.485 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 4.3 m-30 -52.69 137.04 32.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.475 -0.765 . . . . 0.0 110.0 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -83.75 171.55 13.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.896 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.49 32.4 73.02 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -140.44 162.94 34.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.132 -1.216 . . . . 0.0 111.088 -179.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.43 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . . . -50.04 -56.59 10.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.523 -0.735 . . . . 0.0 111.461 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB1' ' CD2' ' A' ' 14' ' ' LEU . . . -55.67 -35.51 66.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.245 -0.909 . . . . 0.0 112.092 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.437 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 22.0 t70 -95.74 -3.11 46.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.916 -1.115 . . . . 0.0 111.474 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.43 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 1.4 pp0? -110.34 16.98 21.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.728 -1.233 . . . . 0.0 110.354 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.4 t -108.47 14.72 24.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.945 . . . . 0.0 110.777 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 45.5 54.38 7.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.197 -0.94 . . . . 0.0 111.343 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.484 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . . . -175.72 -50.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.127 -0.983 . . . . 0.0 110.445 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.473 ' CD2' ' CD1' ' A' ' 30' ' ' ILE . 1.4 mt -70.51 84.56 0.6 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.871 -1.143 . . . . 0.0 108.92 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.592 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -112.88 152.28 29.46 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.56 -179.399 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.407 ' N ' HG13 ' A' ' 33' ' ' ILE . 60.3 t -47.74 168.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.028 -1.045 . . . . 0.0 110.607 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.8 37.22 92.15 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.477 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 27.8 m-20 -120.89 107.61 12.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.256 -1.143 . . . . 0.0 110.483 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' N ' HD22 ' A' ' 29' ' ' LEU . . . -84.57 105.12 15.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.835 . . . . 0.0 110.147 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.0 mt -71.03 135.95 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.363 -0.835 . . . . 0.0 110.854 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.473 ' CD1' ' HB2' ' A' ' 27' ' ' PRO . 6.5 mp -125.63 6.97 7.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.391 -0.818 . . . . 0.0 110.96 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 176.1 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.97 -1.082 . . . . 0.0 109.978 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.491 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 17.5 m -96.53 119.22 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.134 -0.979 . . . . 0.0 110.865 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 45.8 m-80 57.06 33.52 23.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.53 -0.731 . . . . 0.0 111.573 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.82 12.05 61.07 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.944 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 53' ' ' SER . 10.1 mt-10 -105.46 90.5 3.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.7 -1.47 . . . . 0.0 109.741 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.33 102.01 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.479 0.656 . . . . 0.0 110.977 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.471 ' CD1' ' CB ' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -94.8 -14.04 25.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.429 -0.794 . . . . 0.0 110.703 -179.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.5 p -50.01 -32.62 15.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.004 -1.06 . . . . 0.0 110.437 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 t -107.75 31.41 5.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 109.987 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.471 ' CB ' ' CD1' ' A' ' 59' ' ' LEU . . . -122.43 163.66 19.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.378 -0.826 . . . . 0.0 110.346 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -85.12 165.07 17.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.399 -0.813 . . . . 0.0 110.375 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.554 ' CD2' ' CD ' ' B' ' 3' ' ' LYS . 3.4 t60 -53.72 -26.17 21.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 109.831 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -73.75 -36.58 65.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.081 -1.012 . . . . 0.0 109.335 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.419 ' CB ' ' HB2' ' A' ' 62' ' ' ALA . 1.3 mm-40 -68.86 -22.96 64.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.588 -0.695 . . . . 0.0 109.724 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.458 ' CA ' HD13 ' A' ' 59' ' ' LEU . . . -82.83 -41.05 19.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.299 -0.876 . . . . 0.0 110.545 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.442 HG21 ' CD1' ' A' ' 18' ' ' ILE . 2.9 t -72.85 -32.86 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.152 -0.968 . . . . 0.0 109.372 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -59.65 -38.1 80.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.371 -0.831 . . . . 0.0 109.952 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.491 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -70.45 -53.1 17.73 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.152 -0.967 . . . . 0.0 108.81 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.447 ' HA ' ' CG2' ' A' ' 74' ' ' THR . 96.4 mt -56.78 -22.43 35.89 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.709 -0.619 . . . . 0.0 109.485 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -79.52 -40.42 29.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.859 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 1.5 ttmt -119.11 59.54 0.83 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.405 -0.809 . . . . 0.0 109.869 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.447 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 66.4 p -78.06 -175.04 3.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.324 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.06 -171.46 20.13 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -48.57 -48.37 38.92 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.101 -1.235 . . . . 0.0 110.455 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 12.4 pt-20 -108.73 119.88 40.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.328 -0.857 . . . . 0.0 109.863 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.446 HG11 ' CD2' ' A' ' 80' ' ' LEU . 85.6 t -89.42 82.02 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.176 -0.952 . . . . 0.0 110.721 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.27 107.11 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.446 ' CD2' HG11 ' A' ' 78' ' ' VAL . 14.1 mt -113.34 115.77 28.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.805 -1.184 . . . . 0.0 111.576 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.407 ' CB ' ' OG ' ' A' ' 53' ' ' SER . 5.9 tp10 -67.79 124.59 23.75 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.442 HG11 ' CB ' ' A' ' 2' ' ' ARG . 2.4 p -121.74 141.53 41.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.003 -1.06 . . . . 0.0 112.199 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -107.41 81.3 1.51 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.592 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -50.52 122.19 6.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.576 -0.703 . . . . 0.0 111.191 -178.002 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.405 ' HG3' ' CD2' ' A' ' 29' ' ' LEU . 6.3 mmt -96.39 49.0 1.1 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.281 -0.887 . . . . 0.0 109.023 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.874 -1.06 . . . . 0.0 110.295 -179.512 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.554 ' CD ' ' CD2' ' A' ' 64' ' ' HIS . 1.6 mttm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.32 0.581 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 54.19 41.45 32.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 109.679 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.407 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . 1.3 m -57.28 -169.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.359 -0.838 . . . . 0.0 110.783 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.485 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 39.2 tp -156.71 117.58 3.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.387 -0.821 . . . . 0.0 110.086 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 66.2 t . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.157 179.749 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.44 0.638 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.44 ' HG2' ' CG1' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -161.91 146.61 12.83 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.461 -0.774 . . . . 0.0 109.586 -179.306 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.408 ' N ' ' HG3' ' A' ' 2' ' ' ARG . 1.6 mpp_? -120.59 126.57 50.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 109.927 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.454 ' CG2' HG12 ' A' ' 82' ' ' VAL . 54.5 t -121.51 153.87 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 110.549 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 84.8 m -139.16 109.69 6.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.514 -0.741 . . . . 0.0 109.513 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 78' ' ' VAL . 56.6 t -100.53 125.19 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 0.0 109.813 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.9 mtt-85 -99.11 96.91 8.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.933 . . . . 0.0 110.29 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -52.33 101.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.343 -0.848 . . . . 0.0 110.117 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.18 119.35 23.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.326 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.54 21.61 2.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.28 -0.888 . . . . 0.0 110.514 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.15 84.31 1.82 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 110.245 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.02 -41.65 53.04 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.89 154.92 42.06 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.431 ' CD2' ' HB3' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -105.62 -15.95 14.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.291 -1.123 . . . . 0.0 110.464 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.451 ' N ' ' CD2' ' A' ' 37' ' ' LEU . . . 56.9 86.72 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.417 ' CD1' HD22 ' A' ' 45' ' ' LEU . 6.2 tt -174.34 115.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.107 -1.231 . . . . 0.0 110.534 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.22 98.18 7.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.937 . . . . 0.0 109.728 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.476 HG13 ' CE1' ' A' ' 64' ' ' HIS . 44.7 pt -74.55 146.93 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 110.615 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -132.97 116.14 16.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.462 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.11 -160.38 30.78 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.17 134.47 1.65 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -14.85 23.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.465 -1.021 . . . . 0.0 110.807 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.29 5.53 22.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.984 -1.073 . . . . 0.0 110.138 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -140.94 25.65 2.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.093 -1.004 . . . . 0.0 109.463 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 54.75 83.23 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.333 -0.855 . . . . 0.0 109.62 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.452 ' HE2' ' HB2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -169.11 126.92 0.85 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.254 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.417 ' N ' ' HE1' ' A' ' 26' ' ' MET . 56.0 Cg_endo -76.76 45.66 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.459 1.241 . . . . 0.0 111.972 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.42 ' N ' ' HE3' ' A' ' 26' ' ' MET . 19.9 mm 45.07 89.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 O-C-N 120.869 -1.144 . . . . 0.0 110.218 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.477 HD13 ' N ' ' A' ' 49' ' ' ASP . 36.6 tp -103.7 127.58 51.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.853 -1.155 . . . . 0.0 111.751 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 61.8 mt -62.05 136.2 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.464 -0.772 . . . . 0.0 109.734 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 t -120.5 -18.59 7.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.218 -0.926 . . . . 0.0 110.734 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.5 104.77 4.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.972 -1.08 . . . . 0.0 110.517 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.448 ' CG2' ' HB2' ' A' ' 40' ' ' ASP . 10.8 mm -92.56 99.51 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.146 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.541 ' CE1' ' CD2' ' B' ' 6' ' ' LEU . 94.7 m-85 -59.64 136.34 57.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.488 -0.758 . . . . 0.0 110.271 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -80.37 174.49 11.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 110.649 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.77 28.33 62.91 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -136.54 160.45 38.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.106 -1.232 . . . . 0.0 110.726 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.433 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . . . -48.43 -57.71 5.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 111.502 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.481 ' CB ' ' CD2' ' A' ' 45' ' ' LEU . . . -52.04 -45.79 64.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 111.808 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.448 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 7.3 t70 -85.01 -17.29 38.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.913 -1.117 . . . . 0.0 111.623 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.433 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 1.5 pp0? -99.42 13.2 34.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.797 -1.189 . . . . 0.0 110.851 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.0 t -107.84 14.83 25.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.997 -1.064 . . . . 0.0 110.775 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 45.39 49.71 10.32 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.252 -0.905 . . . . 0.0 111.079 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.499 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -167.43 -55.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.585 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.481 ' CD2' ' CB ' ' A' ' 39' ' ' ALA . 2.4 tp -69.43 84.03 0.4 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.853 -1.154 . . . . 0.0 108.683 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.602 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.58 152.55 28.76 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.86 -0.525 . . . . 0.0 109.665 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.416 ' N ' HG13 ' A' ' 33' ' ' ILE . 65.7 t -49.26 153.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.919 -1.113 . . . . 0.0 110.035 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.76 24.08 50.84 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.487 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 69.4 m-20 -109.69 100.38 9.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.398 -1.06 . . . . 0.0 110.675 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . . . -78.28 102.23 7.55 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.152 -0.968 . . . . 0.0 110.022 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 81' ' ' GLU . 69.4 mt -71.03 138.03 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.428 -0.795 . . . . 0.0 110.702 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 83.0 mt -136.32 9.83 3.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.287 -0.883 . . . . 0.0 111.269 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.417 ' OG ' ' CB ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER 179.09 92.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.922 -1.111 . . . . 0.0 109.832 179.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.482 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 33.1 m -91.51 121.04 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.287 -0.883 . . . . 0.0 110.156 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 55.69 36.42 27.19 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.495 -0.753 . . . . 0.0 110.838 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.99 -7.35 78.08 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.743 -1.218 . . . . 0.0 110.388 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -78.63 93.81 4.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.741 -1.447 . . . . 0.0 109.513 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.71 102.87 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.525 0.678 . . . . 0.0 111.021 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.436 HD13 ' CB ' ' A' ' 67' ' ' ALA . 0.5 OUTLIER -91.0 -4.89 56.07 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.5 -0.75 . . . . 0.0 110.556 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 t -58.54 -43.16 89.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 110.242 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.2 m -102.27 35.25 2.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 110.343 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.426 ' CB ' HD11 ' A' ' 59' ' ' LEU . . . -119.29 145.39 46.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 110.274 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.2 p -78.23 168.6 19.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.911 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.527 ' CE1' ' HB3' ' B' ' 3' ' ' LYS . 7.7 t60 -54.51 -24.04 18.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.01 -1.056 . . . . 0.0 109.871 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.25 -43.39 42.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.12 -0.987 . . . . 0.0 109.12 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -65.61 -21.49 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.586 -0.696 . . . . 0.0 109.648 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.436 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -83.54 -47.5 11.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 110.583 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.466 HG22 ' CD2' ' A' ' 64' ' ' HIS . 7.8 t -62.8 -27.14 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.126 -0.983 . . . . 0.0 108.797 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -39.4 81.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.425 -0.797 . . . . 0.0 109.202 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.482 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -62.8 -44.35 96.39 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.355 -0.84 . . . . 0.0 108.849 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.449 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 3.8 mm? -69.7 -23.39 63.42 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -84.27 -42.04 16.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.977 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -100.79 24.33 9.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.0 109.89 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.38 154.23 36.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.916 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.54 -172.01 20.6 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -48.95 -62.32 1.59 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.061 -1.258 . . . . 0.0 110.389 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -83.62 115.92 22.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.083 -1.011 . . . . 0.0 108.639 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.451 ' CG1' ' CD2' ' A' ' 80' ' ' LEU . 71.5 t -109.39 89.85 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.072 -1.018 . . . . 0.0 111.154 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.7 t -76.96 123.46 33.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.451 ' CD2' ' CG1' ' A' ' 78' ' ' VAL . 15.5 mt -128.09 109.33 11.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.822 -1.174 . . . . 0.0 111.64 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.417 ' CB ' ' OG ' ' A' ' 53' ' ' SER . 13.6 tp10 -66.29 129.63 40.47 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.454 HG12 ' CG2' ' A' ' 4' ' ' VAL . 2.4 p -132.68 146.7 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.873 -1.142 . . . . 0.0 112.119 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -107.7 85.09 2.06 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.602 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -55.51 123.53 14.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.741 . . . . 0.0 110.99 -177.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.1 mmt -99.47 51.63 0.94 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.375 -0.828 . . . . 0.0 109.866 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.268 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.527 ' HB3' ' CE1' ' A' ' 64' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.185 0.517 . . . . 0.0 110.355 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 54.6 68.89 0.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.883 . . . . 0.0 110.361 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 39.8 t -66.21 -153.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.097 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.541 ' CD2' ' CE1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -175.81 66.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.115 -0.991 . . . . 0.0 110.328 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.439 ' CG1' ' HB3' ' A' ' 71' ' ' LEU . 46.6 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.236 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.312 0.577 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.446 ' CB ' HG11 ' A' ' 82' ' ' VAL . 1.6 mtp85 -157.15 165.42 36.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.319 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -140.97 112.53 7.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.409 -0.807 . . . . 0.0 109.229 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.445 ' CG2' ' HB2' ' A' ' 44' ' ' ALA . 37.5 t -124.56 152.85 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.039 -1.038 . . . . 0.0 110.529 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.3 m -139.99 143.57 36.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.365 -0.835 . . . . 0.0 110.124 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.5 t -130.75 109.7 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.919 . . . . 0.0 109.849 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.436 ' HD3' ' N ' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -72.19 113.52 9.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 110.159 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.98 62.04 0.44 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.351 -0.843 . . . . 0.0 110.408 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.5 -60.22 4.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 109.987 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -160.94 113.38 1.92 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.344 -0.848 . . . . 0.0 110.194 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -176.45 126.7 0.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -0.881 . . . . 0.0 110.015 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.92 58.86 3.89 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.29 146.61 4.53 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.408 ' CD2' HG23 ' A' ' 16' ' ' ILE . 1.4 tt -88.07 -23.98 23.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.255 -1.144 . . . . 0.0 110.215 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.446 ' HA3' ' HG ' ' A' ' 37' ' ' LEU . . . 70.94 79.93 0.35 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.436 HD11 ' CD1' ' A' ' 45' ' ' LEU . 2.7 tt -176.58 117.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.314 -1.109 . . . . 0.0 109.876 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.1 t -108.69 114.56 28.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.29 -0.881 . . . . 0.0 110.263 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 30' ' ' ILE . 27.2 pt -88.06 153.84 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 110.637 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' B' ' 3' ' ' LYS . 16.4 ttpp -142.83 118.47 10.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.272 -0.893 . . . . 0.0 110.054 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.55 -161.07 32.87 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 169.12 131.95 1.38 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -60.31 -15.34 24.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -1.191 . . . . 0.0 110.71 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.95 -14.02 58.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.94 -1.1 . . . . 0.0 109.977 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.87 24.0 11.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.809 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.1 tttt 54.67 78.81 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.995 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.442 ' HE2' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -161.95 120.77 1.42 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 110.409 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.45 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 50.6 Cg_endo -71.35 52.45 1.55 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 O-C-N 123.514 1.271 . . . . 0.0 111.966 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.427 ' N ' ' HE3' ' A' ' 26' ' ' MET . 6.9 mm 42.57 89.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.09 -1.006 . . . . 0.0 110.574 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 50' ' ' ALA . 6.0 mt -98.66 132.69 43.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.768 -1.208 . . . . 0.0 111.975 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 49.1 mt -66.52 133.53 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.306 -0.872 . . . . 0.0 108.815 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 t -116.79 -16.53 10.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.066 -1.021 . . . . 0.0 110.888 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.02 106.63 4.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.998 -1.064 . . . . 0.0 111.143 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 33' ' ' ILE . 12.2 mm -93.32 115.16 31.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.261 -0.899 . . . . 0.0 108.601 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.486 ' CZ ' HD23 ' B' ' 6' ' ' LEU . 10.0 m-85 -66.82 134.39 52.02 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.405 -0.809 . . . . 0.0 109.988 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.81 151.88 30.05 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.259 -0.9 . . . . 0.0 110.821 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.16 16.5 60.13 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.446 ' HG ' ' HA3' ' A' ' 15' ' ' GLY . 3.2 mm? -105.4 165.3 11.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -1.164 . . . . 0.0 110.298 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -48.42 -63.73 1.0 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.22 -0.925 . . . . 0.0 111.036 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.427 ' O ' ' CG2' ' A' ' 42' ' ' THR . . . -50.45 -53.0 32.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 110.721 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.439 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 24.1 t70 -73.09 -4.93 35.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.026 -1.046 . . . . 0.0 111.152 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -97.01 3.54 51.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.773 -1.205 . . . . 0.0 110.899 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.427 ' CG2' ' O ' ' A' ' 39' ' ' ALA . 7.2 t -107.68 15.17 24.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.805 -1.184 . . . . 0.0 110.781 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 47.31 56.95 6.27 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.12 -0.988 . . . . 0.0 110.954 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.488 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -173.74 -44.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 110.245 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.436 ' CD1' HD11 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -69.09 81.94 0.33 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.975 -1.078 . . . . 0.0 108.687 179.208 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.587 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.21 149.32 32.44 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.601 -0.687 . . . . 0.0 110.231 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.438 ' N ' HG13 ' A' ' 33' ' ' ILE . 84.5 t -49.89 169.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.124 -0.985 . . . . 0.0 110.404 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.61 32.96 75.35 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.479 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 27.6 m-20 -117.95 108.57 15.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.559 -0.965 . . . . 0.0 110.423 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.45 ' CB ' ' HG2' ' A' ' 27' ' ' PRO . . . -85.8 104.69 15.71 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.442 HG22 ' CG1' ' A' ' 54' ' ' VAL . 30.7 mt -70.36 134.05 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.356 -0.84 . . . . 0.0 110.136 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.44 ' CD1' ' HB2' ' A' ' 27' ' ' PRO . 2.4 mp -132.25 17.69 4.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 110.368 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 174.58 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.214 -0.929 . . . . 0.0 109.967 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.469 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 21.2 m -91.08 127.0 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.107 -0.996 . . . . 0.0 109.846 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.3 m120 57.72 38.64 27.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 0.0 110.013 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.83 29.87 70.74 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 53' ' ' SER . 7.4 tt0 -115.81 91.8 3.71 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -1.108 . . . . 0.0 109.579 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' HA ' ' OG ' ' A' ' 53' ' ' SER . 10.3 m-20 -37.91 102.04 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.691 0.758 . . . . 0.0 112.071 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.444 HD11 ' CB ' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -91.48 -13.63 31.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.648 -0.658 . . . . 0.0 110.483 179.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.1 m -53.52 -37.14 62.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.014 -1.054 . . . . 0.0 110.182 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.9 m -96.86 25.88 4.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 110.035 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.444 ' CB ' HD11 ' A' ' 59' ' ' LEU . . . -120.18 157.54 28.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 110.233 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 22' ' ' ARG . 32.0 p -88.95 164.96 14.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 110.081 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.529 ' CD2' ' HD2' ' B' ' 3' ' ' LYS . 2.1 t60 -52.0 -25.76 9.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.953 . . . . 0.0 109.578 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -73.13 -40.19 65.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.096 -1.003 . . . . 0.0 109.082 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -71.06 -25.57 62.69 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.441 -0.787 . . . . 0.0 109.452 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.441 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -76.35 -42.2 45.62 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.445 -0.784 . . . . 0.0 110.0 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.488 HG22 ' CD2' ' A' ' 64' ' ' HIS . 6.3 t -70.47 -30.63 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.189 -0.944 . . . . 0.0 109.08 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -58.87 -40.27 83.87 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.375 -0.828 . . . . 0.0 109.16 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.469 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -68.68 -46.75 68.23 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.355 -0.841 . . . . 0.0 108.814 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.459 ' N ' HD21 ' A' ' 71' ' ' LEU . 3.0 mm? -56.75 -30.13 63.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.681 -0.637 . . . . 0.0 109.63 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.3 -41.52 22.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.1 -1.0 . . . . 0.0 109.983 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -106.58 55.17 0.67 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.667 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 70' ' ' ALA . 33.2 p -79.11 149.14 32.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.323 -0.861 . . . . 0.0 109.657 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.04 -177.63 45.88 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -50.94 47.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.253 -1.145 . . . . 0.0 110.122 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -98.35 94.18 6.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -0.87 . . . . 0.0 109.423 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.8 t -63.72 78.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 111.085 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 77' ' ' GLU . 12.8 t -75.81 123.7 32.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.405 ' CD2' ' O ' ' A' ' 79' ' ' VAL . 13.0 mt -128.98 117.62 21.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.747 -1.22 . . . . 0.0 111.465 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -73.78 125.21 27.61 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.446 HG11 ' CB ' ' A' ' 2' ' ' ARG . 3.0 p -125.72 145.48 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.052 -1.03 . . . . 0.0 112.206 -177.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.53 86.41 2.36 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.587 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -52.91 129.46 30.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.572 -0.705 . . . . 0.0 110.959 -178.121 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.4 mmt -101.29 46.66 0.93 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.292 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.284 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.529 ' HD2' ' CD2' ' A' ' 64' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.29 0.566 . . . . 0.0 110.59 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.8 mt-10 -109.37 -158.89 0.66 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.455 -0.778 . . . . 0.0 109.048 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.85 -48.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.83 -1.169 . . . . 0.0 110.806 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.486 HD23 ' CZ ' ' A' ' 34' ' ' PHE . 13.0 tp 54.6 92.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 109.936 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.028 179.82 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.271 0.558 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.534 ' HD2' ' CD2' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -122.52 147.35 46.47 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.272 -0.892 . . . . 0.0 109.032 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -105.24 106.49 17.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.054 -1.029 . . . . 0.0 110.058 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.424 ' CG1' HD21 ' A' ' 45' ' ' LEU . 61.1 t -107.48 128.86 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.948 . . . . 0.0 110.266 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.0 m -115.28 111.23 20.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 110.125 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.0 t -97.09 118.54 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.846 . . . . 0.0 109.823 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.13 110.23 19.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.232 -0.917 . . . . 0.0 110.288 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -85.11 90.14 7.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.347 -0.846 . . . . 0.0 110.18 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.11 -74.2 0.43 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.929 . . . . 0.0 110.333 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.7 -19.03 65.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.035 -1.041 . . . . 0.0 110.641 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 52.41 54.62 10.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.051 -1.031 . . . . 0.0 110.239 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -117.38 50.57 0.79 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.36 139.01 10.54 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.21 -21.1 18.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -1.183 . . . . 0.0 110.132 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.476 ' CA ' ' HB2' ' A' ' 34' ' ' PHE . . . 58.27 87.46 0.02 OUTLIER Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.6 tt -176.51 117.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.184 -1.186 . . . . 0.0 110.404 -178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.2 t -106.94 117.82 35.06 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.295 -0.878 . . . . 0.0 109.619 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.498 HG13 ' CE1' ' A' ' 64' ' ' HIS . 43.7 pt -94.85 150.26 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 110.817 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -138.49 120.26 15.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 110.183 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.18 -153.43 24.61 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 157.19 134.13 1.71 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -14.77 22.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.374 -1.074 . . . . 0.0 110.547 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' OE2' ' ND2' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -80.32 1.88 26.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.949 -1.094 . . . . 0.0 110.469 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.414 ' ND2' ' OE2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -138.07 26.17 2.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.973 -1.08 . . . . 0.0 109.795 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 54.47 66.99 1.08 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 110.113 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.459 ' CE ' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -149.86 115.89 3.52 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.436 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.459 ' HD2' ' CE ' ' A' ' 26' ' ' MET . 49.2 Cg_endo -68.2 55.38 0.76 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.321 1.347 . . . . 0.0 111.793 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 64' ' ' HIS . 16.0 mm 41.66 88.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 121.286 -0.884 . . . . 0.0 110.446 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 34.3 tp -101.88 126.66 48.83 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.831 -1.168 . . . . 0.0 112.121 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 55.6 mt -64.41 140.88 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.686 -0.634 . . . . 0.0 109.953 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.6 t -128.68 4.14 5.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 110.718 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' CE ' ' OE2' ' B' ' 4' ' ' GLU . 1.9 ttmt -165.03 99.89 0.75 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.818 -1.176 . . . . 0.0 110.263 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.432 HG13 ' N ' ' A' ' 47' ' ' VAL . 14.4 mm -89.64 111.88 23.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.32 -0.862 . . . . 0.0 109.318 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.487 ' CE1' HD12 ' B' ' 6' ' ' LEU . 16.2 m-85 -74.3 126.83 31.51 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.47 -0.769 . . . . 0.0 109.984 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -75.62 170.54 15.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.312 -0.867 . . . . 0.0 110.548 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.52 26.19 71.77 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.447 ' CD1' ' HB3' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -138.99 159.55 41.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -1.19 . . . . 0.0 110.918 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -42.72 -66.36 0.37 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.648 -0.658 . . . . 0.0 112.128 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 45' ' ' LEU . . . -45.83 -59.3 2.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.316 -0.865 . . . . 0.0 111.354 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.401 ' HB2' HG21 ' A' ' 33' ' ' ILE . 39.7 t0 -71.97 -4.19 27.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.904 -1.123 . . . . 0.0 111.114 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -107.78 11.82 27.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.555 -1.341 . . . . 0.0 110.726 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 t -108.42 15.73 23.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.956 -1.09 . . . . 0.0 110.708 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 47.86 51.08 14.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.07 -1.019 . . . . 0.0 110.846 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.48 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -172.73 -45.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -0.918 . . . . 0.0 110.017 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.436 ' CD1' HD12 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -67.26 81.49 0.14 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.017 -1.052 . . . . 0.0 109.344 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -113.21 152.7 29.42 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.479 -0.763 . . . . 0.0 109.978 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.432 ' N ' HG13 ' A' ' 33' ' ' ILE . 86.4 t -50.94 163.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.783 -1.198 . . . . 0.0 109.98 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.0 28.5 62.36 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.449 ' N ' HD13 ' A' ' 29' ' ' LEU . 46.3 m-20 -109.81 98.15 7.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.387 -1.066 . . . . 0.0 110.705 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 29' ' ' LEU . . . -75.4 92.61 2.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 0.0 110.282 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 51.6 mt -64.13 136.72 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.386 -0.821 . . . . 0.0 110.191 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.448 ' CD2' ' HB3' ' A' ' 27' ' ' PRO . 10.5 mt -136.11 19.82 3.21 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.375 -0.828 . . . . 0.0 109.591 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.444 ' HB3' ' CB ' ' A' ' 81' ' ' GLU . 22.6 t 177.72 126.46 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.594 -0.691 . . . . 0.0 109.351 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.463 HG23 ' CB ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -124.81 116.68 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 58.58 31.95 21.62 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.481 -0.762 . . . . 0.0 110.643 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.44 23.92 32.61 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 53' ' ' SER . 4.9 tt0 -115.4 88.23 2.83 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.026 -1.279 . . . . 0.0 110.079 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -44.62 101.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.504 -0.748 . . . . 0.0 111.28 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.438 ' CD1' HG21 ' A' ' 54' ' ' VAL . 70.5 mt -81.3 -13.04 58.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 110.358 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 t -48.5 -33.45 9.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.16 -0.963 . . . . 0.0 110.284 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.43 27.97 7.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.353 -0.842 . . . . 0.0 109.591 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.81 149.07 46.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.407 -0.808 . . . . 0.0 110.493 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 p -79.86 166.43 21.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.312 -0.868 . . . . 0.0 109.812 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.498 ' CE1' HG13 ' A' ' 18' ' ' ILE . 2.4 t60 -55.48 -31.83 62.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.082 -1.011 . . . . 0.0 109.854 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.66 -32.43 65.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.824 -1.173 . . . . 0.0 109.547 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -72.65 -28.39 62.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.55 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.08 -41.72 41.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.757 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.46 HG21 ' CD1' ' A' ' 18' ' ' ILE . 7.3 t -63.79 -26.96 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.544 -0.862 . . . . 0.0 108.98 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -36.58 81.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.522 -0.736 . . . . 0.0 109.549 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.463 ' CB ' HG23 ' A' ' 54' ' ' VAL . . . -72.36 -39.89 67.73 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.169 -0.957 . . . . 0.0 109.262 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.428 ' N ' HD21 ' A' ' 71' ' ' LEU . 4.0 mm? -60.64 -29.92 69.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.368 -0.832 . . . . 0.0 108.918 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -84.75 -36.77 21.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.853 . . . . 0.0 110.118 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -106.05 27.34 8.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.974 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -67.29 166.58 14.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.133 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.19 -176.01 21.4 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -51.78 -63.1 1.24 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.204 -1.174 . . . . 0.0 110.4 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -81.8 88.02 6.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.206 -0.934 . . . . 0.0 109.915 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.428 HG13 ' CG ' ' A' ' 80' ' ' LEU . 53.9 t -80.4 90.35 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.932 . . . . 0.0 110.644 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 t -80.68 117.3 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.433 HD21 ' CG1' ' A' ' 54' ' ' VAL . 17.3 mt -122.5 116.02 23.2 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.409 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.444 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 0.8 OUTLIER -74.0 133.51 42.98 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.655 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.498 ' CG1' ' HB2' ' A' ' 2' ' ' ARG . 4.0 p -129.99 153.68 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.95 -1.093 . . . . 0.0 112.519 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.424 ' N ' HG21 ' A' ' 82' ' ' VAL . 2.6 mtpt -115.53 81.55 1.61 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -47.96 121.13 3.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.457 -0.777 . . . . 0.0 111.334 -177.668 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.3 mtt -116.15 52.21 0.92 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.48 -0.762 . . . . 0.0 109.311 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.396 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.48 ' HG2' ' CD2' ' A' ' 64' ' ' HIS . 6.9 tttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.167 0.508 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.416 ' OE2' ' CE ' ' A' ' 32' ' ' LYS . 1.2 tt0 -113.71 70.31 0.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 109.938 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.6 -176.42 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.265 -0.897 . . . . 0.0 110.73 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.487 HD12 ' CE1' ' A' ' 34' ' ' PHE . 21.8 tp -160.15 90.64 0.91 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.443 -0.785 . . . . 0.0 109.855 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' A' ' 71' ' ' LEU . 93.1 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.122 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.267 0.556 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.487 ' HD2' ' CD2' ' A' ' 84' ' ' TYR . 1.1 ttm-85 -152.83 172.65 16.41 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 0.0 109.939 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.84 135.44 14.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.916 . . . . 0.0 109.349 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.448 ' CG2' ' HB2' ' A' ' 44' ' ' ALA . 66.6 t -142.19 137.67 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.05 -1.031 . . . . 0.0 110.997 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.9 m -121.08 114.08 20.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.522 -0.736 . . . . 0.0 109.304 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.421 ' HB ' ' HB ' ' A' ' 78' ' ' VAL . 83.1 t -105.53 119.51 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.123 -0.986 . . . . 0.0 110.826 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.03 123.38 42.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.396 -0.815 . . . . 0.0 109.74 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -131.38 173.03 11.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.136 -0.977 . . . . 0.0 110.468 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -163.92 142.6 7.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 109.947 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 t0 62.99 133.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.29 -0.881 . . . . 0.0 110.116 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 61.56 121.88 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.652 -0.655 . . . . 0.0 110.324 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.75 62.73 4.37 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.99 96.96 0.93 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.73 -19.94 21.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -1.142 . . . . 0.0 110.505 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.454 ' N ' ' CD2' ' A' ' 37' ' ' LEU . . . 57.84 89.78 0.01 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.48 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 0.9 OUTLIER -174.92 120.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.237 -1.155 . . . . 0.0 110.316 -179.043 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.416 ' HB3' ' CB ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -110.56 93.62 4.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.253 -0.904 . . . . 0.0 109.755 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.46 ' CD1' HG21 ' A' ' 68' ' ' VAL . 28.9 pt -73.62 148.67 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.378 -0.826 . . . . 0.0 110.557 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -136.88 144.46 43.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.01 . . . . 0.0 110.183 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 136.85 -158.34 24.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 165.89 133.24 1.48 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.432 ' CB ' ' HA ' ' A' ' 63' ' ' THR . 1.9 ttp85 -59.53 -15.64 19.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -1.13 . . . . 0.0 110.64 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -14.2 60.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.946 -1.096 . . . . 0.0 109.922 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.02 24.36 10.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.189 -0.944 . . . . 0.0 109.704 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.39 73.21 0.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 110.166 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.434 ' HE1' ' N ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -150.4 123.96 4.4 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.93 . . . . 0.0 110.317 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.443 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 54.8 Cg_endo -73.04 50.23 1.78 Allowed 'Trans proline' 0 N--CA 1.493 1.448 0 O-C-N 123.35 1.184 . . . . 0.0 111.752 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.0 mm 43.06 89.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.498 0 O-C-N 121.101 -0.999 . . . . 0.0 110.656 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 50' ' ' ALA . 6.1 mt -96.57 132.87 41.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.88 -1.137 . . . . 0.0 111.723 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 30' ' ' ILE . 52.3 mt -67.49 135.55 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.7 t -116.29 -36.04 4.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.062 -1.024 . . . . 0.0 110.815 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' CB ' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -129.06 105.04 7.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.056 -1.028 . . . . 0.0 110.82 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.434 ' CD1' HG23 ' A' ' 30' ' ' ILE . 10.1 mm -90.45 97.2 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.198 -0.939 . . . . 0.0 109.139 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.535 ' CZ ' ' CD1' ' B' ' 6' ' ' LEU . 96.3 m-85 -61.89 133.86 55.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.476 -0.765 . . . . 0.0 110.529 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -79.06 175.91 10.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.829 . . . . 0.0 110.432 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.61 25.08 60.51 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -134.88 159.42 41.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.144 . . . . 0.0 110.386 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -47.54 -59.06 3.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.382 -0.824 . . . . 0.0 111.17 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.4 -44.55 34.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.279 -0.888 . . . . 0.0 111.334 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.426 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 16.4 t70 -95.87 11.13 34.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 111.092 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -107.12 -4.74 18.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.823 -1.173 . . . . 0.0 110.588 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 t -105.56 14.44 28.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.827 -1.171 . . . . 0.0 110.704 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 46.21 53.85 8.97 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.23 -0.919 . . . . 0.0 110.951 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.489 ' O ' ' CE2' ' A' ' 46' ' ' PHE . . . -160.74 -48.43 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.239 -0.913 . . . . 0.0 110.036 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.48 ' CD2' ' CD1' ' A' ' 16' ' ' ILE . 0.3 OUTLIER -72.64 87.63 1.24 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.843 -1.161 . . . . 0.0 108.0 178.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.589 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -113.2 149.57 33.53 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.133 0.492 . . . . 0.0 110.175 -178.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.413 ' N ' HG13 ' A' ' 33' ' ' ILE . 56.3 t -47.19 154.2 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.048 -1.032 . . . . 0.0 110.331 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.18 28.74 43.68 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.485 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 62.3 m-20 -113.43 103.38 11.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.438 -1.036 . . . . 0.0 110.435 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.447 ' N ' HD22 ' A' ' 29' ' ' LEU . . . -80.29 108.28 13.77 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.186 -0.946 . . . . 0.0 109.295 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.446 HD12 HG22 ' A' ' 51' ' ' ILE . 51.4 mt -75.4 134.55 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 111.085 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.432 ' N ' HD21 ' A' ' 52' ' ' LEU . 4.5 mm? -119.58 14.04 12.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.505 -0.747 . . . . 0.0 109.81 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 1.3 t 178.02 146.33 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 108.997 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.48 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 2.6 m -138.72 125.28 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.985 -1.072 . . . . 0.0 111.186 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.445 ' ND2' ' HA ' ' A' ' 78' ' ' VAL . 6.3 m120 59.12 16.08 4.55 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.411 -0.806 . . . . 0.0 111.233 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.9 24.98 7.02 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.481 ' O ' ' CB ' ' A' ' 53' ' ' SER . 2.4 mm-40 -116.26 166.14 12.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -1.163 . . . . 0.0 108.686 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.16 119.57 39.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.058 -1.026 . . . . 0.0 110.062 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.446 HD13 ' CB ' ' A' ' 67' ' ' ALA . 2.0 mm? -101.1 -9.52 21.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 110.693 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -51.64 -28.87 15.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.972 -1.08 . . . . 0.0 110.483 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.9 m -120.65 46.76 1.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.37 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.427 ' CB ' HD11 ' A' ' 59' ' ' LEU . . . -135.57 157.2 47.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 110.207 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.432 ' HA ' ' CB ' ' A' ' 22' ' ' ARG . 33.7 p -87.94 167.79 13.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.398 -0.814 . . . . 0.0 110.34 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.491 ' CD2' HG22 ' A' ' 68' ' ' VAL . 6.1 t60 -53.69 -24.51 14.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.181 -0.95 . . . . 0.0 109.622 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.37 -39.99 52.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 109.455 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -68.32 -25.87 65.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.482 -0.761 . . . . 0.0 109.623 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.446 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -79.33 -44.32 21.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.345 -0.847 . . . . 0.0 110.38 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.491 HG22 ' CD2' ' A' ' 64' ' ' HIS . 4.0 t -69.06 -30.49 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.064 -1.022 . . . . 0.0 108.745 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.65 -38.07 71.64 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.484 -0.76 . . . . 0.0 109.236 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.48 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -74.02 -25.87 60.11 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.402 -0.811 . . . . 0.0 109.478 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.443 ' HB3' ' CG1' ' B' ' 7' ' ' VAL . 3.6 mm? -75.18 -27.86 59.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.408 -0.808 . . . . 0.0 109.893 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -76.61 -42.5 42.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.907 . . . . 0.0 110.162 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -95.16 22.23 6.96 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.246 -0.909 . . . . 0.0 109.965 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.484 ' CG2' ' CG2' ' A' ' 78' ' ' VAL . 60.2 m -52.91 132.51 37.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 110.518 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.39 178.29 51.65 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -52.99 -32.76 48.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.209 -1.171 . . . . 0.0 110.34 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.427 ' N ' ' HG3' ' A' ' 76' ' ' LYS . 9.3 tt0 -101.81 109.0 20.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 108.983 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.484 ' CG2' ' CG2' ' A' ' 74' ' ' THR . 22.0 t -97.0 82.41 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 0.0 111.052 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.422 ' CG2' ' OE2' ' A' ' 77' ' ' GLU . 3.3 t -78.2 108.48 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.446 ' CD1' HG13 ' A' ' 78' ' ' VAL . 5.7 mp -118.73 109.09 15.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.025 -1.047 . . . . 0.0 112.508 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -71.04 137.9 49.39 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.448 ' CG1' ' HB3' ' A' ' 2' ' ' ARG . 2.2 p -139.22 145.64 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.81 -1.181 . . . . 0.0 112.093 -177.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.75 88.57 2.79 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.589 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -55.62 114.78 2.0 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.463 -0.773 . . . . 0.0 111.151 -177.671 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.4 mtt -100.38 50.93 0.89 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 108.992 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.197 -179.406 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 tttt . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.188 0.518 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 47.2 tt0 -153.66 106.46 2.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.322 -0.861 . . . . 0.0 110.065 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 70.3 m -109.01 131.29 55.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.143 -0.973 . . . . 0.0 110.206 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.535 ' CD1' ' CZ ' ' A' ' 34' ' ' PHE . 0.5 OUTLIER -100.13 96.81 7.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -0.836 . . . . 0.0 110.751 -179.601 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 71' ' ' LEU . 44.5 t . . . . . 0 N--CA 1.492 1.667 0 O-C-N 120.919 -1.113 . . . . 0.0 110.133 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.442 0.639 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.445 ' CB ' HG11 ' A' ' 82' ' ' VAL . 1.7 mtp85 -153.51 168.17 27.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.409 -0.807 . . . . 0.0 110.187 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -135.57 118.83 16.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 0.0 109.384 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 44' ' ' ALA . 60.3 t -124.04 128.85 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.004 -1.06 . . . . 0.0 110.691 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.7 m -118.26 118.8 32.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.453 -0.78 . . . . 0.0 109.768 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.445 ' CG2' HD11 ' A' ' 45' ' ' LEU . 89.7 t -113.73 108.08 24.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.63 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.7 mtm105 -65.34 110.78 2.74 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.524 -0.735 . . . . 0.0 110.048 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.425 ' HE2' ' CD1' ' A' ' 14' ' ' LEU . 2.3 tttp -125.14 149.9 47.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.359 -0.838 . . . . 0.0 110.423 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.58 -158.08 0.64 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.416 -0.803 . . . . 0.0 110.117 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.11 20.81 4.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.167 -0.958 . . . . 0.0 110.377 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.44 118.86 2.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 110.05 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.403 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . . . 134.81 106.84 0.9 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.94 157.46 1.77 Allowed Glycine 0 N--CA 1.495 2.584 0 O-C-N 120.784 -1.421 . . . . 0.0 109.842 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.43 ' CD2' ' HB3' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -93.43 -14.99 26.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.277 -1.131 . . . . 0.0 110.756 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.462 ' N ' ' CD2' ' A' ' 37' ' ' LEU . . . 58.21 83.39 0.05 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.4 tt -175.16 117.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.218 -1.166 . . . . 0.0 110.002 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' B' ' 6' ' ' LEU . 1.2 t -108.44 106.52 16.66 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.131 -0.981 . . . . 0.0 110.089 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.465 ' CD1' HG21 ' A' ' 68' ' ' VAL . 20.4 pt -83.65 145.85 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.406 -0.809 . . . . 0.0 110.275 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.447 ' CG ' ' HB2' ' A' ' 31' ' ' SER . 3.2 ptmt -128.61 153.19 47.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.974 -1.079 . . . . 0.0 109.066 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 127.89 -157.65 21.14 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.274 -1.441 . . . . 0.0 110.338 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 162.22 134.68 1.68 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -16.66 16.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -1.08 . . . . 0.0 110.603 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -14.74 60.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.736 -1.227 . . . . 0.0 110.246 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.3 28.14 7.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.976 . . . . 0.0 110.006 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt 52.48 81.76 0.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.218 -0.926 . . . . 0.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.431 ' HE3' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -160.23 122.46 1.82 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.185 -0.947 . . . . 0.0 110.336 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.441 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 54.3 Cg_endo -72.38 50.95 1.69 Allowed 'Trans proline' 0 N--CA 1.494 1.554 0 O-C-N 123.42 1.221 . . . . 0.0 111.773 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.434 HG22 ' CB ' ' A' ' 67' ' ' ALA . 17.6 mm 42.36 87.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 121.108 -0.995 . . . . 0.0 110.746 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 50' ' ' ALA . 5.9 mt -95.28 134.58 37.89 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.822 -1.174 . . . . 0.0 111.849 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.471 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 59.5 mt -66.95 138.03 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.218 -0.926 . . . . 0.0 108.831 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.447 ' HB2' ' CG ' ' A' ' 19' ' ' LYS . 47.4 t -120.37 -26.29 5.45 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.975 -1.078 . . . . 0.0 110.941 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.84 105.5 5.59 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.069 -1.019 . . . . 0.0 111.019 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.453 HD11 HG21 ' A' ' 33' ' ' ILE . 15.3 mm -90.71 96.97 6.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.53 ' CE1' ' CD2' ' B' ' 6' ' ' LEU . 95.9 m-85 -62.34 134.79 56.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.605 -0.685 . . . . 0.0 110.625 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.17 176.1 9.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.421 -0.8 . . . . 0.0 110.528 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.55 28.62 51.81 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.462 ' CD2' ' N ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -136.42 162.69 32.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -1.162 . . . . 0.0 110.65 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.8 -55.21 24.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.582 -0.699 . . . . 0.0 111.916 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.43 ' HB3' ' CD2' ' A' ' 14' ' ' LEU . . . -56.37 -37.01 69.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.115 -0.99 . . . . 0.0 112.126 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.414 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 17.6 t70 -92.77 -6.23 49.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.807 -1.183 . . . . 0.0 111.615 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.82 15.7 25.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.807 -1.183 . . . . 0.0 110.525 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.9 t -108.91 14.56 24.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.101 -1.0 . . . . 0.0 110.812 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 45.22 48.41 10.11 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.199 -0.938 . . . . 0.0 111.419 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.493 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . . . -169.15 -46.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 0.0 110.471 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.471 ' CD2' ' CD1' ' A' ' 30' ' ' ILE . 2.2 mt -71.66 84.83 0.89 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.812 -1.18 . . . . 0.0 108.568 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.595 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -111.13 151.22 28.39 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.739 -179.198 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.451 ' N ' HG13 ' A' ' 33' ' ' ILE . 98.3 t -50.36 159.14 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.851 -1.156 . . . . 0.0 110.008 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.56 31.11 51.6 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 42.2 m-20 -114.25 104.77 12.42 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.542 -0.975 . . . . 0.0 110.354 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.446 ' N ' HD22 ' A' ' 29' ' ' LEU . . . -82.86 110.58 17.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.151 -0.968 . . . . 0.0 109.761 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 51' ' ' ILE . 71.9 mt -77.28 136.89 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.87 . . . . 0.0 110.891 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.438 ' CD2' ' N ' ' A' ' 52' ' ' LEU . 4.4 mm? -120.43 -0.44 10.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.464 -0.772 . . . . 0.0 110.844 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 2.5 p -178.79 103.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.875 -1.141 . . . . 0.0 109.819 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.503 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 17.1 m -92.46 121.38 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.167 -0.958 . . . . 0.0 110.351 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 57.65 34.2 24.21 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.135 -0.978 . . . . 0.0 110.917 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.96 17.62 67.08 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 53' ' ' SER . 4.8 tt0 -105.01 91.24 3.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.019 -1.283 . . . . 0.0 109.805 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -43.49 99.52 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.523 0.678 . . . . 0.0 111.135 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.468 ' CD1' ' CB ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -92.54 24.88 3.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -0.796 . . . . 0.0 110.292 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 61' ' ' SER . 52.6 p -73.92 -58.71 3.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.147 -0.971 . . . . 0.0 110.397 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.425 ' N ' ' OG ' ' A' ' 60' ' ' SER . 0.8 OUTLIER -80.47 -19.21 46.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 110.096 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.468 ' CB ' ' CD1' ' A' ' 59' ' ' LEU . . . -57.54 167.54 1.01 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.36 -0.837 . . . . 0.0 110.589 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.5 p -100.72 -166.76 1.35 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.398 -0.814 . . . . 0.0 108.98 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.49 ' CE1' ' HG3' ' B' ' 3' ' ' LYS . 7.3 t60 -75.18 -23.6 57.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.006 -1.059 . . . . 0.0 109.981 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.01 -34.76 61.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.961 . . . . 0.0 109.663 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -72.55 -25.55 61.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 109.849 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.451 ' CA ' HD13 ' A' ' 59' ' ' LEU . . . -78.91 -38.88 36.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 110.205 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' A' ' 18' ' ' ILE . 2.9 t -75.03 -37.86 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.216 -0.928 . . . . 0.0 108.806 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -55.47 -38.89 69.69 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.443 -0.786 . . . . 0.0 109.965 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.503 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -70.53 -49.4 48.54 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.112 -0.992 . . . . 0.0 109.107 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.436 ' HA ' ' CG2' ' A' ' 74' ' ' THR . 79.1 mt -61.1 -23.94 65.86 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.656 -0.653 . . . . 0.0 109.666 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -76.11 -37.17 58.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.084 -1.01 . . . . 0.0 109.082 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 17.0 ttmt -121.72 51.07 1.35 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.436 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 58.8 p -52.44 -85.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 110.615 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.432 ' N ' ' OG1' ' A' ' 74' ' ' THR . . . 147.99 -172.81 28.22 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.412 ' CG ' ' N ' ' A' ' 77' ' ' GLU . 3.7 pttt -49.08 -40.28 31.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.247 -1.149 . . . . 0.0 110.441 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 76' ' ' LYS . 25.8 pt-20 -128.58 129.94 46.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.326 -0.859 . . . . 0.0 109.672 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.45 HG13 ' CD1' ' A' ' 80' ' ' LEU . 45.2 t -96.8 79.63 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.036 -1.04 . . . . 0.0 111.12 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.1 t -73.43 112.09 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.45 ' CD1' HG13 ' A' ' 78' ' ' VAL . 4.8 mp -120.34 110.14 16.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.915 -1.116 . . . . 0.0 111.943 -177.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.412 ' CB ' ' OG ' ' A' ' 53' ' ' SER . 1.1 tp10 -69.32 122.7 19.42 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.445 HG11 ' CB ' ' A' ' 2' ' ' ARG . 2.4 p -118.31 146.35 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.092 -1.005 . . . . 0.0 112.19 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -113.18 82.42 1.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.595 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -50.11 127.11 16.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.529 -0.732 . . . . 0.0 111.211 -177.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.3 mtt -121.87 53.78 1.19 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.421 -0.8 . . . . 0.0 109.518 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.484 ' HD2' ' CE2' ' A' ' 84' ' ' TYR . 6.3 mtpp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.287 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.49 ' HG3' ' CE1' ' A' ' 64' ' ' HIS . 3.1 ptmt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.048 0.451 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 19.9 mt-10 -48.82 126.54 12.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.17 -0.956 . . . . 0.0 110.251 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.43 -24.65 10.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.97 -1.081 . . . . 0.0 111.138 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.53 ' CD2' ' CE1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER 59.06 96.75 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.099 -1.001 . . . . 0.0 110.592 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.046 -1.034 . . . . 0.0 110.071 179.516 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.259 0.552 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.443 ' CB ' HG11 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -163.59 147.3 10.33 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.21 -0.931 . . . . 0.0 109.728 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.417 ' N ' ' HG3' ' A' ' 2' ' ' ARG . 21.5 ptt180 -125.53 136.65 53.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.112 -0.992 . . . . 0.0 110.041 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.428 HG22 ' CG1' ' A' ' 82' ' ' VAL . 46.6 t -140.42 157.06 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.102 -0.999 . . . . 0.0 110.567 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.1 m -144.24 125.69 14.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 110.212 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.409 ' HB ' ' HB ' ' A' ' 78' ' ' VAL . 87.7 t -117.75 114.4 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.649 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -80.27 118.99 22.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.73 105.18 0.1 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.324 -0.86 . . . . 0.0 110.288 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.59 122.79 11.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.943 . . . . 0.0 110.225 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.32 128.73 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.374 -0.829 . . . . 0.0 110.403 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.94 92.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.456 -0.778 . . . . 0.0 110.445 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.8 -30.72 15.33 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.53 120.53 11.93 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.79 -20.36 61.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -1.15 . . . . 0.0 110.365 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.473 ' HA3' ' CG ' ' A' ' 37' ' ' LEU . . . 63.38 83.94 0.07 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 tt -176.43 120.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -1.175 . . . . 0.0 109.921 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.488 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -111.53 106.1 14.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.89 . . . . 0.0 109.469 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 30' ' ' ILE . 22.0 pt -82.41 156.54 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.449 -0.782 . . . . 0.0 111.522 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' CB ' ' HB2' ' A' ' 31' ' ' SER . 7.9 ttmm -139.73 119.98 13.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.493 -0.755 . . . . 0.0 109.772 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.71 -159.46 28.09 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.43 ' CA ' ' HB2' ' A' ' 64' ' ' HIS . . . 156.88 140.27 2.91 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.88 -14.64 23.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -1.084 . . . . 0.0 110.713 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -72.73 -19.12 61.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.893 -1.129 . . . . 0.0 110.006 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -123.38 28.22 7.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 109.879 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.24 83.91 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.392 -0.817 . . . . 0.0 110.166 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.445 ' HE3' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -167.39 123.13 0.87 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.29 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.441 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 55.2 Cg_endo -71.61 52.32 1.63 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 O-C-N 123.39 1.205 . . . . 0.0 111.729 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.438 HG22 HD11 ' A' ' 28' ' ' ILE . 13.9 mm 42.39 88.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 O-C-N 121.093 -1.005 . . . . 0.0 110.817 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 50' ' ' ALA . 6.0 mt -97.39 131.6 43.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.757 -1.214 . . . . 0.0 111.89 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.472 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 39.6 mt -67.18 132.22 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.284 -0.885 . . . . 0.0 108.74 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.438 ' HB2' ' CB ' ' A' ' 19' ' ' LYS . 6.9 t -119.51 -10.4 9.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.167 -0.958 . . . . 0.0 111.092 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.38 99.4 2.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.987 -1.071 . . . . 0.0 110.707 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.438 ' CG2' ' HB2' ' A' ' 40' ' ' ASP . 13.4 mm -89.58 95.92 5.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.318 -0.864 . . . . 0.0 108.682 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.49 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 4.8 m-30 -45.02 137.45 4.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.818 -0.551 . . . . 0.0 110.85 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -79.98 158.42 26.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.279 -0.888 . . . . 0.0 110.479 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.27 22.31 29.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.473 ' CG ' ' HA3' ' A' ' 15' ' ' GLY . 1.9 mm? -112.01 168.82 9.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -1.111 . . . . 0.0 109.718 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.1 -70.46 0.11 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.135 -0.978 . . . . 0.0 111.174 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.423 ' HA ' HD11 ' A' ' 45' ' ' LEU . . . -47.1 -24.66 0.7 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.332 -0.855 . . . . 0.0 111.671 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 4.8 t70 -93.91 -31.81 14.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.888 -1.133 . . . . 0.0 110.456 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -87.13 12.0 12.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.062 -1.024 . . . . 0.0 110.491 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.3 p -98.88 6.62 46.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.053 -1.029 . . . . 0.0 110.815 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 49.98 53.83 12.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.864 -1.147 . . . . 0.0 110.818 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.489 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -177.13 -52.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.134 -0.979 . . . . 0.0 110.547 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.472 ' CD2' ' CD1' ' A' ' 30' ' ' ILE . 2.6 mt -69.56 85.96 0.45 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.874 -1.141 . . . . 0.0 108.808 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.606 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -112.59 151.38 30.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.942 -0.474 . . . . 0.0 109.801 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.419 ' N ' HG13 ' A' ' 33' ' ' ILE . 53.7 t -49.1 162.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 120.903 -1.123 . . . . 0.0 110.127 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.07 32.18 58.86 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.786 -1.725 . . . . 0.0 108.786 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.484 ' OD2' ' CD1' ' A' ' 46' ' ' PHE . 54.2 m-20 -116.96 104.8 11.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.603 -0.939 . . . . 0.0 110.173 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.45 ' N ' HD22 ' A' ' 29' ' ' LEU . . . -81.94 97.04 7.88 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 110.158 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.422 HD12 HG22 ' A' ' 51' ' ' ILE . 51.4 mt -62.1 135.07 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 0.0 110.155 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.3 mt -132.53 14.0 4.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.465 -0.772 . . . . 0.0 110.217 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 178.96 96.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.505 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.481 ' CG2' ' CB ' ' A' ' 70' ' ' ALA . 14.5 m -95.46 126.48 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.216 -0.927 . . . . 0.0 110.452 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.2 m120 59.28 24.4 12.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.382 -0.824 . . . . 0.0 110.609 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.6 30.78 17.62 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.1 mm-40 -123.07 95.58 4.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.134 -1.215 . . . . 0.0 109.647 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.6 97.55 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.561 0.696 . . . . 0.0 111.356 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.48 ' CD1' ' CB ' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -80.58 -8.12 59.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.54 -0.725 . . . . 0.0 110.548 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.8 p -54.36 -36.7 64.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.011 -1.055 . . . . 0.0 110.152 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t -95.39 22.33 7.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 110.108 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.48 ' CB ' ' CD1' ' A' ' 59' ' ' LEU . . . -118.76 161.48 20.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 110.281 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.1 p -91.08 -170.71 2.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 109.926 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.498 ' CE1' ' O ' ' B' ' 3' ' ' LYS . 10.2 t60 -69.07 -23.57 64.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.031 -1.043 . . . . 0.0 109.806 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -77.42 -39.73 45.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.617 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.3 -24.72 67.36 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.424 -0.797 . . . . 0.0 109.953 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.443 ' CA ' HD13 ' A' ' 59' ' ' LEU . . . -82.83 -41.11 19.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.175 -0.953 . . . . 0.0 110.587 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.496 HG22 ' CD2' ' A' ' 64' ' ' HIS . 5.4 t -73.45 -28.45 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.141 -0.974 . . . . 0.0 109.398 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -40.33 93.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -0.801 . . . . 0.0 109.81 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.481 ' CB ' ' CG2' ' A' ' 54' ' ' VAL . . . -68.47 -49.3 60.85 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.209 -0.932 . . . . 0.0 108.976 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.407 ' HA ' ' CG2' ' A' ' 74' ' ' THR . 82.4 mt -58.51 -23.35 57.85 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.641 -0.662 . . . . 0.0 109.362 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -77.54 -40.12 43.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 109.624 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.11 64.82 0.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.403 -0.811 . . . . 0.0 109.364 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.407 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 30.4 p -82.23 174.4 11.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.375 -0.828 . . . . 0.0 109.933 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.17 -175.03 34.61 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.67 -37.88 19.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.148 -1.207 . . . . 0.0 110.544 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 4.2 pt-20 -117.76 101.9 8.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.397 -0.814 . . . . 0.0 109.894 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.409 ' HB ' ' HB ' ' A' ' 6' ' ' VAL . 59.9 t -67.28 73.5 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.0 110.795 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.0 t -69.53 106.47 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.0 119.79 38.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.884 -1.135 . . . . 0.0 112.235 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -73.34 133.39 43.82 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.443 HG11 ' CB ' ' A' ' 2' ' ' ARG . 2.2 p -135.16 144.35 34.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.837 -1.164 . . . . 0.0 111.741 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.51 86.57 2.33 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.606 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -54.33 122.86 11.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.472 -0.768 . . . . 0.0 110.662 -177.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -111.78 52.3 0.76 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.636 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.3 pttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.27 -179.762 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.498 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 56.3 tttt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.128 0.489 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.54 87.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.431 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.431 ' N ' ' O ' ' B' ' 3' ' ' LYS . 0.4 OUTLIER -90.86 -163.54 1.04 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 109.865 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.49 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 30.5 tp -163.27 121.49 1.98 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 109.995 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.435 ' CG2' ' CG1' ' A' ' 68' ' ' VAL . 83.1 t . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.082 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.436 0.636 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.834 ' CB ' HG13 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -155.18 168.03 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.409 -0.807 . . . . 0.0 110.692 -179.362 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -141.55 121.12 13.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.468 -0.77 . . . . 0.0 109.197 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.669 HG13 ' CB ' ' A' ' 44' ' ' ALA . 64.3 t -131.94 139.48 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.931 -1.105 . . . . 0.0 111.05 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.8 m -119.14 116.47 26.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.459 -0.776 . . . . 0.0 109.683 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.667 HG22 HG21 ' A' ' 42' ' ' THR . 90.9 t -103.83 111.57 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 110.207 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.86 . . . . 0.0 109.916 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.993 0.425 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.882 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 56.0 87.0 0.02 OUTLIER Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.413 HG23 ' HB ' ' B' ' 7' ' ' VAL . 3.3 tt -176.32 118.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.223 -1.163 . . . . 0.0 110.345 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -112.94 101.09 9.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.561 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.124 HD11 HG22 ' A' ' 68' ' ' VAL . 28.4 pt -78.31 151.06 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.95 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' B' ' 3' ' ' LYS . 46.6 tttt -137.83 122.22 18.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.452 -0.78 . . . . 0.0 110.209 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.08 -153.05 24.16 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 160.44 133.85 1.56 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.578 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.2 OUTLIER -60.12 -15.43 23.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.424 -1.045 . . . . 0.0 110.617 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.68 7.07 15.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.719 -1.238 . . . . 0.0 110.487 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.53 23.76 2.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.085 -1.009 . . . . 0.0 109.749 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm 53.88 64.87 1.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.883 . . . . 0.0 110.213 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.523 ' HE3' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.51 117.84 5.2 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 110.236 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.745 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 48.3 Cg_endo -69.54 54.34 1.09 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 O-C-N 123.425 1.224 . . . . 0.0 111.653 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 64' ' ' HIS . 16.3 mm 42.33 88.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 O-C-N 121.268 -0.895 . . . . 0.0 110.304 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' A' ' 50' ' ' ALA . 31.8 tp -100.89 125.72 47.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.843 -1.16 . . . . 0.0 111.888 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.864 HD12 ' HB2' ' A' ' 49' ' ' ASP . 57.4 mt -61.82 136.26 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.588 -0.695 . . . . 0.0 110.188 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.3 t -121.98 -11.4 8.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 110.686 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 106.78 3.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.956 -1.09 . . . . 0.0 110.703 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.539 HD11 HG21 ' A' ' 30' ' ' ILE . 11.8 mm -95.6 94.74 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 109.45 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.964 ' CE1' HD13 ' B' ' 6' ' ' LEU . 88.3 m-85 -54.27 141.55 29.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.841 . . . . 0.0 110.26 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.849 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.0 mmmt -86.42 171.57 11.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 110.805 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.58 30.89 73.13 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.882 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.7 OUTLIER -138.28 162.61 33.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -1.196 . . . . 0.0 110.78 -179.586 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.615 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -46.5 -64.08 0.85 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.514 -0.741 . . . . 0.0 111.63 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.758 ' O ' HG22 ' A' ' 42' ' ' THR . . . -48.6 -53.75 17.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.96 -1.087 . . . . 0.0 111.385 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.448 ' HB2' HG22 ' A' ' 33' ' ' ILE . 16.3 t70 -77.3 -9.26 58.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.86 -1.15 . . . . 0.0 111.891 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.496 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -107.41 10.95 29.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.67 -1.268 . . . . 0.0 110.746 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 39' ' ' ALA . 5.4 t -106.82 15.62 25.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.017 -1.052 . . . . 0.0 110.512 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER 47.74 55.31 8.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.117 -0.989 . . . . 0.0 110.991 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.669 ' CB ' HG13 ' A' ' 4' ' ' VAL . . . -176.64 -47.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.083 -1.011 . . . . 0.0 110.524 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -67.93 82.44 0.21 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.973 -1.079 . . . . 0.0 109.154 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.588 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.91 150.01 32.39 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.548 -0.72 . . . . 0.0 109.835 -179.74 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 48' ' ' GLY . 96.2 t -50.24 167.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.97 -1.081 . . . . 0.0 110.253 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.503 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 70.88 30.21 68.35 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.864 ' HB2' HD12 ' A' ' 30' ' ' ILE . 36.5 m-20 -114.06 99.57 7.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.485 -1.009 . . . . 0.0 110.968 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.779 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -78.43 107.11 10.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 109.518 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.811 ' C ' HD22 ' A' ' 52' ' ' LEU . 61.2 mt -77.46 134.33 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 110.939 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.811 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.0 mm? -120.9 7.3 10.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.488 -0.757 . . . . 0.0 110.003 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 4.8 t -175.76 131.92 0.26 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.148 -0.97 . . . . 0.0 109.871 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.766 HG12 ' HG ' ' A' ' 80' ' ' LEU . 2.0 m -123.9 113.96 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.302 -0.873 . . . . 0.0 109.721 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.6 34.29 20.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.292 -0.88 . . . . 0.0 110.283 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.99 21.02 51.8 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 53' ' ' SER . 3.3 tm-20 -109.51 84.9 2.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.064 -1.257 . . . . 0.0 110.417 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -44.56 97.88 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.432 -0.793 . . . . 0.0 110.947 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.643 HD11 HG22 ' A' ' 54' ' ' VAL . 37.3 mt -79.09 -8.78 59.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.473 -0.767 . . . . 0.0 110.877 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.427 ' O ' ' CZ ' ' A' ' 22' ' ' ARG . 21.7 p -47.01 -36.19 7.58 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.212 -0.93 . . . . 0.0 110.611 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -106.85 29.86 6.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.752 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.634 ' HB1' ' CB ' ' A' ' 66' ' ' GLU . . . -119.72 153.65 35.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.355 -0.841 . . . . 0.0 110.133 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.578 HG22 ' HB3' ' A' ' 22' ' ' ARG . 2.9 p -86.32 171.56 11.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.303 -0.873 . . . . 0.0 110.071 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.909 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.2 t60 -55.29 -24.65 29.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 109.777 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -77.14 -38.24 52.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.014 . . . . 0.0 109.761 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.634 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 4.1 mm-40 -67.94 -25.89 65.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.832 . . . . 0.0 110.166 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.87 -38.82 24.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 110.416 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.124 HG22 HD11 ' A' ' 18' ' ' ILE . 8.2 t -73.26 -27.38 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.068 -1.02 . . . . 0.0 109.334 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -65.09 -38.16 89.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.363 -0.835 . . . . 0.0 109.767 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.6 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.26 -48.53 56.45 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.15 -0.969 . . . . 0.0 108.726 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.69 ' CD2' HD21 ' A' ' 80' ' ' LEU . 82.7 mt -59.62 -22.49 61.92 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.661 -0.649 . . . . 0.0 109.674 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -80.11 -45.11 18.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.654 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 5.5 tttt -112.74 59.79 0.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.38 -0.825 . . . . 0.0 109.719 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.601 ' HB ' HG22 ' A' ' 78' ' ' VAL . 47.3 p -78.08 174.2 11.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 110.248 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.88 -169.48 29.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -52.11 23.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.017 -1.284 . . . . 0.0 110.448 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 1.8 pt-20 -107.74 117.24 33.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.902 . . . . 0.0 109.778 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.007 HG12 HD13 ' A' ' 80' ' ' LEU . 45.8 t -83.11 78.56 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.938 -1.101 . . . . 0.0 110.781 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.6 ' O ' HD12 ' A' ' 80' ' ' LEU . 16.8 t -68.53 112.53 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.101 -0.999 . . . . 0.0 108.329 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.007 HD13 HG12 ' A' ' 78' ' ' VAL . 4.4 mp -119.94 115.79 24.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.993 -1.067 . . . . 0.0 111.87 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 7.3 tp10 -73.56 128.63 36.02 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.834 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.5 p -127.23 150.27 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.044 -1.035 . . . . 0.0 112.15 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.779 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 34.5 tttp -115.58 85.04 2.2 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.588 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -51.56 130.65 28.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.468 -0.77 . . . . 0.0 111.119 -177.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.4 mtt -115.47 51.74 0.92 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.765 . . . . 0.0 109.451 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.338 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 10.6 tttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.174 0.511 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -121.49 94.34 4.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.154 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.417 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -91.28 -169.52 2.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.394 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.964 HD13 ' CE1' ' A' ' 34' ' ' PHE . 5.1 tp -157.77 94.83 1.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.82 . . . . 0.0 109.883 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 71' ' ' LEU . 94.9 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.088 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.499 0.666 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.48 ' CG ' HG13 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -158.77 146.51 17.9 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.548 -0.72 . . . . 0.0 109.736 -179.421 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.413 ' N ' ' HG3' ' A' ' 2' ' ' ARG . 0.4 OUTLIER -124.28 129.33 50.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.057 -1.027 . . . . 0.0 110.307 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.735 HG22 ' HB1' ' A' ' 44' ' ' ALA . 93.5 t -128.79 127.53 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.384 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.6 m -114.69 132.57 56.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.737 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.546 HG21 HD12 ' A' ' 45' ' ' LEU . 90.4 t -122.69 109.96 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 110.304 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 109.549 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.711 HD23 ' HB2' ' A' ' 39' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.067 0.461 . . . . 0.0 110.367 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.962 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 56.21 90.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.691 HD12 HD22 ' A' ' 45' ' ' LEU . 1.1 tt -176.33 120.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.203 -1.175 . . . . 0.0 110.525 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.588 ' OG ' HD13 ' B' ' 6' ' ' LEU . 1.3 m -112.46 106.25 14.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.186 -0.947 . . . . 0.0 109.404 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.974 HD11 ' CG2' ' A' ' 68' ' ' VAL . 12.3 pt -82.58 156.64 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.426 -0.796 . . . . 0.0 111.501 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.431 ' CD ' ' CB ' ' A' ' 31' ' ' SER . 10.4 mtpt -136.44 156.92 47.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.578 -0.702 . . . . 0.0 109.833 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 123.05 -156.49 17.44 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.68 133.98 1.57 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.709 ' HB3' HG22 ' A' ' 63' ' ' THR . 1.9 tpm_? -60.71 -15.39 28.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -1.15 . . . . 0.0 110.62 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.03 5.51 19.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.649 -1.282 . . . . 0.0 110.342 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.9 25.75 2.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.091 -1.006 . . . . 0.0 109.446 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.29 90.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 0.0 109.875 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.526 ' HE2' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -170.03 127.01 0.76 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.305 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.743 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 57.0 Cg_endo -75.88 45.5 1.51 Allowed 'Trans proline' 0 N--CA 1.494 1.541 0 O-C-N 123.371 1.195 . . . . 0.0 111.717 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.514 HG21 ' HB1' ' A' ' 67' ' ' ALA . 27.0 mm 47.51 90.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 120.789 -1.194 . . . . 0.0 109.848 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.629 HD13 ' HB2' ' A' ' 50' ' ' ALA . 36.6 tp -103.15 125.05 49.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.812 -1.18 . . . . 0.0 112.051 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.821 HD12 ' HB2' ' A' ' 49' ' ' ASP . 60.9 mt -58.78 139.39 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.568 -0.707 . . . . 0.0 109.85 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.431 ' CB ' ' CD ' ' A' ' 19' ' ' LYS . 33.3 t -124.6 -10.5 7.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 110.969 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.411 ' CB ' ' NZ ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -154.81 100.4 2.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.905 -1.122 . . . . 0.0 110.843 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.45 HG13 ' HA ' ' A' ' 46' ' ' PHE . 13.7 mm -86.39 101.26 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.212 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.586 ' HB3' HD13 ' A' ' 37' ' ' LEU . 3.3 m-85 -59.36 135.56 57.69 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.604 -0.685 . . . . 0.0 109.698 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.661 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -83.06 169.47 15.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.117 -0.989 . . . . 0.0 110.851 -179.254 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.48 30.29 77.15 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.962 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER -138.28 162.1 35.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.112 -1.228 . . . . 0.0 110.955 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -46.22 -69.06 0.14 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.628 -0.67 . . . . 0.0 111.694 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.711 ' HB2' HD23 ' A' ' 14' ' ' LEU . . . -45.01 -39.25 5.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.472 -0.767 . . . . 0.0 111.575 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.419 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 16.5 t70 -93.61 10.62 31.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.057 -1.027 . . . . 0.0 110.758 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -115.44 3.72 14.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.925 -1.109 . . . . 0.0 110.773 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.521 HG21 HG22 ' A' ' 6' ' ' VAL . 10.1 t -108.22 15.16 24.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.93 -1.106 . . . . 0.0 110.893 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.12 60.98 3.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.084 -1.01 . . . . 0.0 110.926 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.735 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -175.15 -50.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.2 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.691 HD22 HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -70.31 86.83 0.6 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.959 -1.088 . . . . 0.0 108.705 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.603 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -115.96 153.33 31.81 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.825 -0.547 . . . . 0.0 110.029 -179.231 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 48' ' ' GLY . 32.5 t -48.12 165.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 120.899 -1.126 . . . . 0.0 110.151 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.449 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 70.77 31.69 67.33 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.821 ' HB2' HD12 ' A' ' 30' ' ' ILE . 44.9 m-20 -116.58 100.28 7.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -1.041 . . . . 0.0 110.997 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.743 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -79.1 108.88 12.93 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.858 . . . . 0.0 109.831 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.819 ' C ' HD22 ' A' ' 52' ' ' LEU . 55.2 mt -75.4 139.94 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.329 -0.857 . . . . 0.0 110.824 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.819 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.2 mm? -125.05 4.63 7.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.255 -0.903 . . . . 0.0 110.916 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 176.96 103.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.832 -1.168 . . . . 0.0 109.75 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.91 HG21 ' CB ' ' A' ' 70' ' ' ALA . 20.5 m -92.49 121.04 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.223 -0.923 . . . . 0.0 110.602 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 m120 59.41 34.16 22.62 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.168 -0.958 . . . . 0.0 110.809 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.99 19.89 62.12 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.8 mt-10 -110.23 91.83 3.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.941 -1.329 . . . . 0.0 109.91 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -41.44 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.574 0.702 . . . . 0.0 111.488 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.889 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -90.39 14.01 14.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.489 -0.757 . . . . 0.0 110.399 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.6 t -68.88 -49.54 57.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 110.724 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.36 18.58 5.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.061 -1.024 . . . . 0.0 110.523 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.889 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -104.21 158.41 16.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -0.927 . . . . 0.0 110.233 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.709 HG22 ' HB3' ' A' ' 22' ' ' ARG . 12.4 p -90.15 176.23 6.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 110.071 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.718 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.5 t60 -58.64 -26.01 63.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.072 -1.018 . . . . 0.0 109.556 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.45 -30.28 59.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.089 -1.007 . . . . 0.0 109.709 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.76 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 7.3 mm-40 -75.62 -27.03 58.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.838 . . . . 0.0 109.952 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.514 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -80.09 -36.68 35.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.368 -0.832 . . . . 0.0 110.502 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.974 ' CG2' HD11 ' A' ' 18' ' ' ILE . 17.5 t -75.5 -32.71 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.047 -1.033 . . . . 0.0 109.549 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -60.97 -38.32 85.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 109.879 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.91 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.98 -50.58 32.77 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.177 -0.952 . . . . 0.0 108.788 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.682 ' O ' HG11 ' B' ' 7' ' ' VAL . 86.7 mt -58.56 -23.59 58.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.619 -0.676 . . . . 0.0 110.01 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -80.69 -36.78 31.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.124 -0.985 . . . . 0.0 109.941 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -119.43 58.21 0.88 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.111 -0.993 . . . . 0.0 109.871 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.498 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 39.4 p -80.96 -170.65 2.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.904 . . . . 0.0 110.003 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.53 -175.05 15.33 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -49.04 -59.88 3.25 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.056 -1.261 . . . . 0.0 110.298 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -88.4 95.44 10.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 109.582 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.885 HG12 HD13 ' A' ' 80' ' ' LEU . 94.8 t -79.86 78.74 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 110.66 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.602 ' O ' HD12 ' A' ' 80' ' ' LEU . 5.0 t -68.66 116.32 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.083 -1.01 . . . . 0.0 108.352 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.885 HD13 HG12 ' A' ' 78' ' ' VAL . 3.4 mp -121.06 100.8 7.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.978 -1.076 . . . . 0.0 111.743 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 20.5 tt0 -64.13 128.89 37.8 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.636 HG11 HG23 ' A' ' 4' ' ' VAL . 2.2 p -131.9 143.93 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 111.799 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.703 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 79.5 tttt -106.67 88.34 2.74 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.603 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -56.0 111.24 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.456 -0.778 . . . . 0.0 111.165 -177.753 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 mtt -89.21 53.43 2.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 109.198 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.149 -179.535 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.465 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 15.3 tttp . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.157 0.503 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -121.13 90.84 3.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.991 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.413 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -79.9 -161.72 0.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 0.0 110.461 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.588 HD13 ' OG ' ' A' ' 17' ' ' SER . 22.1 tp -171.14 99.88 0.21 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 109.935 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.682 HG11 ' O ' ' A' ' 71' ' ' LEU . 92.5 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.255 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.351 0.596 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.851 ' CB ' HG13 ' A' ' 82' ' ' VAL . 1.7 mtp85 -157.05 167.74 29.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.68 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -138.66 119.01 13.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.497 -0.752 . . . . 0.0 109.189 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.977 HG22 ' HB1' ' A' ' 44' ' ' ALA . 83.2 t -127.63 126.15 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.969 -1.082 . . . . 0.0 110.655 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.5 m -117.29 114.39 23.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.446 -0.784 . . . . 0.0 109.441 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.914 HG21 HD12 ' A' ' 45' ' ' LEU . 98.4 t -102.8 111.04 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.946 . . . . 0.0 109.964 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.436 -0.79 . . . . 0.0 110.044 -179.847 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.714 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.173 0.511 . . . . 0.0 110.277 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.947 ' CA ' HD22 ' A' ' 37' ' ' LEU . . . 63.86 81.65 0.1 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.628 HG21 HD22 ' A' ' 14' ' ' LEU . 3.9 tt -176.42 117.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.326 -1.102 . . . . 0.0 110.325 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' B' ' 5' ' ' SER . 0.7 OUTLIER -111.8 119.57 39.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.186 -0.946 . . . . 0.0 109.577 179.231 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.014 HD11 HG22 ' A' ' 68' ' ' VAL . 8.8 pt -95.6 148.98 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.98 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HG2' ' CA ' ' B' ' 4' ' ' GLU . 0.2 OUTLIER -132.67 134.72 45.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.812 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 142.17 -159.98 27.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 168.32 136.84 2.12 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.545 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.0 OUTLIER -59.46 -16.1 21.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -1.133 . . . . 0.0 110.598 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.43 -12.38 60.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.826 -1.171 . . . . 0.0 110.233 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.14 27.54 8.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.088 -1.007 . . . . 0.0 110.185 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.69 49.68 19.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.126 -0.984 . . . . 0.0 110.043 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.614 ' HE1' ' HB2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -125.33 122.56 25.11 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 110.365 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.693 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 55.5 Cg_endo -72.66 50.86 1.77 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 O-C-N 123.422 1.222 . . . . 0.0 111.735 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 64' ' ' HIS . 25.4 mm 43.37 88.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 O-C-N 121.053 -1.029 . . . . 0.0 110.706 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 85' ' ' MET . 5.6 mt -97.74 132.51 43.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.857 -1.152 . . . . 0.0 111.608 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.801 HG21 HD11 ' A' ' 33' ' ' ILE . 56.9 mt -69.2 138.21 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.284 -0.885 . . . . 0.0 108.952 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 42.6 t -119.83 -24.73 6.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.94 -1.1 . . . . 0.0 110.931 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.43 108.3 5.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.016 -1.053 . . . . 0.0 110.666 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.801 HD11 HG21 ' A' ' 30' ' ' ILE . 15.9 mm -94.24 98.44 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.429 -0.794 . . . . 0.0 109.166 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.756 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 92.0 m-85 -57.9 130.83 48.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.608 -0.683 . . . . 0.0 110.362 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.972 ' O ' HD12 ' A' ' 37' ' ' LEU . 7.3 pttt -76.83 171.68 14.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.402 -0.811 . . . . 0.0 110.95 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.57 30.57 65.53 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.972 HD12 ' O ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -138.47 161.96 35.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.076 -1.249 . . . . 0.0 110.903 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.592 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -48.24 -66.73 0.35 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.579 -0.701 . . . . 0.0 111.592 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.714 ' HB2' ' CD2' ' A' ' 14' ' ' LEU . . . -47.57 -33.03 6.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 112.199 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.441 ' HB2' HG22 ' A' ' 33' ' ' ILE . 5.4 t70 -95.77 -19.91 19.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.719 -1.238 . . . . 0.0 111.302 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.494 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -93.78 14.86 17.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.905 -1.122 . . . . 0.0 110.725 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.509 HG21 HG22 ' A' ' 6' ' ' VAL . 8.9 t -107.74 14.07 25.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.013 -1.055 . . . . 0.0 110.843 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 44.79 46.91 8.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.188 -0.945 . . . . 0.0 111.284 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.977 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -165.62 -51.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 110.515 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.914 HD12 HG21 ' A' ' 6' ' ' VAL . 2.8 mt -70.61 83.07 0.6 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.839 -1.163 . . . . 0.0 108.504 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.591 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -110.29 155.07 22.58 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.361 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 48' ' ' GLY . 90.6 t -51.02 167.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.813 -1.179 . . . . 0.0 110.29 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.5 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 67.84 32.36 77.49 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.796 ' HB2' HD12 ' A' ' 30' ' ' ILE . 32.6 m-20 -114.05 104.44 12.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.484 -1.009 . . . . 0.0 110.431 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -80.56 105.69 12.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.328 -0.857 . . . . 0.0 109.627 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.793 ' C ' HD22 ' A' ' 52' ' ' LEU . 54.7 mt -76.62 135.97 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.405 -0.809 . . . . 0.0 111.07 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.793 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.4 mm? -120.55 8.21 10.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.488 -0.757 . . . . 0.0 110.214 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 26.0 t -178.68 135.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.103 -0.998 . . . . 0.0 109.704 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.664 HG22 HD11 ' A' ' 59' ' ' LEU . 1.5 m -129.24 114.83 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.309 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.75 31.15 20.9 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.262 -0.899 . . . . 0.0 110.76 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.83 21.07 34.72 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.561 ' HB2' HG23 ' A' ' 54' ' ' VAL . 1.3 mm-40 -112.41 88.03 2.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.041 -1.27 . . . . 0.0 110.164 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -46.64 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.276 -0.89 . . . . 0.0 111.004 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.664 HD11 HG22 ' A' ' 54' ' ' VAL . 79.8 mt -81.7 -11.92 58.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.563 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.505 ' HB2' HD12 ' A' ' 52' ' ' LEU . 2.2 t -48.16 -32.41 6.96 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.231 -0.918 . . . . 0.0 110.06 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.9 t -112.06 22.62 14.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.343 -0.848 . . . . 0.0 109.451 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.498 ' HB3' ' HA ' ' A' ' 59' ' ' LEU . . . -113.11 152.57 29.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.425 -0.797 . . . . 0.0 110.143 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.545 HG22 ' HB3' ' A' ' 22' ' ' ARG . 3.1 p -86.9 169.94 12.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 110.053 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.896 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.8 t-80 -54.0 -25.74 22.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.929 . . . . 0.0 109.789 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -77.44 -36.26 53.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.062 -1.024 . . . . 0.0 110.034 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.428 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 46.4 mm-40 -73.11 -23.04 60.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.934 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.36 -38.25 24.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 110.417 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.014 HG22 HD11 ' A' ' 18' ' ' ILE . 14.1 t -72.44 -29.21 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.154 -0.966 . . . . 0.0 109.184 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -61.37 -37.2 82.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.335 -0.853 . . . . 0.0 109.813 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.605 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -71.54 -50.31 32.4 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.171 -0.956 . . . . 0.0 108.81 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.472 ' CD2' HD21 ' A' ' 80' ' ' LEU . 86.7 mt -57.68 -23.67 52.75 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.543 -0.723 . . . . 0.0 109.443 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -78.56 -34.91 46.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.678 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -130.79 54.17 1.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.343 -0.848 . . . . 0.0 109.684 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.706 ' CB ' HG22 ' A' ' 78' ' ' VAL . 66.2 p -57.81 -84.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.855 . . . . 0.0 110.502 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.427 ' N ' ' OG1' ' A' ' 74' ' ' THR . . . 154.12 -170.74 32.7 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -47.23 -35.69 7.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.147 -1.208 . . . . 0.0 110.665 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -132.96 130.39 39.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.223 -0.923 . . . . 0.0 109.705 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.875 HG12 HD13 ' A' ' 80' ' ' LEU . 99.4 t -94.64 81.59 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.072 -1.018 . . . . 0.0 111.196 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.678 ' O ' HD12 ' A' ' 80' ' ' LEU . 22.0 t -72.21 116.74 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.875 HD13 HG12 ' A' ' 78' ' ' VAL . 3.8 mp -124.54 108.49 12.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.959 -1.088 . . . . 0.0 112.108 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -70.26 129.15 38.56 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.851 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.8 p -129.02 145.38 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.855 -1.153 . . . . 0.0 112.602 -177.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.73 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 5.4 tttp -111.51 83.77 1.83 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.591 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -49.31 119.39 3.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.469 -0.77 . . . . 0.0 111.645 -177.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.705 ' HG3' HD21 ' A' ' 29' ' ' LEU . 2.8 mmt -101.21 47.32 0.91 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.6 tptt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.318 -179.449 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.486 ' HD2' ' CG ' ' A' ' 64' ' ' HIS . 12.0 mttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.319 0.58 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.466 ' CA ' ' HG2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER 54.92 49.71 17.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.015 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.577 ' HB2' ' HE1' ' A' ' 64' ' ' HIS . 26.5 t -54.24 -175.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 110.526 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.756 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -149.95 73.31 1.16 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.375 -0.828 . . . . 0.0 110.381 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.463 ' CG2' HG13 ' A' ' 68' ' ' VAL . 59.1 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.168 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.272 0.558 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.828 ' CB ' HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -155.19 162.4 40.95 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.217 -0.927 . . . . 0.0 110.506 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.93 109.92 6.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.438 -0.789 . . . . 0.0 109.295 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.857 HG22 ' HB1' ' A' ' 44' ' ' ALA . 89.6 t -115.49 152.87 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.029 -1.045 . . . . 0.0 110.846 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.6 m -132.79 114.94 14.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 109.564 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.63 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 86.2 t -102.82 118.67 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.086 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.1 mtm180 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.934 179.999 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.023 0.44 . . . . 0.0 110.717 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.883 ' CA ' HD22 ' A' ' 37' ' ' LEU . . . 57.88 90.17 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 tt -176.78 118.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.204 -1.174 . . . . 0.0 110.226 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' B' ' 5' ' ' SER . 1.1 t -112.4 100.24 8.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.182 -0.949 . . . . 0.0 109.783 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.949 HD11 HG22 ' A' ' 68' ' ' VAL . 9.8 pt -77.63 150.48 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 110.693 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 31' ' ' SER . 58.9 tttt -136.18 123.24 21.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 110.103 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.75 -140.44 8.69 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.444 ' CA ' ' HB2' ' A' ' 64' ' ' HIS . . . 138.99 148.11 5.22 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -61.36 -14.11 24.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -1.08 . . . . 0.0 110.844 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -9.08 57.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.921 -1.112 . . . . 0.0 110.559 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -130.32 26.28 5.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.043 -1.036 . . . . 0.0 110.12 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.5 mttp 54.72 40.88 32.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.312 -0.868 . . . . 0.0 110.157 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.593 ' HE1' ' HB2' ' A' ' 29' ' ' LEU . 6.2 mmm -120.88 124.77 27.33 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.377 -0.827 . . . . 0.0 110.034 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.699 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 49.6 Cg_endo -70.21 52.66 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 O-C-N 123.348 1.183 . . . . 0.0 111.745 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.654 HG21 ' HB1' ' A' ' 67' ' ' ALA . 18.0 mm 43.53 89.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.084 -1.01 . . . . 0.0 110.096 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' A' ' 50' ' ' ALA . 32.7 tp -102.41 126.78 49.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.886 -1.134 . . . . 0.0 112.072 -178.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.9 HD12 ' HB2' ' A' ' 49' ' ' ASP . 56.7 mt -62.08 135.81 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.463 -0.773 . . . . 0.0 109.633 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.432 ' HA ' HG13 ' A' ' 47' ' ' VAL . 8.4 t -121.91 -18.49 7.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 110.963 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.89 106.48 4.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.002 -1.061 . . . . 0.0 110.702 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.697 HD11 HG21 ' A' ' 30' ' ' ILE . 16.8 mm -94.77 109.78 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 0.0 109.265 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.824 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 88.6 m-85 -71.54 128.15 34.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.8 ' O ' HD12 ' A' ' 37' ' ' LEU . 1.8 mttp -73.83 173.08 10.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -0.939 . . . . 0.0 110.666 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.23 29.65 69.13 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.883 HD22 ' CA ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -138.26 159.42 42.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -1.163 . . . . 0.0 110.941 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.63 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -44.44 -62.42 1.18 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.628 -0.67 . . . . 0.0 111.604 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.726 ' O ' HG22 ' A' ' 42' ' ' THR . . . -47.82 -57.76 5.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.179 -0.95 . . . . 0.0 110.99 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.439 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 12.8 t70 -75.47 0.51 16.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.998 -1.064 . . . . 0.0 111.332 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -104.66 -2.44 25.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.75 -1.219 . . . . 0.0 110.865 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 39' ' ' ALA . 9.2 t -98.67 14.82 27.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.842 -1.161 . . . . 0.0 110.662 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 47.62 49.31 16.38 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.11 -0.993 . . . . 0.0 110.649 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.857 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -169.11 -43.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 110.206 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.489 ' CD2' HG11 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -68.17 80.1 0.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 108.83 179.139 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.586 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.23 153.67 26.75 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.594 -0.692 . . . . 0.0 110.043 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.526 HG12 ' N ' ' A' ' 48' ' ' GLY . 96.1 t -52.66 168.35 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.075 -1.015 . . . . 0.0 110.362 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.526 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 70.85 30.28 68.33 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.9 ' HB2' HD12 ' A' ' 30' ' ' ILE . 45.6 m-20 -114.92 99.9 7.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -1.036 . . . . 0.0 111.059 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -79.07 107.58 11.93 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.092 -1.005 . . . . 0.0 109.718 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.858 ' C ' HD22 ' A' ' 52' ' ' LEU . 52.2 mt -76.49 138.66 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.441 -0.787 . . . . 0.0 110.683 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.858 HD22 ' C ' ' A' ' 51' ' ' ILE . 3.9 mm? -127.35 7.23 6.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.153 -0.967 . . . . 0.0 110.82 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 176.08 99.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.87 -1.144 . . . . 0.0 109.765 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.927 HG21 ' CB ' ' A' ' 70' ' ' ALA . 23.1 m -91.1 121.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.138 -0.976 . . . . 0.0 110.36 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' A' ' 79' ' ' VAL . 3.8 m120 60.37 36.29 20.45 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.096 -1.002 . . . . 0.0 110.274 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.3 11.42 85.34 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.2 tp10 -96.79 92.34 6.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.882 -1.363 . . . . 0.0 109.429 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -40.89 103.96 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.562 0.696 . . . . 0.0 111.31 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.038 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -92.99 -13.53 28.6 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.61 -0.681 . . . . 0.0 110.499 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.2 p -54.9 -37.64 66.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.004 . . . . 0.0 110.135 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 m -96.96 23.42 7.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -0.935 . . . . 0.0 110.264 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 1.038 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -117.59 155.43 29.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 110.171 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.9 p -85.54 172.6 10.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.314 -0.866 . . . . 0.0 110.18 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.805 ' O ' HG23 ' A' ' 68' ' ' VAL . 5.8 t-80 -53.62 -25.74 18.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.107 -0.996 . . . . 0.0 109.786 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -75.87 -40.91 53.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.017 -1.052 . . . . 0.0 109.27 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.885 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 19.6 mt-10 -65.25 -22.43 66.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.527 -0.733 . . . . 0.0 109.87 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.654 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -83.98 -40.58 18.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.298 -0.877 . . . . 0.0 110.658 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.949 HG22 HD11 ' A' ' 18' ' ' ILE . 9.4 t -74.49 -28.37 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.205 -0.935 . . . . 0.0 109.26 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -65.54 -37.88 88.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.342 -0.849 . . . . 0.0 110.093 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.927 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.06 -37.28 75.46 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.12 -0.988 . . . . 0.0 109.125 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.8 mt -73.81 -19.95 60.6 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.648 -0.658 . . . . 0.0 109.808 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -80.88 -45.0 17.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.904 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -106.22 30.83 5.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.366 -0.834 . . . . 0.0 109.99 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 1.076 HG21 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -65.64 142.66 57.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.845 . . . . 0.0 109.972 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.86 -179.98 40.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 77' ' ' GLU . 8.2 pttt -49.9 -50.92 44.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.363 -1.081 . . . . 0.0 110.688 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.425 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 81.5 mm-40 -88.86 92.87 9.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.908 -1.12 . . . . 0.0 109.133 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.076 HG13 HG21 ' A' ' 74' ' ' THR . 78.3 t -83.06 78.63 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.189 -0.944 . . . . 0.0 110.903 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.65 ' O ' HD12 ' A' ' 80' ' ' LEU . 11.0 t -66.44 124.01 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.892 HD13 HG12 ' A' ' 78' ' ' VAL . 2.3 mp -124.21 106.14 10.07 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.901 -1.125 . . . . 0.0 111.749 -178.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.9 tt0 -68.2 121.59 16.53 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.828 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.6 p -127.05 147.95 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.069 -1.02 . . . . 0.0 112.683 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 13.9 ttmt -112.45 88.2 2.76 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.586 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -56.28 126.68 27.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 111.157 -177.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.0 mmt -105.89 54.89 0.69 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.344 -0.847 . . . . 0.0 109.226 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.5 tttt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.224 -179.527 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.598 ' HB2' ' CD2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.234 0.54 . . . . 0.0 110.178 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER 54.29 62.31 2.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -0.862 . . . . 0.0 109.858 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.77 ' HB2' ' HE1' ' A' ' 64' ' ' HIS . 3.5 t -73.59 -156.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.241 -0.912 . . . . 0.0 110.62 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.824 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -167.07 89.25 0.34 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.317 -0.864 . . . . 0.0 110.515 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.53 ' CG2' HG13 ' A' ' 68' ' ' VAL . 41.9 t . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.066 -1.021 . . . . 0.0 110.082 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 15.5 mtm-85 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.468 0.652 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.884 ' CB ' HG13 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -148.21 164.36 34.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.397 -0.815 . . . . 0.0 110.195 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.43 117.51 18.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 109.461 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.054 HG22 ' HB1' ' A' ' 44' ' ' ALA . 53.3 t -129.63 126.95 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.05 -1.031 . . . . 0.0 110.521 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.1 m -119.79 130.81 55.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.364 -0.835 . . . . 0.0 109.674 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.54 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 89.2 t -117.21 111.1 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.783 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.016 -179.864 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.782 HD23 ' HB2' ' A' ' 39' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.207 0.527 . . . . 0.0 110.283 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.46 ' CA ' ' HB2' ' A' ' 34' ' ' PHE . . . 65.23 76.19 0.34 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.925 HD12 HD21 ' A' ' 45' ' ' LEU . 4.2 tt -166.24 117.18 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -1.055 . . . . 0.0 109.698 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 32' ' ' LYS . 1.2 t -107.29 92.31 4.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.09 -1.006 . . . . 0.0 109.933 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.98 HD11 ' CG2' ' A' ' 68' ' ' VAL . 45.2 pt -69.04 146.67 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.199 -0.938 . . . . 0.0 110.886 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' CB ' ' HB2' ' A' ' 31' ' ' SER . 21.5 tttt -135.41 117.32 15.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.495 -0.753 . . . . 0.0 109.728 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.06 -155.37 26.44 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 155.92 135.66 2.03 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -61.5 -14.47 29.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -1.12 . . . . 0.0 110.698 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.7 2.2 34.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.838 -1.164 . . . . 0.0 110.23 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -138.35 26.77 2.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.517 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.07 74.15 0.38 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.0 109.965 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.703 ' HE1' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -161.82 120.43 1.42 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 110.649 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.674 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 53.6 Cg_endo -72.63 52.85 2.14 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 O-C-N 123.508 1.267 . . . . 0.0 111.408 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 64' ' ' HIS . 11.4 mm 43.45 87.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 120.998 -1.064 . . . . 0.0 110.666 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.703 ' CB ' ' HE1' ' A' ' 26' ' ' MET . 6.0 mt -97.33 132.32 43.18 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.672 -1.268 . . . . 0.0 111.663 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.804 HD12 ' HB2' ' A' ' 49' ' ' ASP . 57.4 mt -65.64 137.17 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.248 -0.907 . . . . 0.0 108.628 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.454 ' HB2' ' CB ' ' A' ' 19' ' ' LYS . 3.1 t -119.73 -29.58 4.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.046 -1.034 . . . . 0.0 110.715 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -133.45 101.43 5.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 110.601 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.673 HD11 HG21 ' A' ' 30' ' ' ILE . 10.2 mm -87.69 106.11 15.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.548 ' CE1' HD13 ' B' ' 6' ' ' LEU . 5.3 m-85 -59.24 123.1 15.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.509 -0.745 . . . . 0.0 110.219 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.417 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -75.21 146.18 41.4 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.228 -0.92 . . . . 0.0 110.563 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.422 ' C ' HD22 ' A' ' 37' ' ' LEU . . . 78.74 0.75 81.84 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.532 ' N ' HD22 ' A' ' 37' ' ' LEU . 4.0 mm? -100.7 163.07 12.5 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.942 -1.328 . . . . 0.0 110.26 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.54 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -47.09 -55.5 8.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.364 -0.835 . . . . 0.0 110.775 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 1.044 ' HB1' HD23 ' A' ' 45' ' ' LEU . . . -51.38 -47.67 62.8 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.363 -0.835 . . . . 0.0 111.024 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 13.8 t70 -86.72 3.43 44.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.157 -0.964 . . . . 0.0 111.267 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -103.58 4.56 35.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.815 -1.178 . . . . 0.0 110.783 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 39' ' ' ALA . 4.9 t -107.66 14.65 25.44 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.854 -1.154 . . . . 0.0 110.712 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 45.4 56.79 5.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.263 -0.898 . . . . 0.0 111.068 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 1.054 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -170.57 -48.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.109 -0.994 . . . . 0.0 110.315 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.044 HD23 ' HB1' ' A' ' 39' ' ' ALA . 3.5 tp -70.45 84.58 0.59 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.831 -1.168 . . . . 0.0 108.489 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -111.04 147.44 34.77 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.758 -0.589 . . . . 0.0 110.039 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.504 ' HA ' HG22 ' A' ' 30' ' ' ILE . 52.0 t -47.35 147.47 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.274 -0.891 . . . . 0.0 110.3 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.32 26.85 26.99 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.421 -1.872 . . . . 0.0 108.421 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.804 ' HB2' HD12 ' A' ' 30' ' ' ILE . 58.2 m-20 -110.26 106.82 16.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.524 -0.986 . . . . 0.0 110.384 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.674 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -84.41 108.95 17.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.938 . . . . 0.0 109.593 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.794 ' C ' HD22 ' A' ' 52' ' ' LEU . 63.8 mt -76.57 136.31 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 111.042 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.794 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.2 mm? -124.63 15.5 8.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.476 -0.765 . . . . 0.0 109.886 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 4.6 t 176.81 135.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 108.967 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.88 HG12 HD22 ' A' ' 80' ' ' LEU . 1.2 m -128.68 118.15 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.041 -1.037 . . . . 0.0 110.497 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 54.72 37.91 29.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.332 -0.855 . . . . 0.0 110.554 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.75 26.93 40.07 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.596 ' HB2' HG23 ' A' ' 54' ' ' VAL . 47.7 mt-10 -118.93 93.19 4.01 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.081 -1.247 . . . . 0.0 110.173 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -44.96 111.79 0.36 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.448 -0.783 . . . . 0.0 110.93 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.934 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -101.48 17.18 23.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.508 -0.745 . . . . 0.0 110.658 -179.385 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 t -66.3 -50.37 63.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 0.0 110.29 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.28 36.62 1.57 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.066 -1.021 . . . . 0.0 110.48 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.934 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -116.46 149.44 39.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.957 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.8 p -83.09 171.58 13.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 0.0 110.418 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.916 ' O ' HG23 ' A' ' 68' ' ' VAL . 8.7 t60 -56.61 -23.45 41.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.231 -0.918 . . . . 0.0 109.91 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.91 -42.83 31.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 109.447 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 2.5 mt-10 -65.65 -21.16 66.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.349 -0.844 . . . . 0.0 109.784 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.614 ' CA ' HD11 ' A' ' 59' ' ' LEU . . . -84.5 -45.41 12.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.371 -0.831 . . . . 0.0 110.53 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.98 ' CG2' HD11 ' A' ' 18' ' ' ILE . 6.0 t -67.03 -31.48 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.124 -0.985 . . . . 0.0 109.186 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -42.04 82.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.401 -0.812 . . . . 0.0 109.444 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.681 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -67.93 -46.0 72.74 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.115 -0.991 . . . . 0.0 108.741 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.67 ' HB3' HG11 ' B' ' 7' ' ' VAL . 3.8 mm? -52.88 -29.79 30.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.672 -0.643 . . . . 0.0 109.697 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.599 ' HG2' HG13 ' B' ' 7' ' ' VAL . 7.8 mttm -82.19 -40.15 22.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.242 -0.911 . . . . 0.0 110.24 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -110.59 34.66 3.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 110.117 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.827 ' HB ' HG22 ' A' ' 78' ' ' VAL . 21.3 p -51.97 -79.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 0.0 110.309 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.39 -176.99 25.96 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -50.59 -41.04 54.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.206 -1.173 . . . . 0.0 110.169 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 3.7 pt-20 -117.61 112.64 20.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.852 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.827 HG22 ' HB ' ' A' ' 74' ' ' THR . 53.1 t -84.94 83.66 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.076 -1.015 . . . . 0.0 110.407 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.799 ' O ' HD23 ' A' ' 80' ' ' LEU . 11.1 t -76.1 116.68 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.88 HD22 HG12 ' A' ' 54' ' ' VAL . 14.8 mt -125.06 116.45 22.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.842 -1.161 . . . . 0.0 111.523 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -74.19 122.57 22.99 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.884 HG13 ' CB ' ' A' ' 2' ' ' ARG . 3.1 p -119.21 144.63 27.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.543 -177.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 7.0 tptm -110.15 90.06 3.2 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.58 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -55.21 125.12 19.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.448 -0.783 . . . . 0.0 111.067 -177.579 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.4 mmm -116.3 51.91 0.95 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.462 -0.774 . . . . 0.0 109.41 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.7 pttt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.256 -179.605 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.469 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 14.9 tttt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.211 0.529 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -112.68 97.88 6.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.215 -0.928 . . . . 0.0 110.02 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 17' ' ' SER . 33.1 m -103.99 133.07 49.57 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.201 -0.937 . . . . 0.0 110.398 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.548 HD13 ' CE1' ' A' ' 34' ' ' PHE . 41.0 tp -105.92 108.35 19.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -0.863 . . . . 0.0 110.207 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.67 HG11 ' HB3' ' A' ' 71' ' ' LEU . 40.2 t . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.053 -1.029 . . . . 0.0 110.203 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.304 0.573 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.872 ' CB ' HG13 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -147.85 158.72 44.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.537 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.7 115.26 16.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.215 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.742 HG13 ' HB3' ' A' ' 44' ' ' ALA . 37.9 t -132.0 139.32 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.07 -1.018 . . . . 0.0 110.689 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.8 m -128.26 126.54 41.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.311 -0.868 . . . . 0.0 110.271 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.093 HG22 HG21 ' A' ' 42' ' ' THR . 98.2 t -106.07 126.37 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.047 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 110.203 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.544 ' O ' HD23 ' A' ' 14' ' ' LEU . 1.2 tt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.118 0.485 . . . . 0.0 110.726 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.494 ' HA3' ' CG ' ' A' ' 37' ' ' LEU . . . 64.86 87.53 0.05 OUTLIER Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -178.8 121.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.113 -1.227 . . . . 0.0 110.28 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.49 109.78 21.55 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.918 HD11 HG22 ' A' ' 68' ' ' VAL . 27.5 pt -92.05 143.08 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -0.89 . . . . 0.0 111.171 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -125.69 170.14 11.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.57 179.466 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.09 -143.28 15.91 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.451 ' CA ' ' HB2' ' A' ' 64' ' ' HIS . . . 138.43 143.04 4.41 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -60.53 -14.56 20.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -1.116 . . . . 0.0 110.99 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.14 -20.35 64.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.934 -1.104 . . . . 0.0 110.106 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.73 24.33 7.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 109.726 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.2 tttt 55.58 82.59 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.41 -0.806 . . . . 0.0 110.218 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.535 ' HE1' ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -159.12 127.89 3.03 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 109.879 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.829 ' HB2' HD11 ' A' ' 52' ' ' LEU . 52.9 Cg_endo -70.28 50.61 0.96 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 O-C-N 123.321 1.169 . . . . 0.0 112.376 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.467 ' N ' ' HE2' ' A' ' 26' ' ' MET . 21.0 mm 38.88 88.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.549 0 O-C-N 121.201 -0.937 . . . . 0.0 111.189 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.619 HD11 ' HG3' ' A' ' 85' ' ' MET . 6.1 mt -96.66 133.23 41.44 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.88 -1.138 . . . . 0.0 111.765 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.842 HD12 ' HB2' ' A' ' 49' ' ' ASP . 67.8 mt -65.74 144.25 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 108.806 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.3 t -123.85 -23.88 4.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.925 -1.11 . . . . 0.0 111.252 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.06 95.26 2.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.97 -1.081 . . . . 0.0 111.04 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.481 HG22 ' HB2' ' A' ' 40' ' ' ASP . 10.7 mm -77.47 100.24 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.36 -0.837 . . . . 0.0 108.831 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.791 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 17.2 m-85 -49.76 137.17 16.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.637 -0.664 . . . . 0.0 110.644 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.615 ' O ' HD23 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -79.29 159.0 27.41 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.177 -0.952 . . . . 0.0 110.487 -179.418 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.58 21.37 27.97 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 35' ' ' LYS . 2.1 mm? -111.09 167.9 9.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -1.191 . . . . 0.0 109.865 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.889 ' O ' HG23 ' A' ' 42' ' ' THR . . . -51.84 -66.89 0.31 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.139 -0.975 . . . . 0.0 111.164 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 45' ' ' LEU . . . -47.62 -47.25 29.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.253 -0.905 . . . . 0.0 111.108 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.481 ' HB2' HG22 ' A' ' 33' ' ' ILE . 4.8 t70 -71.88 -11.76 60.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.097 -1.002 . . . . 0.0 110.861 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -105.48 15.87 26.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.828 -1.17 . . . . 0.0 110.547 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 1.093 HG21 HG22 ' A' ' 6' ' ' VAL . 48.3 p -106.06 12.81 29.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.027 -1.045 . . . . 0.0 110.73 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 48.24 44.88 20.0 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.056 -1.027 . . . . 0.0 110.538 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.742 ' HB3' HG13 ' A' ' 4' ' ' VAL . . . -174.72 -43.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.551 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.433 HD21 HD12 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -66.83 83.37 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.81 -1.181 . . . . 0.0 109.049 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.585 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -114.24 151.39 32.9 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.579 -0.7 . . . . 0.0 110.094 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 48' ' ' GLY . 24.5 t -47.66 169.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.21 -0.931 . . . . 0.0 110.35 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 66.46 33.77 85.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.842 ' HB2' HD12 ' A' ' 30' ' ' ILE . 28.4 m-20 -115.16 106.23 13.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.432 -1.04 . . . . 0.0 110.177 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.951 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -83.76 108.78 17.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.212 -0.93 . . . . 0.0 110.383 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.812 ' C ' HD12 ' A' ' 52' ' ' LEU . 60.1 mt -77.67 134.79 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.413 -0.805 . . . . 0.0 110.379 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.829 HD11 ' HB2' ' A' ' 27' ' ' PRO . 10.0 mp -126.6 10.14 7.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.877 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 176.31 96.97 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.983 -1.073 . . . . 0.0 110.013 179.06 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.969 HG21 ' CB ' ' A' ' 70' ' ' ALA . 33.7 m -86.99 118.32 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.858 . . . . 0.0 110.508 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 55.49 33.96 22.07 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.362 -0.836 . . . . 0.0 111.089 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.11 -11.4 72.03 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.555 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' SER . 0.3 OUTLIER -77.53 90.23 3.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.787 -1.42 . . . . 0.0 109.593 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -41.97 106.51 0.06 Allowed 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.557 0.694 . . . . 0.0 111.075 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.943 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -98.9 -10.32 22.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.546 -0.722 . . . . 0.0 110.92 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.2 p -52.65 -36.53 57.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.02 -1.05 . . . . 0.0 110.296 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 m -113.57 49.34 0.98 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.167 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.943 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -130.74 149.2 52.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.236 -0.915 . . . . 0.0 110.303 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.9 p -72.41 163.01 28.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.369 -0.832 . . . . 0.0 109.882 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.889 ' O ' HG23 ' A' ' 68' ' ' VAL . 7.7 t60 -54.48 -25.16 23.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.004 -1.06 . . . . 0.0 109.729 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -75.17 -43.93 49.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.063 -1.023 . . . . 0.0 108.796 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.724 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -60.38 -28.83 68.52 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.502 -0.749 . . . . 0.0 109.419 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.682 ' CA ' HD11 ' A' ' 59' ' ' LEU . . . -77.51 -49.49 14.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.688 -0.633 . . . . 0.0 110.881 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.918 HG22 HD11 ' A' ' 18' ' ' ILE . 3.0 t -66.56 -30.54 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 119.206 -0.998 . . . . 0.0 108.927 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.58 -36.61 71.93 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.308 -0.87 . . . . 0.0 109.202 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.969 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -72.49 -35.76 68.24 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.245 -0.909 . . . . 0.0 109.302 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.706 ' C ' HG11 ' B' ' 7' ' ' VAL . 4.1 mm? -69.18 -29.08 66.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.698 -0.626 . . . . 0.0 109.918 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -79.1 -37.85 37.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.212 -0.93 . . . . 0.0 109.87 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -104.33 33.52 3.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.423 -0.798 . . . . 0.0 109.591 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.96 HG22 HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -73.39 138.09 45.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.403 -0.811 . . . . 0.0 110.188 -179.654 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.99 -178.46 52.4 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -53.31 -62.98 1.3 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -1.126 . . . . 0.0 110.366 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -73.59 90.59 1.78 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.209 -0.932 . . . . 0.0 109.223 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.96 HG22 HG22 ' A' ' 74' ' ' THR . 99.2 t -84.33 83.29 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 110.92 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.966 ' O ' HD23 ' A' ' 80' ' ' LEU . 9.0 t -74.98 124.92 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.966 HD23 ' O ' ' A' ' 79' ' ' VAL . 13.0 mt -130.25 118.67 21.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.744 -1.223 . . . . 0.0 111.71 -178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 35.0 tt0 -76.59 121.47 23.24 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.872 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.7 p -120.28 149.31 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 0.0 112.447 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.951 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -114.54 86.49 2.44 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.611 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.585 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -55.09 118.17 4.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.414 -0.804 . . . . 0.0 111.475 -177.766 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.619 ' HG3' HD11 ' A' ' 29' ' ' LEU . 4.1 mmt -95.98 51.01 1.21 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.319 -0.863 . . . . 0.0 108.769 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.8 tttt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.302 -179.402 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 64' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.376 0.608 . . . . 0.0 110.523 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 16.8 tt0 -58.5 96.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.468 -0.77 . . . . 0.0 110.593 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 8.2 m -84.22 -162.15 0.63 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.217 -0.927 . . . . 0.0 110.01 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.791 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -161.6 86.3 0.65 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.068 -1.02 . . . . 0.0 110.326 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.706 HG11 ' C ' ' A' ' 71' ' ' LEU . 39.1 t . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.05 -1.031 . . . . 0.0 109.979 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.53 0.681 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.524 ' CG ' HG13 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -158.78 143.47 15.9 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.483 -0.761 . . . . 0.0 109.614 -179.349 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.9 ptt-85 -122.28 136.56 54.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.121 -0.987 . . . . 0.0 110.115 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.739 HG13 ' CB ' ' A' ' 44' ' ' ALA . 46.6 t -139.31 134.26 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.103 -0.998 . . . . 0.0 110.538 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.7 m -118.04 125.22 49.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.393 -0.817 . . . . 0.0 110.08 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.566 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 83.2 t -118.39 129.14 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.353 -0.842 . . . . 0.0 109.185 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.6 mtm-85 . . . . . 0 C--N 1.301 -1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.912 -179.427 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.91 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.033 0.444 . . . . 0.0 110.382 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.887 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 56.48 90.47 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.628 ' CD1' HD22 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -175.04 123.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.175 -1.191 . . . . 0.0 110.826 -178.572 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.441 ' HB3' ' CB ' ' A' ' 32' ' ' LYS . 29.7 t -111.07 125.04 53.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 109.403 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.934 HD11 ' CG2' ' A' ' 68' ' ' VAL . 42.4 pt -105.0 150.66 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.135 -0.978 . . . . 0.0 110.883 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -133.9 158.97 42.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.377 -0.827 . . . . 0.0 109.848 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.1 -159.86 13.85 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 164.83 148.25 5.4 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.419 ' CB ' ' HA ' ' A' ' 63' ' ' THR . 10.5 ttp85 -60.46 -14.94 22.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -1.085 . . . . 0.0 110.809 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.63 -19.8 54.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.897 -1.127 . . . . 0.0 110.021 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -111.34 23.08 14.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.266 -0.896 . . . . 0.0 109.932 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 tptp 54.49 54.88 8.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.323 -0.86 . . . . 0.0 110.355 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.454 ' CE ' ' HB2' ' A' ' 29' ' ' LEU . 4.9 mmm -138.05 125.66 13.79 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.218 -0.926 . . . . 0.0 110.233 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.764 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 48.3 Cg_endo -69.53 52.33 0.91 Allowed 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.104 1.203 . . . . 0.0 111.882 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 64' ' ' HIS . 13.0 mm 42.96 90.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 121.116 -0.99 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 50' ' ' ALA . 30.4 tp -98.9 124.97 44.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.887 -1.133 . . . . 0.0 111.785 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.836 HD12 ' HB2' ' A' ' 49' ' ' ASP . 56.2 mt -57.27 142.31 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.47 -0.769 . . . . 0.0 109.671 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.3 -25.9 4.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.136 -0.977 . . . . 0.0 110.904 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.441 ' CB ' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -141.11 105.59 4.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.02 -1.05 . . . . 0.0 110.628 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.669 HD11 HG21 ' A' ' 30' ' ' ILE . 15.9 mm -90.38 115.71 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 109.085 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.525 ' HB3' HD13 ' A' ' 37' ' ' LEU . 17.2 m-85 -75.99 136.75 39.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.443 -0.785 . . . . 0.0 109.774 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.668 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -82.68 167.59 18.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.152 -0.968 . . . . 0.0 110.855 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.88 29.01 74.19 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.887 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER -137.47 160.23 39.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -1.157 . . . . 0.0 110.834 -179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -44.11 -69.63 0.13 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.495 -0.753 . . . . 0.0 111.935 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.91 ' HB2' ' CD2' ' A' ' 14' ' ' LEU . . . -45.55 -47.65 14.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.482 -0.761 . . . . 0.0 111.532 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.428 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 13.7 t70 -85.18 4.84 32.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.959 -1.088 . . . . 0.0 110.892 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -106.11 -3.14 21.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.822 -1.174 . . . . 0.0 110.835 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.501 HG21 HG22 ' A' ' 6' ' ' VAL . 8.7 t -99.82 14.71 29.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.922 -1.111 . . . . 0.0 110.643 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 47.43 39.24 8.87 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.043 -1.035 . . . . 0.0 110.904 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.739 ' CB ' HG13 ' A' ' 4' ' ' VAL . . . -152.28 -46.38 0.1 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.152 -0.967 . . . . 0.0 110.428 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.628 HD22 ' CD1' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -71.69 85.62 0.91 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.781 -1.2 . . . . 0.0 108.649 179.36 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.602 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.82 156.12 23.44 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.655 -179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.497 ' HA ' HG22 ' A' ' 30' ' ' ILE . 89.3 t -52.04 163.37 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.659 -1.275 . . . . 0.0 109.575 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.441 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 75.59 26.17 66.0 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.836 ' HB2' HD12 ' A' ' 30' ' ' ILE . 59.5 m-20 -112.94 101.24 9.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.506 -0.996 . . . . 0.0 110.57 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.764 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -79.4 110.0 14.29 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.369 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 52' ' ' LEU . 42.9 mt -78.28 138.81 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.426 -0.796 . . . . 0.0 110.325 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.644 HD11 ' HB2' ' A' ' 27' ' ' PRO . 3.3 mp -135.34 15.35 3.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.591 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 14.6 t 175.59 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.409 -0.807 . . . . 0.0 109.267 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.092 HG21 ' HB1' ' A' ' 70' ' ' ALA . 33.8 m -100.68 122.23 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.253 -0.904 . . . . 0.0 110.96 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 57.43 28.24 15.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.442 -0.786 . . . . 0.0 111.466 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.26 22.46 32.14 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.585 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 53' ' ' SER . 9.1 mt-10 -115.72 93.22 4.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.97 -1.312 . . . . 0.0 109.539 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.42 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.62 0.724 . . . . 0.0 111.438 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.034 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -87.61 -12.65 44.99 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.607 -0.683 . . . . 0.0 110.622 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.448 ' OG ' HD23 ' A' ' 52' ' ' LEU . 49.3 m -53.09 -31.8 43.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.994 -1.066 . . . . 0.0 110.442 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.61 33.25 3.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.194 -0.941 . . . . 0.0 110.475 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 1.034 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -124.7 144.94 49.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 0.0 110.203 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.419 ' HA ' ' CB ' ' A' ' 22' ' ' ARG . 51.1 p -76.9 166.19 23.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 109.835 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.915 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.6 t60 -51.59 -25.04 6.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.056 -1.028 . . . . 0.0 110.071 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.69 -44.0 35.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.117 -0.989 . . . . 0.0 109.057 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.587 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 15.3 mm-40 -66.59 -22.34 66.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.387 -0.821 . . . . 0.0 109.499 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.795 ' HA ' HD11 ' A' ' 59' ' ' LEU . . . -80.6 -46.91 14.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.388 -0.82 . . . . 0.0 110.44 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.934 ' CG2' HD11 ' A' ' 18' ' ' ILE . 10.4 t -64.73 -29.82 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.99 -31.01 69.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.351 -0.843 . . . . 0.0 109.468 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.092 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -74.25 -33.31 63.27 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.276 -0.89 . . . . 0.0 109.679 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.67 ' HB3' HG11 ' B' ' 7' ' ' VAL . 4.4 mm? -72.02 -26.38 62.19 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.537 -0.727 . . . . 0.0 109.782 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.4 -41.36 24.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.251 -0.906 . . . . 0.0 109.939 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -93.63 23.21 4.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.678 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.788 ' CG2' HG22 ' A' ' 78' ' ' VAL . 74.4 m -54.83 129.86 38.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.394 -0.816 . . . . 0.0 110.16 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.79 176.91 46.32 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.422 ' HG3' ' HG2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -49.82 -46.03 50.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -1.146 . . . . 0.0 110.517 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.422 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 20.1 mm-40 -90.94 106.15 18.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.026 -1.047 . . . . 0.0 109.092 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.892 HG12 HD13 ' A' ' 80' ' ' LEU . 20.3 t -97.5 82.0 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.132 -0.98 . . . . 0.0 111.15 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.499 ' O ' HD12 ' A' ' 80' ' ' LEU . 10.8 t -78.64 108.2 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.892 HD13 HG12 ' A' ' 78' ' ' VAL . 4.4 mp -114.82 112.22 22.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.78 -1.2 . . . . 0.0 112.529 -177.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 32.0 tt0 -74.89 124.48 26.96 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.524 HG13 ' CG ' ' A' ' 2' ' ' ARG . 2.2 p -127.53 147.6 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.949 -1.095 . . . . 0.0 111.768 -177.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 3.4 mttt -107.75 87.4 2.49 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.602 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -59.51 114.08 2.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.505 -0.747 . . . . 0.0 110.788 -177.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 mmm -93.62 59.95 2.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.883 . . . . 0.0 109.756 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.0 tttt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.285 -179.81 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.459 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 8.9 tttt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.236 0.541 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 5.7 tt0 -117.88 86.23 2.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 110.196 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.04 -169.44 2.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.209 -0.932 . . . . 0.0 110.258 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.713 ' O ' HD13 ' B' ' 6' ' ' LEU . 2.5 tm? -160.51 106.75 1.5 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 110.122 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.67 HG11 ' HB3' ' A' ' 71' ' ' LEU . 61.6 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.163 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 121.225 0.536 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.516 ' CG ' HG13 ' A' ' 82' ' ' VAL . 1.6 tpt180 -167.6 143.92 4.17 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.321 -0.862 . . . . 0.0 109.74 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -119.98 136.75 54.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.09 -1.006 . . . . 0.0 110.29 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 44' ' ' ALA . 54.9 t -142.75 159.6 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.968 . . . . 0.0 110.528 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 54.0 m -146.73 143.38 28.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.356 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.628 ' CG2' HD12 ' A' ' 45' ' ' LEU . 80.7 t -130.28 118.03 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.334 -0.854 . . . . 0.0 109.804 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.851 179.734 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.566 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.179 0.514 . . . . 0.0 110.51 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.505 ' HA3' ' HG ' ' A' ' 37' ' ' LEU . . . 66.6 91.71 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.55 HG22 ' OXT' ' B' ' 7' ' ' VAL . 2.2 tt -179.15 119.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.094 -1.239 . . . . 0.0 110.56 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.83 ' HB2' HD12 ' B' ' 6' ' ' LEU . 0.3 OUTLIER -105.71 91.48 3.77 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.24 -0.913 . . . . 0.0 109.177 178.619 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.059 HD11 HG22 ' A' ' 68' ' ' VAL . 25.2 pt -69.16 155.35 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 111.131 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' CG ' ' HG3' ' B' ' 4' ' ' GLU . 0.7 OUTLIER -136.11 175.2 9.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.089 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.61 -154.97 19.36 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 157.57 134.53 1.76 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.496 ' HB3' HG22 ' A' ' 63' ' ' THR . 7.2 ttp85 -60.07 -15.47 23.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.4 -1.059 . . . . 0.0 110.762 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.61 -15.15 61.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.856 -1.152 . . . . 0.0 109.813 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.93 22.15 11.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.16 -0.962 . . . . 0.0 109.663 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.67 58.16 5.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.888 . . . . 0.0 109.842 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.435 ' HE3' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -138.7 132.59 16.35 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.935 -179.454 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.546 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 46.3 Cg_endo -68.83 132.31 24.57 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 N-CA-C 108.332 -1.449 . . . . 0.0 108.332 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.603 HG13 ' HB2' ' A' ' 67' ' ' ALA . 17.4 mm -48.77 97.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.055 -1.028 . . . . 0.0 109.591 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.621 HD13 ' HB2' ' A' ' 50' ' ' ALA . 39.9 tp -101.24 128.73 47.23 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.438 -0.789 . . . . 0.0 112.149 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.887 HD12 ' HB2' ' A' ' 49' ' ' ASP . 64.0 mt -63.91 139.23 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.601 -0.687 . . . . 0.0 110.18 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.2 t -121.83 -25.3 5.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 110.641 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -137.25 108.83 6.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.088 -1.007 . . . . 0.0 110.501 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.623 HD11 HG21 ' A' ' 30' ' ' ILE . 10.5 mm -94.64 105.55 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.13 -0.981 . . . . 0.0 108.853 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.814 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 4.2 m-85 -56.75 134.41 54.9 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.274 0.559 . . . . 0.0 110.495 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.574 ' O ' HD23 ' A' ' 37' ' ' LEU . 2.2 mptt -80.76 158.64 25.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.184 -0.947 . . . . 0.0 110.36 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.49 19.29 47.31 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 35' ' ' LYS . 2.4 mm? -109.91 167.48 10.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.18 -1.188 . . . . 0.0 109.698 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . . . -56.53 -65.84 0.54 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.013 -1.054 . . . . 0.0 110.96 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.534 ' O ' HG22 ' A' ' 42' ' ' THR . . . -47.58 -37.7 12.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.309 -0.869 . . . . 0.0 111.284 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 9.3 t70 -86.62 -6.78 58.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.038 -1.039 . . . . 0.0 111.047 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -97.85 -1.86 42.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.825 -1.172 . . . . 0.0 110.911 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 39' ' ' ALA . 9.6 t -97.81 13.61 29.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.839 -1.163 . . . . 0.0 110.708 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 45.52 59.18 3.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.316 -0.865 . . . . 0.0 111.141 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.634 ' HB3' HG13 ' A' ' 4' ' ' VAL . . . -174.1 -49.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.153 -0.967 . . . . 0.0 110.128 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.628 HD12 ' CG2' ' A' ' 6' ' ' VAL . 1.7 mt -70.95 84.02 0.68 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.933 -1.104 . . . . 0.0 108.303 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.597 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -111.0 153.13 25.99 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.879 -0.513 . . . . 0.0 110.083 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.464 ' N ' HG13 ' A' ' 33' ' ' ILE . 91.7 t -50.26 152.26 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.833 -1.167 . . . . 0.0 109.767 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.79 26.06 39.46 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.544 -1.823 . . . . 0.0 108.544 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.887 ' HB2' HD12 ' A' ' 30' ' ' ILE . 67.6 m-20 -111.53 100.08 8.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.396 -1.061 . . . . 0.0 110.627 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.67 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -77.9 110.38 12.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.095 -1.003 . . . . 0.0 110.67 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.859 ' C ' HD22 ' A' ' 52' ' ' LEU . 61.6 mt -79.29 134.64 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 110.232 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.859 HD22 ' C ' ' A' ' 51' ' ' ILE . 3.9 mm? -125.64 10.95 7.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.258 -0.902 . . . . 0.0 110.439 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 175.99 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.031 -1.043 . . . . 0.0 109.765 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.943 HG21 ' CB ' ' A' ' 70' ' ' ALA . 27.5 m -76.24 126.46 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.365 -0.834 . . . . 0.0 110.847 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.0 p30 37.19 40.45 0.18 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.57 -7.18 63.37 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.565 -1.302 . . . . 0.0 111.142 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.532 ' O ' HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -89.81 91.9 8.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.671 -1.488 . . . . 0.0 109.848 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -44.33 112.16 0.38 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.381 0.61 . . . . 0.0 110.888 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.986 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -101.8 -5.97 24.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.323 -0.86 . . . . 0.0 110.962 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.45 ' OG ' HD12 ' A' ' 52' ' ' LEU . 34.5 m -55.36 -32.65 62.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.875 -1.141 . . . . 0.0 110.287 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.3 m -113.13 35.64 3.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.092 -1.005 . . . . 0.0 110.345 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.986 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -121.5 152.8 38.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.178 -0.951 . . . . 0.0 110.193 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.496 HG22 ' HB3' ' A' ' 22' ' ' ARG . 18.0 p -81.79 165.13 21.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.857 . . . . 0.0 109.87 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 68' ' ' VAL . 9.5 t-80 -52.55 -26.15 12.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.014 -1.054 . . . . 0.0 109.903 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.63 -45.73 51.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.052 -1.03 . . . . 0.0 108.923 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.554 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 13.0 mt-10 -61.26 -23.01 65.35 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.597 -0.689 . . . . 0.0 109.4 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.603 ' HB2' HG13 ' A' ' 28' ' ' ILE . . . -80.42 -47.22 14.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.788 . . . . 0.0 110.319 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.059 HG22 HD11 ' A' ' 18' ' ' ILE . 2.6 t -66.3 -33.07 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.481 -0.888 . . . . 0.0 108.773 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -56.25 -41.23 75.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.415 -0.803 . . . . 0.0 109.131 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.943 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.91 -26.35 63.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.439 -0.788 . . . . 0.0 109.35 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.767 ' C ' HG11 ' B' ' 7' ' ' VAL . 3.5 mm? -80.6 -34.57 35.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.628 -0.67 . . . . 0.0 110.082 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -75.93 -33.87 59.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.064 -1.023 . . . . 0.0 110.125 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -112.07 36.27 3.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.631 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.84 HG22 HG22 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -71.42 137.65 48.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.391 -0.818 . . . . 0.0 110.077 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.18 -177.95 34.44 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 78' ' ' VAL . 22.5 tttp -55.45 -76.61 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -1.158 . . . . 0.0 110.022 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -63.91 101.56 0.39 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.095 -1.003 . . . . 0.0 109.466 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.84 HG22 HG22 ' A' ' 74' ' ' THR . 94.5 t -96.61 82.78 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 111.32 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.558 ' O ' HD23 ' A' ' 80' ' ' LEU . 35.0 t -80.26 113.73 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.798 HD21 ' CG1' ' A' ' 78' ' ' VAL . 13.0 mt -117.42 125.03 50.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.956 -1.09 . . . . 0.0 111.917 -177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -77.78 125.39 29.28 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.665 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.516 HG13 ' CG ' ' A' ' 2' ' ' ARG . 1.8 p -126.03 147.94 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.993 -1.067 . . . . 0.0 111.749 -177.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.67 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -108.2 85.79 2.18 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.417 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.597 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -55.62 118.58 4.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.433 -0.792 . . . . 0.0 110.957 -177.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.9 mmm -96.76 49.58 1.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.184 -0.948 . . . . 0.0 109.401 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.8 tptt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.236 -179.669 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.617 ' HB3' ' CD2' ' A' ' 64' ' ' HIS . 32.2 tttt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.282 0.563 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 3.4 tt0 -153.87 138.31 16.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 110.032 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.511 ' OG ' HG11 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -126.59 -163.37 1.23 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.192 -0.942 . . . . 0.0 110.419 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.83 HD12 ' HB2' ' A' ' 17' ' ' SER . 1.4 tp -159.16 56.57 0.41 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.321 -0.862 . . . . 0.0 110.187 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.767 HG11 ' C ' ' A' ' 71' ' ' LEU . 53.4 t . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.048 -1.032 . . . . 0.0 110.255 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.408 ' O ' ' CG ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.317 0.58 . . . . 0.0 110.257 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.839 ' CB ' HG13 ' A' ' 82' ' ' VAL . 3.9 mtp85 -161.94 170.54 19.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 110.408 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' A' ' 3' ' ' ARG . 0.5 OUTLIER -138.88 116.7 11.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.408 -0.808 . . . . 0.0 109.206 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.79 HG22 ' HB1' ' A' ' 44' ' ' ALA . 65.7 t -121.24 136.85 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.992 -1.067 . . . . 0.0 110.841 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.8 m -125.08 126.26 45.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.371 -0.83 . . . . 0.0 109.881 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.83 HG21 HD12 ' A' ' 45' ' ' LEU . 89.3 t -121.79 115.35 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.138 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.127 -0.983 . . . . 0.0 109.871 179.872 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.76 HD23 ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.048 0.451 . . . . 0.0 110.534 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.924 ' CA ' HD22 ' A' ' 37' ' ' LEU . . . 60.61 82.49 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 16' ' ' ILE . 1.1 tt -173.11 120.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.427 -1.043 . . . . 0.0 110.341 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.481 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -112.08 119.38 38.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 109.543 179.152 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.092 HD11 HG22 ' A' ' 68' ' ' VAL . 21.2 pt -100.72 151.66 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.236 -0.915 . . . . 0.0 111.266 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 9.9 pttt -131.04 160.74 33.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 109.643 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.59 -163.78 12.13 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.439 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 160.51 141.0 3.02 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.576 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.0 OUTLIER -60.15 -15.59 25.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -1.091 . . . . 0.0 110.695 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -71.93 -16.86 62.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.886 -1.134 . . . . 0.0 109.796 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -125.66 24.18 7.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.246 -0.908 . . . . 0.0 109.706 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.19 92.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.336 -0.852 . . . . 0.0 110.259 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.512 ' HE2' ' N ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -170.92 128.25 0.71 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.904 . . . . 0.0 110.208 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.71 ' CB ' HD11 ' A' ' 52' ' ' LEU . 55.9 Cg_endo -72.82 46.51 1.07 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 O-C-N 123.448 1.236 . . . . 0.0 112.19 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.637 HD12 ' HA ' ' A' ' 64' ' ' HIS . 12.9 mm 44.33 90.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 120.797 -1.189 . . . . 0.0 110.756 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.828 HD21 ' HG3' ' A' ' 85' ' ' MET . 5.4 mt -97.28 132.84 42.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.799 -1.188 . . . . 0.0 111.613 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.713 HD12 ' HB2' ' A' ' 49' ' ' ASP . 54.8 mt -67.63 136.99 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.868 . . . . 0.0 108.854 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.1 -16.27 8.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.955 -1.091 . . . . 0.0 110.997 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.95 100.47 3.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.995 -1.065 . . . . 0.0 110.682 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.676 HD11 HG21 ' A' ' 30' ' ' ILE . 16.7 mm -86.83 94.12 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.417 -0.802 . . . . 0.0 108.894 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.644 ' HB3' HD13 ' A' ' 37' ' ' LEU . 4.3 m-30 -52.69 137.04 32.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.475 -0.765 . . . . 0.0 110.0 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.826 ' O ' HD12 ' A' ' 37' ' ' LEU . 12.8 tttt -83.75 171.55 13.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.896 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.49 32.4 73.02 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.924 HD22 ' CA ' ' A' ' 15' ' ' GLY . 0.4 OUTLIER -140.44 162.94 34.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.132 -1.216 . . . . 0.0 111.088 -179.431 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.7 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -50.04 -56.59 10.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.523 -0.735 . . . . 0.0 111.461 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.76 ' HB2' HD23 ' A' ' 14' ' ' LEU . . . -55.67 -35.51 66.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.245 -0.909 . . . . 0.0 112.092 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.532 ' HB2' HG22 ' A' ' 33' ' ' ILE . 22.0 t70 -95.74 -3.11 46.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.916 -1.115 . . . . 0.0 111.474 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.484 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 1.4 pp0? -110.34 16.98 21.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.728 -1.233 . . . . 0.0 110.354 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.523 HG21 HG22 ' A' ' 6' ' ' VAL . 7.4 t -108.47 14.72 24.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.945 . . . . 0.0 110.777 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 45.5 54.38 7.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.197 -0.94 . . . . 0.0 111.343 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.79 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -175.72 -50.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.127 -0.983 . . . . 0.0 110.445 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.83 HD12 HG21 ' A' ' 6' ' ' VAL . 1.4 mt -70.51 84.56 0.6 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.871 -1.143 . . . . 0.0 108.92 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.592 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -112.88 152.28 29.46 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.56 -179.399 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 48' ' ' GLY . 60.3 t -47.74 168.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.028 -1.045 . . . . 0.0 110.607 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.519 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 66.8 37.22 92.15 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.713 ' HB2' HD12 ' A' ' 30' ' ' ILE . 27.8 m-20 -120.89 107.61 12.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.256 -1.143 . . . . 0.0 110.483 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.795 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -84.57 105.12 15.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.835 . . . . 0.0 110.147 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.766 ' O ' HD12 ' A' ' 52' ' ' LEU . 65.0 mt -71.03 135.95 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.363 -0.835 . . . . 0.0 110.854 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 51' ' ' ILE . 6.5 mp -125.63 6.97 7.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.391 -0.818 . . . . 0.0 110.96 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 176.1 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.97 -1.082 . . . . 0.0 109.978 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.913 HG21 ' CB ' ' A' ' 70' ' ' ALA . 17.5 m -96.53 119.22 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.134 -0.979 . . . . 0.0 110.865 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 45.8 m-80 57.06 33.52 23.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.53 -0.731 . . . . 0.0 111.573 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.82 12.05 61.07 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.944 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.474 ' O ' HD23 ' A' ' 59' ' ' LEU . 10.1 mt-10 -105.46 90.5 3.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.7 -1.47 . . . . 0.0 109.741 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.33 102.01 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.479 0.656 . . . . 0.0 110.977 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.867 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -94.8 -14.04 25.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.429 -0.794 . . . . 0.0 110.703 -179.384 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.5 p -50.01 -32.62 15.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.004 -1.06 . . . . 0.0 110.437 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 t -107.75 31.41 5.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 109.987 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.867 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -122.43 163.66 19.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.378 -0.826 . . . . 0.0 110.346 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.576 HG22 ' HB3' ' A' ' 22' ' ' ARG . 12.7 p -85.12 165.07 17.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.399 -0.813 . . . . 0.0 110.375 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.871 ' O ' HG23 ' A' ' 68' ' ' VAL . 3.4 t60 -53.72 -26.17 21.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 109.831 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -73.75 -36.58 65.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.081 -1.012 . . . . 0.0 109.335 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.626 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 1.3 mm-40 -68.86 -22.96 64.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.588 -0.695 . . . . 0.0 109.724 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.417 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -82.83 -41.05 19.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.299 -0.876 . . . . 0.0 110.545 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.092 HG22 HD11 ' A' ' 18' ' ' ILE . 2.9 t -72.85 -32.86 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.152 -0.968 . . . . 0.0 109.372 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -59.65 -38.1 80.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.371 -0.831 . . . . 0.0 109.952 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.913 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.45 -53.1 17.73 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.152 -0.967 . . . . 0.0 108.81 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.563 ' HB3' HG11 ' B' ' 7' ' ' VAL . 96.4 mt -56.78 -22.43 35.89 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.709 -0.619 . . . . 0.0 109.485 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -79.52 -40.42 29.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.859 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 1.5 ttmt -119.11 59.54 0.83 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.405 -0.809 . . . . 0.0 109.869 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.651 ' HB ' HG22 ' A' ' 78' ' ' VAL . 66.4 p -78.06 -175.04 3.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.324 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.06 -171.46 20.13 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -48.57 -48.37 38.92 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.101 -1.235 . . . . 0.0 110.455 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 12.4 pt-20 -108.73 119.88 40.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.328 -0.857 . . . . 0.0 109.863 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.706 ' CG1' HD21 ' A' ' 80' ' ' LEU . 85.6 t -89.42 82.02 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.176 -0.952 . . . . 0.0 110.721 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.459 ' C ' HD23 ' A' ' 80' ' ' LEU . 2.8 t -77.27 107.11 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.706 HD21 ' CG1' ' A' ' 78' ' ' VAL . 14.1 mt -113.34 115.77 28.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.805 -1.184 . . . . 0.0 111.576 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.416 ' HB3' ' OG ' ' A' ' 53' ' ' SER . 5.9 tp10 -67.79 124.59 23.75 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.839 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.4 p -121.74 141.53 41.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.003 -1.06 . . . . 0.0 112.199 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.795 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 40.4 tttm -107.41 81.3 1.51 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.592 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -50.52 122.19 6.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.576 -0.703 . . . . 0.0 111.191 -178.002 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.828 ' HG3' HD21 ' A' ' 29' ' ' LEU . 6.3 mmt -96.39 49.0 1.1 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.281 -0.887 . . . . 0.0 109.023 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.874 -1.06 . . . . 0.0 110.295 -179.512 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.554 ' CD ' ' CD2' ' A' ' 64' ' ' HIS . 1.6 mttm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.32 0.581 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER 54.19 41.45 32.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 109.679 -179.51 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.405 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . 1.3 m -57.28 -169.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.359 -0.838 . . . . 0.0 110.783 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.558 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 39.2 tp -156.71 117.58 3.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.387 -0.821 . . . . 0.0 110.086 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.563 HG11 ' HB3' ' A' ' 71' ' ' LEU . 66.2 t . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.157 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.44 0.638 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.522 ' CG ' HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -161.91 146.61 12.83 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.461 -0.774 . . . . 0.0 109.586 -179.306 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.416 ' N ' ' HG3' ' A' ' 2' ' ' ARG . 1.6 mpp_? -120.59 126.57 50.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 109.927 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.739 HG23 HG11 ' A' ' 82' ' ' VAL . 54.5 t -121.51 153.87 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 110.549 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 84.8 m -139.16 109.69 6.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.514 -0.741 . . . . 0.0 109.513 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.811 HG22 HG21 ' A' ' 42' ' ' THR . 56.6 t -100.53 125.19 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 0.0 109.813 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.9 mtt-85 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.933 . . . . 0.0 110.29 -179.58 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.555 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.119 0.485 . . . . 0.0 110.464 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.948 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 56.9 86.72 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.665 HD12 ' CD2' ' A' ' 45' ' ' LEU . 6.2 tt -174.34 115.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.107 -1.231 . . . . 0.0 110.534 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.22 98.18 7.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.937 . . . . 0.0 109.728 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.066 HD11 HG22 ' A' ' 68' ' ' VAL . 44.7 pt -74.55 146.93 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 110.615 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -132.97 116.14 16.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.462 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.11 -160.38 30.78 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 163.17 134.47 1.65 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -60.72 -14.85 23.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.465 -1.021 . . . . 0.0 110.807 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.29 5.53 22.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.984 -1.073 . . . . 0.0 110.138 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -140.94 25.65 2.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.093 -1.004 . . . . 0.0 109.463 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 54.75 83.23 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.333 -0.855 . . . . 0.0 109.62 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.598 ' HE1' ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -169.11 126.92 0.85 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.254 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.893 ' CB ' HD21 ' A' ' 52' ' ' LEU . 56.0 Cg_endo -76.76 45.66 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.459 1.241 . . . . 0.0 111.972 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 19.9 mm 45.07 89.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 O-C-N 120.869 -1.144 . . . . 0.0 110.218 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.604 HD13 ' HB2' ' A' ' 50' ' ' ALA . 36.6 tp -103.7 127.58 51.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.853 -1.155 . . . . 0.0 111.751 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.827 HD12 ' HB2' ' A' ' 49' ' ' ASP . 61.8 mt -62.05 136.2 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.464 -0.772 . . . . 0.0 109.734 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 t -120.5 -18.59 7.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.218 -0.926 . . . . 0.0 110.734 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.5 104.77 4.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.972 -1.08 . . . . 0.0 110.517 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.712 HD11 HG21 ' A' ' 30' ' ' ILE . 10.8 mm -92.56 99.51 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.146 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.648 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 94.7 m-85 -59.64 136.34 57.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.488 -0.758 . . . . 0.0 110.271 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.836 ' O ' HD12 ' A' ' 37' ' ' LEU . 21.4 mtmt -80.37 174.49 11.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 110.649 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.77 28.33 62.91 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.948 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -136.54 160.45 38.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.106 -1.232 . . . . 0.0 110.726 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.743 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -48.43 -57.71 5.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 111.502 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.943 ' HB1' HD23 ' A' ' 45' ' ' LEU . . . -52.04 -45.79 64.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 111.808 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.458 ' HB2' HG22 ' A' ' 33' ' ' ILE . 7.3 t70 -85.01 -17.29 38.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.913 -1.117 . . . . 0.0 111.623 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.493 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 1.5 pp0? -99.42 13.2 34.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.797 -1.189 . . . . 0.0 110.851 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.811 HG21 HG22 ' A' ' 6' ' ' VAL . 10.0 t -107.84 14.83 25.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.997 -1.064 . . . . 0.0 110.775 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 45.39 49.71 10.32 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.252 -0.905 . . . . 0.0 111.079 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.71 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -167.43 -55.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.585 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.943 HD23 ' HB1' ' A' ' 39' ' ' ALA . 2.4 tp -69.43 84.03 0.4 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.853 -1.154 . . . . 0.0 108.683 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.602 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.58 152.55 28.76 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.86 -0.525 . . . . 0.0 109.665 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.44 ' N ' HG13 ' A' ' 33' ' ' ILE . 65.7 t -49.26 153.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.919 -1.113 . . . . 0.0 110.035 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.427 ' C ' HD11 ' A' ' 29' ' ' LEU . . . 83.76 24.08 50.84 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.827 ' HB2' HD12 ' A' ' 30' ' ' ILE . 69.4 m-20 -109.69 100.38 9.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.398 -1.06 . . . . 0.0 110.675 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.891 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -78.28 102.23 7.55 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.152 -0.968 . . . . 0.0 110.022 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 81' ' ' GLU . 69.4 mt -71.03 138.03 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.428 -0.795 . . . . 0.0 110.702 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.893 HD21 ' CB ' ' A' ' 27' ' ' PRO . 83.0 mt -136.32 9.83 3.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.287 -0.883 . . . . 0.0 111.269 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 179.09 92.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.922 -1.111 . . . . 0.0 109.832 179.465 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.999 HG21 ' CB ' ' A' ' 70' ' ' ALA . 33.1 m -91.51 121.04 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.287 -0.883 . . . . 0.0 110.156 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 55.69 36.42 27.19 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.495 -0.753 . . . . 0.0 110.838 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.99 -7.35 78.08 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.743 -1.218 . . . . 0.0 110.388 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -78.63 93.81 4.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.741 -1.447 . . . . 0.0 109.513 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.71 102.87 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.525 0.678 . . . . 0.0 111.021 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.878 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.5 OUTLIER -91.0 -4.89 56.07 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.5 -0.75 . . . . 0.0 110.556 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 t -58.54 -43.16 89.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 110.242 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.2 m -102.27 35.25 2.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 110.343 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.878 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -119.29 145.39 46.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 110.274 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.2 p -78.23 168.6 19.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.911 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.881 ' O ' HG23 ' A' ' 68' ' ' VAL . 7.7 t60 -54.51 -24.04 18.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.01 -1.056 . . . . 0.0 109.871 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.25 -43.39 42.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.12 -0.987 . . . . 0.0 109.12 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.622 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 32.9 mm-40 -65.61 -21.49 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.586 -0.696 . . . . 0.0 109.648 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.726 ' HA ' HD11 ' A' ' 59' ' ' LEU . . . -83.54 -47.5 11.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 110.583 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.066 HG22 HD11 ' A' ' 18' ' ' ILE . 7.8 t -62.8 -27.14 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.126 -0.983 . . . . 0.0 108.797 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -39.4 81.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.425 -0.797 . . . . 0.0 109.202 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.999 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -62.8 -44.35 96.39 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.355 -0.84 . . . . 0.0 108.849 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.702 ' C ' HG11 ' B' ' 7' ' ' VAL . 3.8 mm? -69.7 -23.39 63.42 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -84.27 -42.04 16.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.977 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -100.79 24.33 9.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.0 109.89 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -64.38 154.23 36.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.916 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.54 -172.01 20.6 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -48.95 -62.32 1.59 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.061 -1.258 . . . . 0.0 110.389 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -83.62 115.92 22.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.083 -1.011 . . . . 0.0 108.639 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.886 ' CG1' HD21 ' A' ' 80' ' ' LEU . 71.5 t -109.39 89.85 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.072 -1.018 . . . . 0.0 111.154 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.895 ' O ' HD23 ' A' ' 80' ' ' LEU . 48.7 t -76.96 123.46 33.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.895 HD23 ' O ' ' A' ' 79' ' ' VAL . 15.5 mt -128.09 109.33 11.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.822 -1.174 . . . . 0.0 111.64 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 13.6 tp10 -66.29 129.63 40.47 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.739 HG11 HG23 ' A' ' 4' ' ' VAL . 2.4 p -132.68 146.7 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.873 -1.142 . . . . 0.0 112.119 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.891 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 13.5 tttt -107.7 85.09 2.06 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.602 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -55.51 123.53 14.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.741 . . . . 0.0 110.99 -177.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.1 mmt -99.47 51.63 0.94 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.375 -0.828 . . . . 0.0 109.866 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.268 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 64' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.185 0.517 . . . . 0.0 110.355 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 36.2 tt0 54.6 68.89 0.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.883 . . . . 0.0 110.361 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 39.8 t -66.21 -153.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.097 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.648 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -175.81 66.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.115 -0.991 . . . . 0.0 110.328 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.702 HG11 ' C ' ' A' ' 71' ' ' LEU . 46.6 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.236 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.312 0.577 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.854 ' CB ' HG13 ' A' ' 82' ' ' VAL . 1.6 mtp85 -157.15 165.42 36.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.319 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -140.97 112.53 7.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.409 -0.807 . . . . 0.0 109.229 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.629 HG13 ' HB3' ' A' ' 44' ' ' ALA . 37.5 t -124.56 152.85 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.039 -1.038 . . . . 0.0 110.529 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.3 m -139.99 143.57 36.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.365 -0.835 . . . . 0.0 110.124 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.461 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 98.5 t -130.75 109.7 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.919 . . . . 0.0 109.849 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.421 ' HD3' ' N ' ' A' ' 7' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 110.159 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.842 HD22 HG21 ' A' ' 16' ' ' ILE . 1.4 tt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.28 0.562 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.49 ' HA3' ' HG ' ' A' ' 37' ' ' LEU . . . 70.94 79.93 0.35 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.842 HG21 HD22 ' A' ' 14' ' ' LEU . 2.7 tt -176.58 117.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.314 -1.109 . . . . 0.0 109.876 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.416 ' HB3' ' HB3' ' A' ' 32' ' ' LYS . 4.1 t -108.69 114.56 28.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.29 -0.881 . . . . 0.0 110.263 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.01 HD11 HG22 ' A' ' 68' ' ' VAL . 27.2 pt -88.06 153.84 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 110.637 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' B' ' 3' ' ' LYS . 16.4 ttpp -142.83 118.47 10.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.272 -0.893 . . . . 0.0 110.054 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.55 -161.07 32.87 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.448 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 169.12 131.95 1.38 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.607 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.0 OUTLIER -60.31 -15.34 24.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -1.191 . . . . 0.0 110.71 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.95 -14.02 58.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.94 -1.1 . . . . 0.0 109.977 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.87 24.0 11.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.809 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.1 tttt 54.67 78.81 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.995 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.611 ' HE1' ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -161.95 120.77 1.42 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 110.409 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.733 ' HB2' HD11 ' A' ' 52' ' ' LEU . 50.6 Cg_endo -71.35 52.45 1.55 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 O-C-N 123.514 1.271 . . . . 0.0 111.966 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 64' ' ' HIS . 6.9 mm 42.57 89.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.09 -1.006 . . . . 0.0 110.574 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.611 ' N ' ' HE1' ' A' ' 26' ' ' MET . 6.0 mt -98.66 132.69 43.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.768 -1.208 . . . . 0.0 111.975 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.593 HD12 ' HB2' ' A' ' 49' ' ' ASP . 49.1 mt -66.52 133.53 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.306 -0.872 . . . . 0.0 108.815 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 t -116.79 -16.53 10.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.066 -1.021 . . . . 0.0 110.888 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -146.02 106.63 4.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.998 -1.064 . . . . 0.0 111.143 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.568 HD11 HG21 ' A' ' 30' ' ' ILE . 12.2 mm -93.32 115.16 31.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.261 -0.899 . . . . 0.0 108.601 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.861 ' CE1' HD13 ' B' ' 6' ' ' LEU . 10.0 m-85 -66.82 134.39 52.02 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.405 -0.809 . . . . 0.0 109.988 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.557 ' O ' HD23 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -79.81 151.88 30.05 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.259 -0.9 . . . . 0.0 110.821 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.16 16.5 60.13 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.557 HD23 ' O ' ' A' ' 35' ' ' LYS . 3.2 mm? -105.4 165.3 11.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -1.164 . . . . 0.0 110.298 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.461 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -48.42 -63.73 1.0 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.22 -0.925 . . . . 0.0 111.036 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.886 ' O ' HG22 ' A' ' 42' ' ' THR . . . -50.45 -53.0 32.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 110.721 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 24.1 t70 -73.09 -4.93 35.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.026 -1.046 . . . . 0.0 111.152 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -97.01 3.54 51.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.773 -1.205 . . . . 0.0 110.899 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 39' ' ' ALA . 7.2 t -107.68 15.17 24.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.805 -1.184 . . . . 0.0 110.781 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 47.31 56.95 6.27 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.12 -0.988 . . . . 0.0 110.954 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.629 ' HB3' HG13 ' A' ' 4' ' ' VAL . . . -173.74 -44.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 110.245 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.544 ' CD1' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -69.09 81.94 0.33 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.975 -1.078 . . . . 0.0 108.687 179.208 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.587 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.21 149.32 32.44 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.601 -0.687 . . . . 0.0 110.231 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 48' ' ' GLY . 84.5 t -49.89 169.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.124 -0.985 . . . . 0.0 110.404 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.534 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 68.61 32.96 75.35 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.597 ' C ' HD23 ' A' ' 29' ' ' LEU . 27.6 m-20 -117.95 108.57 15.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.559 -0.965 . . . . 0.0 110.423 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.648 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -85.8 104.69 15.71 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.465 HG21 ' CG1' ' A' ' 54' ' ' VAL . 30.7 mt -70.36 134.05 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.356 -0.84 . . . . 0.0 110.136 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 27' ' ' PRO . 2.4 mp -132.25 17.69 4.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 110.368 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 174.58 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.214 -0.929 . . . . 0.0 109.967 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.952 HG21 ' CB ' ' A' ' 70' ' ' ALA . 21.2 m -91.08 127.0 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.107 -0.996 . . . . 0.0 109.846 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 57.72 38.64 27.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 0.0 110.013 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.83 29.87 70.74 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 53' ' ' SER . 7.4 tt0 -115.81 91.8 3.71 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -1.108 . . . . 0.0 109.579 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -37.91 102.04 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.691 0.758 . . . . 0.0 112.071 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.99 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -91.48 -13.63 31.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.648 -0.658 . . . . 0.0 110.483 179.827 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.699 ' OG ' HD23 ' A' ' 52' ' ' LEU . 44.1 m -53.52 -37.14 62.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.014 -1.054 . . . . 0.0 110.182 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.9 m -96.86 25.88 4.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 110.035 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.99 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -120.18 157.54 28.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 110.233 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.607 HG22 ' HB3' ' A' ' 22' ' ' ARG . 32.0 p -88.95 164.96 14.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 110.081 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.926 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.6 t-80 -52.0 -25.76 9.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.953 . . . . 0.0 109.578 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -73.13 -40.19 65.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.096 -1.003 . . . . 0.0 109.082 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.495 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 1.1 mt-10 -71.06 -25.57 62.69 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.441 -0.787 . . . . 0.0 109.452 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.618 ' O ' HD23 ' A' ' 71' ' ' LEU . . . -76.35 -42.2 45.62 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.445 -0.784 . . . . 0.0 110.0 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.01 HG22 HD11 ' A' ' 18' ' ' ILE . 6.3 t -70.47 -30.63 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.189 -0.944 . . . . 0.0 109.08 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -58.87 -40.27 83.87 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.375 -0.828 . . . . 0.0 109.16 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.952 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -68.68 -46.75 68.23 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.355 -0.841 . . . . 0.0 108.814 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.702 ' C ' HG11 ' B' ' 7' ' ' VAL . 3.0 mm? -56.75 -30.13 63.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.681 -0.637 . . . . 0.0 109.63 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.3 -41.52 22.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.1 -1.0 . . . . 0.0 109.983 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -106.58 55.17 0.67 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.667 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.783 ' HB ' HG22 ' A' ' 78' ' ' VAL . 33.2 p -79.11 149.14 32.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.323 -0.861 . . . . 0.0 109.657 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.04 -177.63 45.88 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -50.94 47.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.253 -1.145 . . . . 0.0 110.122 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -98.35 94.18 6.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -0.87 . . . . 0.0 109.423 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.783 HG22 ' HB ' ' A' ' 74' ' ' THR . 92.8 t -63.72 78.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 111.085 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.948 ' O ' HD23 ' A' ' 80' ' ' LEU . 12.8 t -75.81 123.7 32.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.948 HD23 ' O ' ' A' ' 79' ' ' VAL . 13.0 mt -128.98 117.62 21.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.747 -1.22 . . . . 0.0 111.465 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 20.2 tt0 -73.78 125.21 27.61 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.854 HG13 ' CB ' ' A' ' 2' ' ' ARG . 3.0 p -125.72 145.48 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.052 -1.03 . . . . 0.0 112.206 -177.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.547 ' HB2' HD13 ' A' ' 52' ' ' LEU . 1.0 OUTLIER -112.53 86.41 2.36 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.66 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.587 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -52.91 129.46 30.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.572 -0.705 . . . . 0.0 110.959 -178.121 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.4 mmt -101.29 46.66 0.93 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.292 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.284 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.606 ' HG3' ' CD2' ' A' ' 64' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.29 0.566 . . . . 0.0 110.59 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.8 mt-10 -109.37 -158.89 0.66 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.455 -0.778 . . . . 0.0 109.048 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.595 ' OG ' HG11 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -175.85 -48.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.83 -1.169 . . . . 0.0 110.806 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.861 HD13 ' CE1' ' A' ' 34' ' ' PHE . 13.0 tp 54.6 92.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 109.936 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.702 HG11 ' C ' ' A' ' 71' ' ' LEU . 61.2 t . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.028 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.271 0.558 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.811 ' O ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -122.52 147.35 46.47 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.272 -0.892 . . . . 0.0 109.032 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -105.24 106.49 17.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.054 -1.029 . . . . 0.0 110.058 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.767 HG13 ' HB3' ' A' ' 44' ' ' ALA . 61.1 t -107.48 128.86 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.948 . . . . 0.0 110.266 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.0 m -115.28 111.23 20.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 110.125 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.621 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 99.0 t -97.09 118.54 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.846 . . . . 0.0 109.823 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.232 -0.917 . . . . 0.0 110.288 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.213 0.53 . . . . 0.0 110.132 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.882 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 58.27 87.46 0.02 OUTLIER Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 45' ' ' LEU . 4.6 tt -176.51 117.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.184 -1.186 . . . . 0.0 110.404 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 32' ' ' LYS . 35.2 t -106.94 117.82 35.06 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.295 -0.878 . . . . 0.0 109.619 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.961 HD11 ' CG2' ' A' ' 68' ' ' VAL . 43.7 pt -94.85 150.26 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 110.817 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' B' ' 3' ' ' LYS . 17.1 tttt -138.49 120.26 15.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 110.183 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.18 -153.43 24.61 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 157.19 134.13 1.71 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -60.69 -14.77 22.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.374 -1.074 . . . . 0.0 110.547 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' OE2' ' ND2' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -80.32 1.88 26.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.949 -1.094 . . . . 0.0 110.469 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.414 ' ND2' ' OE2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -138.07 26.17 2.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.973 -1.08 . . . . 0.0 109.795 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 54.47 66.99 1.08 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 110.113 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.474 ' HE3' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -149.86 115.89 3.52 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.436 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.937 ' HB3' HD21 ' A' ' 52' ' ' LEU . 49.2 Cg_endo -68.2 55.38 0.76 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.321 1.347 . . . . 0.0 111.793 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 64' ' ' HIS . 16.0 mm 41.66 88.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 121.286 -0.884 . . . . 0.0 110.446 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' A' ' 50' ' ' ALA . 34.3 tp -101.88 126.66 48.83 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.831 -1.168 . . . . 0.0 112.121 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.788 HD12 ' HB2' ' A' ' 49' ' ' ASP . 55.6 mt -64.41 140.88 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.686 -0.634 . . . . 0.0 109.953 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.6 t -128.68 4.14 5.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 110.718 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 1.9 ttmt -165.03 99.89 0.75 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.818 -1.176 . . . . 0.0 110.263 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 30' ' ' ILE . 14.4 mm -89.64 111.88 23.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.32 -0.862 . . . . 0.0 109.318 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.663 ' HB3' HD13 ' A' ' 37' ' ' LEU . 16.2 m-85 -74.3 126.83 31.51 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.47 -0.769 . . . . 0.0 109.984 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.863 ' O ' HD12 ' A' ' 37' ' ' LEU . 20.3 mtmt -75.62 170.54 15.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.312 -0.867 . . . . 0.0 110.548 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.52 26.19 71.77 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.882 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -138.99 159.55 41.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -1.19 . . . . 0.0 110.918 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.621 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -42.72 -66.36 0.37 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.648 -0.658 . . . . 0.0 112.128 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.886 ' O ' HG22 ' A' ' 42' ' ' THR . . . -45.83 -59.3 2.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.316 -0.865 . . . . 0.0 111.354 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -71.97 -4.19 27.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.904 -1.123 . . . . 0.0 111.114 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -107.78 11.82 27.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.555 -1.341 . . . . 0.0 110.726 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 39' ' ' ALA . 8.9 t -108.42 15.73 23.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.956 -1.09 . . . . 0.0 110.708 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 47.86 51.08 14.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.07 -1.019 . . . . 0.0 110.846 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.767 ' HB3' HG13 ' A' ' 4' ' ' VAL . . . -172.73 -45.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -0.918 . . . . 0.0 110.017 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.497 ' HG ' ' HB1' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -67.26 81.49 0.14 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.017 -1.052 . . . . 0.0 109.344 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -113.21 152.7 29.42 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.479 -0.763 . . . . 0.0 109.978 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.456 ' N ' HG13 ' A' ' 33' ' ' ILE . 86.4 t -50.94 163.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.783 -1.198 . . . . 0.0 109.98 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.431 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 75.0 28.5 62.36 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.788 ' HB2' HD12 ' A' ' 30' ' ' ILE . 46.3 m-20 -109.81 98.15 7.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.387 -1.066 . . . . 0.0 110.705 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.795 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -75.4 92.61 2.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 0.0 110.282 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 59' ' ' LEU . 51.6 mt -64.13 136.72 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.386 -0.821 . . . . 0.0 110.191 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.937 HD21 ' HB3' ' A' ' 27' ' ' PRO . 10.5 mt -136.11 19.82 3.21 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.375 -0.828 . . . . 0.0 109.591 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 22.6 t 177.72 126.46 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.594 -0.691 . . . . 0.0 109.351 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.042 HG12 HD22 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -124.81 116.68 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 m120 58.58 31.95 21.62 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.481 -0.762 . . . . 0.0 110.643 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.44 23.92 32.61 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 53' ' ' SER . 4.9 tt0 -115.4 88.23 2.83 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.026 -1.279 . . . . 0.0 110.079 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -44.62 101.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.504 -0.748 . . . . 0.0 111.28 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.703 HD11 HG22 ' A' ' 54' ' ' VAL . 70.5 mt -81.3 -13.04 58.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 110.358 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 t -48.5 -33.45 9.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.16 -0.963 . . . . 0.0 110.284 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.43 27.97 7.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.353 -0.842 . . . . 0.0 109.591 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 66' ' ' GLU . . . -123.81 149.07 46.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.407 -0.808 . . . . 0.0 110.493 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 p -79.86 166.43 21.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.312 -0.868 . . . . 0.0 109.812 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.943 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.3 t-80 -55.48 -31.83 62.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.082 -1.011 . . . . 0.0 109.854 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.66 -32.43 65.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.824 -1.173 . . . . 0.0 109.547 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.488 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 1.2 mm-40 -72.65 -28.39 62.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.55 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.427 ' O ' HD23 ' A' ' 71' ' ' LEU . . . -77.08 -41.72 41.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.757 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.961 ' CG2' HD11 ' A' ' 18' ' ' ILE . 7.3 t -63.79 -26.96 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.544 -0.862 . . . . 0.0 108.98 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -36.58 81.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.522 -0.736 . . . . 0.0 109.549 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.763 ' O ' HG23 ' A' ' 74' ' ' THR . . . -72.36 -39.89 67.73 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.169 -0.957 . . . . 0.0 109.262 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.682 ' HB3' HG11 ' B' ' 7' ' ' VAL . 4.0 mm? -60.64 -29.92 69.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.368 -0.832 . . . . 0.0 108.918 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -84.75 -36.77 21.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.853 . . . . 0.0 110.118 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -106.05 27.34 8.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.974 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.763 HG23 ' O ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -67.29 166.58 14.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.133 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -109.19 -176.01 21.4 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -51.78 -63.1 1.24 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.204 -1.174 . . . . 0.0 110.4 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -81.8 88.02 6.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.206 -0.934 . . . . 0.0 109.915 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.774 ' CG1' HD21 ' A' ' 80' ' ' LEU . 53.9 t -80.4 90.35 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.932 . . . . 0.0 110.644 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.661 ' O ' HD23 ' A' ' 80' ' ' LEU . 7.1 t -80.68 117.3 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.042 HD22 HG12 ' A' ' 54' ' ' VAL . 17.3 mt -122.5 116.02 23.2 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.409 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.459 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 0.8 OUTLIER -74.0 133.51 42.98 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.655 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 2' ' ' ARG . 4.0 p -129.99 153.68 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.95 -1.093 . . . . 0.0 112.519 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.65 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 2.6 mtpt -115.53 81.55 1.61 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -47.96 121.13 3.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.457 -0.777 . . . . 0.0 111.334 -177.668 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.3 mtt -116.15 52.21 0.92 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.48 -0.762 . . . . 0.0 109.311 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.396 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.508 ' HG2' ' CE1' ' A' ' 64' ' ' HIS . 6.9 tttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.167 0.508 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.416 ' OE2' ' CE ' ' A' ' 32' ' ' LYS . 1.2 tt0 -113.71 70.31 0.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 109.938 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.6 -176.42 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.265 -0.897 . . . . 0.0 110.73 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.62 HD13 ' CE1' ' A' ' 34' ' ' PHE . 21.8 tp -160.15 90.64 0.91 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.443 -0.785 . . . . 0.0 109.855 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.682 HG11 ' HB3' ' A' ' 71' ' ' LEU . 93.1 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.122 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.267 0.556 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.983 ' HB3' HG13 ' A' ' 82' ' ' VAL . 1.1 ttm-85 -152.83 172.65 16.41 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 0.0 109.939 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.84 135.44 14.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.916 . . . . 0.0 109.349 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.637 HG22 ' HB1' ' A' ' 44' ' ' ALA . 66.6 t -142.19 137.67 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.05 -1.031 . . . . 0.0 110.997 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.9 m -121.08 114.08 20.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.522 -0.736 . . . . 0.0 109.304 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.933 HG22 HG21 ' A' ' 42' ' ' THR . 83.1 t -105.53 119.51 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.123 -0.986 . . . . 0.0 110.826 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.396 -0.815 . . . . 0.0 109.74 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.539 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.088 0.47 . . . . 0.0 110.505 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.947 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 57.84 89.78 0.01 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.766 HD12 HD23 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -174.92 120.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.237 -1.155 . . . . 0.0 110.316 -179.043 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.425 ' HB3' ' CB ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -110.56 93.62 4.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.253 -0.904 . . . . 0.0 109.755 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.98 HD11 ' CG2' ' A' ' 68' ' ' VAL . 28.9 pt -73.62 148.67 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.378 -0.826 . . . . 0.0 110.557 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 31' ' ' SER . 2.3 mtpt -136.88 144.46 43.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.01 . . . . 0.0 110.183 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 136.85 -158.34 24.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.456 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 165.89 133.24 1.48 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.682 ' HB3' HG22 ' A' ' 63' ' ' THR . 1.9 ttp85 -59.53 -15.64 19.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -1.13 . . . . 0.0 110.64 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -14.2 60.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.946 -1.096 . . . . 0.0 109.922 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.02 24.36 10.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.189 -0.944 . . . . 0.0 109.704 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.39 73.21 0.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 110.166 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.53 ' HE1' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -150.4 123.96 4.4 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.93 . . . . 0.0 110.317 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.64 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 54.8 Cg_endo -73.04 50.23 1.78 Allowed 'Trans proline' 0 N--CA 1.493 1.448 0 O-C-N 123.35 1.184 . . . . 0.0 111.752 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 64' ' ' HIS . 10.0 mm 43.06 89.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.498 0 O-C-N 121.101 -0.999 . . . . 0.0 110.656 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.614 HD23 ' N ' ' A' ' 50' ' ' ALA . 6.1 mt -96.57 132.87 41.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.88 -1.137 . . . . 0.0 111.723 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.786 HD12 ' HB2' ' A' ' 49' ' ' ASP . 52.3 mt -67.49 135.55 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.451 ' HA ' HG13 ' A' ' 47' ' ' VAL . 10.7 t -116.29 -36.04 4.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.062 -1.024 . . . . 0.0 110.815 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.425 ' CB ' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -129.06 105.04 7.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.056 -1.028 . . . . 0.0 110.82 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.707 HD11 HG21 ' A' ' 30' ' ' ILE . 10.1 mm -90.45 97.2 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.198 -0.939 . . . . 0.0 109.139 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.823 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 96.3 m-85 -61.89 133.86 55.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.476 -0.765 . . . . 0.0 110.529 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.793 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.8 ttmt -79.06 175.91 10.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.829 . . . . 0.0 110.432 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.61 25.08 60.51 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.947 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.9 OUTLIER -134.88 159.42 41.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.144 . . . . 0.0 110.386 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.789 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -47.54 -59.06 3.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.382 -0.824 . . . . 0.0 111.17 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.612 ' HB1' HD23 ' A' ' 45' ' ' LEU . . . -48.4 -44.55 34.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.279 -0.888 . . . . 0.0 111.334 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.416 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 16.4 t70 -95.87 11.13 34.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 111.092 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -107.12 -4.74 18.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.823 -1.173 . . . . 0.0 110.588 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.933 HG21 HG22 ' A' ' 6' ' ' VAL . 7.2 t -105.56 14.44 28.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.827 -1.171 . . . . 0.0 110.704 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 46.21 53.85 8.97 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.23 -0.919 . . . . 0.0 110.951 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.637 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -160.74 -48.43 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.239 -0.913 . . . . 0.0 110.036 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.766 HD23 HD12 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -72.64 87.63 1.24 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.843 -1.161 . . . . 0.0 108.0 178.677 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.589 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -113.2 149.57 33.53 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.133 0.492 . . . . 0.0 110.175 -178.734 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.503 ' HA ' HG22 ' A' ' 30' ' ' ILE . 56.3 t -47.19 154.2 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.048 -1.032 . . . . 0.0 110.331 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.18 28.74 43.68 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.786 ' HB2' HD12 ' A' ' 30' ' ' ILE . 62.3 m-20 -113.43 103.38 11.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.438 -1.036 . . . . 0.0 110.435 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.64 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -80.29 108.28 13.77 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.186 -0.946 . . . . 0.0 109.295 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.762 ' C ' HD22 ' A' ' 52' ' ' LEU . 51.4 mt -75.4 134.55 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 111.085 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.762 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.5 mm? -119.58 14.04 12.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.505 -0.747 . . . . 0.0 109.81 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 1.3 t 178.02 146.33 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 108.997 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.756 HG21 ' CB ' ' A' ' 70' ' ' ALA . 2.6 m -138.72 125.28 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.985 -1.072 . . . . 0.0 111.186 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 59.12 16.08 4.55 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.411 -0.806 . . . . 0.0 111.233 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.9 24.98 7.02 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.481 ' O ' ' CB ' ' A' ' 53' ' ' SER . 2.4 mm-40 -116.26 166.14 12.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -1.163 . . . . 0.0 108.686 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.16 119.57 39.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.058 -1.026 . . . . 0.0 110.062 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.793 HD13 ' HB3' ' A' ' 62' ' ' ALA . 2.0 mm? -101.1 -9.52 21.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 110.693 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -51.64 -28.87 15.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.972 -1.08 . . . . 0.0 110.483 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.9 m -120.65 46.76 1.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.37 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.793 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -135.57 157.2 47.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 110.207 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.682 HG22 ' HB3' ' A' ' 22' ' ' ARG . 33.7 p -87.94 167.79 13.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.398 -0.814 . . . . 0.0 110.34 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.93 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.1 t60 -53.69 -24.51 14.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.181 -0.95 . . . . 0.0 109.622 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.37 -39.99 52.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 109.455 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.571 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 19.3 mm-40 -68.32 -25.87 65.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.482 -0.761 . . . . 0.0 109.623 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.638 ' HA ' HD11 ' A' ' 59' ' ' LEU . . . -79.33 -44.32 21.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.345 -0.847 . . . . 0.0 110.38 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.98 ' CG2' HD11 ' A' ' 18' ' ' ILE . 4.0 t -69.06 -30.49 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.064 -1.022 . . . . 0.0 108.745 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.65 -38.07 71.64 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.484 -0.76 . . . . 0.0 109.236 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.756 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -74.02 -25.87 60.11 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.402 -0.811 . . . . 0.0 109.478 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.751 ' HB3' HG11 ' B' ' 7' ' ' VAL . 3.6 mm? -75.18 -27.86 59.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.408 -0.808 . . . . 0.0 109.893 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -76.61 -42.5 42.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.907 . . . . 0.0 110.162 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -95.16 22.23 6.96 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.246 -0.909 . . . . 0.0 109.965 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.929 ' CG2' HG22 ' A' ' 78' ' ' VAL . 60.2 m -52.91 132.51 37.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 110.518 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.39 178.29 51.65 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.434 ' HG3' ' N ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -52.99 -32.76 48.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.209 -1.171 . . . . 0.0 110.34 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.434 ' N ' ' HG3' ' A' ' 76' ' ' LYS . 9.3 tt0 -101.81 109.0 20.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 108.983 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.929 HG22 ' CG2' ' A' ' 74' ' ' THR . 22.0 t -97.0 82.41 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 0.0 111.052 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.649 ' O ' HD12 ' A' ' 80' ' ' LEU . 3.3 t -78.2 108.48 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.854 HD13 HG12 ' A' ' 78' ' ' VAL . 5.7 mp -118.73 109.09 15.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.025 -1.047 . . . . 0.0 112.508 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 51.2 tt0 -71.04 137.9 49.39 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.983 HG13 ' HB3' ' A' ' 2' ' ' ARG . 2.2 p -139.22 145.64 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.81 -1.181 . . . . 0.0 112.093 -177.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -106.75 88.57 2.79 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.164 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.589 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -55.62 114.78 2.0 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.463 -0.773 . . . . 0.0 111.151 -177.671 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.408 ' HG3' HD21 ' A' ' 29' ' ' LEU . 2.4 mtt -100.38 50.93 0.89 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 108.992 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.197 -179.406 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 tttt . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.188 0.518 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 47.2 tt0 -153.66 106.46 2.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.322 -0.861 . . . . 0.0 110.065 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.446 ' HB3' HG11 ' A' ' 68' ' ' VAL . 70.3 m -109.01 131.29 55.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.143 -0.973 . . . . 0.0 110.206 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.823 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 0.5 OUTLIER -100.13 96.81 7.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -0.836 . . . . 0.0 110.751 -179.601 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.751 HG11 ' HB3' ' A' ' 71' ' ' LEU . 44.5 t . . . . . 0 N--CA 1.492 1.667 0 O-C-N 120.919 -1.113 . . . . 0.0 110.133 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.442 0.639 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.848 ' CB ' HG13 ' A' ' 82' ' ' VAL . 1.7 mtp85 -153.51 168.17 27.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.409 -0.807 . . . . 0.0 110.187 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -135.57 118.83 16.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 0.0 109.384 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.736 HG11 ' HG ' ' A' ' 45' ' ' LEU . 60.3 t -124.04 128.85 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.004 -1.06 . . . . 0.0 110.691 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.7 m -118.26 118.8 32.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.453 -0.78 . . . . 0.0 109.768 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.897 HG21 HD12 ' A' ' 45' ' ' LEU . 89.7 t -113.73 108.08 24.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.63 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.7 mtm105 . . . . . 0 C--N 1.299 -1.606 0 O-C-N 121.524 -0.735 . . . . 0.0 110.048 -179.481 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.722 HD23 ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.971 0.415 . . . . 0.0 110.756 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.971 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 58.21 83.39 0.05 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.48 HG21 HD22 ' A' ' 14' ' ' LEU . 3.4 tt -175.16 117.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.218 -1.166 . . . . 0.0 110.002 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.409 ' HB2' ' HG ' ' B' ' 6' ' ' LEU . 1.2 t -108.44 106.52 16.66 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.131 -0.981 . . . . 0.0 110.089 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.028 HD11 HG22 ' A' ' 68' ' ' VAL . 20.4 pt -83.65 145.85 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.406 -0.809 . . . . 0.0 110.275 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.463 ' CG ' ' HB2' ' A' ' 31' ' ' SER . 3.2 ptmt -128.61 153.19 47.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.974 -1.079 . . . . 0.0 109.066 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 127.89 -157.65 21.14 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.274 -1.441 . . . . 0.0 110.338 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.45 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 162.22 134.68 1.68 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.42 ' NH2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -58.46 -16.66 16.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -1.08 . . . . 0.0 110.603 -179.727 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -14.74 60.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.736 -1.227 . . . . 0.0 110.246 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.3 28.14 7.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.976 . . . . 0.0 110.006 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HA ' ' NH2' ' A' ' 22' ' ' ARG . 7.0 mmmt 52.48 81.76 0.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.218 -0.926 . . . . 0.0 110.23 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.612 ' HE1' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -160.23 122.46 1.82 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.185 -0.947 . . . . 0.0 110.336 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.699 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 54.3 Cg_endo -72.38 50.95 1.69 Allowed 'Trans proline' 0 N--CA 1.494 1.554 0 O-C-N 123.42 1.221 . . . . 0.0 111.773 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.586 HG21 ' HB1' ' A' ' 67' ' ' ALA . 17.6 mm 42.36 87.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 121.108 -0.995 . . . . 0.0 110.746 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.612 ' CB ' ' HE1' ' A' ' 26' ' ' MET . 5.9 mt -95.28 134.58 37.89 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.822 -1.174 . . . . 0.0 111.849 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.859 HD12 ' HB2' ' A' ' 49' ' ' ASP . 59.5 mt -66.95 138.03 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.218 -0.926 . . . . 0.0 108.831 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.463 ' HB2' ' CG ' ' A' ' 19' ' ' LYS . 47.4 t -120.37 -26.29 5.45 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.975 -1.078 . . . . 0.0 110.941 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.405 ' CB ' ' HB3' ' A' ' 17' ' ' SER . 0.5 OUTLIER -137.84 105.5 5.59 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.069 -1.019 . . . . 0.0 111.019 -179.398 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.76 HD11 HG21 ' A' ' 30' ' ' ILE . 15.3 mm -90.71 96.97 6.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.586 ' HB2' HD13 ' A' ' 37' ' ' LEU . 95.9 m-85 -62.34 134.79 56.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.605 -0.685 . . . . 0.0 110.625 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.588 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -78.17 176.1 9.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.421 -0.8 . . . . 0.0 110.528 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.55 28.62 51.81 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.971 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -136.42 162.69 32.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -1.162 . . . . 0.0 110.65 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.759 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -52.8 -55.21 24.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.582 -0.699 . . . . 0.0 111.916 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.722 ' HB2' HD23 ' A' ' 14' ' ' LEU . . . -56.37 -37.01 69.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.115 -0.99 . . . . 0.0 112.126 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.432 ' HB2' HG22 ' A' ' 33' ' ' ILE . 17.6 t70 -92.77 -6.23 49.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.807 -1.183 . . . . 0.0 111.615 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -106.82 15.7 25.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.807 -1.183 . . . . 0.0 110.525 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.497 HG21 HG22 ' A' ' 6' ' ' VAL . 4.9 t -108.91 14.56 24.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.101 -1.0 . . . . 0.0 110.812 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 45.22 48.41 10.11 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.199 -0.938 . . . . 0.0 111.419 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.653 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -169.15 -46.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 0.0 110.471 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.897 HD12 HG21 ' A' ' 6' ' ' VAL . 2.2 mt -71.66 84.83 0.89 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.812 -1.18 . . . . 0.0 108.568 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.595 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -111.13 151.22 28.39 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.739 -179.198 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.479 ' N ' HG13 ' A' ' 33' ' ' ILE . 98.3 t -50.36 159.14 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.851 -1.156 . . . . 0.0 110.008 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.56 31.11 51.6 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.859 ' HB2' HD12 ' A' ' 30' ' ' ILE . 42.2 m-20 -114.25 104.77 12.42 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.542 -0.975 . . . . 0.0 110.354 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -82.86 110.58 17.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.151 -0.968 . . . . 0.0 109.761 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.811 ' C ' HD22 ' A' ' 52' ' ' LEU . 71.9 mt -77.28 136.89 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.87 . . . . 0.0 110.891 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.811 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.4 mm? -120.43 -0.44 10.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.464 -0.772 . . . . 0.0 110.844 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 2.5 p -178.79 103.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.875 -1.141 . . . . 0.0 109.819 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.892 HG21 ' CB ' ' A' ' 70' ' ' ALA . 17.1 m -92.46 121.38 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.167 -0.958 . . . . 0.0 110.351 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.65 34.2 24.21 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.135 -0.978 . . . . 0.0 110.917 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.96 17.62 67.08 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.544 ' O ' HD23 ' A' ' 59' ' ' LEU . 4.8 tt0 -105.01 91.24 3.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.019 -1.283 . . . . 0.0 109.805 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -43.49 99.52 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.523 0.678 . . . . 0.0 111.135 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.88 HD13 ' CB ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -92.54 24.88 3.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -0.796 . . . . 0.0 110.292 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 61' ' ' SER . 52.6 p -73.92 -58.71 3.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.147 -0.971 . . . . 0.0 110.397 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.425 ' N ' ' OG ' ' A' ' 60' ' ' SER . 0.8 OUTLIER -80.47 -19.21 46.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 110.096 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.88 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -57.54 167.54 1.01 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.36 -0.837 . . . . 0.0 110.589 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.5 p -100.72 -166.76 1.35 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.398 -0.814 . . . . 0.0 108.98 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.908 ' O ' HG23 ' A' ' 68' ' ' VAL . 13.5 t-80 -75.18 -23.6 57.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.006 -1.059 . . . . 0.0 109.981 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.01 -34.76 61.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.961 . . . . 0.0 109.663 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.487 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 22.6 mm-40 -72.55 -25.55 61.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 109.849 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.586 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -78.91 -38.88 36.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 110.205 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.028 HG22 HD11 ' A' ' 18' ' ' ILE . 2.9 t -75.03 -37.86 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.216 -0.928 . . . . 0.0 108.806 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -55.47 -38.89 69.69 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.443 -0.786 . . . . 0.0 109.965 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.892 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.53 -49.4 48.54 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.112 -0.992 . . . . 0.0 109.107 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.625 ' CB ' HG11 ' B' ' 7' ' ' VAL . 79.1 mt -61.1 -23.94 65.86 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.656 -0.653 . . . . 0.0 109.666 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -76.11 -37.17 58.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.084 -1.01 . . . . 0.0 109.082 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 17.0 ttmt -121.72 51.07 1.35 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.746 ' HB ' HG22 ' A' ' 78' ' ' VAL . 58.8 p -52.44 -85.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 110.615 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.432 ' N ' ' OG1' ' A' ' 74' ' ' THR . . . 147.99 -172.81 28.22 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.412 ' CG ' ' N ' ' A' ' 77' ' ' GLU . 3.7 pttt -49.08 -40.28 31.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.247 -1.149 . . . . 0.0 110.441 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 76' ' ' LYS . 25.8 pt-20 -128.58 129.94 46.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.326 -0.859 . . . . 0.0 109.672 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.848 HG12 HD13 ' A' ' 80' ' ' LEU . 45.2 t -96.8 79.63 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.036 -1.04 . . . . 0.0 111.12 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.643 ' O ' HD12 ' A' ' 80' ' ' LEU . 20.1 t -73.43 112.09 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.848 HD13 HG12 ' A' ' 78' ' ' VAL . 4.8 mp -120.34 110.14 16.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.915 -1.116 . . . . 0.0 111.943 -177.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.1 tp10 -69.32 122.7 19.42 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.848 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.4 p -118.31 146.35 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.092 -1.005 . . . . 0.0 112.19 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -113.18 82.42 1.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.595 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -50.11 127.11 16.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.529 -0.732 . . . . 0.0 111.211 -177.915 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.3 mtt -121.87 53.78 1.19 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.421 -0.8 . . . . 0.0 109.518 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.494 ' HD2' ' CE2' ' A' ' 84' ' ' TYR . 6.3 mtpp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.287 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.648 ' HG2' ' CD2' ' A' ' 64' ' ' HIS . 3.1 ptmt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.048 0.451 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 19.9 mt-10 -48.82 126.54 12.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.17 -0.956 . . . . 0.0 110.251 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.434 ' HB2' ' HE1' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -111.43 -24.65 10.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.97 -1.081 . . . . 0.0 111.138 -179.222 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.56 HD21 ' CE1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER 59.06 96.75 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.099 -1.001 . . . . 0.0 110.592 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.644 ' CG2' HG13 ' A' ' 68' ' ' VAL . 44.8 t . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.046 -1.034 . . . . 0.0 110.071 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.259 0.552 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.542 ' CG ' HG13 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -163.59 147.3 10.33 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.21 -0.931 . . . . 0.0 109.728 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.424 ' N ' ' HG3' ' A' ' 2' ' ' ARG . 21.5 ptt180 -125.53 136.65 53.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.112 -0.992 . . . . 0.0 110.041 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.733 HG13 ' CB ' ' A' ' 44' ' ' ALA . 46.6 t -140.42 157.06 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.102 -0.999 . . . . 0.0 110.567 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.449 ' OG1' HG22 ' A' ' 79' ' ' VAL . 40.1 m -144.24 125.69 14.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 110.212 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.038 HG22 HG21 ' A' ' 42' ' ' THR . 87.7 t -117.75 114.4 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.649 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 -179.675 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.636 HD22 HG21 ' A' ' 16' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.131 0.491 . . . . 0.0 110.365 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.504 ' HA3' ' CG ' ' A' ' 37' ' ' LEU . . . 63.38 83.94 0.07 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.636 HG21 HD22 ' A' ' 14' ' ' LEU . 1.1 tt -176.43 120.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -1.175 . . . . 0.0 109.921 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.488 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -111.53 106.1 14.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.89 . . . . 0.0 109.469 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.038 HD11 HG22 ' A' ' 68' ' ' VAL . 22.0 pt -82.41 156.54 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.449 -0.782 . . . . 0.0 111.522 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.459 ' CB ' ' HB2' ' A' ' 31' ' ' SER . 7.9 ttmm -139.73 119.98 13.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.493 -0.755 . . . . 0.0 109.772 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.71 -159.46 28.09 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.445 ' CA ' ' HB2' ' A' ' 64' ' ' HIS . . . 156.88 140.27 2.91 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.499 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.0 OUTLIER -60.88 -14.64 23.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -1.084 . . . . 0.0 110.713 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -72.73 -19.12 61.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.893 -1.129 . . . . 0.0 110.006 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -123.38 28.22 7.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 109.879 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.24 83.91 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.392 -0.817 . . . . 0.0 110.166 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.581 ' HE1' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -167.39 123.13 0.87 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.29 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.847 ' HB3' HD21 ' A' ' 52' ' ' LEU . 55.2 Cg_endo -71.61 52.32 1.63 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 O-C-N 123.39 1.205 . . . . 0.0 111.729 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 64' ' ' HIS . 13.9 mm 42.39 88.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 O-C-N 121.093 -1.005 . . . . 0.0 110.817 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 50' ' ' ALA . 6.0 mt -97.39 131.6 43.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.757 -1.214 . . . . 0.0 111.89 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.657 HG21 HD11 ' A' ' 33' ' ' ILE . 39.6 mt -67.18 132.22 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.284 -0.885 . . . . 0.0 108.74 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.459 ' HB2' ' CB ' ' A' ' 19' ' ' LYS . 6.9 t -119.51 -10.4 9.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.167 -0.958 . . . . 0.0 111.092 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.38 99.4 2.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.987 -1.071 . . . . 0.0 110.707 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.657 HD11 HG21 ' A' ' 30' ' ' ILE . 13.4 mm -89.58 95.92 5.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.318 -0.864 . . . . 0.0 108.682 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.584 ' CZ ' HD13 ' B' ' 6' ' ' LEU . 4.8 m-30 -45.02 137.45 4.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.818 -0.551 . . . . 0.0 110.85 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 37' ' ' LEU . 1.6 tttp -79.98 158.42 26.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.279 -0.888 . . . . 0.0 110.479 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.27 22.31 29.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 35' ' ' LYS . 1.9 mm? -112.01 168.82 9.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -1.111 . . . . 0.0 109.718 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.78 ' O ' HG23 ' A' ' 42' ' ' THR . . . -56.1 -70.46 0.11 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.135 -0.978 . . . . 0.0 111.174 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 14' ' ' LEU . . . -47.1 -24.66 0.7 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.332 -0.855 . . . . 0.0 111.671 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.475 ' HB2' HG22 ' A' ' 33' ' ' ILE . 4.8 t70 -93.91 -31.81 14.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.888 -1.133 . . . . 0.0 110.456 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 1.4 pp0? -87.13 12.0 12.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.062 -1.024 . . . . 0.0 110.491 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . 1.038 HG21 HG22 ' A' ' 6' ' ' VAL . 35.3 p -98.88 6.62 46.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.053 -1.029 . . . . 0.0 110.815 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER 49.98 53.83 12.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.864 -1.147 . . . . 0.0 110.818 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.733 ' CB ' HG13 ' A' ' 4' ' ' VAL . . . -177.13 -52.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.134 -0.979 . . . . 0.0 110.547 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.817 HD12 HG21 ' A' ' 6' ' ' VAL . 2.6 mt -69.56 85.96 0.45 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.874 -1.141 . . . . 0.0 108.808 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.606 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -112.59 151.38 30.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.942 -0.474 . . . . 0.0 109.801 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.472 ' HA ' HG22 ' A' ' 30' ' ' ILE . 53.7 t -49.1 162.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 120.903 -1.123 . . . . 0.0 110.127 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.406 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 74.07 32.18 58.86 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.786 -1.725 . . . . 0.0 108.786 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.611 ' HB2' HD12 ' A' ' 30' ' ' ILE . 54.2 m-20 -116.96 104.8 11.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.603 -0.939 . . . . 0.0 110.173 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -81.94 97.04 7.88 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 110.158 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.51 HG21 ' CG1' ' A' ' 54' ' ' VAL . 51.4 mt -62.1 135.07 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 0.0 110.155 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.847 HD21 ' HB3' ' A' ' 27' ' ' PRO . 65.3 mt -132.53 14.0 4.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.465 -0.772 . . . . 0.0 110.217 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 178.96 96.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.505 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.849 HG21 ' CB ' ' A' ' 70' ' ' ALA . 14.5 m -95.46 126.48 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.216 -0.927 . . . . 0.0 110.452 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 59.28 24.4 12.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.382 -0.824 . . . . 0.0 110.609 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.6 30.78 17.62 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.1 mm-40 -123.07 95.58 4.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.134 -1.215 . . . . 0.0 109.647 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.6 97.55 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.561 0.696 . . . . 0.0 111.356 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.976 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -80.58 -8.12 59.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.54 -0.725 . . . . 0.0 110.548 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.8 p -54.36 -36.7 64.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.011 -1.055 . . . . 0.0 110.152 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t -95.39 22.33 7.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 110.108 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.976 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -118.76 161.48 20.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 110.281 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 22' ' ' ARG . 55.1 p -91.08 -170.71 2.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 109.926 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.887 ' O ' HG23 ' A' ' 68' ' ' VAL . 10.2 t60 -69.07 -23.57 64.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.031 -1.043 . . . . 0.0 109.806 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -77.42 -39.73 45.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.617 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.753 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 5.7 mm-40 -65.3 -24.72 67.36 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.424 -0.797 . . . . 0.0 109.953 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.49 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -82.83 -41.11 19.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.175 -0.953 . . . . 0.0 110.587 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.038 HG22 HD11 ' A' ' 18' ' ' ILE . 5.4 t -73.45 -28.45 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.141 -0.974 . . . . 0.0 109.398 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -40.33 93.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -0.801 . . . . 0.0 109.81 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.849 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -68.47 -49.3 60.85 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.209 -0.932 . . . . 0.0 108.976 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 80' ' ' LEU . 82.4 mt -58.51 -23.35 57.85 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.641 -0.662 . . . . 0.0 109.362 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -77.54 -40.12 43.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 109.624 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.11 64.82 0.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.403 -0.811 . . . . 0.0 109.364 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.588 ' CB ' HG22 ' A' ' 78' ' ' VAL . 30.4 p -82.23 174.4 11.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.375 -0.828 . . . . 0.0 109.933 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.17 -175.03 34.61 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.67 -37.88 19.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.148 -1.207 . . . . 0.0 110.544 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -117.76 101.9 8.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.397 -0.814 . . . . 0.0 109.894 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.898 HG12 HD13 ' A' ' 80' ' ' LEU . 59.9 t -67.28 73.5 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.0 110.795 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.449 HG22 ' OG1' ' A' ' 5' ' ' THR . 2.0 t -69.53 106.47 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.898 HD13 HG12 ' A' ' 78' ' ' VAL . 3.8 mp -114.0 119.79 38.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.884 -1.135 . . . . 0.0 112.235 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 14.3 tp10 -73.34 133.39 43.82 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.542 HG13 ' CG ' ' A' ' 2' ' ' ARG . 2.2 p -135.16 144.35 34.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.837 -1.164 . . . . 0.0 111.741 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.683 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -107.51 86.57 2.33 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.524 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.606 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -54.33 122.86 11.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.472 -0.768 . . . . 0.0 110.662 -177.886 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -111.78 52.3 0.76 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.636 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.3 pttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.27 -179.762 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.498 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 56.3 tttt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.128 0.489 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.54 87.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.431 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.431 ' N ' ' O ' ' B' ' 3' ' ' LYS . 0.4 OUTLIER -90.86 -163.54 1.04 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 109.865 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.584 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 30.5 tp -163.27 121.49 1.98 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 109.995 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.714 HG11 ' C ' ' A' ' 71' ' ' LEU . 83.1 t . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.082 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.436 0.636 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.834 ' CB ' HG13 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -155.18 168.03 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.409 -0.807 . . . . 0.0 110.692 -179.362 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -141.55 121.12 13.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.468 -0.77 . . . . 0.0 109.197 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.669 HG13 ' CB ' ' A' ' 44' ' ' ALA . 64.3 t -131.94 139.48 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.931 -1.105 . . . . 0.0 111.05 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.8 m -119.14 116.47 26.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.459 -0.776 . . . . 0.0 109.683 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.667 HG22 HG21 ' A' ' 42' ' ' THR . 90.9 t -103.83 111.57 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 110.207 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.88 131.15 42.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.86 . . . . 0.0 109.916 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 1.6 tttt -61.46 -151.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.369 -0.832 . . . . 0.0 110.387 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 8' ' ' LYS . . . 55.63 -171.21 0.07 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.248 -0.907 . . . . 0.0 110.225 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.594 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 6.9 m-20 58.48 113.28 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.594 -0.691 . . . . 0.0 110.583 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 10' ' ' ASP . . . 67.26 -62.02 0.33 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.353 -0.842 . . . . 0.0 110.595 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 10' ' ' ASP . . . 125.46 -74.9 0.41 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.56 160.87 10.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.4 -16.2 22.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -1.186 . . . . 0.0 110.666 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.882 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 56.0 87.0 0.02 OUTLIER Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.413 HG23 ' HB ' ' B' ' 7' ' ' VAL . 3.3 tt -176.32 118.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.223 -1.163 . . . . 0.0 110.345 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -112.94 101.09 9.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.561 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.124 HD11 HG22 ' A' ' 68' ' ' VAL . 28.4 pt -78.31 151.06 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.95 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' B' ' 3' ' ' LYS . 46.6 tttt -137.83 122.22 18.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.452 -0.78 . . . . 0.0 110.209 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.08 -153.05 24.16 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 160.44 133.85 1.56 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.578 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.2 OUTLIER -60.12 -15.43 23.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.424 -1.045 . . . . 0.0 110.617 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.68 7.07 15.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.719 -1.238 . . . . 0.0 110.487 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.53 23.76 2.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.085 -1.009 . . . . 0.0 109.749 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm 53.88 64.87 1.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.883 . . . . 0.0 110.213 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.523 ' HE3' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.51 117.84 5.2 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 110.236 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.745 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 48.3 Cg_endo -69.54 54.34 1.09 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 O-C-N 123.425 1.224 . . . . 0.0 111.653 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 64' ' ' HIS . 16.3 mm 42.33 88.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 O-C-N 121.268 -0.895 . . . . 0.0 110.304 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' A' ' 50' ' ' ALA . 31.8 tp -100.89 125.72 47.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.843 -1.16 . . . . 0.0 111.888 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.864 HD12 ' HB2' ' A' ' 49' ' ' ASP . 57.4 mt -61.82 136.26 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.588 -0.695 . . . . 0.0 110.188 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.3 t -121.98 -11.4 8.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 110.686 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 106.78 3.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.956 -1.09 . . . . 0.0 110.703 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.539 HD11 HG21 ' A' ' 30' ' ' ILE . 11.8 mm -95.6 94.74 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 109.45 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.964 ' CE1' HD13 ' B' ' 6' ' ' LEU . 88.3 m-85 -54.27 141.55 29.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.841 . . . . 0.0 110.26 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.849 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.0 mmmt -86.42 171.57 11.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 110.805 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.58 30.89 73.13 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.882 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.7 OUTLIER -138.28 162.61 33.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -1.196 . . . . 0.0 110.78 -179.586 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.615 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -46.5 -64.08 0.85 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.514 -0.741 . . . . 0.0 111.63 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.758 ' O ' HG22 ' A' ' 42' ' ' THR . . . -48.6 -53.75 17.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.96 -1.087 . . . . 0.0 111.385 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.448 ' HB2' HG22 ' A' ' 33' ' ' ILE . 16.3 t70 -77.3 -9.26 58.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.86 -1.15 . . . . 0.0 111.891 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.496 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -107.41 10.95 29.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.67 -1.268 . . . . 0.0 110.746 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 39' ' ' ALA . 5.4 t -106.82 15.62 25.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.017 -1.052 . . . . 0.0 110.512 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER 47.74 55.31 8.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.117 -0.989 . . . . 0.0 110.991 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.669 ' CB ' HG13 ' A' ' 4' ' ' VAL . . . -176.64 -47.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.083 -1.011 . . . . 0.0 110.524 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -67.93 82.44 0.21 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.973 -1.079 . . . . 0.0 109.154 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.588 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.91 150.01 32.39 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.548 -0.72 . . . . 0.0 109.835 -179.74 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 48' ' ' GLY . 96.2 t -50.24 167.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.97 -1.081 . . . . 0.0 110.253 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.503 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 70.88 30.21 68.35 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.864 ' HB2' HD12 ' A' ' 30' ' ' ILE . 36.5 m-20 -114.06 99.57 7.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.485 -1.009 . . . . 0.0 110.968 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.779 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -78.43 107.11 10.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 109.518 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.811 ' C ' HD22 ' A' ' 52' ' ' LEU . 61.2 mt -77.46 134.33 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 110.939 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.811 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.0 mm? -120.9 7.3 10.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.488 -0.757 . . . . 0.0 110.003 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 4.8 t -175.76 131.92 0.26 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.148 -0.97 . . . . 0.0 109.871 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.766 HG12 ' HG ' ' A' ' 80' ' ' LEU . 2.0 m -123.9 113.96 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.302 -0.873 . . . . 0.0 109.721 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.6 34.29 20.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.292 -0.88 . . . . 0.0 110.283 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.99 21.02 51.8 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 53' ' ' SER . 3.3 tm-20 -109.51 84.9 2.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.064 -1.257 . . . . 0.0 110.417 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -44.56 97.88 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.432 -0.793 . . . . 0.0 110.947 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.643 HD11 HG22 ' A' ' 54' ' ' VAL . 37.3 mt -79.09 -8.78 59.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.473 -0.767 . . . . 0.0 110.877 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.427 ' O ' ' CZ ' ' A' ' 22' ' ' ARG . 21.7 p -47.01 -36.19 7.58 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.212 -0.93 . . . . 0.0 110.611 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -106.85 29.86 6.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.752 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.634 ' HB1' ' CB ' ' A' ' 66' ' ' GLU . . . -119.72 153.65 35.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.355 -0.841 . . . . 0.0 110.133 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.578 HG22 ' HB3' ' A' ' 22' ' ' ARG . 2.9 p -86.32 171.56 11.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.303 -0.873 . . . . 0.0 110.071 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.909 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.2 t60 -55.29 -24.65 29.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 109.777 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -77.14 -38.24 52.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.014 . . . . 0.0 109.761 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.634 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 4.1 mm-40 -67.94 -25.89 65.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.832 . . . . 0.0 110.166 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.87 -38.82 24.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 110.416 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.124 HG22 HD11 ' A' ' 18' ' ' ILE . 8.2 t -73.26 -27.38 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.068 -1.02 . . . . 0.0 109.334 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -65.09 -38.16 89.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.363 -0.835 . . . . 0.0 109.767 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.6 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.26 -48.53 56.45 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.15 -0.969 . . . . 0.0 108.726 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.69 ' CD2' HD21 ' A' ' 80' ' ' LEU . 82.7 mt -59.62 -22.49 61.92 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.661 -0.649 . . . . 0.0 109.674 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -80.11 -45.11 18.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.654 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 5.5 tttt -112.74 59.79 0.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.38 -0.825 . . . . 0.0 109.719 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.601 ' HB ' HG22 ' A' ' 78' ' ' VAL . 47.3 p -78.08 174.2 11.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 110.248 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.88 -169.48 29.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -52.11 23.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.017 -1.284 . . . . 0.0 110.448 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 1.8 pt-20 -107.74 117.24 33.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.902 . . . . 0.0 109.778 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.007 HG12 HD13 ' A' ' 80' ' ' LEU . 45.8 t -83.11 78.56 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.938 -1.101 . . . . 0.0 110.781 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.6 ' O ' HD12 ' A' ' 80' ' ' LEU . 16.8 t -68.53 112.53 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.101 -0.999 . . . . 0.0 108.329 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.007 HD13 HG12 ' A' ' 78' ' ' VAL . 4.4 mp -119.94 115.79 24.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.993 -1.067 . . . . 0.0 111.87 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 7.3 tp10 -73.56 128.63 36.02 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.834 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.5 p -127.23 150.27 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.044 -1.035 . . . . 0.0 112.15 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.779 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 34.5 tttp -115.58 85.04 2.2 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.588 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -51.56 130.65 28.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.468 -0.77 . . . . 0.0 111.119 -177.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.4 mtt -115.47 51.74 0.92 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.765 . . . . 0.0 109.451 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.338 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 10.6 tttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.174 0.511 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -121.49 94.34 4.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.154 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.417 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -91.28 -169.52 2.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.394 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.964 HD13 ' CE1' ' A' ' 34' ' ' PHE . 5.1 tp -157.77 94.83 1.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.82 . . . . 0.0 109.883 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 71' ' ' LEU . 94.9 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.088 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.499 0.666 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.48 ' CG ' HG13 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -158.77 146.51 17.9 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.548 -0.72 . . . . 0.0 109.736 -179.421 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.413 ' N ' ' HG3' ' A' ' 2' ' ' ARG . 0.4 OUTLIER -124.28 129.33 50.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.057 -1.027 . . . . 0.0 110.307 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.735 HG22 ' HB1' ' A' ' 44' ' ' ALA . 93.5 t -128.79 127.53 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.384 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.6 m -114.69 132.57 56.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.737 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.546 HG21 HD12 ' A' ' 45' ' ' LEU . 90.4 t -122.69 109.96 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 110.304 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.12 78.12 0.95 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 109.549 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.49 155.92 0.32 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.314 -0.866 . . . . 0.0 110.786 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.84 -168.27 1.69 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.87 . . . . 0.0 110.199 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.7 -43.64 88.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 110.229 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.8 121.66 1.31 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 110.172 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.0 -78.23 0.04 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.75 165.57 21.15 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.711 HD23 ' HB2' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -109.83 -23.07 11.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -1.194 . . . . 0.0 110.367 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.962 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 56.21 90.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.691 HD12 HD22 ' A' ' 45' ' ' LEU . 1.1 tt -176.33 120.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.203 -1.175 . . . . 0.0 110.525 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.588 ' OG ' HD13 ' B' ' 6' ' ' LEU . 1.3 m -112.46 106.25 14.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.186 -0.947 . . . . 0.0 109.404 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.974 HD11 ' CG2' ' A' ' 68' ' ' VAL . 12.3 pt -82.58 156.64 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.426 -0.796 . . . . 0.0 111.501 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.431 ' CD ' ' CB ' ' A' ' 31' ' ' SER . 10.4 mtpt -136.44 156.92 47.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.578 -0.702 . . . . 0.0 109.833 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 123.05 -156.49 17.44 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.68 133.98 1.57 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.709 ' HB3' HG22 ' A' ' 63' ' ' THR . 1.9 tpm_? -60.71 -15.39 28.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -1.15 . . . . 0.0 110.62 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.03 5.51 19.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.649 -1.282 . . . . 0.0 110.342 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.9 25.75 2.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.091 -1.006 . . . . 0.0 109.446 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.29 90.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 0.0 109.875 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.526 ' HE2' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -170.03 127.01 0.76 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.305 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.743 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 57.0 Cg_endo -75.88 45.5 1.51 Allowed 'Trans proline' 0 N--CA 1.494 1.541 0 O-C-N 123.371 1.195 . . . . 0.0 111.717 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.514 HG21 ' HB1' ' A' ' 67' ' ' ALA . 27.0 mm 47.51 90.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 120.789 -1.194 . . . . 0.0 109.848 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.629 HD13 ' HB2' ' A' ' 50' ' ' ALA . 36.6 tp -103.15 125.05 49.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.812 -1.18 . . . . 0.0 112.051 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.821 HD12 ' HB2' ' A' ' 49' ' ' ASP . 60.9 mt -58.78 139.39 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.568 -0.707 . . . . 0.0 109.85 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.431 ' CB ' ' CD ' ' A' ' 19' ' ' LYS . 33.3 t -124.6 -10.5 7.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 110.969 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' CB ' ' NZ ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -154.81 100.4 2.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.905 -1.122 . . . . 0.0 110.843 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.45 HG13 ' HA ' ' A' ' 46' ' ' PHE . 13.7 mm -86.39 101.26 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.212 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.586 ' HB3' HD13 ' A' ' 37' ' ' LEU . 3.3 m-85 -59.36 135.56 57.69 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.604 -0.685 . . . . 0.0 109.698 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.661 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -83.06 169.47 15.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.117 -0.989 . . . . 0.0 110.851 -179.254 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.48 30.29 77.15 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.962 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER -138.28 162.1 35.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.112 -1.228 . . . . 0.0 110.955 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -46.22 -69.06 0.14 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.628 -0.67 . . . . 0.0 111.694 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.711 ' HB2' HD23 ' A' ' 14' ' ' LEU . . . -45.01 -39.25 5.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.472 -0.767 . . . . 0.0 111.575 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.419 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 16.5 t70 -93.61 10.62 31.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.057 -1.027 . . . . 0.0 110.758 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -115.44 3.72 14.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.925 -1.109 . . . . 0.0 110.773 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.521 HG21 HG22 ' A' ' 6' ' ' VAL . 10.1 t -108.22 15.16 24.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.93 -1.106 . . . . 0.0 110.893 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.12 60.98 3.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.084 -1.01 . . . . 0.0 110.926 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.735 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -175.15 -50.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.2 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.691 HD22 HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -70.31 86.83 0.6 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.959 -1.088 . . . . 0.0 108.705 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.603 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -115.96 153.33 31.81 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.825 -0.547 . . . . 0.0 110.029 -179.231 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 48' ' ' GLY . 32.5 t -48.12 165.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 120.899 -1.126 . . . . 0.0 110.151 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.449 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 70.77 31.69 67.33 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.821 ' HB2' HD12 ' A' ' 30' ' ' ILE . 44.9 m-20 -116.58 100.28 7.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -1.041 . . . . 0.0 110.997 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.743 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -79.1 108.88 12.93 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.858 . . . . 0.0 109.831 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.819 ' C ' HD22 ' A' ' 52' ' ' LEU . 55.2 mt -75.4 139.94 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.329 -0.857 . . . . 0.0 110.824 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.819 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.2 mm? -125.05 4.63 7.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.255 -0.903 . . . . 0.0 110.916 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 176.96 103.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.832 -1.168 . . . . 0.0 109.75 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.91 HG21 ' CB ' ' A' ' 70' ' ' ALA . 20.5 m -92.49 121.04 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.223 -0.923 . . . . 0.0 110.602 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 m120 59.41 34.16 22.62 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.168 -0.958 . . . . 0.0 110.809 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.99 19.89 62.12 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.8 mt-10 -110.23 91.83 3.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.941 -1.329 . . . . 0.0 109.91 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -41.44 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.574 0.702 . . . . 0.0 111.488 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.889 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -90.39 14.01 14.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.489 -0.757 . . . . 0.0 110.399 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.6 t -68.88 -49.54 57.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 110.724 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.36 18.58 5.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.061 -1.024 . . . . 0.0 110.523 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.889 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -104.21 158.41 16.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -0.927 . . . . 0.0 110.233 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.709 HG22 ' HB3' ' A' ' 22' ' ' ARG . 12.4 p -90.15 176.23 6.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 110.071 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.718 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.5 t60 -58.64 -26.01 63.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.072 -1.018 . . . . 0.0 109.556 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.45 -30.28 59.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.089 -1.007 . . . . 0.0 109.709 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.76 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 7.3 mm-40 -75.62 -27.03 58.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.838 . . . . 0.0 109.952 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.514 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -80.09 -36.68 35.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.368 -0.832 . . . . 0.0 110.502 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.974 ' CG2' HD11 ' A' ' 18' ' ' ILE . 17.5 t -75.5 -32.71 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.047 -1.033 . . . . 0.0 109.549 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -60.97 -38.32 85.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 109.879 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.91 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.98 -50.58 32.77 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.177 -0.952 . . . . 0.0 108.788 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.682 ' O ' HG11 ' B' ' 7' ' ' VAL . 86.7 mt -58.56 -23.59 58.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.619 -0.676 . . . . 0.0 110.01 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -80.69 -36.78 31.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.124 -0.985 . . . . 0.0 109.941 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -119.43 58.21 0.88 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.111 -0.993 . . . . 0.0 109.871 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.498 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 39.4 p -80.96 -170.65 2.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.904 . . . . 0.0 110.003 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.53 -175.05 15.33 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -49.04 -59.88 3.25 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.056 -1.261 . . . . 0.0 110.298 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -88.4 95.44 10.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 109.582 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.885 HG12 HD13 ' A' ' 80' ' ' LEU . 94.8 t -79.86 78.74 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 110.66 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.602 ' O ' HD12 ' A' ' 80' ' ' LEU . 5.0 t -68.66 116.32 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.083 -1.01 . . . . 0.0 108.352 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.885 HD13 HG12 ' A' ' 78' ' ' VAL . 3.4 mp -121.06 100.8 7.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.978 -1.076 . . . . 0.0 111.743 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 20.5 tt0 -64.13 128.89 37.8 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.636 HG11 HG23 ' A' ' 4' ' ' VAL . 2.2 p -131.9 143.93 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 111.799 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.703 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 79.5 tttt -106.67 88.34 2.74 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.603 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -56.0 111.24 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.456 -0.778 . . . . 0.0 111.165 -177.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 mtt -89.21 53.43 2.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 109.198 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.149 -179.535 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.465 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 15.3 tttp . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.157 0.503 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -121.13 90.84 3.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.991 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.413 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -79.9 -161.72 0.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 0.0 110.461 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.588 HD13 ' OG ' ' A' ' 17' ' ' SER . 22.1 tp -171.14 99.88 0.21 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 109.935 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.682 HG11 ' O ' ' A' ' 71' ' ' LEU . 92.5 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.255 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.351 0.596 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.851 ' CB ' HG13 ' A' ' 82' ' ' VAL . 1.7 mtp85 -157.05 167.74 29.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.68 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -138.66 119.01 13.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.497 -0.752 . . . . 0.0 109.189 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.977 HG22 ' HB1' ' A' ' 44' ' ' ALA . 83.2 t -127.63 126.15 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.969 -1.082 . . . . 0.0 110.655 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.5 m -117.29 114.39 23.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.446 -0.784 . . . . 0.0 109.441 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.914 HG21 HD12 ' A' ' 45' ' ' LEU . 98.4 t -102.8 111.04 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.946 . . . . 0.0 109.964 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -71.72 123.68 23.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.436 -0.79 . . . . 0.0 110.044 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -67.61 -70.72 0.24 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 110.2 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 8' ' ' LYS . . . 64.39 -70.61 0.08 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.636 -0.665 . . . . 0.0 110.39 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 8' ' ' LYS . 15.9 m-20 -163.17 117.01 1.62 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.062 -1.024 . . . . 0.0 109.882 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -174.87 126.09 0.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.834 . . . . 0.0 110.015 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -50.91 -64.07 4.04 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.3 -168.1 15.46 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.714 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -113.39 -17.84 12.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.409 -1.053 . . . . 0.0 110.277 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.947 ' CA ' HD22 ' A' ' 37' ' ' LEU . . . 63.86 81.65 0.1 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.628 HG21 HD22 ' A' ' 14' ' ' LEU . 3.9 tt -176.42 117.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.326 -1.102 . . . . 0.0 110.325 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' B' ' 5' ' ' SER . 0.7 OUTLIER -111.8 119.57 39.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.186 -0.946 . . . . 0.0 109.577 179.231 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.014 HD11 HG22 ' A' ' 68' ' ' VAL . 8.8 pt -95.6 148.98 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.98 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HG2' ' CA ' ' B' ' 4' ' ' GLU . 0.2 OUTLIER -132.67 134.72 45.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.812 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 142.17 -159.98 27.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 168.32 136.84 2.12 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.545 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.0 OUTLIER -59.46 -16.1 21.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -1.133 . . . . 0.0 110.598 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.43 -12.38 60.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.826 -1.171 . . . . 0.0 110.233 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.14 27.54 8.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.088 -1.007 . . . . 0.0 110.185 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.69 49.68 19.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.126 -0.984 . . . . 0.0 110.043 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.614 ' HE1' ' HB2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -125.33 122.56 25.11 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 110.365 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.693 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 55.5 Cg_endo -72.66 50.86 1.77 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 O-C-N 123.422 1.222 . . . . 0.0 111.735 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 64' ' ' HIS . 25.4 mm 43.37 88.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 O-C-N 121.053 -1.029 . . . . 0.0 110.706 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 85' ' ' MET . 5.6 mt -97.74 132.51 43.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.857 -1.152 . . . . 0.0 111.608 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.801 HG21 HD11 ' A' ' 33' ' ' ILE . 56.9 mt -69.2 138.21 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.284 -0.885 . . . . 0.0 108.952 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 42.6 t -119.83 -24.73 6.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.94 -1.1 . . . . 0.0 110.931 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.43 108.3 5.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.016 -1.053 . . . . 0.0 110.666 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.801 HD11 HG21 ' A' ' 30' ' ' ILE . 15.9 mm -94.24 98.44 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.429 -0.794 . . . . 0.0 109.166 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.756 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 92.0 m-85 -57.9 130.83 48.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.608 -0.683 . . . . 0.0 110.362 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.972 ' O ' HD12 ' A' ' 37' ' ' LEU . 7.3 pttt -76.83 171.68 14.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.402 -0.811 . . . . 0.0 110.95 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.57 30.57 65.53 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.972 HD12 ' O ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -138.47 161.96 35.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.076 -1.249 . . . . 0.0 110.903 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.592 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -48.24 -66.73 0.35 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.579 -0.701 . . . . 0.0 111.592 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.714 ' HB2' ' CD2' ' A' ' 14' ' ' LEU . . . -47.57 -33.03 6.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 112.199 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.441 ' HB2' HG22 ' A' ' 33' ' ' ILE . 5.4 t70 -95.77 -19.91 19.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.719 -1.238 . . . . 0.0 111.302 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.494 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -93.78 14.86 17.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.905 -1.122 . . . . 0.0 110.725 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.509 HG21 HG22 ' A' ' 6' ' ' VAL . 8.9 t -107.74 14.07 25.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.013 -1.055 . . . . 0.0 110.843 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 44.79 46.91 8.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.188 -0.945 . . . . 0.0 111.284 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.977 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -165.62 -51.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 110.515 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.914 HD12 HG21 ' A' ' 6' ' ' VAL . 2.8 mt -70.61 83.07 0.6 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.839 -1.163 . . . . 0.0 108.504 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.591 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -110.29 155.07 22.58 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.361 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 48' ' ' GLY . 90.6 t -51.02 167.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.813 -1.179 . . . . 0.0 110.29 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.5 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 67.84 32.36 77.49 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.796 ' HB2' HD12 ' A' ' 30' ' ' ILE . 32.6 m-20 -114.05 104.44 12.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.484 -1.009 . . . . 0.0 110.431 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -80.56 105.69 12.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.328 -0.857 . . . . 0.0 109.627 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.793 ' C ' HD22 ' A' ' 52' ' ' LEU . 54.7 mt -76.62 135.97 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.405 -0.809 . . . . 0.0 111.07 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.793 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.4 mm? -120.55 8.21 10.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.488 -0.757 . . . . 0.0 110.214 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 26.0 t -178.68 135.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.103 -0.998 . . . . 0.0 109.704 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.664 HG22 HD11 ' A' ' 59' ' ' LEU . 1.5 m -129.24 114.83 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.309 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.75 31.15 20.9 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.262 -0.899 . . . . 0.0 110.76 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.83 21.07 34.72 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.561 ' HB2' HG23 ' A' ' 54' ' ' VAL . 1.3 mm-40 -112.41 88.03 2.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.041 -1.27 . . . . 0.0 110.164 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -46.64 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.276 -0.89 . . . . 0.0 111.004 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.664 HD11 HG22 ' A' ' 54' ' ' VAL . 79.8 mt -81.7 -11.92 58.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.563 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.505 ' HB2' HD12 ' A' ' 52' ' ' LEU . 2.2 t -48.16 -32.41 6.96 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.231 -0.918 . . . . 0.0 110.06 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.9 t -112.06 22.62 14.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.343 -0.848 . . . . 0.0 109.451 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.498 ' HB3' ' HA ' ' A' ' 59' ' ' LEU . . . -113.11 152.57 29.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.425 -0.797 . . . . 0.0 110.143 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.545 HG22 ' HB3' ' A' ' 22' ' ' ARG . 3.1 p -86.9 169.94 12.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 110.053 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.896 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.8 t-80 -54.0 -25.74 22.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.929 . . . . 0.0 109.789 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -77.44 -36.26 53.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.062 -1.024 . . . . 0.0 110.034 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.428 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 46.4 mm-40 -73.11 -23.04 60.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.934 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.36 -38.25 24.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 110.417 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.014 HG22 HD11 ' A' ' 18' ' ' ILE . 14.1 t -72.44 -29.21 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.154 -0.966 . . . . 0.0 109.184 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -61.37 -37.2 82.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.335 -0.853 . . . . 0.0 109.813 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.605 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -71.54 -50.31 32.4 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.171 -0.956 . . . . 0.0 108.81 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.472 ' CD2' HD21 ' A' ' 80' ' ' LEU . 86.7 mt -57.68 -23.67 52.75 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.543 -0.723 . . . . 0.0 109.443 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -78.56 -34.91 46.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.678 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -130.79 54.17 1.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.343 -0.848 . . . . 0.0 109.684 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.706 ' CB ' HG22 ' A' ' 78' ' ' VAL . 66.2 p -57.81 -84.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.855 . . . . 0.0 110.502 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.427 ' N ' ' OG1' ' A' ' 74' ' ' THR . . . 154.12 -170.74 32.7 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -47.23 -35.69 7.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.147 -1.208 . . . . 0.0 110.665 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -132.96 130.39 39.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.223 -0.923 . . . . 0.0 109.705 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.875 HG12 HD13 ' A' ' 80' ' ' LEU . 99.4 t -94.64 81.59 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.072 -1.018 . . . . 0.0 111.196 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.678 ' O ' HD12 ' A' ' 80' ' ' LEU . 22.0 t -72.21 116.74 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.875 HD13 HG12 ' A' ' 78' ' ' VAL . 3.8 mp -124.54 108.49 12.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.959 -1.088 . . . . 0.0 112.108 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -70.26 129.15 38.56 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.851 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.8 p -129.02 145.38 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.855 -1.153 . . . . 0.0 112.602 -177.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.73 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 5.4 tttp -111.51 83.77 1.83 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.591 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -49.31 119.39 3.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.469 -0.77 . . . . 0.0 111.645 -177.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.705 ' HG3' HD21 ' A' ' 29' ' ' LEU . 2.8 mmt -101.21 47.32 0.91 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.6 tptt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.318 -179.449 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.486 ' HD2' ' CG ' ' A' ' 64' ' ' HIS . 12.0 mttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.319 0.58 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.466 ' CA ' ' HG2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER 54.92 49.71 17.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.015 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.577 ' HB2' ' HE1' ' A' ' 64' ' ' HIS . 26.5 t -54.24 -175.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 110.526 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.756 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -149.95 73.31 1.16 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.375 -0.828 . . . . 0.0 110.381 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.463 ' CG2' HG13 ' A' ' 68' ' ' VAL . 59.1 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.168 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.272 0.558 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.828 ' CB ' HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -155.19 162.4 40.95 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.217 -0.927 . . . . 0.0 110.506 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.93 109.92 6.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.438 -0.789 . . . . 0.0 109.295 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.857 HG22 ' HB1' ' A' ' 44' ' ' ALA . 89.6 t -115.49 152.87 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.029 -1.045 . . . . 0.0 110.846 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.6 m -132.79 114.94 14.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 109.564 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.63 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 86.2 t -102.82 118.67 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.086 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.1 mtm180 -88.05 87.81 7.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.934 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.408 ' HG3' HG21 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -49.4 112.32 0.62 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.298 -0.877 . . . . 0.0 110.637 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.87 50.55 1.42 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.35 -0.844 . . . . 0.0 109.907 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.35 26.22 10.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.37 -0.831 . . . . 0.0 109.968 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.95 59.34 0.7 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.369 -0.832 . . . . 0.0 110.511 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.61 36.74 32.33 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.38 -149.13 18.21 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -116.72 -18.92 10.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -1.154 . . . . 0.0 110.717 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.883 ' CA ' HD22 ' A' ' 37' ' ' LEU . . . 57.88 90.17 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 tt -176.78 118.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.204 -1.174 . . . . 0.0 110.226 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' B' ' 5' ' ' SER . 1.1 t -112.4 100.24 8.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.182 -0.949 . . . . 0.0 109.783 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.949 HD11 HG22 ' A' ' 68' ' ' VAL . 9.8 pt -77.63 150.48 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 110.693 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 31' ' ' SER . 58.9 tttt -136.18 123.24 21.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 110.103 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.75 -140.44 8.69 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.444 ' CA ' ' HB2' ' A' ' 64' ' ' HIS . . . 138.99 148.11 5.22 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -61.36 -14.11 24.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -1.08 . . . . 0.0 110.844 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -9.08 57.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.921 -1.112 . . . . 0.0 110.559 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -130.32 26.28 5.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.043 -1.036 . . . . 0.0 110.12 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.5 mttp 54.72 40.88 32.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.312 -0.868 . . . . 0.0 110.157 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.593 ' HE1' ' HB2' ' A' ' 29' ' ' LEU . 6.2 mmm -120.88 124.77 27.33 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.377 -0.827 . . . . 0.0 110.034 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.699 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 49.6 Cg_endo -70.21 52.66 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 O-C-N 123.348 1.183 . . . . 0.0 111.745 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.654 HG21 ' HB1' ' A' ' 67' ' ' ALA . 18.0 mm 43.53 89.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.084 -1.01 . . . . 0.0 110.096 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' A' ' 50' ' ' ALA . 32.7 tp -102.41 126.78 49.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.886 -1.134 . . . . 0.0 112.072 -178.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.9 HD12 ' HB2' ' A' ' 49' ' ' ASP . 56.7 mt -62.08 135.81 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.463 -0.773 . . . . 0.0 109.633 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.432 ' HA ' HG13 ' A' ' 47' ' ' VAL . 8.4 t -121.91 -18.49 7.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 110.963 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.89 106.48 4.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.002 -1.061 . . . . 0.0 110.702 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.697 HD11 HG21 ' A' ' 30' ' ' ILE . 16.8 mm -94.77 109.78 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 0.0 109.265 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.824 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 88.6 m-85 -71.54 128.15 34.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.8 ' O ' HD12 ' A' ' 37' ' ' LEU . 1.8 mttp -73.83 173.08 10.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -0.939 . . . . 0.0 110.666 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.23 29.65 69.13 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.883 HD22 ' CA ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -138.26 159.42 42.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -1.163 . . . . 0.0 110.941 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.63 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -44.44 -62.42 1.18 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.628 -0.67 . . . . 0.0 111.604 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.726 ' O ' HG22 ' A' ' 42' ' ' THR . . . -47.82 -57.76 5.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.179 -0.95 . . . . 0.0 110.99 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.439 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 12.8 t70 -75.47 0.51 16.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.998 -1.064 . . . . 0.0 111.332 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -104.66 -2.44 25.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.75 -1.219 . . . . 0.0 110.865 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 39' ' ' ALA . 9.2 t -98.67 14.82 27.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.842 -1.161 . . . . 0.0 110.662 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 47.62 49.31 16.38 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.11 -0.993 . . . . 0.0 110.649 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.857 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -169.11 -43.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 110.206 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.489 ' CD2' HG11 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -68.17 80.1 0.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 108.83 179.139 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.586 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.23 153.67 26.75 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.594 -0.692 . . . . 0.0 110.043 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.526 HG12 ' N ' ' A' ' 48' ' ' GLY . 96.1 t -52.66 168.35 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.075 -1.015 . . . . 0.0 110.362 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.526 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 70.85 30.28 68.33 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.9 ' HB2' HD12 ' A' ' 30' ' ' ILE . 45.6 m-20 -114.92 99.9 7.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -1.036 . . . . 0.0 111.059 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -79.07 107.58 11.93 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.092 -1.005 . . . . 0.0 109.718 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.858 ' C ' HD22 ' A' ' 52' ' ' LEU . 52.2 mt -76.49 138.66 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.441 -0.787 . . . . 0.0 110.683 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.858 HD22 ' C ' ' A' ' 51' ' ' ILE . 3.9 mm? -127.35 7.23 6.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.153 -0.967 . . . . 0.0 110.82 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 176.08 99.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.87 -1.144 . . . . 0.0 109.765 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.927 HG21 ' CB ' ' A' ' 70' ' ' ALA . 23.1 m -91.1 121.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.138 -0.976 . . . . 0.0 110.36 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' A' ' 79' ' ' VAL . 3.8 m120 60.37 36.29 20.45 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.096 -1.002 . . . . 0.0 110.274 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.3 11.42 85.34 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.2 tp10 -96.79 92.34 6.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.882 -1.363 . . . . 0.0 109.429 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -40.89 103.96 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.562 0.696 . . . . 0.0 111.31 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.038 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -92.99 -13.53 28.6 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.61 -0.681 . . . . 0.0 110.499 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.2 p -54.9 -37.64 66.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.004 . . . . 0.0 110.135 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 m -96.96 23.42 7.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -0.935 . . . . 0.0 110.264 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 1.038 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -117.59 155.43 29.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 110.171 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.9 p -85.54 172.6 10.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.314 -0.866 . . . . 0.0 110.18 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.805 ' O ' HG23 ' A' ' 68' ' ' VAL . 5.8 t-80 -53.62 -25.74 18.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.107 -0.996 . . . . 0.0 109.786 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -75.87 -40.91 53.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.017 -1.052 . . . . 0.0 109.27 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.885 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 19.6 mt-10 -65.25 -22.43 66.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.527 -0.733 . . . . 0.0 109.87 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.654 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -83.98 -40.58 18.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.298 -0.877 . . . . 0.0 110.658 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.949 HG22 HD11 ' A' ' 18' ' ' ILE . 9.4 t -74.49 -28.37 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.205 -0.935 . . . . 0.0 109.26 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -65.54 -37.88 88.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.342 -0.849 . . . . 0.0 110.093 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.927 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.06 -37.28 75.46 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.12 -0.988 . . . . 0.0 109.125 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.8 mt -73.81 -19.95 60.6 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.648 -0.658 . . . . 0.0 109.808 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -80.88 -45.0 17.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.904 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -106.22 30.83 5.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.366 -0.834 . . . . 0.0 109.99 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 1.076 HG21 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -65.64 142.66 57.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.845 . . . . 0.0 109.972 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.86 -179.98 40.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 77' ' ' GLU . 8.2 pttt -49.9 -50.92 44.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.363 -1.081 . . . . 0.0 110.688 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.425 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 81.5 mm-40 -88.86 92.87 9.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.908 -1.12 . . . . 0.0 109.133 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.076 HG13 HG21 ' A' ' 74' ' ' THR . 78.3 t -83.06 78.63 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.189 -0.944 . . . . 0.0 110.903 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.65 ' O ' HD12 ' A' ' 80' ' ' LEU . 11.0 t -66.44 124.01 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.892 HD13 HG12 ' A' ' 78' ' ' VAL . 2.3 mp -124.21 106.14 10.07 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.901 -1.125 . . . . 0.0 111.749 -178.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.9 tt0 -68.2 121.59 16.53 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.828 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.6 p -127.05 147.95 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.069 -1.02 . . . . 0.0 112.683 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 13.9 ttmt -112.45 88.2 2.76 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.586 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -56.28 126.68 27.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 111.157 -177.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.0 mmt -105.89 54.89 0.69 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.344 -0.847 . . . . 0.0 109.226 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.5 tttt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.224 -179.527 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.598 ' HB2' ' CD2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.234 0.54 . . . . 0.0 110.178 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER 54.29 62.31 2.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -0.862 . . . . 0.0 109.858 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.77 ' HB2' ' HE1' ' A' ' 64' ' ' HIS . 3.5 t -73.59 -156.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.241 -0.912 . . . . 0.0 110.62 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.824 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -167.07 89.25 0.34 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.317 -0.864 . . . . 0.0 110.515 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.53 ' CG2' HG13 ' A' ' 68' ' ' VAL . 41.9 t . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.066 -1.021 . . . . 0.0 110.082 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 15.5 mtm-85 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.468 0.652 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.884 ' CB ' HG13 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -148.21 164.36 34.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.397 -0.815 . . . . 0.0 110.195 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.43 117.51 18.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 109.461 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.054 HG22 ' HB1' ' A' ' 44' ' ' ALA . 53.3 t -129.63 126.95 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.05 -1.031 . . . . 0.0 110.521 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.1 m -119.79 130.81 55.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.364 -0.835 . . . . 0.0 109.674 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.54 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 89.2 t -117.21 111.1 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.783 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -72.3 94.46 1.6 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.016 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -61.21 100.18 0.12 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.384 -0.823 . . . . 0.0 110.43 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.37 32.42 2.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 110.156 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 56.91 108.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.527 -0.733 . . . . 0.0 110.595 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -175.34 80.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 110.217 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.31 -62.43 1.81 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.15 -151.77 10.54 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.782 HD23 ' HB2' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -102.7 -19.63 14.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -1.175 . . . . 0.0 110.283 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.46 ' CA ' ' HB2' ' A' ' 34' ' ' PHE . . . 65.23 76.19 0.34 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.925 HD12 HD21 ' A' ' 45' ' ' LEU . 4.2 tt -166.24 117.18 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -1.055 . . . . 0.0 109.698 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 32' ' ' LYS . 1.2 t -107.29 92.31 4.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.09 -1.006 . . . . 0.0 109.933 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.98 HD11 ' CG2' ' A' ' 68' ' ' VAL . 45.2 pt -69.04 146.67 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.199 -0.938 . . . . 0.0 110.886 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' CB ' ' HB2' ' A' ' 31' ' ' SER . 21.5 tttt -135.41 117.32 15.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.495 -0.753 . . . . 0.0 109.728 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.06 -155.37 26.44 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 155.92 135.66 2.03 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -61.5 -14.47 29.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -1.12 . . . . 0.0 110.698 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.7 2.2 34.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.838 -1.164 . . . . 0.0 110.23 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -138.35 26.77 2.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.517 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.07 74.15 0.38 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.0 109.965 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.703 ' HE1' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -161.82 120.43 1.42 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 110.649 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.674 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 53.6 Cg_endo -72.63 52.85 2.14 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 O-C-N 123.508 1.267 . . . . 0.0 111.408 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 64' ' ' HIS . 11.4 mm 43.45 87.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 120.998 -1.064 . . . . 0.0 110.666 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.703 ' CB ' ' HE1' ' A' ' 26' ' ' MET . 6.0 mt -97.33 132.32 43.18 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.672 -1.268 . . . . 0.0 111.663 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.804 HD12 ' HB2' ' A' ' 49' ' ' ASP . 57.4 mt -65.64 137.17 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.248 -0.907 . . . . 0.0 108.628 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.454 ' HB2' ' CB ' ' A' ' 19' ' ' LYS . 3.1 t -119.73 -29.58 4.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.046 -1.034 . . . . 0.0 110.715 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -133.45 101.43 5.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 110.601 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.673 HD11 HG21 ' A' ' 30' ' ' ILE . 10.2 mm -87.69 106.11 15.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.548 ' CE1' HD13 ' B' ' 6' ' ' LEU . 5.3 m-85 -59.24 123.1 15.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.509 -0.745 . . . . 0.0 110.219 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.417 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -75.21 146.18 41.4 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.228 -0.92 . . . . 0.0 110.563 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.422 ' C ' HD22 ' A' ' 37' ' ' LEU . . . 78.74 0.75 81.84 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.532 ' N ' HD22 ' A' ' 37' ' ' LEU . 4.0 mm? -100.7 163.07 12.5 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.942 -1.328 . . . . 0.0 110.26 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.54 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -47.09 -55.5 8.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.364 -0.835 . . . . 0.0 110.775 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 1.044 ' HB1' HD23 ' A' ' 45' ' ' LEU . . . -51.38 -47.67 62.8 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.363 -0.835 . . . . 0.0 111.024 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 13.8 t70 -86.72 3.43 44.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.157 -0.964 . . . . 0.0 111.267 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -103.58 4.56 35.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.815 -1.178 . . . . 0.0 110.783 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 39' ' ' ALA . 4.9 t -107.66 14.65 25.44 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.854 -1.154 . . . . 0.0 110.712 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 45.4 56.79 5.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.263 -0.898 . . . . 0.0 111.068 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 1.054 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -170.57 -48.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.109 -0.994 . . . . 0.0 110.315 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.044 HD23 ' HB1' ' A' ' 39' ' ' ALA . 3.5 tp -70.45 84.58 0.59 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.831 -1.168 . . . . 0.0 108.489 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -111.04 147.44 34.77 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.758 -0.589 . . . . 0.0 110.039 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.504 ' HA ' HG22 ' A' ' 30' ' ' ILE . 52.0 t -47.35 147.47 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.274 -0.891 . . . . 0.0 110.3 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.32 26.85 26.99 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.421 -1.872 . . . . 0.0 108.421 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.804 ' HB2' HD12 ' A' ' 30' ' ' ILE . 58.2 m-20 -110.26 106.82 16.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.524 -0.986 . . . . 0.0 110.384 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.674 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -84.41 108.95 17.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.938 . . . . 0.0 109.593 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.794 ' C ' HD22 ' A' ' 52' ' ' LEU . 63.8 mt -76.57 136.31 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 111.042 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.794 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.2 mm? -124.63 15.5 8.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.476 -0.765 . . . . 0.0 109.886 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 4.6 t 176.81 135.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 108.967 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.88 HG12 HD22 ' A' ' 80' ' ' LEU . 1.2 m -128.68 118.15 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.041 -1.037 . . . . 0.0 110.497 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 54.72 37.91 29.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.332 -0.855 . . . . 0.0 110.554 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.75 26.93 40.07 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.596 ' HB2' HG23 ' A' ' 54' ' ' VAL . 47.7 mt-10 -118.93 93.19 4.01 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.081 -1.247 . . . . 0.0 110.173 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -44.96 111.79 0.36 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.448 -0.783 . . . . 0.0 110.93 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.934 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -101.48 17.18 23.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.508 -0.745 . . . . 0.0 110.658 -179.385 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 t -66.3 -50.37 63.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 0.0 110.29 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.28 36.62 1.57 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.066 -1.021 . . . . 0.0 110.48 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.934 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -116.46 149.44 39.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.957 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.8 p -83.09 171.58 13.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 0.0 110.418 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.916 ' O ' HG23 ' A' ' 68' ' ' VAL . 8.7 t60 -56.61 -23.45 41.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.231 -0.918 . . . . 0.0 109.91 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.91 -42.83 31.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 109.447 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 2.5 mt-10 -65.65 -21.16 66.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.349 -0.844 . . . . 0.0 109.784 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.614 ' CA ' HD11 ' A' ' 59' ' ' LEU . . . -84.5 -45.41 12.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.371 -0.831 . . . . 0.0 110.53 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.98 ' CG2' HD11 ' A' ' 18' ' ' ILE . 6.0 t -67.03 -31.48 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.124 -0.985 . . . . 0.0 109.186 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -42.04 82.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.401 -0.812 . . . . 0.0 109.444 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.681 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -67.93 -46.0 72.74 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.115 -0.991 . . . . 0.0 108.741 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.67 ' HB3' HG11 ' B' ' 7' ' ' VAL . 3.8 mm? -52.88 -29.79 30.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.672 -0.643 . . . . 0.0 109.697 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.599 ' HG2' HG13 ' B' ' 7' ' ' VAL . 7.8 mttm -82.19 -40.15 22.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.242 -0.911 . . . . 0.0 110.24 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -110.59 34.66 3.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 110.117 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.827 ' HB ' HG22 ' A' ' 78' ' ' VAL . 21.3 p -51.97 -79.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 0.0 110.309 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.39 -176.99 25.96 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -50.59 -41.04 54.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.206 -1.173 . . . . 0.0 110.169 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 3.7 pt-20 -117.61 112.64 20.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.852 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.827 HG22 ' HB ' ' A' ' 74' ' ' THR . 53.1 t -84.94 83.66 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.076 -1.015 . . . . 0.0 110.407 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.799 ' O ' HD23 ' A' ' 80' ' ' LEU . 11.1 t -76.1 116.68 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.88 HD22 HG12 ' A' ' 54' ' ' VAL . 14.8 mt -125.06 116.45 22.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.842 -1.161 . . . . 0.0 111.523 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -74.19 122.57 22.99 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.884 HG13 ' CB ' ' A' ' 2' ' ' ARG . 3.1 p -119.21 144.63 27.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.543 -177.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 7.0 tptm -110.15 90.06 3.2 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.58 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -55.21 125.12 19.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.448 -0.783 . . . . 0.0 111.067 -177.579 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.4 mmm -116.3 51.91 0.95 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.462 -0.774 . . . . 0.0 109.41 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.7 pttt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.256 -179.605 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.469 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 14.9 tttt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.211 0.529 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -112.68 97.88 6.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.215 -0.928 . . . . 0.0 110.02 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 17' ' ' SER . 33.1 m -103.99 133.07 49.57 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.201 -0.937 . . . . 0.0 110.398 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.548 HD13 ' CE1' ' A' ' 34' ' ' PHE . 41.0 tp -105.92 108.35 19.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -0.863 . . . . 0.0 110.207 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.67 HG11 ' HB3' ' A' ' 71' ' ' LEU . 40.2 t . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.053 -1.029 . . . . 0.0 110.203 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.304 0.573 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.872 ' CB ' HG13 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -147.85 158.72 44.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.537 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.7 115.26 16.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.215 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.742 HG13 ' HB3' ' A' ' 44' ' ' ALA . 37.9 t -132.0 139.32 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.07 -1.018 . . . . 0.0 110.689 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.8 m -128.26 126.54 41.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.311 -0.868 . . . . 0.0 110.271 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.093 HG22 HG21 ' A' ' 42' ' ' THR . 98.2 t -106.07 126.37 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.047 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.89 85.03 2.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 110.203 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -80.21 166.69 21.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 110.155 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.41 63.73 1.46 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.943 . . . . 0.0 110.366 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 52.84 23.01 2.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.435 -0.791 . . . . 0.0 110.396 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.13 -58.73 6.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.235 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.15 -73.38 0.08 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.36 143.88 15.18 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.544 ' O ' HD23 ' A' ' 14' ' ' LEU . 1.2 tt -63.23 -17.39 62.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -1.105 . . . . 0.0 110.726 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.494 ' HA3' ' CG ' ' A' ' 37' ' ' LEU . . . 64.86 87.53 0.05 OUTLIER Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -178.8 121.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.113 -1.227 . . . . 0.0 110.28 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.49 109.78 21.55 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.918 HD11 HG22 ' A' ' 68' ' ' VAL . 27.5 pt -92.05 143.08 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -0.89 . . . . 0.0 111.171 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -125.69 170.14 11.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.57 179.466 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.09 -143.28 15.91 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' CA ' ' HB2' ' A' ' 64' ' ' HIS . . . 138.43 143.04 4.41 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -60.53 -14.56 20.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -1.116 . . . . 0.0 110.99 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.14 -20.35 64.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.934 -1.104 . . . . 0.0 110.106 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.73 24.33 7.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 109.726 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.2 tttt 55.58 82.59 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.41 -0.806 . . . . 0.0 110.218 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.535 ' HE1' ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -159.12 127.89 3.03 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 109.879 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.829 ' HB2' HD11 ' A' ' 52' ' ' LEU . 52.9 Cg_endo -70.28 50.61 0.96 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 O-C-N 123.321 1.169 . . . . 0.0 112.376 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.467 ' N ' ' HE2' ' A' ' 26' ' ' MET . 21.0 mm 38.88 88.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.549 0 O-C-N 121.201 -0.937 . . . . 0.0 111.189 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.619 HD11 ' HG3' ' A' ' 85' ' ' MET . 6.1 mt -96.66 133.23 41.44 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.88 -1.138 . . . . 0.0 111.765 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.842 HD12 ' HB2' ' A' ' 49' ' ' ASP . 67.8 mt -65.74 144.25 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 108.806 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.3 t -123.85 -23.88 4.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.925 -1.11 . . . . 0.0 111.252 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.06 95.26 2.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.97 -1.081 . . . . 0.0 111.04 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.481 HG22 ' HB2' ' A' ' 40' ' ' ASP . 10.7 mm -77.47 100.24 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.36 -0.837 . . . . 0.0 108.831 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.791 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 17.2 m-85 -49.76 137.17 16.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.637 -0.664 . . . . 0.0 110.644 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.615 ' O ' HD23 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -79.29 159.0 27.41 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.177 -0.952 . . . . 0.0 110.487 -179.418 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.58 21.37 27.97 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 35' ' ' LYS . 2.1 mm? -111.09 167.9 9.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -1.191 . . . . 0.0 109.865 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.889 ' O ' HG23 ' A' ' 42' ' ' THR . . . -51.84 -66.89 0.31 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.139 -0.975 . . . . 0.0 111.164 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 45' ' ' LEU . . . -47.62 -47.25 29.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.253 -0.905 . . . . 0.0 111.108 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.481 ' HB2' HG22 ' A' ' 33' ' ' ILE . 4.8 t70 -71.88 -11.76 60.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.097 -1.002 . . . . 0.0 110.861 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -105.48 15.87 26.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.828 -1.17 . . . . 0.0 110.547 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 1.093 HG21 HG22 ' A' ' 6' ' ' VAL . 48.3 p -106.06 12.81 29.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.027 -1.045 . . . . 0.0 110.73 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 48.24 44.88 20.0 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.056 -1.027 . . . . 0.0 110.538 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.742 ' HB3' HG13 ' A' ' 4' ' ' VAL . . . -174.72 -43.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.551 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.433 HD21 HD12 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -66.83 83.37 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.81 -1.181 . . . . 0.0 109.049 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.585 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -114.24 151.39 32.9 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.579 -0.7 . . . . 0.0 110.094 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 48' ' ' GLY . 24.5 t -47.66 169.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.21 -0.931 . . . . 0.0 110.35 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 66.46 33.77 85.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.842 ' HB2' HD12 ' A' ' 30' ' ' ILE . 28.4 m-20 -115.16 106.23 13.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.432 -1.04 . . . . 0.0 110.177 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.951 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -83.76 108.78 17.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.212 -0.93 . . . . 0.0 110.383 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.812 ' C ' HD12 ' A' ' 52' ' ' LEU . 60.1 mt -77.67 134.79 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.413 -0.805 . . . . 0.0 110.379 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.829 HD11 ' HB2' ' A' ' 27' ' ' PRO . 10.0 mp -126.6 10.14 7.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.877 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 176.31 96.97 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.983 -1.073 . . . . 0.0 110.013 179.06 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.969 HG21 ' CB ' ' A' ' 70' ' ' ALA . 33.7 m -86.99 118.32 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.858 . . . . 0.0 110.508 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 55.49 33.96 22.07 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.362 -0.836 . . . . 0.0 111.089 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.11 -11.4 72.03 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.555 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' SER . 0.3 OUTLIER -77.53 90.23 3.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.787 -1.42 . . . . 0.0 109.593 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -41.97 106.51 0.06 Allowed 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.557 0.694 . . . . 0.0 111.075 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.943 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -98.9 -10.32 22.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.546 -0.722 . . . . 0.0 110.92 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.2 p -52.65 -36.53 57.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.02 -1.05 . . . . 0.0 110.296 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 m -113.57 49.34 0.98 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.167 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.943 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -130.74 149.2 52.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.236 -0.915 . . . . 0.0 110.303 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.9 p -72.41 163.01 28.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.369 -0.832 . . . . 0.0 109.882 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.889 ' O ' HG23 ' A' ' 68' ' ' VAL . 7.7 t60 -54.48 -25.16 23.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.004 -1.06 . . . . 0.0 109.729 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -75.17 -43.93 49.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.063 -1.023 . . . . 0.0 108.796 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.724 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -60.38 -28.83 68.52 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.502 -0.749 . . . . 0.0 109.419 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.682 ' CA ' HD11 ' A' ' 59' ' ' LEU . . . -77.51 -49.49 14.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.688 -0.633 . . . . 0.0 110.881 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.918 HG22 HD11 ' A' ' 18' ' ' ILE . 3.0 t -66.56 -30.54 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 119.206 -0.998 . . . . 0.0 108.927 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.58 -36.61 71.93 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.308 -0.87 . . . . 0.0 109.202 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.969 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -72.49 -35.76 68.24 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.245 -0.909 . . . . 0.0 109.302 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.706 ' C ' HG11 ' B' ' 7' ' ' VAL . 4.1 mm? -69.18 -29.08 66.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.698 -0.626 . . . . 0.0 109.918 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -79.1 -37.85 37.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.212 -0.93 . . . . 0.0 109.87 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -104.33 33.52 3.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.423 -0.798 . . . . 0.0 109.591 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.96 HG22 HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -73.39 138.09 45.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.403 -0.811 . . . . 0.0 110.188 -179.654 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.99 -178.46 52.4 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.429 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 20.7 mtpt -53.31 -62.98 1.3 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -1.126 . . . . 0.0 110.366 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -73.59 90.59 1.78 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.209 -0.932 . . . . 0.0 109.223 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.96 HG22 HG22 ' A' ' 74' ' ' THR . 99.2 t -84.33 83.29 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 110.92 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.966 ' O ' HD23 ' A' ' 80' ' ' LEU . 9.0 t -74.98 124.92 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.966 HD23 ' O ' ' A' ' 79' ' ' VAL . 13.0 mt -130.25 118.67 21.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.744 -1.223 . . . . 0.0 111.71 -178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 35.0 tt0 -76.59 121.47 23.24 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.872 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.7 p -120.28 149.31 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 0.0 112.447 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.951 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -114.54 86.49 2.44 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.611 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.585 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -55.09 118.17 4.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.414 -0.804 . . . . 0.0 111.475 -177.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.619 ' HG3' HD11 ' A' ' 29' ' ' LEU . 4.1 mmt -95.98 51.01 1.21 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.319 -0.863 . . . . 0.0 108.769 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.8 tttt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.302 -179.402 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 64' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.376 0.608 . . . . 0.0 110.523 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 16.8 tt0 -58.5 96.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.468 -0.77 . . . . 0.0 110.593 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 8.2 m -84.22 -162.15 0.63 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.217 -0.927 . . . . 0.0 110.01 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.791 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -161.6 86.3 0.65 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.068 -1.02 . . . . 0.0 110.326 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.706 HG11 ' C ' ' A' ' 71' ' ' LEU . 39.1 t . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.05 -1.031 . . . . 0.0 109.979 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.53 0.681 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.524 ' CG ' HG13 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -158.78 143.47 15.9 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.483 -0.761 . . . . 0.0 109.614 -179.349 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.9 ptt-85 -122.28 136.56 54.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.121 -0.987 . . . . 0.0 110.115 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.739 HG13 ' CB ' ' A' ' 44' ' ' ALA . 46.6 t -139.31 134.26 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.103 -0.998 . . . . 0.0 110.538 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.7 m -118.04 125.22 49.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.393 -0.817 . . . . 0.0 110.08 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.566 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 83.2 t -118.39 129.14 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.353 -0.842 . . . . 0.0 109.185 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.6 mtm-85 -96.61 85.47 3.87 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.912 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -83.96 176.5 8.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 110.392 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.9 -156.78 0.59 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.891 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -51.13 -53.12 37.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.027 -1.045 . . . . 0.0 110.317 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.45 70.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.27 -0.894 . . . . 0.0 110.293 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.18 33.73 6.08 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.86 143.73 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.91 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -109.82 -16.81 13.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -1.15 . . . . 0.0 110.382 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.887 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 56.48 90.47 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.628 ' CD1' HD22 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -175.04 123.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.175 -1.191 . . . . 0.0 110.826 -178.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.441 ' HB3' ' CB ' ' A' ' 32' ' ' LYS . 29.7 t -111.07 125.04 53.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 109.403 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.934 HD11 ' CG2' ' A' ' 68' ' ' VAL . 42.4 pt -105.0 150.66 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.135 -0.978 . . . . 0.0 110.883 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -133.9 158.97 42.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.377 -0.827 . . . . 0.0 109.848 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.1 -159.86 13.85 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 164.83 148.25 5.4 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.419 ' CB ' ' HA ' ' A' ' 63' ' ' THR . 10.5 ttp85 -60.46 -14.94 22.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -1.085 . . . . 0.0 110.809 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.63 -19.8 54.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.897 -1.127 . . . . 0.0 110.021 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -111.34 23.08 14.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.266 -0.896 . . . . 0.0 109.932 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 tptp 54.49 54.88 8.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.323 -0.86 . . . . 0.0 110.355 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.454 ' CE ' ' HB2' ' A' ' 29' ' ' LEU . 4.9 mmm -138.05 125.66 13.79 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.218 -0.926 . . . . 0.0 110.233 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.764 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 48.3 Cg_endo -69.53 52.33 0.91 Allowed 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.104 1.203 . . . . 0.0 111.882 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 64' ' ' HIS . 13.0 mm 42.96 90.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 121.116 -0.99 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 50' ' ' ALA . 30.4 tp -98.9 124.97 44.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.887 -1.133 . . . . 0.0 111.785 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.836 HD12 ' HB2' ' A' ' 49' ' ' ASP . 56.2 mt -57.27 142.31 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.47 -0.769 . . . . 0.0 109.671 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.3 -25.9 4.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.136 -0.977 . . . . 0.0 110.904 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.441 ' CB ' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -141.11 105.59 4.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.02 -1.05 . . . . 0.0 110.628 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.669 HD11 HG21 ' A' ' 30' ' ' ILE . 15.9 mm -90.38 115.71 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 109.085 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.525 ' HB3' HD13 ' A' ' 37' ' ' LEU . 17.2 m-85 -75.99 136.75 39.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.443 -0.785 . . . . 0.0 109.774 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.668 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -82.68 167.59 18.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.152 -0.968 . . . . 0.0 110.855 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.88 29.01 74.19 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.887 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER -137.47 160.23 39.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -1.157 . . . . 0.0 110.834 -179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -44.11 -69.63 0.13 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.495 -0.753 . . . . 0.0 111.935 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.91 ' HB2' ' CD2' ' A' ' 14' ' ' LEU . . . -45.55 -47.65 14.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.482 -0.761 . . . . 0.0 111.532 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.428 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 13.7 t70 -85.18 4.84 32.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.959 -1.088 . . . . 0.0 110.892 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -106.11 -3.14 21.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.822 -1.174 . . . . 0.0 110.835 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.501 HG21 HG22 ' A' ' 6' ' ' VAL . 8.7 t -99.82 14.71 29.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.922 -1.111 . . . . 0.0 110.643 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 47.43 39.24 8.87 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.043 -1.035 . . . . 0.0 110.904 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.739 ' CB ' HG13 ' A' ' 4' ' ' VAL . . . -152.28 -46.38 0.1 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.152 -0.967 . . . . 0.0 110.428 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.628 HD22 ' CD1' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -71.69 85.62 0.91 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.781 -1.2 . . . . 0.0 108.649 179.36 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.602 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.82 156.12 23.44 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.655 -179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.497 ' HA ' HG22 ' A' ' 30' ' ' ILE . 89.3 t -52.04 163.37 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.659 -1.275 . . . . 0.0 109.575 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.441 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 75.59 26.17 66.0 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.836 ' HB2' HD12 ' A' ' 30' ' ' ILE . 59.5 m-20 -112.94 101.24 9.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.506 -0.996 . . . . 0.0 110.57 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.764 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -79.4 110.0 14.29 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.369 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 52' ' ' LEU . 42.9 mt -78.28 138.81 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.426 -0.796 . . . . 0.0 110.325 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.644 HD11 ' HB2' ' A' ' 27' ' ' PRO . 3.3 mp -135.34 15.35 3.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.591 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 14.6 t 175.59 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.409 -0.807 . . . . 0.0 109.267 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.092 HG21 ' HB1' ' A' ' 70' ' ' ALA . 33.8 m -100.68 122.23 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.253 -0.904 . . . . 0.0 110.96 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 57.43 28.24 15.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.442 -0.786 . . . . 0.0 111.466 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.26 22.46 32.14 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.585 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 53' ' ' SER . 9.1 mt-10 -115.72 93.22 4.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.97 -1.312 . . . . 0.0 109.539 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.42 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.62 0.724 . . . . 0.0 111.438 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.034 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -87.61 -12.65 44.99 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.607 -0.683 . . . . 0.0 110.622 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.448 ' OG ' HD23 ' A' ' 52' ' ' LEU . 49.3 m -53.09 -31.8 43.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.994 -1.066 . . . . 0.0 110.442 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.61 33.25 3.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.194 -0.941 . . . . 0.0 110.475 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 1.034 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -124.7 144.94 49.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 0.0 110.203 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.419 ' HA ' ' CB ' ' A' ' 22' ' ' ARG . 51.1 p -76.9 166.19 23.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 109.835 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.915 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.6 t60 -51.59 -25.04 6.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.056 -1.028 . . . . 0.0 110.071 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.69 -44.0 35.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.117 -0.989 . . . . 0.0 109.057 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.587 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 15.3 mm-40 -66.59 -22.34 66.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.387 -0.821 . . . . 0.0 109.499 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.795 ' HA ' HD11 ' A' ' 59' ' ' LEU . . . -80.6 -46.91 14.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.388 -0.82 . . . . 0.0 110.44 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.934 ' CG2' HD11 ' A' ' 18' ' ' ILE . 10.4 t -64.73 -29.82 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.99 -31.01 69.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.351 -0.843 . . . . 0.0 109.468 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.092 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -74.25 -33.31 63.27 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.276 -0.89 . . . . 0.0 109.679 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.67 ' HB3' HG11 ' B' ' 7' ' ' VAL . 4.4 mm? -72.02 -26.38 62.19 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.537 -0.727 . . . . 0.0 109.782 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.4 -41.36 24.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.251 -0.906 . . . . 0.0 109.939 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -93.63 23.21 4.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.678 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.788 ' CG2' HG22 ' A' ' 78' ' ' VAL . 74.4 m -54.83 129.86 38.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.394 -0.816 . . . . 0.0 110.16 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.79 176.91 46.32 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.422 ' HG3' ' HG2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -49.82 -46.03 50.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -1.146 . . . . 0.0 110.517 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.422 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 20.1 mm-40 -90.94 106.15 18.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.026 -1.047 . . . . 0.0 109.092 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.892 HG12 HD13 ' A' ' 80' ' ' LEU . 20.3 t -97.5 82.0 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.132 -0.98 . . . . 0.0 111.15 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.499 ' O ' HD12 ' A' ' 80' ' ' LEU . 10.8 t -78.64 108.2 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.892 HD13 HG12 ' A' ' 78' ' ' VAL . 4.4 mp -114.82 112.22 22.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.78 -1.2 . . . . 0.0 112.529 -177.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 32.0 tt0 -74.89 124.48 26.96 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.524 HG13 ' CG ' ' A' ' 2' ' ' ARG . 2.2 p -127.53 147.6 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.949 -1.095 . . . . 0.0 111.768 -177.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 3.4 mttt -107.75 87.4 2.49 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.602 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -59.51 114.08 2.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.505 -0.747 . . . . 0.0 110.788 -177.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 mmm -93.62 59.95 2.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.883 . . . . 0.0 109.756 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.0 tttt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.285 -179.81 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.459 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 8.9 tttt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.236 0.541 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 5.7 tt0 -117.88 86.23 2.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 110.196 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.04 -169.44 2.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.209 -0.932 . . . . 0.0 110.258 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.713 ' O ' HD13 ' B' ' 6' ' ' LEU . 2.5 tm? -160.51 106.75 1.5 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 110.122 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.67 HG11 ' HB3' ' A' ' 71' ' ' LEU . 61.6 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.163 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 121.225 0.536 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.516 ' CG ' HG13 ' A' ' 82' ' ' VAL . 1.6 tpt180 -167.6 143.92 4.17 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.321 -0.862 . . . . 0.0 109.74 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -119.98 136.75 54.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.09 -1.006 . . . . 0.0 110.29 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 44' ' ' ALA . 54.9 t -142.75 159.6 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.968 . . . . 0.0 110.528 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 54.0 m -146.73 143.38 28.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.356 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.628 ' CG2' HD12 ' A' ' 45' ' ' LEU . 80.7 t -130.28 118.03 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.334 -0.854 . . . . 0.0 109.804 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -92.01 95.91 10.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.851 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt -49.76 119.15 3.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.318 -0.864 . . . . 0.0 110.722 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.81 118.68 24.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.839 . . . . 0.0 109.912 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.78 21.47 3.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.908 . . . . 0.0 110.285 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.32 98.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.291 -0.881 . . . . 0.0 110.432 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.13 -84.69 0.25 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.25 -178.18 22.34 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.566 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -122.67 -32.92 3.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.233 -1.157 . . . . 0.0 110.51 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.505 ' HA3' ' HG ' ' A' ' 37' ' ' LEU . . . 66.6 91.71 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.55 HG22 ' OXT' ' B' ' 7' ' ' VAL . 2.2 tt -179.15 119.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.094 -1.239 . . . . 0.0 110.56 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.83 ' HB2' HD12 ' B' ' 6' ' ' LEU . 0.3 OUTLIER -105.71 91.48 3.77 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.24 -0.913 . . . . 0.0 109.177 178.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.059 HD11 HG22 ' A' ' 68' ' ' VAL . 25.2 pt -69.16 155.35 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 111.131 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' CG ' ' HG3' ' B' ' 4' ' ' GLU . 0.7 OUTLIER -136.11 175.2 9.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.089 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.61 -154.97 19.36 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 157.57 134.53 1.76 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.496 ' HB3' HG22 ' A' ' 63' ' ' THR . 7.2 ttp85 -60.07 -15.47 23.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.4 -1.059 . . . . 0.0 110.762 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.61 -15.15 61.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.856 -1.152 . . . . 0.0 109.813 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.93 22.15 11.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.16 -0.962 . . . . 0.0 109.663 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.67 58.16 5.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.888 . . . . 0.0 109.842 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.435 ' HE3' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -138.7 132.59 16.35 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.935 -179.454 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.546 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 46.3 Cg_endo -68.83 132.31 24.57 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 N-CA-C 108.332 -1.449 . . . . 0.0 108.332 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.603 HG13 ' HB2' ' A' ' 67' ' ' ALA . 17.4 mm -48.77 97.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.055 -1.028 . . . . 0.0 109.591 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.621 HD13 ' HB2' ' A' ' 50' ' ' ALA . 39.9 tp -101.24 128.73 47.23 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.438 -0.789 . . . . 0.0 112.149 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.887 HD12 ' HB2' ' A' ' 49' ' ' ASP . 64.0 mt -63.91 139.23 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.601 -0.687 . . . . 0.0 110.18 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.2 t -121.83 -25.3 5.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 110.641 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -137.25 108.83 6.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.088 -1.007 . . . . 0.0 110.501 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.623 HD11 HG21 ' A' ' 30' ' ' ILE . 10.5 mm -94.64 105.55 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.13 -0.981 . . . . 0.0 108.853 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.814 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 4.2 m-85 -56.75 134.41 54.9 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.274 0.559 . . . . 0.0 110.495 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.574 ' O ' HD23 ' A' ' 37' ' ' LEU . 2.2 mptt -80.76 158.64 25.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.184 -0.947 . . . . 0.0 110.36 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.49 19.29 47.31 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 35' ' ' LYS . 2.4 mm? -109.91 167.48 10.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.18 -1.188 . . . . 0.0 109.698 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . . . -56.53 -65.84 0.54 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.013 -1.054 . . . . 0.0 110.96 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.534 ' O ' HG22 ' A' ' 42' ' ' THR . . . -47.58 -37.7 12.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.309 -0.869 . . . . 0.0 111.284 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 9.3 t70 -86.62 -6.78 58.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.038 -1.039 . . . . 0.0 111.047 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -97.85 -1.86 42.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.825 -1.172 . . . . 0.0 110.911 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 39' ' ' ALA . 9.6 t -97.81 13.61 29.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.839 -1.163 . . . . 0.0 110.708 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 45.52 59.18 3.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.316 -0.865 . . . . 0.0 111.141 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.634 ' HB3' HG13 ' A' ' 4' ' ' VAL . . . -174.1 -49.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.153 -0.967 . . . . 0.0 110.128 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.628 HD12 ' CG2' ' A' ' 6' ' ' VAL . 1.7 mt -70.95 84.02 0.68 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.933 -1.104 . . . . 0.0 108.303 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.597 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -111.0 153.13 25.99 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.879 -0.513 . . . . 0.0 110.083 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.464 ' N ' HG13 ' A' ' 33' ' ' ILE . 91.7 t -50.26 152.26 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.833 -1.167 . . . . 0.0 109.767 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.79 26.06 39.46 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.544 -1.823 . . . . 0.0 108.544 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.887 ' HB2' HD12 ' A' ' 30' ' ' ILE . 67.6 m-20 -111.53 100.08 8.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.396 -1.061 . . . . 0.0 110.627 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.67 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -77.9 110.38 12.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.095 -1.003 . . . . 0.0 110.67 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.859 ' C ' HD22 ' A' ' 52' ' ' LEU . 61.6 mt -79.29 134.64 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 110.232 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.859 HD22 ' C ' ' A' ' 51' ' ' ILE . 3.9 mm? -125.64 10.95 7.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.258 -0.902 . . . . 0.0 110.439 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 175.99 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.031 -1.043 . . . . 0.0 109.765 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.943 HG21 ' CB ' ' A' ' 70' ' ' ALA . 27.5 m -76.24 126.46 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.365 -0.834 . . . . 0.0 110.847 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.0 p30 37.19 40.45 0.18 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.57 -7.18 63.37 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.565 -1.302 . . . . 0.0 111.142 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.532 ' O ' HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -89.81 91.9 8.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.671 -1.488 . . . . 0.0 109.848 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -44.33 112.16 0.38 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.381 0.61 . . . . 0.0 110.888 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.986 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -101.8 -5.97 24.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.323 -0.86 . . . . 0.0 110.962 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.45 ' OG ' HD12 ' A' ' 52' ' ' LEU . 34.5 m -55.36 -32.65 62.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.875 -1.141 . . . . 0.0 110.287 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.3 m -113.13 35.64 3.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.092 -1.005 . . . . 0.0 110.345 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.986 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -121.5 152.8 38.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.178 -0.951 . . . . 0.0 110.193 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.496 HG22 ' HB3' ' A' ' 22' ' ' ARG . 18.0 p -81.79 165.13 21.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.857 . . . . 0.0 109.87 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 68' ' ' VAL . 9.5 t-80 -52.55 -26.15 12.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.014 -1.054 . . . . 0.0 109.903 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.63 -45.73 51.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.052 -1.03 . . . . 0.0 108.923 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.554 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 13.0 mt-10 -61.26 -23.01 65.35 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.597 -0.689 . . . . 0.0 109.4 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.603 ' HB2' HG13 ' A' ' 28' ' ' ILE . . . -80.42 -47.22 14.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.788 . . . . 0.0 110.319 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.059 HG22 HD11 ' A' ' 18' ' ' ILE . 2.6 t -66.3 -33.07 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.481 -0.888 . . . . 0.0 108.773 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -56.25 -41.23 75.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.415 -0.803 . . . . 0.0 109.131 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.943 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.91 -26.35 63.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.439 -0.788 . . . . 0.0 109.35 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.767 ' C ' HG11 ' B' ' 7' ' ' VAL . 3.5 mm? -80.6 -34.57 35.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.628 -0.67 . . . . 0.0 110.082 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -75.93 -33.87 59.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.064 -1.023 . . . . 0.0 110.125 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -112.07 36.27 3.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.631 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.84 HG22 HG22 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -71.42 137.65 48.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.391 -0.818 . . . . 0.0 110.077 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.18 -177.95 34.44 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 78' ' ' VAL . 22.5 tttp -55.45 -76.61 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -1.158 . . . . 0.0 110.022 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -63.91 101.56 0.39 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.095 -1.003 . . . . 0.0 109.466 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.84 HG22 HG22 ' A' ' 74' ' ' THR . 94.5 t -96.61 82.78 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 111.32 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.558 ' O ' HD23 ' A' ' 80' ' ' LEU . 35.0 t -80.26 113.73 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.798 HD21 ' CG1' ' A' ' 78' ' ' VAL . 13.0 mt -117.42 125.03 50.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.956 -1.09 . . . . 0.0 111.917 -177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -77.78 125.39 29.28 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.665 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.516 HG13 ' CG ' ' A' ' 2' ' ' ARG . 1.8 p -126.03 147.94 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.993 -1.067 . . . . 0.0 111.749 -177.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.67 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -108.2 85.79 2.18 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.417 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.597 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -55.62 118.58 4.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.433 -0.792 . . . . 0.0 110.957 -177.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.9 mmm -96.76 49.58 1.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.184 -0.948 . . . . 0.0 109.401 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.8 tptt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.236 -179.669 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.617 ' HB3' ' CD2' ' A' ' 64' ' ' HIS . 32.2 tttt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.282 0.563 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 3.4 tt0 -153.87 138.31 16.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 110.032 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.511 ' OG ' HG11 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -126.59 -163.37 1.23 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.192 -0.942 . . . . 0.0 110.419 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.83 HD12 ' HB2' ' A' ' 17' ' ' SER . 1.4 tp -159.16 56.57 0.41 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.321 -0.862 . . . . 0.0 110.187 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.767 HG11 ' C ' ' A' ' 71' ' ' LEU . 53.4 t . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.048 -1.032 . . . . 0.0 110.255 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.408 ' O ' ' CG ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.317 0.58 . . . . 0.0 110.257 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.839 ' CB ' HG13 ' A' ' 82' ' ' VAL . 3.9 mtp85 -161.94 170.54 19.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 110.408 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' A' ' 3' ' ' ARG . 0.5 OUTLIER -138.88 116.7 11.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.408 -0.808 . . . . 0.0 109.206 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.79 HG22 ' HB1' ' A' ' 44' ' ' ALA . 65.7 t -121.24 136.85 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.992 -1.067 . . . . 0.0 110.841 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.8 m -125.08 126.26 45.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.371 -0.83 . . . . 0.0 109.881 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.83 HG21 HD12 ' A' ' 45' ' ' LEU . 89.3 t -121.79 115.35 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.138 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -87.7 114.87 24.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.127 -0.983 . . . . 0.0 109.871 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -115.51 79.37 1.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 110.662 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.34 -58.32 7.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.903 . . . . 0.0 110.078 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.09 -23.28 65.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 110.252 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.28 46.61 26.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.24 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.85 75.2 0.22 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.18 138.79 0.35 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.76 HD23 ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -102.03 -14.61 17.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -1.116 . . . . 0.0 110.534 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.924 ' CA ' HD22 ' A' ' 37' ' ' LEU . . . 60.61 82.49 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 16' ' ' ILE . 1.1 tt -173.11 120.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.427 -1.043 . . . . 0.0 110.341 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.481 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -112.08 119.38 38.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 109.543 179.152 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.092 HD11 HG22 ' A' ' 68' ' ' VAL . 21.2 pt -100.72 151.66 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.236 -0.915 . . . . 0.0 111.266 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 9.9 pttt -131.04 160.74 33.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 109.643 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.59 -163.78 12.13 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.439 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 160.51 141.0 3.02 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.576 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.0 OUTLIER -60.15 -15.59 25.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -1.091 . . . . 0.0 110.695 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -71.93 -16.86 62.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.886 -1.134 . . . . 0.0 109.796 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -125.66 24.18 7.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.246 -0.908 . . . . 0.0 109.706 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.19 92.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.336 -0.852 . . . . 0.0 110.259 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.512 ' HE2' ' N ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -170.92 128.25 0.71 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.904 . . . . 0.0 110.208 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.71 ' CB ' HD11 ' A' ' 52' ' ' LEU . 55.9 Cg_endo -72.82 46.51 1.07 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 O-C-N 123.448 1.236 . . . . 0.0 112.19 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.637 HD12 ' HA ' ' A' ' 64' ' ' HIS . 12.9 mm 44.33 90.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 120.797 -1.189 . . . . 0.0 110.756 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.828 HD21 ' HG3' ' A' ' 85' ' ' MET . 5.4 mt -97.28 132.84 42.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.799 -1.188 . . . . 0.0 111.613 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.713 HD12 ' HB2' ' A' ' 49' ' ' ASP . 54.8 mt -67.63 136.99 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.868 . . . . 0.0 108.854 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.1 -16.27 8.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.955 -1.091 . . . . 0.0 110.997 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.95 100.47 3.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.995 -1.065 . . . . 0.0 110.682 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.676 HD11 HG21 ' A' ' 30' ' ' ILE . 16.7 mm -86.83 94.12 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.417 -0.802 . . . . 0.0 108.894 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.644 ' HB3' HD13 ' A' ' 37' ' ' LEU . 4.3 m-30 -52.69 137.04 32.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.475 -0.765 . . . . 0.0 110.0 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.826 ' O ' HD12 ' A' ' 37' ' ' LEU . 12.8 tttt -83.75 171.55 13.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.896 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.49 32.4 73.02 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.924 HD22 ' CA ' ' A' ' 15' ' ' GLY . 0.4 OUTLIER -140.44 162.94 34.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.132 -1.216 . . . . 0.0 111.088 -179.431 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.7 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -50.04 -56.59 10.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.523 -0.735 . . . . 0.0 111.461 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.76 ' HB2' HD23 ' A' ' 14' ' ' LEU . . . -55.67 -35.51 66.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.245 -0.909 . . . . 0.0 112.092 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.532 ' HB2' HG22 ' A' ' 33' ' ' ILE . 22.0 t70 -95.74 -3.11 46.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.916 -1.115 . . . . 0.0 111.474 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.484 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 1.4 pp0? -110.34 16.98 21.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.728 -1.233 . . . . 0.0 110.354 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.523 HG21 HG22 ' A' ' 6' ' ' VAL . 7.4 t -108.47 14.72 24.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.945 . . . . 0.0 110.777 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 45.5 54.38 7.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.197 -0.94 . . . . 0.0 111.343 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.79 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -175.72 -50.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.127 -0.983 . . . . 0.0 110.445 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.83 HD12 HG21 ' A' ' 6' ' ' VAL . 1.4 mt -70.51 84.56 0.6 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.871 -1.143 . . . . 0.0 108.92 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.592 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -112.88 152.28 29.46 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.56 -179.399 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 48' ' ' GLY . 60.3 t -47.74 168.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.028 -1.045 . . . . 0.0 110.607 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.519 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 66.8 37.22 92.15 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.713 ' HB2' HD12 ' A' ' 30' ' ' ILE . 27.8 m-20 -120.89 107.61 12.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.256 -1.143 . . . . 0.0 110.483 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.795 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -84.57 105.12 15.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.835 . . . . 0.0 110.147 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.766 ' O ' HD12 ' A' ' 52' ' ' LEU . 65.0 mt -71.03 135.95 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.363 -0.835 . . . . 0.0 110.854 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 51' ' ' ILE . 6.5 mp -125.63 6.97 7.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.391 -0.818 . . . . 0.0 110.96 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 176.1 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.97 -1.082 . . . . 0.0 109.978 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.913 HG21 ' CB ' ' A' ' 70' ' ' ALA . 17.5 m -96.53 119.22 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.134 -0.979 . . . . 0.0 110.865 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 45.8 m-80 57.06 33.52 23.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.53 -0.731 . . . . 0.0 111.573 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.82 12.05 61.07 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.944 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.474 ' O ' HD23 ' A' ' 59' ' ' LEU . 10.1 mt-10 -105.46 90.5 3.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.7 -1.47 . . . . 0.0 109.741 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.33 102.01 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.479 0.656 . . . . 0.0 110.977 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.867 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -94.8 -14.04 25.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.429 -0.794 . . . . 0.0 110.703 -179.384 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.5 p -50.01 -32.62 15.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.004 -1.06 . . . . 0.0 110.437 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 t -107.75 31.41 5.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 109.987 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.867 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -122.43 163.66 19.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.378 -0.826 . . . . 0.0 110.346 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.576 HG22 ' HB3' ' A' ' 22' ' ' ARG . 12.7 p -85.12 165.07 17.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.399 -0.813 . . . . 0.0 110.375 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.871 ' O ' HG23 ' A' ' 68' ' ' VAL . 3.4 t60 -53.72 -26.17 21.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 109.831 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -73.75 -36.58 65.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.081 -1.012 . . . . 0.0 109.335 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.626 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 1.3 mm-40 -68.86 -22.96 64.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.588 -0.695 . . . . 0.0 109.724 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.417 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -82.83 -41.05 19.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.299 -0.876 . . . . 0.0 110.545 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.092 HG22 HD11 ' A' ' 18' ' ' ILE . 2.9 t -72.85 -32.86 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.152 -0.968 . . . . 0.0 109.372 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -59.65 -38.1 80.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.371 -0.831 . . . . 0.0 109.952 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.913 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.45 -53.1 17.73 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.152 -0.967 . . . . 0.0 108.81 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.563 ' HB3' HG11 ' B' ' 7' ' ' VAL . 96.4 mt -56.78 -22.43 35.89 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.709 -0.619 . . . . 0.0 109.485 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -79.52 -40.42 29.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.859 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 1.5 ttmt -119.11 59.54 0.83 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.405 -0.809 . . . . 0.0 109.869 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.651 ' HB ' HG22 ' A' ' 78' ' ' VAL . 66.4 p -78.06 -175.04 3.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.324 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.06 -171.46 20.13 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -48.57 -48.37 38.92 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.101 -1.235 . . . . 0.0 110.455 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 12.4 pt-20 -108.73 119.88 40.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.328 -0.857 . . . . 0.0 109.863 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.706 ' CG1' HD21 ' A' ' 80' ' ' LEU . 85.6 t -89.42 82.02 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.176 -0.952 . . . . 0.0 110.721 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.459 ' C ' HD23 ' A' ' 80' ' ' LEU . 2.8 t -77.27 107.11 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.706 HD21 ' CG1' ' A' ' 78' ' ' VAL . 14.1 mt -113.34 115.77 28.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.805 -1.184 . . . . 0.0 111.576 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.416 ' HB3' ' OG ' ' A' ' 53' ' ' SER . 5.9 tp10 -67.79 124.59 23.75 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.839 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.4 p -121.74 141.53 41.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.003 -1.06 . . . . 0.0 112.199 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.795 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 40.4 tttm -107.41 81.3 1.51 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.592 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -50.52 122.19 6.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.576 -0.703 . . . . 0.0 111.191 -178.002 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.828 ' HG3' HD21 ' A' ' 29' ' ' LEU . 6.3 mmt -96.39 49.0 1.1 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.281 -0.887 . . . . 0.0 109.023 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.874 -1.06 . . . . 0.0 110.295 -179.512 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.554 ' CD ' ' CD2' ' A' ' 64' ' ' HIS . 1.6 mttm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.32 0.581 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER 54.19 41.45 32.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 109.679 -179.51 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.405 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . 1.3 m -57.28 -169.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.359 -0.838 . . . . 0.0 110.783 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.558 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 39.2 tp -156.71 117.58 3.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.387 -0.821 . . . . 0.0 110.086 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.563 HG11 ' HB3' ' A' ' 71' ' ' LEU . 66.2 t . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.157 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.44 0.638 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.522 ' CG ' HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -161.91 146.61 12.83 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.461 -0.774 . . . . 0.0 109.586 -179.306 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.416 ' N ' ' HG3' ' A' ' 2' ' ' ARG . 1.6 mpp_? -120.59 126.57 50.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 109.927 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.739 HG23 HG11 ' A' ' 82' ' ' VAL . 54.5 t -121.51 153.87 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 110.549 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 84.8 m -139.16 109.69 6.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.514 -0.741 . . . . 0.0 109.513 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.811 HG22 HG21 ' A' ' 42' ' ' THR . 56.6 t -100.53 125.19 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 0.0 109.813 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.9 mtt-85 -99.11 96.91 8.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.933 . . . . 0.0 110.29 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 1.2 mttt -52.33 101.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.343 -0.848 . . . . 0.0 110.117 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.18 119.35 23.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.326 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.54 21.61 2.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.28 -0.888 . . . . 0.0 110.514 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.15 84.31 1.82 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 110.245 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.02 -41.65 53.04 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.89 154.92 42.06 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.555 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -105.62 -15.95 14.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.291 -1.123 . . . . 0.0 110.464 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.948 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 56.9 86.72 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.665 HD12 ' CD2' ' A' ' 45' ' ' LEU . 6.2 tt -174.34 115.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.107 -1.231 . . . . 0.0 110.534 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.22 98.18 7.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.937 . . . . 0.0 109.728 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.066 HD11 HG22 ' A' ' 68' ' ' VAL . 44.7 pt -74.55 146.93 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 110.615 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -132.97 116.14 16.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.462 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.11 -160.38 30.78 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 163.17 134.47 1.65 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -60.72 -14.85 23.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.465 -1.021 . . . . 0.0 110.807 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.29 5.53 22.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.984 -1.073 . . . . 0.0 110.138 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -140.94 25.65 2.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.093 -1.004 . . . . 0.0 109.463 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 54.75 83.23 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.333 -0.855 . . . . 0.0 109.62 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.598 ' HE1' ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -169.11 126.92 0.85 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.254 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.893 ' CB ' HD21 ' A' ' 52' ' ' LEU . 56.0 Cg_endo -76.76 45.66 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.459 1.241 . . . . 0.0 111.972 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 19.9 mm 45.07 89.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 O-C-N 120.869 -1.144 . . . . 0.0 110.218 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.604 HD13 ' HB2' ' A' ' 50' ' ' ALA . 36.6 tp -103.7 127.58 51.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.853 -1.155 . . . . 0.0 111.751 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.827 HD12 ' HB2' ' A' ' 49' ' ' ASP . 61.8 mt -62.05 136.2 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.464 -0.772 . . . . 0.0 109.734 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 t -120.5 -18.59 7.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.218 -0.926 . . . . 0.0 110.734 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.5 104.77 4.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.972 -1.08 . . . . 0.0 110.517 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.712 HD11 HG21 ' A' ' 30' ' ' ILE . 10.8 mm -92.56 99.51 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.146 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.648 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 94.7 m-85 -59.64 136.34 57.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.488 -0.758 . . . . 0.0 110.271 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.836 ' O ' HD12 ' A' ' 37' ' ' LEU . 21.4 mtmt -80.37 174.49 11.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 110.649 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.77 28.33 62.91 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.948 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -136.54 160.45 38.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.106 -1.232 . . . . 0.0 110.726 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.743 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -48.43 -57.71 5.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 111.502 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.943 ' HB1' HD23 ' A' ' 45' ' ' LEU . . . -52.04 -45.79 64.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 111.808 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.458 ' HB2' HG22 ' A' ' 33' ' ' ILE . 7.3 t70 -85.01 -17.29 38.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.913 -1.117 . . . . 0.0 111.623 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.493 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 1.5 pp0? -99.42 13.2 34.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.797 -1.189 . . . . 0.0 110.851 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.811 HG21 HG22 ' A' ' 6' ' ' VAL . 10.0 t -107.84 14.83 25.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.997 -1.064 . . . . 0.0 110.775 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 45.39 49.71 10.32 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.252 -0.905 . . . . 0.0 111.079 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.71 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -167.43 -55.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.585 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.943 HD23 ' HB1' ' A' ' 39' ' ' ALA . 2.4 tp -69.43 84.03 0.4 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.853 -1.154 . . . . 0.0 108.683 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.602 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.58 152.55 28.76 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.86 -0.525 . . . . 0.0 109.665 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.44 ' N ' HG13 ' A' ' 33' ' ' ILE . 65.7 t -49.26 153.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.919 -1.113 . . . . 0.0 110.035 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.427 ' C ' HD11 ' A' ' 29' ' ' LEU . . . 83.76 24.08 50.84 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.827 ' HB2' HD12 ' A' ' 30' ' ' ILE . 69.4 m-20 -109.69 100.38 9.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.398 -1.06 . . . . 0.0 110.675 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.891 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -78.28 102.23 7.55 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.152 -0.968 . . . . 0.0 110.022 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 81' ' ' GLU . 69.4 mt -71.03 138.03 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.428 -0.795 . . . . 0.0 110.702 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.893 HD21 ' CB ' ' A' ' 27' ' ' PRO . 83.0 mt -136.32 9.83 3.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.287 -0.883 . . . . 0.0 111.269 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 179.09 92.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.922 -1.111 . . . . 0.0 109.832 179.465 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.999 HG21 ' CB ' ' A' ' 70' ' ' ALA . 33.1 m -91.51 121.04 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.287 -0.883 . . . . 0.0 110.156 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 55.69 36.42 27.19 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.495 -0.753 . . . . 0.0 110.838 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.99 -7.35 78.08 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.743 -1.218 . . . . 0.0 110.388 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -78.63 93.81 4.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.741 -1.447 . . . . 0.0 109.513 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.71 102.87 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.525 0.678 . . . . 0.0 111.021 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.878 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.5 OUTLIER -91.0 -4.89 56.07 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.5 -0.75 . . . . 0.0 110.556 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 t -58.54 -43.16 89.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 110.242 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.2 m -102.27 35.25 2.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 110.343 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.878 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -119.29 145.39 46.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 110.274 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.2 p -78.23 168.6 19.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.911 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.881 ' O ' HG23 ' A' ' 68' ' ' VAL . 7.7 t60 -54.51 -24.04 18.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.01 -1.056 . . . . 0.0 109.871 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.25 -43.39 42.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.12 -0.987 . . . . 0.0 109.12 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.622 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 32.9 mm-40 -65.61 -21.49 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.586 -0.696 . . . . 0.0 109.648 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.726 ' HA ' HD11 ' A' ' 59' ' ' LEU . . . -83.54 -47.5 11.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 110.583 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.066 HG22 HD11 ' A' ' 18' ' ' ILE . 7.8 t -62.8 -27.14 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.126 -0.983 . . . . 0.0 108.797 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -39.4 81.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.425 -0.797 . . . . 0.0 109.202 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.999 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -62.8 -44.35 96.39 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.355 -0.84 . . . . 0.0 108.849 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.702 ' C ' HG11 ' B' ' 7' ' ' VAL . 3.8 mm? -69.7 -23.39 63.42 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -84.27 -42.04 16.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.977 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -100.79 24.33 9.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.0 109.89 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -64.38 154.23 36.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.916 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.54 -172.01 20.6 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 8' ' ' LYS . 19.2 mttt -48.95 -62.32 1.59 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.061 -1.258 . . . . 0.0 110.389 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -83.62 115.92 22.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.083 -1.011 . . . . 0.0 108.639 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.886 ' CG1' HD21 ' A' ' 80' ' ' LEU . 71.5 t -109.39 89.85 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.072 -1.018 . . . . 0.0 111.154 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.895 ' O ' HD23 ' A' ' 80' ' ' LEU . 48.7 t -76.96 123.46 33.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.895 HD23 ' O ' ' A' ' 79' ' ' VAL . 15.5 mt -128.09 109.33 11.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.822 -1.174 . . . . 0.0 111.64 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 13.6 tp10 -66.29 129.63 40.47 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.739 HG11 HG23 ' A' ' 4' ' ' VAL . 2.4 p -132.68 146.7 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.873 -1.142 . . . . 0.0 112.119 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.891 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 13.5 tttt -107.7 85.09 2.06 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.602 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -55.51 123.53 14.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.741 . . . . 0.0 110.99 -177.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.1 mmt -99.47 51.63 0.94 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.375 -0.828 . . . . 0.0 109.866 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.268 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 64' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.185 0.517 . . . . 0.0 110.355 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 36.2 tt0 54.6 68.89 0.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.883 . . . . 0.0 110.361 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 39.8 t -66.21 -153.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.097 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.648 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -175.81 66.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.115 -0.991 . . . . 0.0 110.328 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.702 HG11 ' C ' ' A' ' 71' ' ' LEU . 46.6 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.236 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.312 0.577 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.854 ' CB ' HG13 ' A' ' 82' ' ' VAL . 1.6 mtp85 -157.15 165.42 36.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.319 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -140.97 112.53 7.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.409 -0.807 . . . . 0.0 109.229 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.629 HG13 ' HB3' ' A' ' 44' ' ' ALA . 37.5 t -124.56 152.85 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.039 -1.038 . . . . 0.0 110.529 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.3 m -139.99 143.57 36.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.365 -0.835 . . . . 0.0 110.124 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.461 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 98.5 t -130.75 109.7 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.919 . . . . 0.0 109.849 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.421 ' HD3' ' N ' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -72.19 113.52 9.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 110.159 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.98 62.04 0.44 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.351 -0.843 . . . . 0.0 110.408 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.5 -60.22 4.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 109.987 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -160.94 113.38 1.92 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.344 -0.848 . . . . 0.0 110.194 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -176.45 126.7 0.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -0.881 . . . . 0.0 110.015 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.92 58.86 3.89 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.29 146.61 4.53 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.842 HD22 HG21 ' A' ' 16' ' ' ILE . 1.4 tt -88.07 -23.98 23.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.255 -1.144 . . . . 0.0 110.215 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.49 ' HA3' ' HG ' ' A' ' 37' ' ' LEU . . . 70.94 79.93 0.35 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.842 HG21 HD22 ' A' ' 14' ' ' LEU . 2.7 tt -176.58 117.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.314 -1.109 . . . . 0.0 109.876 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.416 ' HB3' ' HB3' ' A' ' 32' ' ' LYS . 4.1 t -108.69 114.56 28.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.29 -0.881 . . . . 0.0 110.263 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.01 HD11 HG22 ' A' ' 68' ' ' VAL . 27.2 pt -88.06 153.84 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 110.637 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' B' ' 3' ' ' LYS . 16.4 ttpp -142.83 118.47 10.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.272 -0.893 . . . . 0.0 110.054 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.55 -161.07 32.87 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.448 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 169.12 131.95 1.38 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.607 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.0 OUTLIER -60.31 -15.34 24.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -1.191 . . . . 0.0 110.71 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.95 -14.02 58.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.94 -1.1 . . . . 0.0 109.977 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.87 24.0 11.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.809 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.1 tttt 54.67 78.81 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.995 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.611 ' HE1' ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -161.95 120.77 1.42 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 110.409 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.733 ' HB2' HD11 ' A' ' 52' ' ' LEU . 50.6 Cg_endo -71.35 52.45 1.55 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 O-C-N 123.514 1.271 . . . . 0.0 111.966 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 64' ' ' HIS . 6.9 mm 42.57 89.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.09 -1.006 . . . . 0.0 110.574 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.611 ' N ' ' HE1' ' A' ' 26' ' ' MET . 6.0 mt -98.66 132.69 43.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.768 -1.208 . . . . 0.0 111.975 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.593 HD12 ' HB2' ' A' ' 49' ' ' ASP . 49.1 mt -66.52 133.53 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.306 -0.872 . . . . 0.0 108.815 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 t -116.79 -16.53 10.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.066 -1.021 . . . . 0.0 110.888 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -146.02 106.63 4.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.998 -1.064 . . . . 0.0 111.143 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.568 HD11 HG21 ' A' ' 30' ' ' ILE . 12.2 mm -93.32 115.16 31.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.261 -0.899 . . . . 0.0 108.601 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.861 ' CE1' HD13 ' B' ' 6' ' ' LEU . 10.0 m-85 -66.82 134.39 52.02 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.405 -0.809 . . . . 0.0 109.988 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.557 ' O ' HD23 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -79.81 151.88 30.05 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.259 -0.9 . . . . 0.0 110.821 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.16 16.5 60.13 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.557 HD23 ' O ' ' A' ' 35' ' ' LYS . 3.2 mm? -105.4 165.3 11.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -1.164 . . . . 0.0 110.298 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.461 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -48.42 -63.73 1.0 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.22 -0.925 . . . . 0.0 111.036 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.886 ' O ' HG22 ' A' ' 42' ' ' THR . . . -50.45 -53.0 32.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 110.721 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 24.1 t70 -73.09 -4.93 35.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.026 -1.046 . . . . 0.0 111.152 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -97.01 3.54 51.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.773 -1.205 . . . . 0.0 110.899 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 39' ' ' ALA . 7.2 t -107.68 15.17 24.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.805 -1.184 . . . . 0.0 110.781 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 47.31 56.95 6.27 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.12 -0.988 . . . . 0.0 110.954 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.629 ' HB3' HG13 ' A' ' 4' ' ' VAL . . . -173.74 -44.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 110.245 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.544 ' CD1' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -69.09 81.94 0.33 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.975 -1.078 . . . . 0.0 108.687 179.208 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.587 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.21 149.32 32.44 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.601 -0.687 . . . . 0.0 110.231 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 48' ' ' GLY . 84.5 t -49.89 169.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.124 -0.985 . . . . 0.0 110.404 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.534 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 68.61 32.96 75.35 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.597 ' C ' HD23 ' A' ' 29' ' ' LEU . 27.6 m-20 -117.95 108.57 15.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.559 -0.965 . . . . 0.0 110.423 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.648 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -85.8 104.69 15.71 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.465 HG21 ' CG1' ' A' ' 54' ' ' VAL . 30.7 mt -70.36 134.05 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.356 -0.84 . . . . 0.0 110.136 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 27' ' ' PRO . 2.4 mp -132.25 17.69 4.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 110.368 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 174.58 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.214 -0.929 . . . . 0.0 109.967 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.952 HG21 ' CB ' ' A' ' 70' ' ' ALA . 21.2 m -91.08 127.0 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.107 -0.996 . . . . 0.0 109.846 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 57.72 38.64 27.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 0.0 110.013 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.83 29.87 70.74 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 53' ' ' SER . 7.4 tt0 -115.81 91.8 3.71 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -1.108 . . . . 0.0 109.579 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -37.91 102.04 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.691 0.758 . . . . 0.0 112.071 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.99 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -91.48 -13.63 31.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.648 -0.658 . . . . 0.0 110.483 179.827 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.699 ' OG ' HD23 ' A' ' 52' ' ' LEU . 44.1 m -53.52 -37.14 62.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.014 -1.054 . . . . 0.0 110.182 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.9 m -96.86 25.88 4.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 110.035 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.99 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -120.18 157.54 28.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 110.233 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.607 HG22 ' HB3' ' A' ' 22' ' ' ARG . 32.0 p -88.95 164.96 14.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 110.081 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.926 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.6 t-80 -52.0 -25.76 9.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.953 . . . . 0.0 109.578 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -73.13 -40.19 65.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.096 -1.003 . . . . 0.0 109.082 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.495 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 1.1 mt-10 -71.06 -25.57 62.69 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.441 -0.787 . . . . 0.0 109.452 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.618 ' O ' HD23 ' A' ' 71' ' ' LEU . . . -76.35 -42.2 45.62 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.445 -0.784 . . . . 0.0 110.0 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.01 HG22 HD11 ' A' ' 18' ' ' ILE . 6.3 t -70.47 -30.63 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.189 -0.944 . . . . 0.0 109.08 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -58.87 -40.27 83.87 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.375 -0.828 . . . . 0.0 109.16 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.952 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -68.68 -46.75 68.23 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.355 -0.841 . . . . 0.0 108.814 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.702 ' C ' HG11 ' B' ' 7' ' ' VAL . 3.0 mm? -56.75 -30.13 63.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.681 -0.637 . . . . 0.0 109.63 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.3 -41.52 22.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.1 -1.0 . . . . 0.0 109.983 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -106.58 55.17 0.67 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.667 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.783 ' HB ' HG22 ' A' ' 78' ' ' VAL . 33.2 p -79.11 149.14 32.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.323 -0.861 . . . . 0.0 109.657 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.04 -177.63 45.88 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -50.94 47.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.253 -1.145 . . . . 0.0 110.122 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -98.35 94.18 6.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -0.87 . . . . 0.0 109.423 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.783 HG22 ' HB ' ' A' ' 74' ' ' THR . 92.8 t -63.72 78.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 111.085 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.948 ' O ' HD23 ' A' ' 80' ' ' LEU . 12.8 t -75.81 123.7 32.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.948 HD23 ' O ' ' A' ' 79' ' ' VAL . 13.0 mt -128.98 117.62 21.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.747 -1.22 . . . . 0.0 111.465 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 20.2 tt0 -73.78 125.21 27.61 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.854 HG13 ' CB ' ' A' ' 2' ' ' ARG . 3.0 p -125.72 145.48 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.052 -1.03 . . . . 0.0 112.206 -177.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.547 ' HB2' HD13 ' A' ' 52' ' ' LEU . 1.0 OUTLIER -112.53 86.41 2.36 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.66 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.587 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -52.91 129.46 30.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.572 -0.705 . . . . 0.0 110.959 -178.121 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.4 mmt -101.29 46.66 0.93 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.292 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.284 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.606 ' HG3' ' CD2' ' A' ' 64' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.29 0.566 . . . . 0.0 110.59 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.8 mt-10 -109.37 -158.89 0.66 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.455 -0.778 . . . . 0.0 109.048 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.595 ' OG ' HG11 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -175.85 -48.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.83 -1.169 . . . . 0.0 110.806 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.861 HD13 ' CE1' ' A' ' 34' ' ' PHE . 13.0 tp 54.6 92.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 109.936 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.702 HG11 ' C ' ' A' ' 71' ' ' LEU . 61.2 t . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.028 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.271 0.558 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.811 ' O ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -122.52 147.35 46.47 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.272 -0.892 . . . . 0.0 109.032 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -105.24 106.49 17.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.054 -1.029 . . . . 0.0 110.058 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.767 HG13 ' HB3' ' A' ' 44' ' ' ALA . 61.1 t -107.48 128.86 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.948 . . . . 0.0 110.266 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.0 m -115.28 111.23 20.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 110.125 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.621 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 99.0 t -97.09 118.54 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.846 . . . . 0.0 109.823 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.13 110.23 19.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.232 -0.917 . . . . 0.0 110.288 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HE3' HD12 ' A' ' 14' ' ' LEU . 2.4 mmmp? -85.11 90.14 7.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.347 -0.846 . . . . 0.0 110.18 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.11 -74.2 0.43 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.929 . . . . 0.0 110.333 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.7 -19.03 65.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.035 -1.041 . . . . 0.0 110.641 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 52.41 54.62 10.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.051 -1.031 . . . . 0.0 110.239 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -117.38 50.57 0.79 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.36 139.01 10.54 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -96.21 -21.1 18.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -1.183 . . . . 0.0 110.132 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.882 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 58.27 87.46 0.02 OUTLIER Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 45' ' ' LEU . 4.6 tt -176.51 117.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.184 -1.186 . . . . 0.0 110.404 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 32' ' ' LYS . 35.2 t -106.94 117.82 35.06 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.295 -0.878 . . . . 0.0 109.619 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.961 HD11 ' CG2' ' A' ' 68' ' ' VAL . 43.7 pt -94.85 150.26 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 110.817 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' B' ' 3' ' ' LYS . 17.1 tttt -138.49 120.26 15.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 110.183 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.18 -153.43 24.61 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 157.19 134.13 1.71 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -60.69 -14.77 22.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.374 -1.074 . . . . 0.0 110.547 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' OE2' ' ND2' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -80.32 1.88 26.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.949 -1.094 . . . . 0.0 110.469 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.414 ' ND2' ' OE2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -138.07 26.17 2.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.973 -1.08 . . . . 0.0 109.795 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 54.47 66.99 1.08 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 110.113 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.474 ' HE3' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -149.86 115.89 3.52 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.436 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.937 ' HB3' HD21 ' A' ' 52' ' ' LEU . 49.2 Cg_endo -68.2 55.38 0.76 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.321 1.347 . . . . 0.0 111.793 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 64' ' ' HIS . 16.0 mm 41.66 88.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 121.286 -0.884 . . . . 0.0 110.446 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' A' ' 50' ' ' ALA . 34.3 tp -101.88 126.66 48.83 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.831 -1.168 . . . . 0.0 112.121 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.788 HD12 ' HB2' ' A' ' 49' ' ' ASP . 55.6 mt -64.41 140.88 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.686 -0.634 . . . . 0.0 109.953 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.6 t -128.68 4.14 5.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 110.718 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 1.9 ttmt -165.03 99.89 0.75 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.818 -1.176 . . . . 0.0 110.263 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 30' ' ' ILE . 14.4 mm -89.64 111.88 23.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.32 -0.862 . . . . 0.0 109.318 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.663 ' HB3' HD13 ' A' ' 37' ' ' LEU . 16.2 m-85 -74.3 126.83 31.51 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.47 -0.769 . . . . 0.0 109.984 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.863 ' O ' HD12 ' A' ' 37' ' ' LEU . 20.3 mtmt -75.62 170.54 15.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.312 -0.867 . . . . 0.0 110.548 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.52 26.19 71.77 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.882 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -138.99 159.55 41.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -1.19 . . . . 0.0 110.918 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.621 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -42.72 -66.36 0.37 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.648 -0.658 . . . . 0.0 112.128 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.886 ' O ' HG22 ' A' ' 42' ' ' THR . . . -45.83 -59.3 2.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.316 -0.865 . . . . 0.0 111.354 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -71.97 -4.19 27.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.904 -1.123 . . . . 0.0 111.114 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -107.78 11.82 27.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.555 -1.341 . . . . 0.0 110.726 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 39' ' ' ALA . 8.9 t -108.42 15.73 23.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.956 -1.09 . . . . 0.0 110.708 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 47.86 51.08 14.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.07 -1.019 . . . . 0.0 110.846 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.767 ' HB3' HG13 ' A' ' 4' ' ' VAL . . . -172.73 -45.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -0.918 . . . . 0.0 110.017 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.497 ' HG ' ' HB1' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -67.26 81.49 0.14 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.017 -1.052 . . . . 0.0 109.344 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -113.21 152.7 29.42 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.479 -0.763 . . . . 0.0 109.978 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.456 ' N ' HG13 ' A' ' 33' ' ' ILE . 86.4 t -50.94 163.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.783 -1.198 . . . . 0.0 109.98 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.431 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 75.0 28.5 62.36 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.788 ' HB2' HD12 ' A' ' 30' ' ' ILE . 46.3 m-20 -109.81 98.15 7.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.387 -1.066 . . . . 0.0 110.705 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.795 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -75.4 92.61 2.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 0.0 110.282 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 59' ' ' LEU . 51.6 mt -64.13 136.72 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.386 -0.821 . . . . 0.0 110.191 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.937 HD21 ' HB3' ' A' ' 27' ' ' PRO . 10.5 mt -136.11 19.82 3.21 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.375 -0.828 . . . . 0.0 109.591 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 22.6 t 177.72 126.46 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.594 -0.691 . . . . 0.0 109.351 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.042 HG12 HD22 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -124.81 116.68 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 m120 58.58 31.95 21.62 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.481 -0.762 . . . . 0.0 110.643 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.44 23.92 32.61 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 53' ' ' SER . 4.9 tt0 -115.4 88.23 2.83 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.026 -1.279 . . . . 0.0 110.079 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -44.62 101.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.504 -0.748 . . . . 0.0 111.28 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.703 HD11 HG22 ' A' ' 54' ' ' VAL . 70.5 mt -81.3 -13.04 58.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 110.358 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 t -48.5 -33.45 9.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.16 -0.963 . . . . 0.0 110.284 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.43 27.97 7.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.353 -0.842 . . . . 0.0 109.591 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 66' ' ' GLU . . . -123.81 149.07 46.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.407 -0.808 . . . . 0.0 110.493 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 p -79.86 166.43 21.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.312 -0.868 . . . . 0.0 109.812 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.943 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.3 t-80 -55.48 -31.83 62.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.082 -1.011 . . . . 0.0 109.854 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.66 -32.43 65.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.824 -1.173 . . . . 0.0 109.547 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.488 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 1.2 mm-40 -72.65 -28.39 62.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.55 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.427 ' O ' HD23 ' A' ' 71' ' ' LEU . . . -77.08 -41.72 41.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.757 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.961 ' CG2' HD11 ' A' ' 18' ' ' ILE . 7.3 t -63.79 -26.96 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.544 -0.862 . . . . 0.0 108.98 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -36.58 81.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.522 -0.736 . . . . 0.0 109.549 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.763 ' O ' HG23 ' A' ' 74' ' ' THR . . . -72.36 -39.89 67.73 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.169 -0.957 . . . . 0.0 109.262 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.682 ' HB3' HG11 ' B' ' 7' ' ' VAL . 4.0 mm? -60.64 -29.92 69.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.368 -0.832 . . . . 0.0 108.918 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -84.75 -36.77 21.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.853 . . . . 0.0 110.118 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -106.05 27.34 8.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.974 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.763 HG23 ' O ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -67.29 166.58 14.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.133 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -109.19 -176.01 21.4 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -51.78 -63.1 1.24 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.204 -1.174 . . . . 0.0 110.4 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -81.8 88.02 6.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.206 -0.934 . . . . 0.0 109.915 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.774 ' CG1' HD21 ' A' ' 80' ' ' LEU . 53.9 t -80.4 90.35 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.932 . . . . 0.0 110.644 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.661 ' O ' HD23 ' A' ' 80' ' ' LEU . 7.1 t -80.68 117.3 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.042 HD22 HG12 ' A' ' 54' ' ' VAL . 17.3 mt -122.5 116.02 23.2 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.409 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.459 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 0.8 OUTLIER -74.0 133.51 42.98 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.655 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 2' ' ' ARG . 4.0 p -129.99 153.68 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.95 -1.093 . . . . 0.0 112.519 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.65 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 2.6 mtpt -115.53 81.55 1.61 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -47.96 121.13 3.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.457 -0.777 . . . . 0.0 111.334 -177.668 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.3 mtt -116.15 52.21 0.92 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.48 -0.762 . . . . 0.0 109.311 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.396 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.508 ' HG2' ' CE1' ' A' ' 64' ' ' HIS . 6.9 tttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.167 0.508 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.416 ' OE2' ' CE ' ' A' ' 32' ' ' LYS . 1.2 tt0 -113.71 70.31 0.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 109.938 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.6 -176.42 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.265 -0.897 . . . . 0.0 110.73 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.62 HD13 ' CE1' ' A' ' 34' ' ' PHE . 21.8 tp -160.15 90.64 0.91 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.443 -0.785 . . . . 0.0 109.855 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.682 HG11 ' HB3' ' A' ' 71' ' ' LEU . 93.1 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.122 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.267 0.556 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.983 ' HB3' HG13 ' A' ' 82' ' ' VAL . 1.1 ttm-85 -152.83 172.65 16.41 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 0.0 109.939 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.84 135.44 14.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.916 . . . . 0.0 109.349 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.637 HG22 ' HB1' ' A' ' 44' ' ' ALA . 66.6 t -142.19 137.67 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.05 -1.031 . . . . 0.0 110.997 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.9 m -121.08 114.08 20.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.522 -0.736 . . . . 0.0 109.304 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.933 HG22 HG21 ' A' ' 42' ' ' THR . 83.1 t -105.53 119.51 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.123 -0.986 . . . . 0.0 110.826 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.03 123.38 42.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.396 -0.815 . . . . 0.0 109.74 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -131.38 173.03 11.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.136 -0.977 . . . . 0.0 110.468 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -163.92 142.6 7.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 109.947 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 6.8 t0 62.99 133.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.29 -0.881 . . . . 0.0 110.116 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 10' ' ' ASP . . . 61.56 121.88 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.652 -0.655 . . . . 0.0 110.324 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.75 62.73 4.37 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.99 96.96 0.93 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.539 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -92.73 -19.94 21.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -1.142 . . . . 0.0 110.505 -179.638 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.947 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 57.84 89.78 0.01 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.766 HD12 HD23 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -174.92 120.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.237 -1.155 . . . . 0.0 110.316 -179.043 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.425 ' HB3' ' CB ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -110.56 93.62 4.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.253 -0.904 . . . . 0.0 109.755 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.98 HD11 ' CG2' ' A' ' 68' ' ' VAL . 28.9 pt -73.62 148.67 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.378 -0.826 . . . . 0.0 110.557 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 31' ' ' SER . 2.3 mtpt -136.88 144.46 43.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.01 . . . . 0.0 110.183 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 136.85 -158.34 24.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.456 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 165.89 133.24 1.48 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.682 ' HB3' HG22 ' A' ' 63' ' ' THR . 1.9 ttp85 -59.53 -15.64 19.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -1.13 . . . . 0.0 110.64 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -14.2 60.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.946 -1.096 . . . . 0.0 109.922 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.02 24.36 10.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.189 -0.944 . . . . 0.0 109.704 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.39 73.21 0.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 110.166 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.53 ' HE1' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -150.4 123.96 4.4 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.93 . . . . 0.0 110.317 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.64 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 54.8 Cg_endo -73.04 50.23 1.78 Allowed 'Trans proline' 0 N--CA 1.493 1.448 0 O-C-N 123.35 1.184 . . . . 0.0 111.752 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 64' ' ' HIS . 10.0 mm 43.06 89.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.498 0 O-C-N 121.101 -0.999 . . . . 0.0 110.656 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.614 HD23 ' N ' ' A' ' 50' ' ' ALA . 6.1 mt -96.57 132.87 41.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.88 -1.137 . . . . 0.0 111.723 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.786 HD12 ' HB2' ' A' ' 49' ' ' ASP . 52.3 mt -67.49 135.55 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.451 ' HA ' HG13 ' A' ' 47' ' ' VAL . 10.7 t -116.29 -36.04 4.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.062 -1.024 . . . . 0.0 110.815 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.425 ' CB ' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -129.06 105.04 7.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.056 -1.028 . . . . 0.0 110.82 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.707 HD11 HG21 ' A' ' 30' ' ' ILE . 10.1 mm -90.45 97.2 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.198 -0.939 . . . . 0.0 109.139 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.823 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 96.3 m-85 -61.89 133.86 55.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.476 -0.765 . . . . 0.0 110.529 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.793 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.8 ttmt -79.06 175.91 10.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.829 . . . . 0.0 110.432 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.61 25.08 60.51 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.947 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.9 OUTLIER -134.88 159.42 41.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.144 . . . . 0.0 110.386 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.789 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -47.54 -59.06 3.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.382 -0.824 . . . . 0.0 111.17 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.612 ' HB1' HD23 ' A' ' 45' ' ' LEU . . . -48.4 -44.55 34.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.279 -0.888 . . . . 0.0 111.334 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.416 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 16.4 t70 -95.87 11.13 34.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 111.092 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -107.12 -4.74 18.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.823 -1.173 . . . . 0.0 110.588 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.933 HG21 HG22 ' A' ' 6' ' ' VAL . 7.2 t -105.56 14.44 28.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.827 -1.171 . . . . 0.0 110.704 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 46.21 53.85 8.97 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.23 -0.919 . . . . 0.0 110.951 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.637 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -160.74 -48.43 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.239 -0.913 . . . . 0.0 110.036 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.766 HD23 HD12 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -72.64 87.63 1.24 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.843 -1.161 . . . . 0.0 108.0 178.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.589 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -113.2 149.57 33.53 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.133 0.492 . . . . 0.0 110.175 -178.734 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.503 ' HA ' HG22 ' A' ' 30' ' ' ILE . 56.3 t -47.19 154.2 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.048 -1.032 . . . . 0.0 110.331 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.18 28.74 43.68 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.786 ' HB2' HD12 ' A' ' 30' ' ' ILE . 62.3 m-20 -113.43 103.38 11.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.438 -1.036 . . . . 0.0 110.435 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.64 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -80.29 108.28 13.77 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.186 -0.946 . . . . 0.0 109.295 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.762 ' C ' HD22 ' A' ' 52' ' ' LEU . 51.4 mt -75.4 134.55 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 111.085 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.762 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.5 mm? -119.58 14.04 12.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.505 -0.747 . . . . 0.0 109.81 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 1.3 t 178.02 146.33 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 108.997 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.756 HG21 ' CB ' ' A' ' 70' ' ' ALA . 2.6 m -138.72 125.28 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.985 -1.072 . . . . 0.0 111.186 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 59.12 16.08 4.55 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.411 -0.806 . . . . 0.0 111.233 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.9 24.98 7.02 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.481 ' O ' ' CB ' ' A' ' 53' ' ' SER . 2.4 mm-40 -116.26 166.14 12.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -1.163 . . . . 0.0 108.686 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.16 119.57 39.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.058 -1.026 . . . . 0.0 110.062 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.793 HD13 ' HB3' ' A' ' 62' ' ' ALA . 2.0 mm? -101.1 -9.52 21.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 110.693 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -51.64 -28.87 15.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.972 -1.08 . . . . 0.0 110.483 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.9 m -120.65 46.76 1.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.37 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.793 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -135.57 157.2 47.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 110.207 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.682 HG22 ' HB3' ' A' ' 22' ' ' ARG . 33.7 p -87.94 167.79 13.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.398 -0.814 . . . . 0.0 110.34 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.93 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.1 t60 -53.69 -24.51 14.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.181 -0.95 . . . . 0.0 109.622 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.37 -39.99 52.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 109.455 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.571 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 19.3 mm-40 -68.32 -25.87 65.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.482 -0.761 . . . . 0.0 109.623 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.638 ' HA ' HD11 ' A' ' 59' ' ' LEU . . . -79.33 -44.32 21.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.345 -0.847 . . . . 0.0 110.38 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.98 ' CG2' HD11 ' A' ' 18' ' ' ILE . 4.0 t -69.06 -30.49 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.064 -1.022 . . . . 0.0 108.745 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.65 -38.07 71.64 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.484 -0.76 . . . . 0.0 109.236 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.756 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -74.02 -25.87 60.11 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.402 -0.811 . . . . 0.0 109.478 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.751 ' HB3' HG11 ' B' ' 7' ' ' VAL . 3.6 mm? -75.18 -27.86 59.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.408 -0.808 . . . . 0.0 109.893 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -76.61 -42.5 42.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.907 . . . . 0.0 110.162 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -95.16 22.23 6.96 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.246 -0.909 . . . . 0.0 109.965 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.929 ' CG2' HG22 ' A' ' 78' ' ' VAL . 60.2 m -52.91 132.51 37.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 110.518 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.39 178.29 51.65 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.434 ' HG3' ' N ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -52.99 -32.76 48.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.209 -1.171 . . . . 0.0 110.34 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.434 ' N ' ' HG3' ' A' ' 76' ' ' LYS . 9.3 tt0 -101.81 109.0 20.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 108.983 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.929 HG22 ' CG2' ' A' ' 74' ' ' THR . 22.0 t -97.0 82.41 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 0.0 111.052 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.649 ' O ' HD12 ' A' ' 80' ' ' LEU . 3.3 t -78.2 108.48 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.854 HD13 HG12 ' A' ' 78' ' ' VAL . 5.7 mp -118.73 109.09 15.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.025 -1.047 . . . . 0.0 112.508 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 51.2 tt0 -71.04 137.9 49.39 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.983 HG13 ' HB3' ' A' ' 2' ' ' ARG . 2.2 p -139.22 145.64 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.81 -1.181 . . . . 0.0 112.093 -177.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -106.75 88.57 2.79 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.164 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.589 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -55.62 114.78 2.0 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.463 -0.773 . . . . 0.0 111.151 -177.671 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.408 ' HG3' HD21 ' A' ' 29' ' ' LEU . 2.4 mtt -100.38 50.93 0.89 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 108.992 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.197 -179.406 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 tttt . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.188 0.518 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 47.2 tt0 -153.66 106.46 2.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.322 -0.861 . . . . 0.0 110.065 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.446 ' HB3' HG11 ' A' ' 68' ' ' VAL . 70.3 m -109.01 131.29 55.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.143 -0.973 . . . . 0.0 110.206 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.823 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 0.5 OUTLIER -100.13 96.81 7.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -0.836 . . . . 0.0 110.751 -179.601 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.751 HG11 ' HB3' ' A' ' 71' ' ' LEU . 44.5 t . . . . . 0 N--CA 1.492 1.667 0 O-C-N 120.919 -1.113 . . . . 0.0 110.133 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.442 0.639 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.848 ' CB ' HG13 ' A' ' 82' ' ' VAL . 1.7 mtp85 -153.51 168.17 27.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.409 -0.807 . . . . 0.0 110.187 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -135.57 118.83 16.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 0.0 109.384 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.736 HG11 ' HG ' ' A' ' 45' ' ' LEU . 60.3 t -124.04 128.85 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.004 -1.06 . . . . 0.0 110.691 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.7 m -118.26 118.8 32.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.453 -0.78 . . . . 0.0 109.768 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.897 HG21 HD12 ' A' ' 45' ' ' LEU . 89.7 t -113.73 108.08 24.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.63 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.7 mtm105 -65.34 110.78 2.74 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.524 -0.735 . . . . 0.0 110.048 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.919 ' HE2' HD12 ' A' ' 14' ' ' LEU . 2.3 tttp -125.14 149.9 47.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.359 -0.838 . . . . 0.0 110.423 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.58 -158.08 0.64 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.416 -0.803 . . . . 0.0 110.117 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.11 20.81 4.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.167 -0.958 . . . . 0.0 110.377 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.44 118.86 2.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 110.05 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.81 106.84 0.9 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.94 157.46 1.77 Allowed Glycine 0 N--CA 1.495 2.584 0 O-C-N 120.784 -1.421 . . . . 0.0 109.842 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.919 HD12 ' HE2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -93.43 -14.99 26.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.277 -1.131 . . . . 0.0 110.756 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.971 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 58.21 83.39 0.05 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.48 HG21 HD22 ' A' ' 14' ' ' LEU . 3.4 tt -175.16 117.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.218 -1.166 . . . . 0.0 110.002 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.409 ' HB2' ' HG ' ' B' ' 6' ' ' LEU . 1.2 t -108.44 106.52 16.66 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.131 -0.981 . . . . 0.0 110.089 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.028 HD11 HG22 ' A' ' 68' ' ' VAL . 20.4 pt -83.65 145.85 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.406 -0.809 . . . . 0.0 110.275 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' CG ' ' HB2' ' A' ' 31' ' ' SER . 3.2 ptmt -128.61 153.19 47.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.974 -1.079 . . . . 0.0 109.066 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 127.89 -157.65 21.14 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.274 -1.441 . . . . 0.0 110.338 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.45 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 162.22 134.68 1.68 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' NH2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -58.46 -16.66 16.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -1.08 . . . . 0.0 110.603 -179.727 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -14.74 60.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.736 -1.227 . . . . 0.0 110.246 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.3 28.14 7.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.976 . . . . 0.0 110.006 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HA ' ' NH2' ' A' ' 22' ' ' ARG . 7.0 mmmt 52.48 81.76 0.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.218 -0.926 . . . . 0.0 110.23 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.612 ' HE1' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -160.23 122.46 1.82 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.185 -0.947 . . . . 0.0 110.336 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.699 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 54.3 Cg_endo -72.38 50.95 1.69 Allowed 'Trans proline' 0 N--CA 1.494 1.554 0 O-C-N 123.42 1.221 . . . . 0.0 111.773 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.586 HG21 ' HB1' ' A' ' 67' ' ' ALA . 17.6 mm 42.36 87.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 121.108 -0.995 . . . . 0.0 110.746 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.612 ' CB ' ' HE1' ' A' ' 26' ' ' MET . 5.9 mt -95.28 134.58 37.89 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.822 -1.174 . . . . 0.0 111.849 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.859 HD12 ' HB2' ' A' ' 49' ' ' ASP . 59.5 mt -66.95 138.03 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.218 -0.926 . . . . 0.0 108.831 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.463 ' HB2' ' CG ' ' A' ' 19' ' ' LYS . 47.4 t -120.37 -26.29 5.45 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.975 -1.078 . . . . 0.0 110.941 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.405 ' CB ' ' HB3' ' A' ' 17' ' ' SER . 0.5 OUTLIER -137.84 105.5 5.59 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.069 -1.019 . . . . 0.0 111.019 -179.398 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.76 HD11 HG21 ' A' ' 30' ' ' ILE . 15.3 mm -90.71 96.97 6.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.586 ' HB2' HD13 ' A' ' 37' ' ' LEU . 95.9 m-85 -62.34 134.79 56.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.605 -0.685 . . . . 0.0 110.625 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.588 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -78.17 176.1 9.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.421 -0.8 . . . . 0.0 110.528 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.55 28.62 51.81 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.971 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -136.42 162.69 32.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -1.162 . . . . 0.0 110.65 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.759 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -52.8 -55.21 24.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.582 -0.699 . . . . 0.0 111.916 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.722 ' HB2' HD23 ' A' ' 14' ' ' LEU . . . -56.37 -37.01 69.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.115 -0.99 . . . . 0.0 112.126 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.432 ' HB2' HG22 ' A' ' 33' ' ' ILE . 17.6 t70 -92.77 -6.23 49.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.807 -1.183 . . . . 0.0 111.615 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -106.82 15.7 25.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.807 -1.183 . . . . 0.0 110.525 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.497 HG21 HG22 ' A' ' 6' ' ' VAL . 4.9 t -108.91 14.56 24.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.101 -1.0 . . . . 0.0 110.812 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 45.22 48.41 10.11 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.199 -0.938 . . . . 0.0 111.419 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.653 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -169.15 -46.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 0.0 110.471 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.897 HD12 HG21 ' A' ' 6' ' ' VAL . 2.2 mt -71.66 84.83 0.89 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.812 -1.18 . . . . 0.0 108.568 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.595 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -111.13 151.22 28.39 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.739 -179.198 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.479 ' N ' HG13 ' A' ' 33' ' ' ILE . 98.3 t -50.36 159.14 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.851 -1.156 . . . . 0.0 110.008 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.56 31.11 51.6 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.859 ' HB2' HD12 ' A' ' 30' ' ' ILE . 42.2 m-20 -114.25 104.77 12.42 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.542 -0.975 . . . . 0.0 110.354 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -82.86 110.58 17.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.151 -0.968 . . . . 0.0 109.761 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.811 ' C ' HD22 ' A' ' 52' ' ' LEU . 71.9 mt -77.28 136.89 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.87 . . . . 0.0 110.891 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.811 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.4 mm? -120.43 -0.44 10.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.464 -0.772 . . . . 0.0 110.844 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 2.5 p -178.79 103.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.875 -1.141 . . . . 0.0 109.819 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.892 HG21 ' CB ' ' A' ' 70' ' ' ALA . 17.1 m -92.46 121.38 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.167 -0.958 . . . . 0.0 110.351 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.65 34.2 24.21 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.135 -0.978 . . . . 0.0 110.917 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.96 17.62 67.08 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.544 ' O ' HD23 ' A' ' 59' ' ' LEU . 4.8 tt0 -105.01 91.24 3.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.019 -1.283 . . . . 0.0 109.805 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -43.49 99.52 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.523 0.678 . . . . 0.0 111.135 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.88 HD13 ' CB ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -92.54 24.88 3.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -0.796 . . . . 0.0 110.292 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 61' ' ' SER . 52.6 p -73.92 -58.71 3.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.147 -0.971 . . . . 0.0 110.397 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.425 ' N ' ' OG ' ' A' ' 60' ' ' SER . 0.8 OUTLIER -80.47 -19.21 46.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 110.096 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.88 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -57.54 167.54 1.01 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.36 -0.837 . . . . 0.0 110.589 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.5 p -100.72 -166.76 1.35 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.398 -0.814 . . . . 0.0 108.98 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.908 ' O ' HG23 ' A' ' 68' ' ' VAL . 13.5 t-80 -75.18 -23.6 57.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.006 -1.059 . . . . 0.0 109.981 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.01 -34.76 61.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.961 . . . . 0.0 109.663 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.487 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 22.6 mm-40 -72.55 -25.55 61.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 109.849 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.586 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -78.91 -38.88 36.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 110.205 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.028 HG22 HD11 ' A' ' 18' ' ' ILE . 2.9 t -75.03 -37.86 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.216 -0.928 . . . . 0.0 108.806 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -55.47 -38.89 69.69 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.443 -0.786 . . . . 0.0 109.965 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.892 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.53 -49.4 48.54 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.112 -0.992 . . . . 0.0 109.107 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.625 ' CB ' HG11 ' B' ' 7' ' ' VAL . 79.1 mt -61.1 -23.94 65.86 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.656 -0.653 . . . . 0.0 109.666 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -76.11 -37.17 58.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.084 -1.01 . . . . 0.0 109.082 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 17.0 ttmt -121.72 51.07 1.35 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.746 ' HB ' HG22 ' A' ' 78' ' ' VAL . 58.8 p -52.44 -85.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 110.615 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.432 ' N ' ' OG1' ' A' ' 74' ' ' THR . . . 147.99 -172.81 28.22 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.412 ' CG ' ' N ' ' A' ' 77' ' ' GLU . 3.7 pttt -49.08 -40.28 31.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.247 -1.149 . . . . 0.0 110.441 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 76' ' ' LYS . 25.8 pt-20 -128.58 129.94 46.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.326 -0.859 . . . . 0.0 109.672 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.848 HG12 HD13 ' A' ' 80' ' ' LEU . 45.2 t -96.8 79.63 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.036 -1.04 . . . . 0.0 111.12 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.643 ' O ' HD12 ' A' ' 80' ' ' LEU . 20.1 t -73.43 112.09 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.848 HD13 HG12 ' A' ' 78' ' ' VAL . 4.8 mp -120.34 110.14 16.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.915 -1.116 . . . . 0.0 111.943 -177.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.1 tp10 -69.32 122.7 19.42 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.848 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.4 p -118.31 146.35 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.092 -1.005 . . . . 0.0 112.19 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -113.18 82.42 1.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.595 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -50.11 127.11 16.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.529 -0.732 . . . . 0.0 111.211 -177.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.3 mtt -121.87 53.78 1.19 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.421 -0.8 . . . . 0.0 109.518 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.494 ' HD2' ' CE2' ' A' ' 84' ' ' TYR . 6.3 mtpp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.287 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.648 ' HG2' ' CD2' ' A' ' 64' ' ' HIS . 3.1 ptmt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.048 0.451 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 19.9 mt-10 -48.82 126.54 12.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.17 -0.956 . . . . 0.0 110.251 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.434 ' HB2' ' HE1' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -111.43 -24.65 10.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.97 -1.081 . . . . 0.0 111.138 -179.222 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.56 HD21 ' CE1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER 59.06 96.75 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.099 -1.001 . . . . 0.0 110.592 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.644 ' CG2' HG13 ' A' ' 68' ' ' VAL . 44.8 t . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.046 -1.034 . . . . 0.0 110.071 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.259 0.552 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.542 ' CG ' HG13 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -163.59 147.3 10.33 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.21 -0.931 . . . . 0.0 109.728 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.424 ' N ' ' HG3' ' A' ' 2' ' ' ARG . 21.5 ptt180 -125.53 136.65 53.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.112 -0.992 . . . . 0.0 110.041 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.733 HG13 ' CB ' ' A' ' 44' ' ' ALA . 46.6 t -140.42 157.06 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.102 -0.999 . . . . 0.0 110.567 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.449 ' OG1' HG22 ' A' ' 79' ' ' VAL . 40.1 m -144.24 125.69 14.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 110.212 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.038 HG22 HG21 ' A' ' 42' ' ' THR . 87.7 t -117.75 114.4 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.649 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -80.27 118.99 22.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.73 105.18 0.1 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.324 -0.86 . . . . 0.0 110.288 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.59 122.79 11.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.943 . . . . 0.0 110.225 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.2 OUTLIER 62.32 128.73 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.374 -0.829 . . . . 0.0 110.403 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 10' ' ' ASP . . . 55.94 92.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.456 -0.778 . . . . 0.0 110.445 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.8 -30.72 15.33 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.53 120.53 11.93 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.636 HD22 HG21 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -72.79 -20.36 61.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -1.15 . . . . 0.0 110.365 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.504 ' HA3' ' CG ' ' A' ' 37' ' ' LEU . . . 63.38 83.94 0.07 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.636 HG21 HD22 ' A' ' 14' ' ' LEU . 1.1 tt -176.43 120.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -1.175 . . . . 0.0 109.921 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.488 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -111.53 106.1 14.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.89 . . . . 0.0 109.469 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.038 HD11 HG22 ' A' ' 68' ' ' VAL . 22.0 pt -82.41 156.54 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.449 -0.782 . . . . 0.0 111.522 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.459 ' CB ' ' HB2' ' A' ' 31' ' ' SER . 7.9 ttmm -139.73 119.98 13.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.493 -0.755 . . . . 0.0 109.772 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.71 -159.46 28.09 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.445 ' CA ' ' HB2' ' A' ' 64' ' ' HIS . . . 156.88 140.27 2.91 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.499 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.0 OUTLIER -60.88 -14.64 23.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -1.084 . . . . 0.0 110.713 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -72.73 -19.12 61.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.893 -1.129 . . . . 0.0 110.006 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -123.38 28.22 7.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 109.879 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.24 83.91 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.392 -0.817 . . . . 0.0 110.166 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.581 ' HE1' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -167.39 123.13 0.87 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.29 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.847 ' HB3' HD21 ' A' ' 52' ' ' LEU . 55.2 Cg_endo -71.61 52.32 1.63 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 O-C-N 123.39 1.205 . . . . 0.0 111.729 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 64' ' ' HIS . 13.9 mm 42.39 88.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 O-C-N 121.093 -1.005 . . . . 0.0 110.817 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 50' ' ' ALA . 6.0 mt -97.39 131.6 43.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.757 -1.214 . . . . 0.0 111.89 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.657 HG21 HD11 ' A' ' 33' ' ' ILE . 39.6 mt -67.18 132.22 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.284 -0.885 . . . . 0.0 108.74 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.459 ' HB2' ' CB ' ' A' ' 19' ' ' LYS . 6.9 t -119.51 -10.4 9.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.167 -0.958 . . . . 0.0 111.092 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.38 99.4 2.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.987 -1.071 . . . . 0.0 110.707 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.657 HD11 HG21 ' A' ' 30' ' ' ILE . 13.4 mm -89.58 95.92 5.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.318 -0.864 . . . . 0.0 108.682 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.584 ' CZ ' HD13 ' B' ' 6' ' ' LEU . 4.8 m-30 -45.02 137.45 4.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.818 -0.551 . . . . 0.0 110.85 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 37' ' ' LEU . 1.6 tttp -79.98 158.42 26.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.279 -0.888 . . . . 0.0 110.479 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.27 22.31 29.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 35' ' ' LYS . 1.9 mm? -112.01 168.82 9.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -1.111 . . . . 0.0 109.718 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.78 ' O ' HG23 ' A' ' 42' ' ' THR . . . -56.1 -70.46 0.11 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.135 -0.978 . . . . 0.0 111.174 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 14' ' ' LEU . . . -47.1 -24.66 0.7 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.332 -0.855 . . . . 0.0 111.671 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.475 ' HB2' HG22 ' A' ' 33' ' ' ILE . 4.8 t70 -93.91 -31.81 14.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.888 -1.133 . . . . 0.0 110.456 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 1.4 pp0? -87.13 12.0 12.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.062 -1.024 . . . . 0.0 110.491 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . 1.038 HG21 HG22 ' A' ' 6' ' ' VAL . 35.3 p -98.88 6.62 46.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.053 -1.029 . . . . 0.0 110.815 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER 49.98 53.83 12.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.864 -1.147 . . . . 0.0 110.818 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.733 ' CB ' HG13 ' A' ' 4' ' ' VAL . . . -177.13 -52.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.134 -0.979 . . . . 0.0 110.547 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.817 HD12 HG21 ' A' ' 6' ' ' VAL . 2.6 mt -69.56 85.96 0.45 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.874 -1.141 . . . . 0.0 108.808 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.606 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -112.59 151.38 30.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.942 -0.474 . . . . 0.0 109.801 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.472 ' HA ' HG22 ' A' ' 30' ' ' ILE . 53.7 t -49.1 162.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 120.903 -1.123 . . . . 0.0 110.127 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.406 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 74.07 32.18 58.86 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.786 -1.725 . . . . 0.0 108.786 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.611 ' HB2' HD12 ' A' ' 30' ' ' ILE . 54.2 m-20 -116.96 104.8 11.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.603 -0.939 . . . . 0.0 110.173 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -81.94 97.04 7.88 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 110.158 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.51 HG21 ' CG1' ' A' ' 54' ' ' VAL . 51.4 mt -62.1 135.07 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 0.0 110.155 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.847 HD21 ' HB3' ' A' ' 27' ' ' PRO . 65.3 mt -132.53 14.0 4.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.465 -0.772 . . . . 0.0 110.217 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 178.96 96.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.505 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.849 HG21 ' CB ' ' A' ' 70' ' ' ALA . 14.5 m -95.46 126.48 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.216 -0.927 . . . . 0.0 110.452 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 59.28 24.4 12.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.382 -0.824 . . . . 0.0 110.609 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.6 30.78 17.62 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.1 mm-40 -123.07 95.58 4.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.134 -1.215 . . . . 0.0 109.647 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.6 97.55 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.561 0.696 . . . . 0.0 111.356 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.976 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -80.58 -8.12 59.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.54 -0.725 . . . . 0.0 110.548 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.8 p -54.36 -36.7 64.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.011 -1.055 . . . . 0.0 110.152 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t -95.39 22.33 7.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 110.108 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.976 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -118.76 161.48 20.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 110.281 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 22' ' ' ARG . 55.1 p -91.08 -170.71 2.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 109.926 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.887 ' O ' HG23 ' A' ' 68' ' ' VAL . 10.2 t60 -69.07 -23.57 64.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.031 -1.043 . . . . 0.0 109.806 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -77.42 -39.73 45.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.617 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.753 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 5.7 mm-40 -65.3 -24.72 67.36 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.424 -0.797 . . . . 0.0 109.953 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.49 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -82.83 -41.11 19.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.175 -0.953 . . . . 0.0 110.587 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.038 HG22 HD11 ' A' ' 18' ' ' ILE . 5.4 t -73.45 -28.45 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.141 -0.974 . . . . 0.0 109.398 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -40.33 93.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -0.801 . . . . 0.0 109.81 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.849 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -68.47 -49.3 60.85 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.209 -0.932 . . . . 0.0 108.976 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 80' ' ' LEU . 82.4 mt -58.51 -23.35 57.85 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.641 -0.662 . . . . 0.0 109.362 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -77.54 -40.12 43.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 109.624 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.11 64.82 0.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.403 -0.811 . . . . 0.0 109.364 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.588 ' CB ' HG22 ' A' ' 78' ' ' VAL . 30.4 p -82.23 174.4 11.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.375 -0.828 . . . . 0.0 109.933 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.17 -175.03 34.61 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.67 -37.88 19.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.148 -1.207 . . . . 0.0 110.544 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -117.76 101.9 8.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.397 -0.814 . . . . 0.0 109.894 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.898 HG12 HD13 ' A' ' 80' ' ' LEU . 59.9 t -67.28 73.5 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.0 110.795 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.449 HG22 ' OG1' ' A' ' 5' ' ' THR . 2.0 t -69.53 106.47 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.898 HD13 HG12 ' A' ' 78' ' ' VAL . 3.8 mp -114.0 119.79 38.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.884 -1.135 . . . . 0.0 112.235 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 14.3 tp10 -73.34 133.39 43.82 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.542 HG13 ' CG ' ' A' ' 2' ' ' ARG . 2.2 p -135.16 144.35 34.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.837 -1.164 . . . . 0.0 111.741 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.683 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -107.51 86.57 2.33 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.524 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.606 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -54.33 122.86 11.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.472 -0.768 . . . . 0.0 110.662 -177.886 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -111.78 52.3 0.76 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.636 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.3 pttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.27 -179.762 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.498 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 56.3 tttt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.128 0.489 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.54 87.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.431 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.431 ' N ' ' O ' ' B' ' 3' ' ' LYS . 0.4 OUTLIER -90.86 -163.54 1.04 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 109.865 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.584 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 30.5 tp -163.27 121.49 1.98 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 109.995 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.714 HG11 ' C ' ' A' ' 71' ' ' LEU . 83.1 t . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.082 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.436 0.636 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.834 ' CB ' HG13 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -155.18 168.03 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.409 -0.807 . . . . 0.0 110.692 -179.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -141.55 121.12 13.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.468 -0.77 . . . . 0.0 109.197 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.669 HG13 ' CB ' ' A' ' 44' ' ' ALA . 64.3 t -131.94 139.48 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.931 -1.105 . . . . 0.0 111.05 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.8 m -119.14 116.47 26.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.459 -0.776 . . . . 0.0 109.683 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.667 HG22 HG21 ' A' ' 42' ' ' THR . 90.9 t -103.83 111.57 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 110.207 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.86 . . . . 0.0 109.916 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.993 0.425 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.882 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 56.0 87.0 0.02 OUTLIER Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.413 HG23 ' HB ' ' B' ' 7' ' ' VAL . 3.3 tt -176.32 118.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.223 -1.163 . . . . 0.0 110.345 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -112.94 101.09 9.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.561 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.124 HD11 HG22 ' A' ' 68' ' ' VAL . 28.4 pt -78.31 151.06 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.95 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' B' ' 3' ' ' LYS . 46.6 tttt -137.83 122.22 18.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.452 -0.78 . . . . 0.0 110.209 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.08 -153.05 24.16 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 160.44 133.85 1.56 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.578 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.2 OUTLIER -60.12 -15.43 23.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.424 -1.045 . . . . 0.0 110.617 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.68 7.07 15.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.719 -1.238 . . . . 0.0 110.487 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.53 23.76 2.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.085 -1.009 . . . . 0.0 109.749 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm 53.88 64.87 1.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.883 . . . . 0.0 110.213 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.523 ' HE3' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.51 117.84 5.2 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 110.236 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.745 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 48.3 Cg_endo -69.54 54.34 1.09 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 O-C-N 123.425 1.224 . . . . 0.0 111.653 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 64' ' ' HIS . 16.3 mm 42.33 88.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 O-C-N 121.268 -0.895 . . . . 0.0 110.304 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' A' ' 50' ' ' ALA . 31.8 tp -100.89 125.72 47.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.843 -1.16 . . . . 0.0 111.888 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.864 HD12 ' HB2' ' A' ' 49' ' ' ASP . 57.4 mt -61.82 136.26 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.588 -0.695 . . . . 0.0 110.188 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.3 t -121.98 -11.4 8.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 110.686 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 106.78 3.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.956 -1.09 . . . . 0.0 110.703 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.539 HD11 HG21 ' A' ' 30' ' ' ILE . 11.8 mm -95.6 94.74 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 109.45 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.964 ' CE1' HD13 ' B' ' 6' ' ' LEU . 88.3 m-85 -54.27 141.55 29.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.841 . . . . 0.0 110.26 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.849 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.0 mmmt -86.42 171.57 11.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 110.805 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.58 30.89 73.13 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.882 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.7 OUTLIER -138.28 162.61 33.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -1.196 . . . . 0.0 110.78 -179.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.615 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -46.5 -64.08 0.85 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.514 -0.741 . . . . 0.0 111.63 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.758 ' O ' HG22 ' A' ' 42' ' ' THR . . . -48.6 -53.75 17.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.96 -1.087 . . . . 0.0 111.385 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.448 ' HB2' HG22 ' A' ' 33' ' ' ILE . 16.3 t70 -77.3 -9.26 58.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.86 -1.15 . . . . 0.0 111.891 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.496 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -107.41 10.95 29.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.67 -1.268 . . . . 0.0 110.746 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 39' ' ' ALA . 5.4 t -106.82 15.62 25.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.017 -1.052 . . . . 0.0 110.512 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER 47.74 55.31 8.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.117 -0.989 . . . . 0.0 110.991 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.669 ' CB ' HG13 ' A' ' 4' ' ' VAL . . . -176.64 -47.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.083 -1.011 . . . . 0.0 110.524 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -67.93 82.44 0.21 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.973 -1.079 . . . . 0.0 109.154 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.588 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.91 150.01 32.39 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.548 -0.72 . . . . 0.0 109.835 -179.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 48' ' ' GLY . 96.2 t -50.24 167.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.97 -1.081 . . . . 0.0 110.253 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.503 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 70.88 30.21 68.35 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.864 ' HB2' HD12 ' A' ' 30' ' ' ILE . 36.5 m-20 -114.06 99.57 7.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.485 -1.009 . . . . 0.0 110.968 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.779 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -78.43 107.11 10.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 109.518 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.811 ' C ' HD22 ' A' ' 52' ' ' LEU . 61.2 mt -77.46 134.33 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 110.939 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.811 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.0 mm? -120.9 7.3 10.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.488 -0.757 . . . . 0.0 110.003 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 4.8 t -175.76 131.92 0.26 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.148 -0.97 . . . . 0.0 109.871 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.766 HG12 ' HG ' ' A' ' 80' ' ' LEU . 2.0 m -123.9 113.96 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.302 -0.873 . . . . 0.0 109.721 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.6 34.29 20.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.292 -0.88 . . . . 0.0 110.283 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.99 21.02 51.8 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 53' ' ' SER . 3.3 tm-20 -109.51 84.9 2.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.064 -1.257 . . . . 0.0 110.417 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -44.56 97.88 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.432 -0.793 . . . . 0.0 110.947 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.643 HD11 HG22 ' A' ' 54' ' ' VAL . 37.3 mt -79.09 -8.78 59.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.473 -0.767 . . . . 0.0 110.877 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.427 ' O ' ' CZ ' ' A' ' 22' ' ' ARG . 21.7 p -47.01 -36.19 7.58 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.212 -0.93 . . . . 0.0 110.611 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -106.85 29.86 6.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.752 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.634 ' HB1' ' CB ' ' A' ' 66' ' ' GLU . . . -119.72 153.65 35.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.355 -0.841 . . . . 0.0 110.133 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.578 HG22 ' HB3' ' A' ' 22' ' ' ARG . 2.9 p -86.32 171.56 11.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.303 -0.873 . . . . 0.0 110.071 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.909 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.2 t60 -55.29 -24.65 29.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 109.777 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -77.14 -38.24 52.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.014 . . . . 0.0 109.761 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.634 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 4.1 mm-40 -67.94 -25.89 65.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.832 . . . . 0.0 110.166 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.87 -38.82 24.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 110.416 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.124 HG22 HD11 ' A' ' 18' ' ' ILE . 8.2 t -73.26 -27.38 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.068 -1.02 . . . . 0.0 109.334 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -65.09 -38.16 89.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.363 -0.835 . . . . 0.0 109.767 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.6 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.26 -48.53 56.45 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.15 -0.969 . . . . 0.0 108.726 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.69 ' CD2' HD21 ' A' ' 80' ' ' LEU . 82.7 mt -59.62 -22.49 61.92 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.661 -0.649 . . . . 0.0 109.674 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -80.11 -45.11 18.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.654 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 5.5 tttt -112.74 59.79 0.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.38 -0.825 . . . . 0.0 109.719 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.601 ' HB ' HG22 ' A' ' 78' ' ' VAL . 47.3 p -78.08 174.2 11.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 110.248 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.88 -169.48 29.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -52.11 23.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.017 -1.284 . . . . 0.0 110.448 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 1.8 pt-20 -107.74 117.24 33.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.902 . . . . 0.0 109.778 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.007 HG12 HD13 ' A' ' 80' ' ' LEU . 45.8 t -83.11 78.56 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.938 -1.101 . . . . 0.0 110.781 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.6 ' O ' HD12 ' A' ' 80' ' ' LEU . 16.8 t -68.53 112.53 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.101 -0.999 . . . . 0.0 108.329 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.007 HD13 HG12 ' A' ' 78' ' ' VAL . 4.4 mp -119.94 115.79 24.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.993 -1.067 . . . . 0.0 111.87 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 7.3 tp10 -73.56 128.63 36.02 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.834 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.5 p -127.23 150.27 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.044 -1.035 . . . . 0.0 112.15 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.779 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 34.5 tttp -115.58 85.04 2.2 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.588 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -51.56 130.65 28.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.468 -0.77 . . . . 0.0 111.119 -177.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.4 mtt -115.47 51.74 0.92 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.765 . . . . 0.0 109.451 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.338 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 10.6 tttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.174 0.511 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -121.49 94.34 4.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.154 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.417 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -91.28 -169.52 2.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.394 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.964 HD13 ' CE1' ' A' ' 34' ' ' PHE . 5.1 tp -157.77 94.83 1.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.82 . . . . 0.0 109.883 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 71' ' ' LEU . 94.9 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.088 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.499 0.666 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.48 ' CG ' HG13 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -158.77 146.51 17.9 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.548 -0.72 . . . . 0.0 109.736 -179.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.413 ' N ' ' HG3' ' A' ' 2' ' ' ARG . 0.4 OUTLIER -124.28 129.33 50.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.057 -1.027 . . . . 0.0 110.307 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.735 HG22 ' HB1' ' A' ' 44' ' ' ALA . 93.5 t -128.79 127.53 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.384 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.6 m -114.69 132.57 56.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.737 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.546 HG21 HD12 ' A' ' 45' ' ' LEU . 90.4 t -122.69 109.96 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 110.304 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 109.549 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.711 HD23 ' HB2' ' A' ' 39' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.067 0.461 . . . . 0.0 110.367 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.962 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 56.21 90.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.691 HD12 HD22 ' A' ' 45' ' ' LEU . 1.1 tt -176.33 120.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.203 -1.175 . . . . 0.0 110.525 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.588 ' OG ' HD13 ' B' ' 6' ' ' LEU . 1.3 m -112.46 106.25 14.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.186 -0.947 . . . . 0.0 109.404 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.974 HD11 ' CG2' ' A' ' 68' ' ' VAL . 12.3 pt -82.58 156.64 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.426 -0.796 . . . . 0.0 111.501 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.431 ' CD ' ' CB ' ' A' ' 31' ' ' SER . 10.4 mtpt -136.44 156.92 47.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.578 -0.702 . . . . 0.0 109.833 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 123.05 -156.49 17.44 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.68 133.98 1.57 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.709 ' HB3' HG22 ' A' ' 63' ' ' THR . 1.9 tpm_? -60.71 -15.39 28.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -1.15 . . . . 0.0 110.62 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.412 ' OE2' ' ND2' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -82.03 5.51 19.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.649 -1.282 . . . . 0.0 110.342 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.412 ' ND2' ' OE2' ' A' ' 23' ' ' GLU . 0.7 OUTLIER -140.9 25.75 2.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.091 -1.006 . . . . 0.0 109.446 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.29 90.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 0.0 109.875 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.526 ' HE2' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -170.03 127.01 0.76 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.305 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.743 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 57.0 Cg_endo -75.88 45.5 1.51 Allowed 'Trans proline' 0 N--CA 1.494 1.541 0 O-C-N 123.371 1.195 . . . . 0.0 111.717 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.514 HG21 ' HB1' ' A' ' 67' ' ' ALA . 27.0 mm 47.51 90.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 120.789 -1.194 . . . . 0.0 109.848 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.629 HD13 ' HB2' ' A' ' 50' ' ' ALA . 36.6 tp -103.15 125.05 49.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.812 -1.18 . . . . 0.0 112.051 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.821 HD12 ' HB2' ' A' ' 49' ' ' ASP . 60.9 mt -58.78 139.39 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.568 -0.707 . . . . 0.0 109.85 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.431 ' CB ' ' CD ' ' A' ' 19' ' ' LYS . 33.3 t -124.6 -10.5 7.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 110.969 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.411 ' CB ' ' NZ ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -154.81 100.4 2.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.905 -1.122 . . . . 0.0 110.843 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.45 HG13 ' HA ' ' A' ' 46' ' ' PHE . 13.7 mm -86.39 101.26 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.212 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.586 ' HB3' HD13 ' A' ' 37' ' ' LEU . 3.3 m-85 -59.36 135.56 57.69 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.604 -0.685 . . . . 0.0 109.698 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.661 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -83.06 169.47 15.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.117 -0.989 . . . . 0.0 110.851 -179.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.48 30.29 77.15 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.962 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER -138.28 162.1 35.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.112 -1.228 . . . . 0.0 110.955 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -46.22 -69.06 0.14 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.628 -0.67 . . . . 0.0 111.694 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.711 ' HB2' HD23 ' A' ' 14' ' ' LEU . . . -45.01 -39.25 5.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.472 -0.767 . . . . 0.0 111.575 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.419 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 16.5 t70 -93.61 10.62 31.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.057 -1.027 . . . . 0.0 110.758 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -115.44 3.72 14.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.925 -1.109 . . . . 0.0 110.773 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.521 HG21 HG22 ' A' ' 6' ' ' VAL . 10.1 t -108.22 15.16 24.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.93 -1.106 . . . . 0.0 110.893 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.12 60.98 3.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.084 -1.01 . . . . 0.0 110.926 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.735 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -175.15 -50.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.2 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.691 HD22 HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -70.31 86.83 0.6 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.959 -1.088 . . . . 0.0 108.705 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.603 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -115.96 153.33 31.81 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.825 -0.547 . . . . 0.0 110.029 -179.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 48' ' ' GLY . 32.5 t -48.12 165.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 120.899 -1.126 . . . . 0.0 110.151 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.449 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 70.77 31.69 67.33 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.821 ' HB2' HD12 ' A' ' 30' ' ' ILE . 44.9 m-20 -116.58 100.28 7.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -1.041 . . . . 0.0 110.997 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.743 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -79.1 108.88 12.93 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.858 . . . . 0.0 109.831 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.819 ' C ' HD22 ' A' ' 52' ' ' LEU . 55.2 mt -75.4 139.94 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.329 -0.857 . . . . 0.0 110.824 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.819 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.2 mm? -125.05 4.63 7.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.255 -0.903 . . . . 0.0 110.916 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 176.96 103.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.832 -1.168 . . . . 0.0 109.75 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.91 HG21 ' CB ' ' A' ' 70' ' ' ALA . 20.5 m -92.49 121.04 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.223 -0.923 . . . . 0.0 110.602 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 59.41 34.16 22.62 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.168 -0.958 . . . . 0.0 110.809 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.99 19.89 62.12 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.8 mt-10 -110.23 91.83 3.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.941 -1.329 . . . . 0.0 109.91 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -41.44 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.574 0.702 . . . . 0.0 111.488 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.889 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -90.39 14.01 14.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.489 -0.757 . . . . 0.0 110.399 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.6 t -68.88 -49.54 57.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 110.724 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.36 18.58 5.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.061 -1.024 . . . . 0.0 110.523 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.889 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -104.21 158.41 16.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -0.927 . . . . 0.0 110.233 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.709 HG22 ' HB3' ' A' ' 22' ' ' ARG . 12.4 p -90.15 176.23 6.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 110.071 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.718 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.5 t60 -58.64 -26.01 63.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.072 -1.018 . . . . 0.0 109.556 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.45 -30.28 59.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.089 -1.007 . . . . 0.0 109.709 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.76 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 7.3 mm-40 -75.62 -27.03 58.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.838 . . . . 0.0 109.952 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.514 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -80.09 -36.68 35.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.368 -0.832 . . . . 0.0 110.502 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.974 ' CG2' HD11 ' A' ' 18' ' ' ILE . 17.5 t -75.5 -32.71 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.047 -1.033 . . . . 0.0 109.549 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -60.97 -38.32 85.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 109.879 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.91 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.98 -50.58 32.77 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.177 -0.952 . . . . 0.0 108.788 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.682 ' O ' HG11 ' B' ' 7' ' ' VAL . 86.7 mt -58.56 -23.59 58.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.619 -0.676 . . . . 0.0 110.01 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -80.69 -36.78 31.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.124 -0.985 . . . . 0.0 109.941 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -119.43 58.21 0.88 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.111 -0.993 . . . . 0.0 109.871 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.498 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 39.4 p -80.96 -170.65 2.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.904 . . . . 0.0 110.003 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.53 -175.05 15.33 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -49.04 -59.88 3.25 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.056 -1.261 . . . . 0.0 110.298 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -88.4 95.44 10.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 109.582 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.885 HG12 HD13 ' A' ' 80' ' ' LEU . 94.8 t -79.86 78.74 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 110.66 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.602 ' O ' HD12 ' A' ' 80' ' ' LEU . 5.0 t -68.66 116.32 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.083 -1.01 . . . . 0.0 108.352 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.885 HD13 HG12 ' A' ' 78' ' ' VAL . 3.4 mp -121.06 100.8 7.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.978 -1.076 . . . . 0.0 111.743 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 20.5 tt0 -64.13 128.89 37.8 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.636 HG11 HG23 ' A' ' 4' ' ' VAL . 2.2 p -131.9 143.93 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 111.799 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.703 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 79.5 tttt -106.67 88.34 2.74 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.603 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -56.0 111.24 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.456 -0.778 . . . . 0.0 111.165 -177.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 mtt -89.21 53.43 2.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 109.198 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.149 -179.535 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.465 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 15.3 tttp . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.157 0.503 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -121.13 90.84 3.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.991 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.413 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -79.9 -161.72 0.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 0.0 110.461 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.588 HD13 ' OG ' ' A' ' 17' ' ' SER . 22.1 tp -171.14 99.88 0.21 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 109.935 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.682 HG11 ' O ' ' A' ' 71' ' ' LEU . 92.5 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.255 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.351 0.596 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.851 ' CB ' HG13 ' A' ' 82' ' ' VAL . 1.7 mtp85 -157.05 167.74 29.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.68 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -138.66 119.01 13.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.497 -0.752 . . . . 0.0 109.189 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.977 HG22 ' HB1' ' A' ' 44' ' ' ALA . 83.2 t -127.63 126.15 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.969 -1.082 . . . . 0.0 110.655 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.5 m -117.29 114.39 23.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.446 -0.784 . . . . 0.0 109.441 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.914 HG21 HD12 ' A' ' 45' ' ' LEU . 98.4 t -102.8 111.04 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.946 . . . . 0.0 109.964 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.436 -0.79 . . . . 0.0 110.044 -179.847 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.714 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.173 0.511 . . . . 0.0 110.277 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.947 ' CA ' HD22 ' A' ' 37' ' ' LEU . . . 63.86 81.65 0.1 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.628 HG21 HD22 ' A' ' 14' ' ' LEU . 3.9 tt -176.42 117.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.326 -1.102 . . . . 0.0 110.325 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' B' ' 5' ' ' SER . 0.7 OUTLIER -111.8 119.57 39.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.186 -0.946 . . . . 0.0 109.577 179.231 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.014 HD11 HG22 ' A' ' 68' ' ' VAL . 8.8 pt -95.6 148.98 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.98 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HG2' ' CA ' ' B' ' 4' ' ' GLU . 0.2 OUTLIER -132.67 134.72 45.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.812 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 142.17 -159.98 27.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 168.32 136.84 2.12 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.545 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.0 OUTLIER -59.46 -16.1 21.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -1.133 . . . . 0.0 110.598 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.43 -12.38 60.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.826 -1.171 . . . . 0.0 110.233 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.14 27.54 8.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.088 -1.007 . . . . 0.0 110.185 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.69 49.68 19.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.126 -0.984 . . . . 0.0 110.043 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.614 ' HE1' ' HB2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -125.33 122.56 25.11 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 110.365 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.693 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 55.5 Cg_endo -72.66 50.86 1.77 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 O-C-N 123.422 1.222 . . . . 0.0 111.735 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 64' ' ' HIS . 25.4 mm 43.37 88.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 O-C-N 121.053 -1.029 . . . . 0.0 110.706 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 85' ' ' MET . 5.6 mt -97.74 132.51 43.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.857 -1.152 . . . . 0.0 111.608 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.801 HG21 HD11 ' A' ' 33' ' ' ILE . 56.9 mt -69.2 138.21 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.284 -0.885 . . . . 0.0 108.952 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 42.6 t -119.83 -24.73 6.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.94 -1.1 . . . . 0.0 110.931 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.43 108.3 5.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.016 -1.053 . . . . 0.0 110.666 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.801 HD11 HG21 ' A' ' 30' ' ' ILE . 15.9 mm -94.24 98.44 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.429 -0.794 . . . . 0.0 109.166 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.756 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 92.0 m-85 -57.9 130.83 48.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.608 -0.683 . . . . 0.0 110.362 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.972 ' O ' HD12 ' A' ' 37' ' ' LEU . 7.3 pttt -76.83 171.68 14.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.402 -0.811 . . . . 0.0 110.95 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.57 30.57 65.53 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.972 HD12 ' O ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -138.47 161.96 35.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.076 -1.249 . . . . 0.0 110.903 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.592 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -48.24 -66.73 0.35 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.579 -0.701 . . . . 0.0 111.592 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.714 ' HB2' ' CD2' ' A' ' 14' ' ' LEU . . . -47.57 -33.03 6.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 112.199 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.441 ' HB2' HG22 ' A' ' 33' ' ' ILE . 5.4 t70 -95.77 -19.91 19.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.719 -1.238 . . . . 0.0 111.302 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.494 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -93.78 14.86 17.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.905 -1.122 . . . . 0.0 110.725 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.509 HG21 HG22 ' A' ' 6' ' ' VAL . 8.9 t -107.74 14.07 25.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.013 -1.055 . . . . 0.0 110.843 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 44.79 46.91 8.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.188 -0.945 . . . . 0.0 111.284 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.977 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -165.62 -51.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 110.515 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.914 HD12 HG21 ' A' ' 6' ' ' VAL . 2.8 mt -70.61 83.07 0.6 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.839 -1.163 . . . . 0.0 108.504 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.591 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -110.29 155.07 22.58 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 48' ' ' GLY . 90.6 t -51.02 167.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.813 -1.179 . . . . 0.0 110.29 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.5 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 67.84 32.36 77.49 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.796 ' HB2' HD12 ' A' ' 30' ' ' ILE . 32.6 m-20 -114.05 104.44 12.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.484 -1.009 . . . . 0.0 110.431 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -80.56 105.69 12.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.328 -0.857 . . . . 0.0 109.627 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.793 ' C ' HD22 ' A' ' 52' ' ' LEU . 54.7 mt -76.62 135.97 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.405 -0.809 . . . . 0.0 111.07 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.793 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.4 mm? -120.55 8.21 10.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.488 -0.757 . . . . 0.0 110.214 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 26.0 t -178.68 135.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.103 -0.998 . . . . 0.0 109.704 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.664 HG22 HD11 ' A' ' 59' ' ' LEU . 1.5 m -129.24 114.83 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.309 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.42 ' ND2' ' HB ' ' A' ' 74' ' ' THR . 2.9 m-80 58.75 31.15 20.9 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.262 -0.899 . . . . 0.0 110.76 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.83 21.07 34.72 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.561 ' HB2' HG23 ' A' ' 54' ' ' VAL . 1.3 mm-40 -112.41 88.03 2.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.041 -1.27 . . . . 0.0 110.164 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -46.64 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.276 -0.89 . . . . 0.0 111.004 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.664 HD11 HG22 ' A' ' 54' ' ' VAL . 79.8 mt -81.7 -11.92 58.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.563 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.505 ' HB2' HD12 ' A' ' 52' ' ' LEU . 2.2 t -48.16 -32.41 6.96 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.231 -0.918 . . . . 0.0 110.06 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.9 t -112.06 22.62 14.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.343 -0.848 . . . . 0.0 109.451 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.498 ' HB3' ' HA ' ' A' ' 59' ' ' LEU . . . -113.11 152.57 29.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.425 -0.797 . . . . 0.0 110.143 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.545 HG22 ' HB3' ' A' ' 22' ' ' ARG . 3.1 p -86.9 169.94 12.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 110.053 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.896 ' O ' HG23 ' A' ' 68' ' ' VAL . 3.3 t60 -54.0 -25.74 22.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.929 . . . . 0.0 109.789 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -77.44 -36.26 53.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.062 -1.024 . . . . 0.0 110.034 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.428 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 46.4 mm-40 -73.11 -23.04 60.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.934 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.36 -38.25 24.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 110.417 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.014 HG22 HD11 ' A' ' 18' ' ' ILE . 14.1 t -72.44 -29.21 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.154 -0.966 . . . . 0.0 109.184 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -61.37 -37.2 82.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.335 -0.853 . . . . 0.0 109.813 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.605 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -71.54 -50.31 32.4 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.171 -0.956 . . . . 0.0 108.81 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.472 ' CD2' HD21 ' A' ' 80' ' ' LEU . 86.7 mt -57.68 -23.67 52.75 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.543 -0.723 . . . . 0.0 109.443 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -78.56 -34.91 46.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.678 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -130.79 54.17 1.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.343 -0.848 . . . . 0.0 109.684 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.706 ' CB ' HG22 ' A' ' 78' ' ' VAL . 66.2 p -57.81 -84.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.855 . . . . 0.0 110.502 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.427 ' N ' ' OG1' ' A' ' 74' ' ' THR . . . 154.12 -170.74 32.7 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -47.23 -35.69 7.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.147 -1.208 . . . . 0.0 110.665 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -132.96 130.39 39.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.223 -0.923 . . . . 0.0 109.705 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.875 HG12 HD13 ' A' ' 80' ' ' LEU . 99.4 t -94.64 81.59 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.072 -1.018 . . . . 0.0 111.196 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.678 ' O ' HD12 ' A' ' 80' ' ' LEU . 22.0 t -72.21 116.74 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.875 HD13 HG12 ' A' ' 78' ' ' VAL . 3.8 mp -124.54 108.49 12.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.959 -1.088 . . . . 0.0 112.108 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -70.26 129.15 38.56 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.851 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.8 p -129.02 145.38 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.855 -1.153 . . . . 0.0 112.602 -177.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.73 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 5.4 tttp -111.51 83.77 1.83 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.591 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -49.31 119.39 3.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.469 -0.77 . . . . 0.0 111.645 -177.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.705 ' HG3' HD21 ' A' ' 29' ' ' LEU . 2.8 mmt -101.21 47.32 0.91 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.6 tptt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.318 -179.449 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.544 ' CD ' ' CD2' ' A' ' 64' ' ' HIS . 12.0 mttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.319 0.58 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.466 ' CA ' ' HG2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER 54.92 49.71 17.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.015 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.423 ' O ' ' CB ' ' A' ' 17' ' ' SER . 26.5 t -54.24 -175.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 110.526 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.756 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -149.95 73.31 1.16 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.375 -0.828 . . . . 0.0 110.381 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.463 ' CG2' HG13 ' A' ' 68' ' ' VAL . 59.1 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.168 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.272 0.558 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.828 ' CB ' HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -155.19 162.4 40.95 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.217 -0.927 . . . . 0.0 110.506 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.93 109.92 6.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.438 -0.789 . . . . 0.0 109.295 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.857 HG22 ' HB1' ' A' ' 44' ' ' ALA . 89.6 t -115.49 152.87 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.029 -1.045 . . . . 0.0 110.846 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.6 m -132.79 114.94 14.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 109.564 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.63 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 86.2 t -102.82 118.67 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.086 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.1 mtm180 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.934 179.999 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.023 0.44 . . . . 0.0 110.717 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.883 ' CA ' HD22 ' A' ' 37' ' ' LEU . . . 57.88 90.17 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 tt -176.78 118.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.204 -1.174 . . . . 0.0 110.226 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' B' ' 5' ' ' SER . 1.1 t -112.4 100.24 8.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.182 -0.949 . . . . 0.0 109.783 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.949 HD11 HG22 ' A' ' 68' ' ' VAL . 9.8 pt -77.63 150.48 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 110.693 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 31' ' ' SER . 58.9 tttt -136.18 123.24 21.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 110.103 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.75 -140.44 8.69 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.444 ' CA ' ' HB2' ' A' ' 64' ' ' HIS . . . 138.99 148.11 5.22 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -61.36 -14.11 24.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -1.08 . . . . 0.0 110.844 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -9.08 57.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.921 -1.112 . . . . 0.0 110.559 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -130.32 26.28 5.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.043 -1.036 . . . . 0.0 110.12 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.5 mttp 54.72 40.88 32.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.312 -0.868 . . . . 0.0 110.157 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.593 ' HE1' ' HB2' ' A' ' 29' ' ' LEU . 6.2 mmm -120.88 124.77 27.33 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.377 -0.827 . . . . 0.0 110.034 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.699 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 49.6 Cg_endo -70.21 52.66 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 O-C-N 123.348 1.183 . . . . 0.0 111.745 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.654 HG21 ' HB1' ' A' ' 67' ' ' ALA . 18.0 mm 43.53 89.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.084 -1.01 . . . . 0.0 110.096 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' A' ' 50' ' ' ALA . 32.7 tp -102.41 126.78 49.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.886 -1.134 . . . . 0.0 112.072 -178.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.9 HD12 ' HB2' ' A' ' 49' ' ' ASP . 56.7 mt -62.08 135.81 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.463 -0.773 . . . . 0.0 109.633 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.432 ' HA ' HG13 ' A' ' 47' ' ' VAL . 8.4 t -121.91 -18.49 7.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 110.963 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.89 106.48 4.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.002 -1.061 . . . . 0.0 110.702 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.697 HD11 HG21 ' A' ' 30' ' ' ILE . 16.8 mm -94.77 109.78 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 0.0 109.265 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.824 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 88.6 m-85 -71.54 128.15 34.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.8 ' O ' HD12 ' A' ' 37' ' ' LEU . 1.8 mttp -73.83 173.08 10.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -0.939 . . . . 0.0 110.666 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.23 29.65 69.13 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.883 HD22 ' CA ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -138.26 159.42 42.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -1.163 . . . . 0.0 110.941 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.63 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -44.44 -62.42 1.18 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.628 -0.67 . . . . 0.0 111.604 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.726 ' O ' HG22 ' A' ' 42' ' ' THR . . . -47.82 -57.76 5.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.179 -0.95 . . . . 0.0 110.99 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.439 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 12.8 t70 -75.47 0.51 16.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.998 -1.064 . . . . 0.0 111.332 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -104.66 -2.44 25.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.75 -1.219 . . . . 0.0 110.865 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 39' ' ' ALA . 9.2 t -98.67 14.82 27.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.842 -1.161 . . . . 0.0 110.662 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 47.62 49.31 16.38 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.11 -0.993 . . . . 0.0 110.649 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.857 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -169.11 -43.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 110.206 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.489 ' CD2' HG11 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -68.17 80.1 0.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 108.83 179.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.586 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.23 153.67 26.75 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.594 -0.692 . . . . 0.0 110.043 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.526 HG12 ' N ' ' A' ' 48' ' ' GLY . 96.1 t -52.66 168.35 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.075 -1.015 . . . . 0.0 110.362 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.526 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 70.85 30.28 68.33 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.9 ' HB2' HD12 ' A' ' 30' ' ' ILE . 45.6 m-20 -114.92 99.9 7.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -1.036 . . . . 0.0 111.059 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -79.07 107.58 11.93 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.092 -1.005 . . . . 0.0 109.718 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.858 ' C ' HD22 ' A' ' 52' ' ' LEU . 52.2 mt -76.49 138.66 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.441 -0.787 . . . . 0.0 110.683 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.858 HD22 ' C ' ' A' ' 51' ' ' ILE . 3.9 mm? -127.35 7.23 6.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.153 -0.967 . . . . 0.0 110.82 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 176.08 99.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.87 -1.144 . . . . 0.0 109.765 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.927 HG21 ' CB ' ' A' ' 70' ' ' ALA . 23.1 m -91.1 121.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.138 -0.976 . . . . 0.0 110.36 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' A' ' 79' ' ' VAL . 3.8 m120 60.37 36.29 20.45 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.096 -1.002 . . . . 0.0 110.274 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.3 11.42 85.34 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.2 tp10 -96.79 92.34 6.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.882 -1.363 . . . . 0.0 109.429 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -40.89 103.96 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.562 0.696 . . . . 0.0 111.31 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.038 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -92.99 -13.53 28.6 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.61 -0.681 . . . . 0.0 110.499 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.2 p -54.9 -37.64 66.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.004 . . . . 0.0 110.135 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 m -96.96 23.42 7.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -0.935 . . . . 0.0 110.264 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 1.038 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -117.59 155.43 29.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 110.171 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.9 p -85.54 172.6 10.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.314 -0.866 . . . . 0.0 110.18 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.805 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.0 t60 -53.62 -25.74 18.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.107 -0.996 . . . . 0.0 109.786 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -75.87 -40.91 53.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.017 -1.052 . . . . 0.0 109.27 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.885 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 19.6 mt-10 -65.25 -22.43 66.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.527 -0.733 . . . . 0.0 109.87 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.654 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -83.98 -40.58 18.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.298 -0.877 . . . . 0.0 110.658 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.949 HG22 HD11 ' A' ' 18' ' ' ILE . 9.4 t -74.49 -28.37 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.205 -0.935 . . . . 0.0 109.26 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -65.54 -37.88 88.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.342 -0.849 . . . . 0.0 110.093 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.927 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.06 -37.28 75.46 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.12 -0.988 . . . . 0.0 109.125 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.8 mt -73.81 -19.95 60.6 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.648 -0.658 . . . . 0.0 109.808 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -80.88 -45.0 17.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.904 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -106.22 30.83 5.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.366 -0.834 . . . . 0.0 109.99 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 1.076 HG21 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -65.64 142.66 57.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.845 . . . . 0.0 109.972 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.86 -179.98 40.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 77' ' ' GLU . 8.2 pttt -49.9 -50.92 44.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.363 -1.081 . . . . 0.0 110.688 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.425 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 81.5 mm-40 -88.86 92.87 9.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.908 -1.12 . . . . 0.0 109.133 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.076 HG13 HG21 ' A' ' 74' ' ' THR . 78.3 t -83.06 78.63 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.189 -0.944 . . . . 0.0 110.903 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.65 ' O ' HD12 ' A' ' 80' ' ' LEU . 11.0 t -66.44 124.01 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.892 HD13 HG12 ' A' ' 78' ' ' VAL . 2.3 mp -124.21 106.14 10.07 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.901 -1.125 . . . . 0.0 111.749 -178.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.9 tt0 -68.2 121.59 16.53 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.828 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.6 p -127.05 147.95 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.069 -1.02 . . . . 0.0 112.683 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 13.9 ttmt -112.45 88.2 2.76 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.586 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -56.28 126.68 27.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 111.157 -177.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.0 mmt -105.89 54.89 0.69 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.344 -0.847 . . . . 0.0 109.226 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.5 tttt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.224 -179.527 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.54 ' CB ' ' CE1' ' A' ' 64' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.234 0.54 . . . . 0.0 110.178 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER 54.29 62.31 2.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -0.862 . . . . 0.0 109.858 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 17' ' ' SER . 3.5 t -73.59 -156.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.241 -0.912 . . . . 0.0 110.62 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.824 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -167.07 89.25 0.34 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.317 -0.864 . . . . 0.0 110.515 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.53 ' CG2' HG13 ' A' ' 68' ' ' VAL . 41.9 t . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.066 -1.021 . . . . 0.0 110.082 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 15.5 mtm-85 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.468 0.652 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.884 ' CB ' HG13 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -148.21 164.36 34.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.397 -0.815 . . . . 0.0 110.195 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.43 117.51 18.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 109.461 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.054 HG22 ' HB1' ' A' ' 44' ' ' ALA . 53.3 t -129.63 126.95 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.05 -1.031 . . . . 0.0 110.521 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.1 m -119.79 130.81 55.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.364 -0.835 . . . . 0.0 109.674 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.54 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 89.2 t -117.21 111.1 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.783 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.016 -179.864 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.782 HD23 ' HB2' ' A' ' 39' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.207 0.527 . . . . 0.0 110.283 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.46 ' CA ' ' HB2' ' A' ' 34' ' ' PHE . . . 65.23 76.19 0.34 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.925 HD12 HD21 ' A' ' 45' ' ' LEU . 4.2 tt -166.24 117.18 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -1.055 . . . . 0.0 109.698 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 32' ' ' LYS . 1.2 t -107.29 92.31 4.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.09 -1.006 . . . . 0.0 109.933 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.98 HD11 ' CG2' ' A' ' 68' ' ' VAL . 45.2 pt -69.04 146.67 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.199 -0.938 . . . . 0.0 110.886 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' CB ' ' HB2' ' A' ' 31' ' ' SER . 21.5 tttt -135.41 117.32 15.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.495 -0.753 . . . . 0.0 109.728 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.06 -155.37 26.44 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 155.92 135.66 2.03 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -61.5 -14.47 29.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -1.12 . . . . 0.0 110.698 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.7 2.2 34.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.838 -1.164 . . . . 0.0 110.23 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -138.35 26.77 2.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.517 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.07 74.15 0.38 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.0 109.965 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.703 ' HE1' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -161.82 120.43 1.42 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 110.649 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.674 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 53.6 Cg_endo -72.63 52.85 2.14 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 O-C-N 123.508 1.267 . . . . 0.0 111.408 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 64' ' ' HIS . 11.4 mm 43.45 87.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 120.998 -1.064 . . . . 0.0 110.666 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.703 ' CB ' ' HE1' ' A' ' 26' ' ' MET . 6.0 mt -97.33 132.32 43.18 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.672 -1.268 . . . . 0.0 111.663 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.804 HD12 ' HB2' ' A' ' 49' ' ' ASP . 57.4 mt -65.64 137.17 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.248 -0.907 . . . . 0.0 108.628 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.454 ' HB2' ' CB ' ' A' ' 19' ' ' LYS . 3.1 t -119.73 -29.58 4.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.046 -1.034 . . . . 0.0 110.715 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -133.45 101.43 5.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 110.601 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.673 HD11 HG21 ' A' ' 30' ' ' ILE . 10.2 mm -87.69 106.11 15.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.548 ' CE1' HD13 ' B' ' 6' ' ' LEU . 5.3 m-85 -59.24 123.1 15.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.509 -0.745 . . . . 0.0 110.219 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.417 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -75.21 146.18 41.4 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.228 -0.92 . . . . 0.0 110.563 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.422 ' C ' HD22 ' A' ' 37' ' ' LEU . . . 78.74 0.75 81.84 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.532 ' N ' HD22 ' A' ' 37' ' ' LEU . 4.0 mm? -100.7 163.07 12.5 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.942 -1.328 . . . . 0.0 110.26 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.54 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -47.09 -55.5 8.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.364 -0.835 . . . . 0.0 110.775 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 1.044 ' HB1' HD23 ' A' ' 45' ' ' LEU . . . -51.38 -47.67 62.8 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.363 -0.835 . . . . 0.0 111.024 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 13.8 t70 -86.72 3.43 44.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.157 -0.964 . . . . 0.0 111.267 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -103.58 4.56 35.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.815 -1.178 . . . . 0.0 110.783 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 39' ' ' ALA . 4.9 t -107.66 14.65 25.44 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.854 -1.154 . . . . 0.0 110.712 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 45.4 56.79 5.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.263 -0.898 . . . . 0.0 111.068 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 1.054 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -170.57 -48.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.109 -0.994 . . . . 0.0 110.315 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.044 HD23 ' HB1' ' A' ' 39' ' ' ALA . 3.5 tp -70.45 84.58 0.59 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.831 -1.168 . . . . 0.0 108.489 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -111.04 147.44 34.77 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.758 -0.589 . . . . 0.0 110.039 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.504 ' HA ' HG22 ' A' ' 30' ' ' ILE . 52.0 t -47.35 147.47 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.274 -0.891 . . . . 0.0 110.3 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.32 26.85 26.99 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.421 -1.872 . . . . 0.0 108.421 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.804 ' HB2' HD12 ' A' ' 30' ' ' ILE . 58.2 m-20 -110.26 106.82 16.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.524 -0.986 . . . . 0.0 110.384 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.674 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -84.41 108.95 17.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.938 . . . . 0.0 109.593 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.794 ' C ' HD22 ' A' ' 52' ' ' LEU . 63.8 mt -76.57 136.31 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 111.042 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.794 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.2 mm? -124.63 15.5 8.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.476 -0.765 . . . . 0.0 109.886 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 4.6 t 176.81 135.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 108.967 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.88 HG12 HD22 ' A' ' 80' ' ' LEU . 1.2 m -128.68 118.15 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.041 -1.037 . . . . 0.0 110.497 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 54.72 37.91 29.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.332 -0.855 . . . . 0.0 110.554 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.75 26.93 40.07 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.596 ' HB2' HG23 ' A' ' 54' ' ' VAL . 47.7 mt-10 -118.93 93.19 4.01 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.081 -1.247 . . . . 0.0 110.173 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -44.96 111.79 0.36 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.448 -0.783 . . . . 0.0 110.93 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.934 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -101.48 17.18 23.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.508 -0.745 . . . . 0.0 110.658 -179.385 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 t -66.3 -50.37 63.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 0.0 110.29 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.28 36.62 1.57 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.066 -1.021 . . . . 0.0 110.48 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.934 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -116.46 149.44 39.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.957 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.8 p -83.09 171.58 13.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 0.0 110.418 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.916 ' O ' HG23 ' A' ' 68' ' ' VAL . 8.7 t60 -56.61 -23.45 41.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.231 -0.918 . . . . 0.0 109.91 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.91 -42.83 31.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 109.447 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 2.5 mt-10 -65.65 -21.16 66.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.349 -0.844 . . . . 0.0 109.784 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.614 ' CA ' HD11 ' A' ' 59' ' ' LEU . . . -84.5 -45.41 12.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.371 -0.831 . . . . 0.0 110.53 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.98 ' CG2' HD11 ' A' ' 18' ' ' ILE . 6.0 t -67.03 -31.48 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.124 -0.985 . . . . 0.0 109.186 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -42.04 82.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.401 -0.812 . . . . 0.0 109.444 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.681 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -67.93 -46.0 72.74 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.115 -0.991 . . . . 0.0 108.741 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.67 ' HB3' HG11 ' B' ' 7' ' ' VAL . 3.8 mm? -52.88 -29.79 30.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.672 -0.643 . . . . 0.0 109.697 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.599 ' HG2' HG13 ' B' ' 7' ' ' VAL . 7.8 mttm -82.19 -40.15 22.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.242 -0.911 . . . . 0.0 110.24 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -110.59 34.66 3.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 110.117 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.827 ' HB ' HG22 ' A' ' 78' ' ' VAL . 21.3 p -51.97 -79.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 0.0 110.309 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.39 -176.99 25.96 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -50.59 -41.04 54.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.206 -1.173 . . . . 0.0 110.169 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 3.7 pt-20 -117.61 112.64 20.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.852 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.827 HG22 ' HB ' ' A' ' 74' ' ' THR . 53.1 t -84.94 83.66 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.076 -1.015 . . . . 0.0 110.407 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.799 ' O ' HD23 ' A' ' 80' ' ' LEU . 11.1 t -76.1 116.68 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.88 HD22 HG12 ' A' ' 54' ' ' VAL . 14.8 mt -125.06 116.45 22.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.842 -1.161 . . . . 0.0 111.523 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -74.19 122.57 22.99 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.884 HG13 ' CB ' ' A' ' 2' ' ' ARG . 3.1 p -119.21 144.63 27.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.543 -177.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 7.0 tptm -110.15 90.06 3.2 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.58 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -55.21 125.12 19.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.448 -0.783 . . . . 0.0 111.067 -177.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.4 mmm -116.3 51.91 0.95 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.462 -0.774 . . . . 0.0 109.41 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.7 pttt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.256 -179.605 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.469 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 14.9 tttt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.211 0.529 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -112.68 97.88 6.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.215 -0.928 . . . . 0.0 110.02 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 17' ' ' SER . 33.1 m -103.99 133.07 49.57 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.201 -0.937 . . . . 0.0 110.398 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.548 HD13 ' CE1' ' A' ' 34' ' ' PHE . 41.0 tp -105.92 108.35 19.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -0.863 . . . . 0.0 110.207 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.67 HG11 ' HB3' ' A' ' 71' ' ' LEU . 40.2 t . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.053 -1.029 . . . . 0.0 110.203 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.304 0.573 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.872 ' CB ' HG13 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -147.85 158.72 44.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.537 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.7 115.26 16.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.215 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.742 HG13 ' HB3' ' A' ' 44' ' ' ALA . 37.9 t -132.0 139.32 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.07 -1.018 . . . . 0.0 110.689 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.8 m -128.26 126.54 41.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.311 -0.868 . . . . 0.0 110.271 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.093 HG22 HG21 ' A' ' 42' ' ' THR . 98.2 t -106.07 126.37 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.047 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 110.203 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.544 ' O ' HD23 ' A' ' 14' ' ' LEU . 1.2 tt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.118 0.485 . . . . 0.0 110.726 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.494 ' HA3' ' CG ' ' A' ' 37' ' ' LEU . . . 64.86 87.53 0.05 OUTLIER Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -178.8 121.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.113 -1.227 . . . . 0.0 110.28 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.49 109.78 21.55 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.918 HD11 HG22 ' A' ' 68' ' ' VAL . 27.5 pt -92.05 143.08 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -0.89 . . . . 0.0 111.171 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -125.69 170.14 11.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.57 179.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.09 -143.28 15.91 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.451 ' CA ' ' HB2' ' A' ' 64' ' ' HIS . . . 138.43 143.04 4.41 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -60.53 -14.56 20.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -1.116 . . . . 0.0 110.99 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.14 -20.35 64.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.934 -1.104 . . . . 0.0 110.106 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.73 24.33 7.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 109.726 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.2 tttt 55.58 82.59 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.41 -0.806 . . . . 0.0 110.218 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.535 ' HE1' ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -159.12 127.89 3.03 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 109.879 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.829 ' HB2' HD11 ' A' ' 52' ' ' LEU . 52.9 Cg_endo -70.28 50.61 0.96 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 O-C-N 123.321 1.169 . . . . 0.0 112.376 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.467 ' N ' ' HE2' ' A' ' 26' ' ' MET . 21.0 mm 38.88 88.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.549 0 O-C-N 121.201 -0.937 . . . . 0.0 111.189 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.619 HD11 ' HG3' ' A' ' 85' ' ' MET . 6.1 mt -96.66 133.23 41.44 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.88 -1.138 . . . . 0.0 111.765 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.842 HD12 ' HB2' ' A' ' 49' ' ' ASP . 67.8 mt -65.74 144.25 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 108.806 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.3 t -123.85 -23.88 4.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.925 -1.11 . . . . 0.0 111.252 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.06 95.26 2.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.97 -1.081 . . . . 0.0 111.04 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.481 HG22 ' HB2' ' A' ' 40' ' ' ASP . 10.7 mm -77.47 100.24 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.36 -0.837 . . . . 0.0 108.831 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.791 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 17.2 m-85 -49.76 137.17 16.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.637 -0.664 . . . . 0.0 110.644 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.615 ' O ' HD23 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -79.29 159.0 27.41 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.177 -0.952 . . . . 0.0 110.487 -179.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.58 21.37 27.97 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 35' ' ' LYS . 2.1 mm? -111.09 167.9 9.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -1.191 . . . . 0.0 109.865 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.889 ' O ' HG23 ' A' ' 42' ' ' THR . . . -51.84 -66.89 0.31 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.139 -0.975 . . . . 0.0 111.164 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 45' ' ' LEU . . . -47.62 -47.25 29.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.253 -0.905 . . . . 0.0 111.108 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.481 ' HB2' HG22 ' A' ' 33' ' ' ILE . 4.8 t70 -71.88 -11.76 60.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.097 -1.002 . . . . 0.0 110.861 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -105.48 15.87 26.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.828 -1.17 . . . . 0.0 110.547 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 1.093 HG21 HG22 ' A' ' 6' ' ' VAL . 48.3 p -106.06 12.81 29.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.027 -1.045 . . . . 0.0 110.73 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 48.24 44.88 20.0 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.056 -1.027 . . . . 0.0 110.538 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.742 ' HB3' HG13 ' A' ' 4' ' ' VAL . . . -174.72 -43.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.551 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.433 HD21 HD12 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -66.83 83.37 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.81 -1.181 . . . . 0.0 109.049 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.585 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -114.24 151.39 32.9 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.579 -0.7 . . . . 0.0 110.094 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 48' ' ' GLY . 24.5 t -47.66 169.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.21 -0.931 . . . . 0.0 110.35 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 66.46 33.77 85.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.842 ' HB2' HD12 ' A' ' 30' ' ' ILE . 28.4 m-20 -115.16 106.23 13.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.432 -1.04 . . . . 0.0 110.177 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.951 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -83.76 108.78 17.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.212 -0.93 . . . . 0.0 110.383 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.812 ' C ' HD12 ' A' ' 52' ' ' LEU . 60.1 mt -77.67 134.79 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.413 -0.805 . . . . 0.0 110.379 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.829 HD11 ' HB2' ' A' ' 27' ' ' PRO . 10.0 mp -126.6 10.14 7.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.877 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 176.31 96.97 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.983 -1.073 . . . . 0.0 110.013 179.06 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.969 HG21 ' CB ' ' A' ' 70' ' ' ALA . 33.7 m -86.99 118.32 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.858 . . . . 0.0 110.508 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 55.49 33.96 22.07 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.362 -0.836 . . . . 0.0 111.089 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.11 -11.4 72.03 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.555 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' SER . 0.3 OUTLIER -77.53 90.23 3.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.787 -1.42 . . . . 0.0 109.593 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -41.97 106.51 0.06 Allowed 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.557 0.694 . . . . 0.0 111.075 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.943 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -98.9 -10.32 22.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.546 -0.722 . . . . 0.0 110.92 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.2 p -52.65 -36.53 57.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.02 -1.05 . . . . 0.0 110.296 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 m -113.57 49.34 0.98 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.167 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.943 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -130.74 149.2 52.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.236 -0.915 . . . . 0.0 110.303 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.9 p -72.41 163.01 28.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.369 -0.832 . . . . 0.0 109.882 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.889 ' O ' HG23 ' A' ' 68' ' ' VAL . 7.7 t60 -54.48 -25.16 23.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.004 -1.06 . . . . 0.0 109.729 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -75.17 -43.93 49.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.063 -1.023 . . . . 0.0 108.796 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.724 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -60.38 -28.83 68.52 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.502 -0.749 . . . . 0.0 109.419 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.682 ' CA ' HD11 ' A' ' 59' ' ' LEU . . . -77.51 -49.49 14.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.688 -0.633 . . . . 0.0 110.881 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.918 HG22 HD11 ' A' ' 18' ' ' ILE . 3.0 t -66.56 -30.54 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 119.206 -0.998 . . . . 0.0 108.927 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.58 -36.61 71.93 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.308 -0.87 . . . . 0.0 109.202 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.969 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -72.49 -35.76 68.24 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.245 -0.909 . . . . 0.0 109.302 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.706 ' C ' HG11 ' B' ' 7' ' ' VAL . 4.1 mm? -69.18 -29.08 66.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.698 -0.626 . . . . 0.0 109.918 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -79.1 -37.85 37.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.212 -0.93 . . . . 0.0 109.87 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -104.33 33.52 3.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.423 -0.798 . . . . 0.0 109.591 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.96 HG22 HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -73.39 138.09 45.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.403 -0.811 . . . . 0.0 110.188 -179.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.99 -178.46 52.4 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -53.31 -62.98 1.3 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -1.126 . . . . 0.0 110.366 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -73.59 90.59 1.78 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.209 -0.932 . . . . 0.0 109.223 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.96 HG22 HG22 ' A' ' 74' ' ' THR . 99.2 t -84.33 83.29 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 110.92 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.966 ' O ' HD23 ' A' ' 80' ' ' LEU . 9.0 t -74.98 124.92 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.966 HD23 ' O ' ' A' ' 79' ' ' VAL . 13.0 mt -130.25 118.67 21.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.744 -1.223 . . . . 0.0 111.71 -178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 35.0 tt0 -76.59 121.47 23.24 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.872 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.7 p -120.28 149.31 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 0.0 112.447 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.951 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -114.54 86.49 2.44 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.611 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.585 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -55.09 118.17 4.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.414 -0.804 . . . . 0.0 111.475 -177.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.619 ' HG3' HD11 ' A' ' 29' ' ' LEU . 4.1 mmt -95.98 51.01 1.21 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.319 -0.863 . . . . 0.0 108.769 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.8 tttt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.302 -179.402 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 64' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.376 0.608 . . . . 0.0 110.523 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 16.8 tt0 -58.5 96.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.468 -0.77 . . . . 0.0 110.593 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 8.2 m -84.22 -162.15 0.63 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.217 -0.927 . . . . 0.0 110.01 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.791 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -161.6 86.3 0.65 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.068 -1.02 . . . . 0.0 110.326 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.706 HG11 ' C ' ' A' ' 71' ' ' LEU . 39.1 t . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.05 -1.031 . . . . 0.0 109.979 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.53 0.681 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.524 ' CG ' HG13 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -158.78 143.47 15.9 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.483 -0.761 . . . . 0.0 109.614 -179.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.9 ptt-85 -122.28 136.56 54.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.121 -0.987 . . . . 0.0 110.115 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.739 HG13 ' CB ' ' A' ' 44' ' ' ALA . 46.6 t -139.31 134.26 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.103 -0.998 . . . . 0.0 110.538 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.7 m -118.04 125.22 49.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.393 -0.817 . . . . 0.0 110.08 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.566 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 83.2 t -118.39 129.14 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.353 -0.842 . . . . 0.0 109.185 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.6 mtm-85 . . . . . 0 C--N 1.301 -1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.912 -179.427 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.91 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.033 0.444 . . . . 0.0 110.382 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.887 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 56.48 90.47 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.628 ' CD1' HD22 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -175.04 123.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.175 -1.191 . . . . 0.0 110.826 -178.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.441 ' HB3' ' CB ' ' A' ' 32' ' ' LYS . 29.7 t -111.07 125.04 53.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 109.403 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.934 HD11 ' CG2' ' A' ' 68' ' ' VAL . 42.4 pt -105.0 150.66 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.135 -0.978 . . . . 0.0 110.883 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -133.9 158.97 42.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.377 -0.827 . . . . 0.0 109.848 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.1 -159.86 13.85 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 164.83 148.25 5.4 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.419 ' CB ' ' HA ' ' A' ' 63' ' ' THR . 10.5 ttp85 -60.46 -14.94 22.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -1.085 . . . . 0.0 110.809 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.63 -19.8 54.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.897 -1.127 . . . . 0.0 110.021 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -111.34 23.08 14.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.266 -0.896 . . . . 0.0 109.932 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 tptp 54.49 54.88 8.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.323 -0.86 . . . . 0.0 110.355 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.454 ' CE ' ' HB2' ' A' ' 29' ' ' LEU . 4.9 mmm -138.05 125.66 13.79 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.218 -0.926 . . . . 0.0 110.233 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.764 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 48.3 Cg_endo -69.53 52.33 0.91 Allowed 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.104 1.203 . . . . 0.0 111.882 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 64' ' ' HIS . 13.0 mm 42.96 90.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 121.116 -0.99 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 50' ' ' ALA . 30.4 tp -98.9 124.97 44.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.887 -1.133 . . . . 0.0 111.785 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.836 HD12 ' HB2' ' A' ' 49' ' ' ASP . 56.2 mt -57.27 142.31 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.47 -0.769 . . . . 0.0 109.671 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.3 -25.9 4.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.136 -0.977 . . . . 0.0 110.904 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.441 ' CB ' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -141.11 105.59 4.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.02 -1.05 . . . . 0.0 110.628 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.669 HD11 HG21 ' A' ' 30' ' ' ILE . 15.9 mm -90.38 115.71 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 109.085 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.525 ' HB3' HD13 ' A' ' 37' ' ' LEU . 17.2 m-85 -75.99 136.75 39.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.443 -0.785 . . . . 0.0 109.774 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.668 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -82.68 167.59 18.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.152 -0.968 . . . . 0.0 110.855 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.88 29.01 74.19 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.887 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER -137.47 160.23 39.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -1.157 . . . . 0.0 110.834 -179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -44.11 -69.63 0.13 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.495 -0.753 . . . . 0.0 111.935 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.91 ' HB2' ' CD2' ' A' ' 14' ' ' LEU . . . -45.55 -47.65 14.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.482 -0.761 . . . . 0.0 111.532 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.428 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 13.7 t70 -85.18 4.84 32.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.959 -1.088 . . . . 0.0 110.892 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -106.11 -3.14 21.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.822 -1.174 . . . . 0.0 110.835 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.501 HG21 HG22 ' A' ' 6' ' ' VAL . 8.7 t -99.82 14.71 29.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.922 -1.111 . . . . 0.0 110.643 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 47.43 39.24 8.87 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.043 -1.035 . . . . 0.0 110.904 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.739 ' CB ' HG13 ' A' ' 4' ' ' VAL . . . -152.28 -46.38 0.1 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.152 -0.967 . . . . 0.0 110.428 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.628 HD22 ' CD1' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -71.69 85.62 0.91 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.781 -1.2 . . . . 0.0 108.649 179.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.602 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.82 156.12 23.44 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.655 -179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.497 ' HA ' HG22 ' A' ' 30' ' ' ILE . 89.3 t -52.04 163.37 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.659 -1.275 . . . . 0.0 109.575 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.441 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 75.59 26.17 66.0 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.836 ' HB2' HD12 ' A' ' 30' ' ' ILE . 59.5 m-20 -112.94 101.24 9.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.506 -0.996 . . . . 0.0 110.57 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.764 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -79.4 110.0 14.29 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.369 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 52' ' ' LEU . 42.9 mt -78.28 138.81 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.426 -0.796 . . . . 0.0 110.325 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.644 HD11 ' HB2' ' A' ' 27' ' ' PRO . 3.3 mp -135.34 15.35 3.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.591 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 14.6 t 175.59 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.409 -0.807 . . . . 0.0 109.267 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.092 HG21 ' HB1' ' A' ' 70' ' ' ALA . 33.8 m -100.68 122.23 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.253 -0.904 . . . . 0.0 110.96 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 57.43 28.24 15.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.442 -0.786 . . . . 0.0 111.466 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.26 22.46 32.14 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.585 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 53' ' ' SER . 9.1 mt-10 -115.72 93.22 4.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.97 -1.312 . . . . 0.0 109.539 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.42 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.62 0.724 . . . . 0.0 111.438 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.034 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -87.61 -12.65 44.99 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.607 -0.683 . . . . 0.0 110.622 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.448 ' OG ' HD23 ' A' ' 52' ' ' LEU . 49.3 m -53.09 -31.8 43.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.994 -1.066 . . . . 0.0 110.442 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.61 33.25 3.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.194 -0.941 . . . . 0.0 110.475 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 1.034 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -124.7 144.94 49.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 0.0 110.203 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.419 ' HA ' ' CB ' ' A' ' 22' ' ' ARG . 51.1 p -76.9 166.19 23.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 109.835 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.915 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.6 t60 -51.59 -25.04 6.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.056 -1.028 . . . . 0.0 110.071 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.69 -44.0 35.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.117 -0.989 . . . . 0.0 109.057 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.587 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 15.3 mm-40 -66.59 -22.34 66.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.387 -0.821 . . . . 0.0 109.499 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.795 ' HA ' HD11 ' A' ' 59' ' ' LEU . . . -80.6 -46.91 14.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.388 -0.82 . . . . 0.0 110.44 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.934 ' CG2' HD11 ' A' ' 18' ' ' ILE . 10.4 t -64.73 -29.82 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.99 -31.01 69.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.351 -0.843 . . . . 0.0 109.468 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.092 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -74.25 -33.31 63.27 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.276 -0.89 . . . . 0.0 109.679 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.67 ' HB3' HG11 ' B' ' 7' ' ' VAL . 4.4 mm? -72.02 -26.38 62.19 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.537 -0.727 . . . . 0.0 109.782 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.4 -41.36 24.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.251 -0.906 . . . . 0.0 109.939 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -93.63 23.21 4.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.678 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.788 ' CG2' HG22 ' A' ' 78' ' ' VAL . 74.4 m -54.83 129.86 38.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.394 -0.816 . . . . 0.0 110.16 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.79 176.91 46.32 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.422 ' HG3' ' HG2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -49.82 -46.03 50.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -1.146 . . . . 0.0 110.517 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.422 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 20.1 mm-40 -90.94 106.15 18.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.026 -1.047 . . . . 0.0 109.092 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.892 HG12 HD13 ' A' ' 80' ' ' LEU . 20.3 t -97.5 82.0 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.132 -0.98 . . . . 0.0 111.15 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.499 ' O ' HD12 ' A' ' 80' ' ' LEU . 10.8 t -78.64 108.2 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.892 HD13 HG12 ' A' ' 78' ' ' VAL . 4.4 mp -114.82 112.22 22.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.78 -1.2 . . . . 0.0 112.529 -177.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 32.0 tt0 -74.89 124.48 26.96 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.524 HG13 ' CG ' ' A' ' 2' ' ' ARG . 2.2 p -127.53 147.6 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.949 -1.095 . . . . 0.0 111.768 -177.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 3.4 mttt -107.75 87.4 2.49 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.602 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -59.51 114.08 2.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.505 -0.747 . . . . 0.0 110.788 -177.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 mmm -93.62 59.95 2.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.883 . . . . 0.0 109.756 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.0 tttt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.285 -179.81 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.459 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 8.9 tttt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.236 0.541 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 5.7 tt0 -117.88 86.23 2.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 110.196 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.04 -169.44 2.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.209 -0.932 . . . . 0.0 110.258 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.713 ' O ' HD13 ' B' ' 6' ' ' LEU . 2.5 tm? -160.51 106.75 1.5 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 110.122 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.67 HG11 ' HB3' ' A' ' 71' ' ' LEU . 61.6 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.163 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 121.225 0.536 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.516 ' CG ' HG13 ' A' ' 82' ' ' VAL . 1.6 tpt180 -167.6 143.92 4.17 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.321 -0.862 . . . . 0.0 109.74 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -119.98 136.75 54.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.09 -1.006 . . . . 0.0 110.29 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 44' ' ' ALA . 54.9 t -142.75 159.6 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.968 . . . . 0.0 110.528 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 54.0 m -146.73 143.38 28.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.356 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.628 ' CG2' HD12 ' A' ' 45' ' ' LEU . 80.7 t -130.28 118.03 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.334 -0.854 . . . . 0.0 109.804 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.851 179.734 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.566 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.179 0.514 . . . . 0.0 110.51 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.505 ' HA3' ' HG ' ' A' ' 37' ' ' LEU . . . 66.6 91.71 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.55 HG22 ' OXT' ' B' ' 7' ' ' VAL . 2.2 tt -179.15 119.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.094 -1.239 . . . . 0.0 110.56 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.83 ' HB2' HD12 ' B' ' 6' ' ' LEU . 0.3 OUTLIER -105.71 91.48 3.77 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.24 -0.913 . . . . 0.0 109.177 178.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.059 HD11 HG22 ' A' ' 68' ' ' VAL . 25.2 pt -69.16 155.35 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 111.131 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' CG ' ' HG3' ' B' ' 4' ' ' GLU . 0.7 OUTLIER -136.11 175.2 9.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.089 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.61 -154.97 19.36 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 157.57 134.53 1.76 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.496 ' HB3' HG22 ' A' ' 63' ' ' THR . 7.2 ttp85 -60.07 -15.47 23.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.4 -1.059 . . . . 0.0 110.762 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.61 -15.15 61.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.856 -1.152 . . . . 0.0 109.813 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.93 22.15 11.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.16 -0.962 . . . . 0.0 109.663 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.67 58.16 5.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.888 . . . . 0.0 109.842 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.435 ' HE3' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -138.7 132.59 16.35 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.935 -179.454 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.546 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 46.3 Cg_endo -68.83 132.31 24.57 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 N-CA-C 108.332 -1.449 . . . . 0.0 108.332 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.603 HG13 ' HB2' ' A' ' 67' ' ' ALA . 17.4 mm -48.77 97.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.055 -1.028 . . . . 0.0 109.591 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.621 HD13 ' HB2' ' A' ' 50' ' ' ALA . 39.9 tp -101.24 128.73 47.23 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.438 -0.789 . . . . 0.0 112.149 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.887 HD12 ' HB2' ' A' ' 49' ' ' ASP . 64.0 mt -63.91 139.23 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.601 -0.687 . . . . 0.0 110.18 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.2 t -121.83 -25.3 5.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 110.641 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -137.25 108.83 6.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.088 -1.007 . . . . 0.0 110.501 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.623 HD11 HG21 ' A' ' 30' ' ' ILE . 10.5 mm -94.64 105.55 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.13 -0.981 . . . . 0.0 108.853 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.814 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 4.2 m-85 -56.75 134.41 54.9 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.274 0.559 . . . . 0.0 110.495 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.574 ' O ' HD23 ' A' ' 37' ' ' LEU . 2.2 mptt -80.76 158.64 25.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.184 -0.947 . . . . 0.0 110.36 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.49 19.29 47.31 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 35' ' ' LYS . 2.4 mm? -109.91 167.48 10.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.18 -1.188 . . . . 0.0 109.698 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . . . -56.53 -65.84 0.54 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.013 -1.054 . . . . 0.0 110.96 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.534 ' O ' HG22 ' A' ' 42' ' ' THR . . . -47.58 -37.7 12.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.309 -0.869 . . . . 0.0 111.284 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 9.3 t70 -86.62 -6.78 58.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.038 -1.039 . . . . 0.0 111.047 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -97.85 -1.86 42.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.825 -1.172 . . . . 0.0 110.911 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 39' ' ' ALA . 9.6 t -97.81 13.61 29.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.839 -1.163 . . . . 0.0 110.708 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 45.52 59.18 3.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.316 -0.865 . . . . 0.0 111.141 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.634 ' HB3' HG13 ' A' ' 4' ' ' VAL . . . -174.1 -49.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.153 -0.967 . . . . 0.0 110.128 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.628 HD12 ' CG2' ' A' ' 6' ' ' VAL . 1.7 mt -70.95 84.02 0.68 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.933 -1.104 . . . . 0.0 108.303 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.597 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -111.0 153.13 25.99 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.879 -0.513 . . . . 0.0 110.083 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.464 ' N ' HG13 ' A' ' 33' ' ' ILE . 91.7 t -50.26 152.26 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.833 -1.167 . . . . 0.0 109.767 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.79 26.06 39.46 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.544 -1.823 . . . . 0.0 108.544 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.887 ' HB2' HD12 ' A' ' 30' ' ' ILE . 67.6 m-20 -111.53 100.08 8.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.396 -1.061 . . . . 0.0 110.627 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.67 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -77.9 110.38 12.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.095 -1.003 . . . . 0.0 110.67 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.859 ' C ' HD22 ' A' ' 52' ' ' LEU . 61.6 mt -79.29 134.64 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 110.232 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.859 HD22 ' C ' ' A' ' 51' ' ' ILE . 3.9 mm? -125.64 10.95 7.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.258 -0.902 . . . . 0.0 110.439 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 175.99 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.031 -1.043 . . . . 0.0 109.765 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.943 HG21 ' CB ' ' A' ' 70' ' ' ALA . 27.5 m -76.24 126.46 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.365 -0.834 . . . . 0.0 110.847 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.0 p30 37.19 40.45 0.18 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.57 -7.18 63.37 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.565 -1.302 . . . . 0.0 111.142 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.532 ' O ' HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -89.81 91.9 8.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.671 -1.488 . . . . 0.0 109.848 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -44.33 112.16 0.38 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.381 0.61 . . . . 0.0 110.888 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.986 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -101.8 -5.97 24.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.323 -0.86 . . . . 0.0 110.962 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.45 ' OG ' HD12 ' A' ' 52' ' ' LEU . 34.5 m -55.36 -32.65 62.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.875 -1.141 . . . . 0.0 110.287 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.3 m -113.13 35.64 3.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.092 -1.005 . . . . 0.0 110.345 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.986 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -121.5 152.8 38.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.178 -0.951 . . . . 0.0 110.193 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.496 HG22 ' HB3' ' A' ' 22' ' ' ARG . 18.0 p -81.79 165.13 21.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.857 . . . . 0.0 109.87 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.1 t60 -52.55 -26.15 12.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.014 -1.054 . . . . 0.0 109.903 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.63 -45.73 51.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.052 -1.03 . . . . 0.0 108.923 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.554 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 13.0 mt-10 -61.26 -23.01 65.35 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.597 -0.689 . . . . 0.0 109.4 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.603 ' HB2' HG13 ' A' ' 28' ' ' ILE . . . -80.42 -47.22 14.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.788 . . . . 0.0 110.319 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.059 HG22 HD11 ' A' ' 18' ' ' ILE . 2.6 t -66.3 -33.07 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.481 -0.888 . . . . 0.0 108.773 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -56.25 -41.23 75.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.415 -0.803 . . . . 0.0 109.131 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.943 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.91 -26.35 63.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.439 -0.788 . . . . 0.0 109.35 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.767 ' C ' HG11 ' B' ' 7' ' ' VAL . 3.5 mm? -80.6 -34.57 35.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.628 -0.67 . . . . 0.0 110.082 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -75.93 -33.87 59.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.064 -1.023 . . . . 0.0 110.125 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -112.07 36.27 3.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.631 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.84 HG22 HG22 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -71.42 137.65 48.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.391 -0.818 . . . . 0.0 110.077 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.18 -177.95 34.44 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 78' ' ' VAL . 22.5 tttp -55.45 -76.61 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -1.158 . . . . 0.0 110.022 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -63.91 101.56 0.39 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.095 -1.003 . . . . 0.0 109.466 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.84 HG22 HG22 ' A' ' 74' ' ' THR . 94.5 t -96.61 82.78 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 111.32 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.558 ' O ' HD23 ' A' ' 80' ' ' LEU . 35.0 t -80.26 113.73 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.798 HD21 ' CG1' ' A' ' 78' ' ' VAL . 13.0 mt -117.42 125.03 50.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.956 -1.09 . . . . 0.0 111.917 -177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -77.78 125.39 29.28 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.516 HG13 ' CG ' ' A' ' 2' ' ' ARG . 1.8 p -126.03 147.94 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.993 -1.067 . . . . 0.0 111.749 -177.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.67 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -108.2 85.79 2.18 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.597 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -55.62 118.58 4.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.433 -0.792 . . . . 0.0 110.957 -177.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.9 mmm -96.76 49.58 1.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.184 -0.948 . . . . 0.0 109.401 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.8 tptt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.236 -179.669 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.427 ' HB3' ' ND1' ' A' ' 64' ' ' HIS . 32.2 tttt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.282 0.563 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 3.4 tt0 -153.87 138.31 16.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 110.032 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.511 ' OG ' HG11 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -126.59 -163.37 1.23 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.192 -0.942 . . . . 0.0 110.419 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.83 HD12 ' HB2' ' A' ' 17' ' ' SER . 1.4 tp -159.16 56.57 0.41 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.321 -0.862 . . . . 0.0 110.187 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.767 HG11 ' C ' ' A' ' 71' ' ' LEU . 53.4 t . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.048 -1.032 . . . . 0.0 110.255 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.408 ' O ' ' CG ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.317 0.58 . . . . 0.0 110.257 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.839 ' CB ' HG13 ' A' ' 82' ' ' VAL . 3.9 mtp85 -161.94 170.54 19.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 110.408 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' A' ' 3' ' ' ARG . 0.5 OUTLIER -138.88 116.7 11.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.408 -0.808 . . . . 0.0 109.206 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.79 HG22 ' HB1' ' A' ' 44' ' ' ALA . 65.7 t -121.24 136.85 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.992 -1.067 . . . . 0.0 110.841 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.8 m -125.08 126.26 45.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.371 -0.83 . . . . 0.0 109.881 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.83 HG21 HD12 ' A' ' 45' ' ' LEU . 89.3 t -121.79 115.35 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.138 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.127 -0.983 . . . . 0.0 109.871 179.872 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.76 HD23 ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.048 0.451 . . . . 0.0 110.534 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.924 ' CA ' HD22 ' A' ' 37' ' ' LEU . . . 60.61 82.49 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 16' ' ' ILE . 1.1 tt -173.11 120.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.427 -1.043 . . . . 0.0 110.341 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.481 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -112.08 119.38 38.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 109.543 179.152 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.092 HD11 HG22 ' A' ' 68' ' ' VAL . 21.2 pt -100.72 151.66 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.236 -0.915 . . . . 0.0 111.266 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 9.9 pttt -131.04 160.74 33.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 109.643 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.59 -163.78 12.13 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.439 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 160.51 141.0 3.02 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.576 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.0 OUTLIER -60.15 -15.59 25.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -1.091 . . . . 0.0 110.695 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -71.93 -16.86 62.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.886 -1.134 . . . . 0.0 109.796 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -125.66 24.18 7.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.246 -0.908 . . . . 0.0 109.706 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.19 92.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.336 -0.852 . . . . 0.0 110.259 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.512 ' HE2' ' N ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -170.92 128.25 0.71 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.904 . . . . 0.0 110.208 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.71 ' CB ' HD11 ' A' ' 52' ' ' LEU . 55.9 Cg_endo -72.82 46.51 1.07 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 O-C-N 123.448 1.236 . . . . 0.0 112.19 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.637 HD12 ' HA ' ' A' ' 64' ' ' HIS . 12.9 mm 44.33 90.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 120.797 -1.189 . . . . 0.0 110.756 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.828 HD21 ' HG3' ' A' ' 85' ' ' MET . 5.4 mt -97.28 132.84 42.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.799 -1.188 . . . . 0.0 111.613 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.713 HD12 ' HB2' ' A' ' 49' ' ' ASP . 54.8 mt -67.63 136.99 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.868 . . . . 0.0 108.854 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.1 -16.27 8.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.955 -1.091 . . . . 0.0 110.997 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.95 100.47 3.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.995 -1.065 . . . . 0.0 110.682 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.676 HD11 HG21 ' A' ' 30' ' ' ILE . 16.7 mm -86.83 94.12 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.417 -0.802 . . . . 0.0 108.894 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.644 ' HB3' HD13 ' A' ' 37' ' ' LEU . 4.3 m-30 -52.69 137.04 32.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.475 -0.765 . . . . 0.0 110.0 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.826 ' O ' HD12 ' A' ' 37' ' ' LEU . 12.8 tttt -83.75 171.55 13.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.896 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.49 32.4 73.02 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.924 HD22 ' CA ' ' A' ' 15' ' ' GLY . 0.4 OUTLIER -140.44 162.94 34.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.132 -1.216 . . . . 0.0 111.088 -179.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.7 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -50.04 -56.59 10.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.523 -0.735 . . . . 0.0 111.461 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.76 ' HB2' HD23 ' A' ' 14' ' ' LEU . . . -55.67 -35.51 66.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.245 -0.909 . . . . 0.0 112.092 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.532 ' HB2' HG22 ' A' ' 33' ' ' ILE . 22.0 t70 -95.74 -3.11 46.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.916 -1.115 . . . . 0.0 111.474 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.484 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 1.4 pp0? -110.34 16.98 21.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.728 -1.233 . . . . 0.0 110.354 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.523 HG21 HG22 ' A' ' 6' ' ' VAL . 7.4 t -108.47 14.72 24.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.945 . . . . 0.0 110.777 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 45.5 54.38 7.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.197 -0.94 . . . . 0.0 111.343 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.79 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -175.72 -50.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.127 -0.983 . . . . 0.0 110.445 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.83 HD12 HG21 ' A' ' 6' ' ' VAL . 1.4 mt -70.51 84.56 0.6 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.871 -1.143 . . . . 0.0 108.92 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.592 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -112.88 152.28 29.46 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.56 -179.399 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 48' ' ' GLY . 60.3 t -47.74 168.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.028 -1.045 . . . . 0.0 110.607 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.519 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 66.8 37.22 92.15 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.713 ' HB2' HD12 ' A' ' 30' ' ' ILE . 27.8 m-20 -120.89 107.61 12.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.256 -1.143 . . . . 0.0 110.483 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.795 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -84.57 105.12 15.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.835 . . . . 0.0 110.147 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.766 ' O ' HD12 ' A' ' 52' ' ' LEU . 65.0 mt -71.03 135.95 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.363 -0.835 . . . . 0.0 110.854 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 51' ' ' ILE . 6.5 mp -125.63 6.97 7.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.391 -0.818 . . . . 0.0 110.96 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 176.1 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.97 -1.082 . . . . 0.0 109.978 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.913 HG21 ' CB ' ' A' ' 70' ' ' ALA . 17.5 m -96.53 119.22 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.134 -0.979 . . . . 0.0 110.865 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 45.8 m-80 57.06 33.52 23.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.53 -0.731 . . . . 0.0 111.573 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.82 12.05 61.07 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.944 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.474 ' O ' HD23 ' A' ' 59' ' ' LEU . 10.1 mt-10 -105.46 90.5 3.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.7 -1.47 . . . . 0.0 109.741 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.33 102.01 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.479 0.656 . . . . 0.0 110.977 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.867 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -94.8 -14.04 25.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.429 -0.794 . . . . 0.0 110.703 -179.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.5 p -50.01 -32.62 15.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.004 -1.06 . . . . 0.0 110.437 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 t -107.75 31.41 5.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 109.987 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.867 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -122.43 163.66 19.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.378 -0.826 . . . . 0.0 110.346 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.576 HG22 ' HB3' ' A' ' 22' ' ' ARG . 12.7 p -85.12 165.07 17.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.399 -0.813 . . . . 0.0 110.375 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.871 ' O ' HG23 ' A' ' 68' ' ' VAL . 3.4 t60 -53.72 -26.17 21.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 109.831 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -73.75 -36.58 65.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.081 -1.012 . . . . 0.0 109.335 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.626 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 1.3 mm-40 -68.86 -22.96 64.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.588 -0.695 . . . . 0.0 109.724 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.417 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -82.83 -41.05 19.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.299 -0.876 . . . . 0.0 110.545 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.092 HG22 HD11 ' A' ' 18' ' ' ILE . 2.9 t -72.85 -32.86 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.152 -0.968 . . . . 0.0 109.372 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -59.65 -38.1 80.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.371 -0.831 . . . . 0.0 109.952 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.913 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.45 -53.1 17.73 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.152 -0.967 . . . . 0.0 108.81 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.563 ' HB3' HG11 ' B' ' 7' ' ' VAL . 96.4 mt -56.78 -22.43 35.89 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.709 -0.619 . . . . 0.0 109.485 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -79.52 -40.42 29.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.859 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 1.5 ttmt -119.11 59.54 0.83 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.405 -0.809 . . . . 0.0 109.869 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.651 ' HB ' HG22 ' A' ' 78' ' ' VAL . 66.4 p -78.06 -175.04 3.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.324 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.06 -171.46 20.13 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -48.57 -48.37 38.92 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.101 -1.235 . . . . 0.0 110.455 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 12.4 pt-20 -108.73 119.88 40.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.328 -0.857 . . . . 0.0 109.863 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.706 ' CG1' HD21 ' A' ' 80' ' ' LEU . 85.6 t -89.42 82.02 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.176 -0.952 . . . . 0.0 110.721 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.459 ' C ' HD23 ' A' ' 80' ' ' LEU . 2.8 t -77.27 107.11 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.706 HD21 ' CG1' ' A' ' 78' ' ' VAL . 14.1 mt -113.34 115.77 28.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.805 -1.184 . . . . 0.0 111.576 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.416 ' HB3' ' OG ' ' A' ' 53' ' ' SER . 5.9 tp10 -67.79 124.59 23.75 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.839 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.4 p -121.74 141.53 41.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.003 -1.06 . . . . 0.0 112.199 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.795 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 40.4 tttm -107.41 81.3 1.51 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.592 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -50.52 122.19 6.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.576 -0.703 . . . . 0.0 111.191 -178.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.828 ' HG3' HD21 ' A' ' 29' ' ' LEU . 6.3 mmt -96.39 49.0 1.1 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.281 -0.887 . . . . 0.0 109.023 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.874 -1.06 . . . . 0.0 110.295 -179.512 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.554 ' CD ' ' CD2' ' A' ' 64' ' ' HIS . 1.6 mttm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.32 0.581 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER 54.19 41.45 32.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 109.679 -179.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.405 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . 1.3 m -57.28 -169.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.359 -0.838 . . . . 0.0 110.783 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.558 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 39.2 tp -156.71 117.58 3.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.387 -0.821 . . . . 0.0 110.086 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.563 HG11 ' HB3' ' A' ' 71' ' ' LEU . 66.2 t . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.157 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.44 0.638 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.522 ' CG ' HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -161.91 146.61 12.83 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.461 -0.774 . . . . 0.0 109.586 -179.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.416 ' N ' ' HG3' ' A' ' 2' ' ' ARG . 1.6 mpp_? -120.59 126.57 50.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 109.927 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.739 HG23 HG11 ' A' ' 82' ' ' VAL . 54.5 t -121.51 153.87 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 110.549 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 84.8 m -139.16 109.69 6.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.514 -0.741 . . . . 0.0 109.513 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.811 HG22 HG21 ' A' ' 42' ' ' THR . 56.6 t -100.53 125.19 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 0.0 109.813 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.9 mtt-85 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.933 . . . . 0.0 110.29 -179.58 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.555 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.119 0.485 . . . . 0.0 110.464 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.948 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 56.9 86.72 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.665 HD12 ' CD2' ' A' ' 45' ' ' LEU . 6.2 tt -174.34 115.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.107 -1.231 . . . . 0.0 110.534 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.22 98.18 7.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.937 . . . . 0.0 109.728 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.066 HD11 HG22 ' A' ' 68' ' ' VAL . 44.7 pt -74.55 146.93 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 110.615 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -132.97 116.14 16.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.462 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.11 -160.38 30.78 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 163.17 134.47 1.65 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -60.72 -14.85 23.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.465 -1.021 . . . . 0.0 110.807 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.29 5.53 22.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.984 -1.073 . . . . 0.0 110.138 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -140.94 25.65 2.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.093 -1.004 . . . . 0.0 109.463 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 54.75 83.23 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.333 -0.855 . . . . 0.0 109.62 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.598 ' HE1' ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -169.11 126.92 0.85 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.254 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.893 ' CB ' HD21 ' A' ' 52' ' ' LEU . 56.0 Cg_endo -76.76 45.66 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.459 1.241 . . . . 0.0 111.972 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 19.9 mm 45.07 89.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 O-C-N 120.869 -1.144 . . . . 0.0 110.218 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.604 HD13 ' HB2' ' A' ' 50' ' ' ALA . 36.6 tp -103.7 127.58 51.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.853 -1.155 . . . . 0.0 111.751 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.827 HD12 ' HB2' ' A' ' 49' ' ' ASP . 61.8 mt -62.05 136.2 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.464 -0.772 . . . . 0.0 109.734 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 t -120.5 -18.59 7.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.218 -0.926 . . . . 0.0 110.734 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.5 104.77 4.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.972 -1.08 . . . . 0.0 110.517 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.712 HD11 HG21 ' A' ' 30' ' ' ILE . 10.8 mm -92.56 99.51 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.146 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.648 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 94.7 m-85 -59.64 136.34 57.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.488 -0.758 . . . . 0.0 110.271 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.836 ' O ' HD12 ' A' ' 37' ' ' LEU . 21.4 mtmt -80.37 174.49 11.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 110.649 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.77 28.33 62.91 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.948 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -136.54 160.45 38.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.106 -1.232 . . . . 0.0 110.726 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.743 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -48.43 -57.71 5.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 111.502 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.943 ' HB1' HD23 ' A' ' 45' ' ' LEU . . . -52.04 -45.79 64.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 111.808 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.458 ' HB2' HG22 ' A' ' 33' ' ' ILE . 7.3 t70 -85.01 -17.29 38.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.913 -1.117 . . . . 0.0 111.623 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.493 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 1.5 pp0? -99.42 13.2 34.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.797 -1.189 . . . . 0.0 110.851 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.811 HG21 HG22 ' A' ' 6' ' ' VAL . 10.0 t -107.84 14.83 25.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.997 -1.064 . . . . 0.0 110.775 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 45.39 49.71 10.32 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.252 -0.905 . . . . 0.0 111.079 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.71 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -167.43 -55.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.585 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.943 HD23 ' HB1' ' A' ' 39' ' ' ALA . 2.4 tp -69.43 84.03 0.4 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.853 -1.154 . . . . 0.0 108.683 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.602 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.58 152.55 28.76 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.86 -0.525 . . . . 0.0 109.665 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.44 ' N ' HG13 ' A' ' 33' ' ' ILE . 65.7 t -49.26 153.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.919 -1.113 . . . . 0.0 110.035 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.427 ' C ' HD11 ' A' ' 29' ' ' LEU . . . 83.76 24.08 50.84 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.827 ' HB2' HD12 ' A' ' 30' ' ' ILE . 69.4 m-20 -109.69 100.38 9.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.398 -1.06 . . . . 0.0 110.675 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.891 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -78.28 102.23 7.55 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.152 -0.968 . . . . 0.0 110.022 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 81' ' ' GLU . 69.4 mt -71.03 138.03 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.428 -0.795 . . . . 0.0 110.702 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.893 HD21 ' CB ' ' A' ' 27' ' ' PRO . 83.0 mt -136.32 9.83 3.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.287 -0.883 . . . . 0.0 111.269 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 179.09 92.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.922 -1.111 . . . . 0.0 109.832 179.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.999 HG21 ' CB ' ' A' ' 70' ' ' ALA . 33.1 m -91.51 121.04 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.287 -0.883 . . . . 0.0 110.156 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 55.69 36.42 27.19 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.495 -0.753 . . . . 0.0 110.838 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.99 -7.35 78.08 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.743 -1.218 . . . . 0.0 110.388 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -78.63 93.81 4.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.741 -1.447 . . . . 0.0 109.513 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.71 102.87 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.525 0.678 . . . . 0.0 111.021 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.878 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.5 OUTLIER -91.0 -4.89 56.07 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.5 -0.75 . . . . 0.0 110.556 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 t -58.54 -43.16 89.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 110.242 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.2 m -102.27 35.25 2.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 110.343 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.878 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -119.29 145.39 46.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 110.274 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.2 p -78.23 168.6 19.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.911 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.881 ' O ' HG23 ' A' ' 68' ' ' VAL . 7.7 t60 -54.51 -24.04 18.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.01 -1.056 . . . . 0.0 109.871 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.25 -43.39 42.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.12 -0.987 . . . . 0.0 109.12 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.622 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 32.9 mm-40 -65.61 -21.49 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.586 -0.696 . . . . 0.0 109.648 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.726 ' HA ' HD11 ' A' ' 59' ' ' LEU . . . -83.54 -47.5 11.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 110.583 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.066 HG22 HD11 ' A' ' 18' ' ' ILE . 7.8 t -62.8 -27.14 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.126 -0.983 . . . . 0.0 108.797 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -39.4 81.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.425 -0.797 . . . . 0.0 109.202 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.999 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -62.8 -44.35 96.39 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.355 -0.84 . . . . 0.0 108.849 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.702 ' C ' HG11 ' B' ' 7' ' ' VAL . 3.8 mm? -69.7 -23.39 63.42 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -84.27 -42.04 16.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.977 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -100.79 24.33 9.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.0 109.89 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -64.38 154.23 36.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.916 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.54 -172.01 20.6 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -48.95 -62.32 1.59 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.061 -1.258 . . . . 0.0 110.389 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -83.62 115.92 22.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.083 -1.011 . . . . 0.0 108.639 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.886 ' CG1' HD21 ' A' ' 80' ' ' LEU . 71.5 t -109.39 89.85 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.072 -1.018 . . . . 0.0 111.154 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.895 ' O ' HD23 ' A' ' 80' ' ' LEU . 48.7 t -76.96 123.46 33.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.895 HD23 ' O ' ' A' ' 79' ' ' VAL . 15.5 mt -128.09 109.33 11.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.822 -1.174 . . . . 0.0 111.64 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 13.6 tp10 -66.29 129.63 40.47 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.739 HG11 HG23 ' A' ' 4' ' ' VAL . 2.4 p -132.68 146.7 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.873 -1.142 . . . . 0.0 112.119 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.891 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 13.5 tttt -107.7 85.09 2.06 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.602 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -55.51 123.53 14.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.741 . . . . 0.0 110.99 -177.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.1 mmt -99.47 51.63 0.94 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.375 -0.828 . . . . 0.0 109.866 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.268 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 64' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.185 0.517 . . . . 0.0 110.355 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 36.2 tt0 54.6 68.89 0.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.883 . . . . 0.0 110.361 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 39.8 t -66.21 -153.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.097 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.648 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -175.81 66.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.115 -0.991 . . . . 0.0 110.328 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.702 HG11 ' C ' ' A' ' 71' ' ' LEU . 46.6 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.236 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.312 0.577 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.854 ' CB ' HG13 ' A' ' 82' ' ' VAL . 1.6 mtp85 -157.15 165.42 36.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.319 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -140.97 112.53 7.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.409 -0.807 . . . . 0.0 109.229 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.629 HG13 ' HB3' ' A' ' 44' ' ' ALA . 37.5 t -124.56 152.85 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.039 -1.038 . . . . 0.0 110.529 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.3 m -139.99 143.57 36.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.365 -0.835 . . . . 0.0 110.124 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.461 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 98.5 t -130.75 109.7 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.919 . . . . 0.0 109.849 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.421 ' HD3' ' N ' ' A' ' 7' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 110.159 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.842 HD22 HG21 ' A' ' 16' ' ' ILE . 1.4 tt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.28 0.562 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.49 ' HA3' ' HG ' ' A' ' 37' ' ' LEU . . . 70.94 79.93 0.35 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.842 HG21 HD22 ' A' ' 14' ' ' LEU . 2.7 tt -176.58 117.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.314 -1.109 . . . . 0.0 109.876 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.416 ' HB3' ' HB3' ' A' ' 32' ' ' LYS . 4.1 t -108.69 114.56 28.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.29 -0.881 . . . . 0.0 110.263 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.01 HD11 HG22 ' A' ' 68' ' ' VAL . 27.2 pt -88.06 153.84 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 110.637 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' B' ' 3' ' ' LYS . 16.4 ttpp -142.83 118.47 10.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.272 -0.893 . . . . 0.0 110.054 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.55 -161.07 32.87 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.448 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 169.12 131.95 1.38 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.607 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.0 OUTLIER -60.31 -15.34 24.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -1.191 . . . . 0.0 110.71 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.95 -14.02 58.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.94 -1.1 . . . . 0.0 109.977 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.87 24.0 11.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.809 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.1 tttt 54.67 78.81 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.995 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.611 ' HE1' ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -161.95 120.77 1.42 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 110.409 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.733 ' HB2' HD11 ' A' ' 52' ' ' LEU . 50.6 Cg_endo -71.35 52.45 1.55 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 O-C-N 123.514 1.271 . . . . 0.0 111.966 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 64' ' ' HIS . 6.9 mm 42.57 89.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.09 -1.006 . . . . 0.0 110.574 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.611 ' N ' ' HE1' ' A' ' 26' ' ' MET . 6.0 mt -98.66 132.69 43.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.768 -1.208 . . . . 0.0 111.975 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.593 HD12 ' HB2' ' A' ' 49' ' ' ASP . 49.1 mt -66.52 133.53 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.306 -0.872 . . . . 0.0 108.815 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 t -116.79 -16.53 10.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.066 -1.021 . . . . 0.0 110.888 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -146.02 106.63 4.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.998 -1.064 . . . . 0.0 111.143 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.568 HD11 HG21 ' A' ' 30' ' ' ILE . 12.2 mm -93.32 115.16 31.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.261 -0.899 . . . . 0.0 108.601 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.861 ' CE1' HD13 ' B' ' 6' ' ' LEU . 10.0 m-85 -66.82 134.39 52.02 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.405 -0.809 . . . . 0.0 109.988 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.557 ' O ' HD23 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -79.81 151.88 30.05 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.259 -0.9 . . . . 0.0 110.821 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.16 16.5 60.13 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.557 HD23 ' O ' ' A' ' 35' ' ' LYS . 3.2 mm? -105.4 165.3 11.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -1.164 . . . . 0.0 110.298 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.461 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -48.42 -63.73 1.0 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.22 -0.925 . . . . 0.0 111.036 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.886 ' O ' HG22 ' A' ' 42' ' ' THR . . . -50.45 -53.0 32.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 110.721 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 24.1 t70 -73.09 -4.93 35.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.026 -1.046 . . . . 0.0 111.152 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -97.01 3.54 51.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.773 -1.205 . . . . 0.0 110.899 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 39' ' ' ALA . 7.2 t -107.68 15.17 24.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.805 -1.184 . . . . 0.0 110.781 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 47.31 56.95 6.27 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.12 -0.988 . . . . 0.0 110.954 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.629 ' HB3' HG13 ' A' ' 4' ' ' VAL . . . -173.74 -44.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 110.245 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.544 ' CD1' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -69.09 81.94 0.33 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.975 -1.078 . . . . 0.0 108.687 179.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.587 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.21 149.32 32.44 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.601 -0.687 . . . . 0.0 110.231 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 48' ' ' GLY . 84.5 t -49.89 169.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.124 -0.985 . . . . 0.0 110.404 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.534 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 68.61 32.96 75.35 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.597 ' C ' HD23 ' A' ' 29' ' ' LEU . 27.6 m-20 -117.95 108.57 15.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.559 -0.965 . . . . 0.0 110.423 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.648 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -85.8 104.69 15.71 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.465 HG21 ' CG1' ' A' ' 54' ' ' VAL . 30.7 mt -70.36 134.05 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.356 -0.84 . . . . 0.0 110.136 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 27' ' ' PRO . 2.4 mp -132.25 17.69 4.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 110.368 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 174.58 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.214 -0.929 . . . . 0.0 109.967 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.952 HG21 ' CB ' ' A' ' 70' ' ' ALA . 21.2 m -91.08 127.0 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.107 -0.996 . . . . 0.0 109.846 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.3 m120 57.72 38.64 27.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 0.0 110.013 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.83 29.87 70.74 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 53' ' ' SER . 7.4 tt0 -115.81 91.8 3.71 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -1.108 . . . . 0.0 109.579 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -37.91 102.04 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.691 0.758 . . . . 0.0 112.071 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.99 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -91.48 -13.63 31.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.648 -0.658 . . . . 0.0 110.483 179.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.699 ' OG ' HD23 ' A' ' 52' ' ' LEU . 44.1 m -53.52 -37.14 62.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.014 -1.054 . . . . 0.0 110.182 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.9 m -96.86 25.88 4.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 110.035 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.99 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -120.18 157.54 28.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 110.233 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.607 HG22 ' HB3' ' A' ' 22' ' ' ARG . 32.0 p -88.95 164.96 14.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 110.081 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.926 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.1 t60 -52.0 -25.76 9.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.953 . . . . 0.0 109.578 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -73.13 -40.19 65.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.096 -1.003 . . . . 0.0 109.082 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.495 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 1.1 mt-10 -71.06 -25.57 62.69 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.441 -0.787 . . . . 0.0 109.452 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.618 ' O ' HD23 ' A' ' 71' ' ' LEU . . . -76.35 -42.2 45.62 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.445 -0.784 . . . . 0.0 110.0 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.01 HG22 HD11 ' A' ' 18' ' ' ILE . 6.3 t -70.47 -30.63 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.189 -0.944 . . . . 0.0 109.08 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -58.87 -40.27 83.87 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.375 -0.828 . . . . 0.0 109.16 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.952 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -68.68 -46.75 68.23 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.355 -0.841 . . . . 0.0 108.814 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.702 ' C ' HG11 ' B' ' 7' ' ' VAL . 3.0 mm? -56.75 -30.13 63.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.681 -0.637 . . . . 0.0 109.63 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.3 -41.52 22.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.1 -1.0 . . . . 0.0 109.983 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -106.58 55.17 0.67 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.667 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.783 ' HB ' HG22 ' A' ' 78' ' ' VAL . 33.2 p -79.11 149.14 32.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.323 -0.861 . . . . 0.0 109.657 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.04 -177.63 45.88 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -50.94 47.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.253 -1.145 . . . . 0.0 110.122 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -98.35 94.18 6.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -0.87 . . . . 0.0 109.423 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.783 HG22 ' HB ' ' A' ' 74' ' ' THR . 92.8 t -63.72 78.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 111.085 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.948 ' O ' HD23 ' A' ' 80' ' ' LEU . 12.8 t -75.81 123.7 32.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.948 HD23 ' O ' ' A' ' 79' ' ' VAL . 13.0 mt -128.98 117.62 21.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.747 -1.22 . . . . 0.0 111.465 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 20.2 tt0 -73.78 125.21 27.61 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.854 HG13 ' CB ' ' A' ' 2' ' ' ARG . 3.0 p -125.72 145.48 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.052 -1.03 . . . . 0.0 112.206 -177.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.547 ' HB2' HD13 ' A' ' 52' ' ' LEU . 1.0 OUTLIER -112.53 86.41 2.36 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.587 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -52.91 129.46 30.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.572 -0.705 . . . . 0.0 110.959 -178.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.4 mmt -101.29 46.66 0.93 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.292 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.284 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.53 ' HD2' ' CD2' ' A' ' 64' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.29 0.566 . . . . 0.0 110.59 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.8 mt-10 -109.37 -158.89 0.66 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.455 -0.778 . . . . 0.0 109.048 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.595 ' OG ' HG11 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -175.85 -48.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.83 -1.169 . . . . 0.0 110.806 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.861 HD13 ' CE1' ' A' ' 34' ' ' PHE . 13.0 tp 54.6 92.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 109.936 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.702 HG11 ' C ' ' A' ' 71' ' ' LEU . 61.2 t . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.028 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.271 0.558 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.811 ' O ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -122.52 147.35 46.47 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.272 -0.892 . . . . 0.0 109.032 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -105.24 106.49 17.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.054 -1.029 . . . . 0.0 110.058 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.767 HG13 ' HB3' ' A' ' 44' ' ' ALA . 61.1 t -107.48 128.86 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.948 . . . . 0.0 110.266 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.0 m -115.28 111.23 20.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 110.125 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.621 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 99.0 t -97.09 118.54 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.846 . . . . 0.0 109.823 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.232 -0.917 . . . . 0.0 110.288 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.213 0.53 . . . . 0.0 110.132 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.882 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 58.27 87.46 0.02 OUTLIER Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 45' ' ' LEU . 4.6 tt -176.51 117.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.184 -1.186 . . . . 0.0 110.404 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 32' ' ' LYS . 35.2 t -106.94 117.82 35.06 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.295 -0.878 . . . . 0.0 109.619 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.961 HD11 ' CG2' ' A' ' 68' ' ' VAL . 43.7 pt -94.85 150.26 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 110.817 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' B' ' 3' ' ' LYS . 17.1 tttt -138.49 120.26 15.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 110.183 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.18 -153.43 24.61 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 157.19 134.13 1.71 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -60.69 -14.77 22.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.374 -1.074 . . . . 0.0 110.547 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' OE2' ' ND2' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -80.32 1.88 26.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.949 -1.094 . . . . 0.0 110.469 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.414 ' ND2' ' OE2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -138.07 26.17 2.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.973 -1.08 . . . . 0.0 109.795 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 54.47 66.99 1.08 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 110.113 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.474 ' HE3' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -149.86 115.89 3.52 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.436 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.937 ' HB3' HD21 ' A' ' 52' ' ' LEU . 49.2 Cg_endo -68.2 55.38 0.76 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.321 1.347 . . . . 0.0 111.793 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 64' ' ' HIS . 16.0 mm 41.66 88.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 121.286 -0.884 . . . . 0.0 110.446 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' A' ' 50' ' ' ALA . 34.3 tp -101.88 126.66 48.83 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.831 -1.168 . . . . 0.0 112.121 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.788 HD12 ' HB2' ' A' ' 49' ' ' ASP . 55.6 mt -64.41 140.88 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.686 -0.634 . . . . 0.0 109.953 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.6 t -128.68 4.14 5.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 110.718 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 1.9 ttmt -165.03 99.89 0.75 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.818 -1.176 . . . . 0.0 110.263 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 30' ' ' ILE . 14.4 mm -89.64 111.88 23.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.32 -0.862 . . . . 0.0 109.318 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.663 ' HB3' HD13 ' A' ' 37' ' ' LEU . 16.2 m-85 -74.3 126.83 31.51 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.47 -0.769 . . . . 0.0 109.984 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.863 ' O ' HD12 ' A' ' 37' ' ' LEU . 20.3 mtmt -75.62 170.54 15.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.312 -0.867 . . . . 0.0 110.548 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.52 26.19 71.77 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.882 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -138.99 159.55 41.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -1.19 . . . . 0.0 110.918 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.621 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -42.72 -66.36 0.37 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.648 -0.658 . . . . 0.0 112.128 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.886 ' O ' HG22 ' A' ' 42' ' ' THR . . . -45.83 -59.3 2.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.316 -0.865 . . . . 0.0 111.354 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -71.97 -4.19 27.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.904 -1.123 . . . . 0.0 111.114 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -107.78 11.82 27.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.555 -1.341 . . . . 0.0 110.726 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 39' ' ' ALA . 8.9 t -108.42 15.73 23.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.956 -1.09 . . . . 0.0 110.708 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 47.86 51.08 14.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.07 -1.019 . . . . 0.0 110.846 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.767 ' HB3' HG13 ' A' ' 4' ' ' VAL . . . -172.73 -45.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -0.918 . . . . 0.0 110.017 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.497 ' HG ' ' HB1' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -67.26 81.49 0.14 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.017 -1.052 . . . . 0.0 109.344 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -113.21 152.7 29.42 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.479 -0.763 . . . . 0.0 109.978 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.456 ' N ' HG13 ' A' ' 33' ' ' ILE . 86.4 t -50.94 163.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.783 -1.198 . . . . 0.0 109.98 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.431 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 75.0 28.5 62.36 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.788 ' HB2' HD12 ' A' ' 30' ' ' ILE . 46.3 m-20 -109.81 98.15 7.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.387 -1.066 . . . . 0.0 110.705 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.795 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -75.4 92.61 2.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 0.0 110.282 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 59' ' ' LEU . 51.6 mt -64.13 136.72 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.386 -0.821 . . . . 0.0 110.191 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.937 HD21 ' HB3' ' A' ' 27' ' ' PRO . 10.5 mt -136.11 19.82 3.21 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.375 -0.828 . . . . 0.0 109.591 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 22.6 t 177.72 126.46 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.594 -0.691 . . . . 0.0 109.351 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.042 HG12 HD22 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -124.81 116.68 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 58.58 31.95 21.62 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.481 -0.762 . . . . 0.0 110.643 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.44 23.92 32.61 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 53' ' ' SER . 4.9 tt0 -115.4 88.23 2.83 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.026 -1.279 . . . . 0.0 110.079 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -44.62 101.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.504 -0.748 . . . . 0.0 111.28 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.703 HD11 HG22 ' A' ' 54' ' ' VAL . 70.5 mt -81.3 -13.04 58.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 110.358 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 t -48.5 -33.45 9.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.16 -0.963 . . . . 0.0 110.284 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.43 27.97 7.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.353 -0.842 . . . . 0.0 109.591 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 66' ' ' GLU . . . -123.81 149.07 46.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.407 -0.808 . . . . 0.0 110.493 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 p -79.86 166.43 21.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.312 -0.868 . . . . 0.0 109.812 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.943 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.4 t60 -55.48 -31.83 62.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.082 -1.011 . . . . 0.0 109.854 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.66 -32.43 65.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.824 -1.173 . . . . 0.0 109.547 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.488 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 1.2 mm-40 -72.65 -28.39 62.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.55 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.427 ' O ' HD23 ' A' ' 71' ' ' LEU . . . -77.08 -41.72 41.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.757 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.961 ' CG2' HD11 ' A' ' 18' ' ' ILE . 7.3 t -63.79 -26.96 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.544 -0.862 . . . . 0.0 108.98 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -36.58 81.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.522 -0.736 . . . . 0.0 109.549 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.763 ' O ' HG23 ' A' ' 74' ' ' THR . . . -72.36 -39.89 67.73 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.169 -0.957 . . . . 0.0 109.262 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.682 ' HB3' HG11 ' B' ' 7' ' ' VAL . 4.0 mm? -60.64 -29.92 69.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.368 -0.832 . . . . 0.0 108.918 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -84.75 -36.77 21.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.853 . . . . 0.0 110.118 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -106.05 27.34 8.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.974 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.763 HG23 ' O ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -67.29 166.58 14.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.133 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -109.19 -176.01 21.4 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -51.78 -63.1 1.24 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.204 -1.174 . . . . 0.0 110.4 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -81.8 88.02 6.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.206 -0.934 . . . . 0.0 109.915 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.774 ' CG1' HD21 ' A' ' 80' ' ' LEU . 53.9 t -80.4 90.35 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.932 . . . . 0.0 110.644 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.661 ' O ' HD23 ' A' ' 80' ' ' LEU . 7.1 t -80.68 117.3 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.042 HD22 HG12 ' A' ' 54' ' ' VAL . 17.3 mt -122.5 116.02 23.2 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.409 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.459 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 0.8 OUTLIER -74.0 133.51 42.98 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 2' ' ' ARG . 4.0 p -129.99 153.68 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.95 -1.093 . . . . 0.0 112.519 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.65 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 2.6 mtpt -115.53 81.55 1.61 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -47.96 121.13 3.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.457 -0.777 . . . . 0.0 111.334 -177.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.3 mtt -116.15 52.21 0.92 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.48 -0.762 . . . . 0.0 109.311 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.396 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.474 ' HG2' ' CD2' ' A' ' 64' ' ' HIS . 6.9 tttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.167 0.508 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.416 ' OE2' ' CE ' ' A' ' 32' ' ' LYS . 1.2 tt0 -113.71 70.31 0.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 109.938 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.6 -176.42 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.265 -0.897 . . . . 0.0 110.73 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.62 HD13 ' CE1' ' A' ' 34' ' ' PHE . 21.8 tp -160.15 90.64 0.91 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.443 -0.785 . . . . 0.0 109.855 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.682 HG11 ' HB3' ' A' ' 71' ' ' LEU . 93.1 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.122 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.267 0.556 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.983 ' HB3' HG13 ' A' ' 82' ' ' VAL . 1.1 ttm-85 -152.83 172.65 16.41 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 0.0 109.939 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.84 135.44 14.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.916 . . . . 0.0 109.349 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.637 HG22 ' HB1' ' A' ' 44' ' ' ALA . 66.6 t -142.19 137.67 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.05 -1.031 . . . . 0.0 110.997 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.9 m -121.08 114.08 20.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.522 -0.736 . . . . 0.0 109.304 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.933 HG22 HG21 ' A' ' 42' ' ' THR . 83.1 t -105.53 119.51 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.123 -0.986 . . . . 0.0 110.826 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.396 -0.815 . . . . 0.0 109.74 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.539 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.088 0.47 . . . . 0.0 110.505 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.947 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 57.84 89.78 0.01 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.766 HD12 HD23 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -174.92 120.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.237 -1.155 . . . . 0.0 110.316 -179.043 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.425 ' HB3' ' CB ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -110.56 93.62 4.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.253 -0.904 . . . . 0.0 109.755 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.98 HD11 ' CG2' ' A' ' 68' ' ' VAL . 28.9 pt -73.62 148.67 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.378 -0.826 . . . . 0.0 110.557 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 31' ' ' SER . 2.3 mtpt -136.88 144.46 43.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.01 . . . . 0.0 110.183 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 136.85 -158.34 24.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.456 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 165.89 133.24 1.48 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.682 ' HB3' HG22 ' A' ' 63' ' ' THR . 1.9 ttp85 -59.53 -15.64 19.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -1.13 . . . . 0.0 110.64 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -14.2 60.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.946 -1.096 . . . . 0.0 109.922 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.02 24.36 10.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.189 -0.944 . . . . 0.0 109.704 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.39 73.21 0.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 110.166 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.53 ' HE1' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -150.4 123.96 4.4 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.93 . . . . 0.0 110.317 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.64 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 54.8 Cg_endo -73.04 50.23 1.78 Allowed 'Trans proline' 0 N--CA 1.493 1.448 0 O-C-N 123.35 1.184 . . . . 0.0 111.752 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 64' ' ' HIS . 10.0 mm 43.06 89.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.498 0 O-C-N 121.101 -0.999 . . . . 0.0 110.656 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.614 HD23 ' N ' ' A' ' 50' ' ' ALA . 6.1 mt -96.57 132.87 41.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.88 -1.137 . . . . 0.0 111.723 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.786 HD12 ' HB2' ' A' ' 49' ' ' ASP . 52.3 mt -67.49 135.55 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.451 ' HA ' HG13 ' A' ' 47' ' ' VAL . 10.7 t -116.29 -36.04 4.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.062 -1.024 . . . . 0.0 110.815 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.425 ' CB ' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -129.06 105.04 7.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.056 -1.028 . . . . 0.0 110.82 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.707 HD11 HG21 ' A' ' 30' ' ' ILE . 10.1 mm -90.45 97.2 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.198 -0.939 . . . . 0.0 109.139 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.823 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 96.3 m-85 -61.89 133.86 55.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.476 -0.765 . . . . 0.0 110.529 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.793 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.8 ttmt -79.06 175.91 10.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.829 . . . . 0.0 110.432 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.61 25.08 60.51 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.947 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.9 OUTLIER -134.88 159.42 41.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.144 . . . . 0.0 110.386 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.789 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -47.54 -59.06 3.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.382 -0.824 . . . . 0.0 111.17 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.612 ' HB1' HD23 ' A' ' 45' ' ' LEU . . . -48.4 -44.55 34.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.279 -0.888 . . . . 0.0 111.334 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.416 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 16.4 t70 -95.87 11.13 34.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 111.092 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -107.12 -4.74 18.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.823 -1.173 . . . . 0.0 110.588 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.933 HG21 HG22 ' A' ' 6' ' ' VAL . 7.2 t -105.56 14.44 28.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.827 -1.171 . . . . 0.0 110.704 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 46.21 53.85 8.97 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.23 -0.919 . . . . 0.0 110.951 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.637 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -160.74 -48.43 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.239 -0.913 . . . . 0.0 110.036 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.766 HD23 HD12 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -72.64 87.63 1.24 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.843 -1.161 . . . . 0.0 108.0 178.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.589 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -113.2 149.57 33.53 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.133 0.492 . . . . 0.0 110.175 -178.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.503 ' HA ' HG22 ' A' ' 30' ' ' ILE . 56.3 t -47.19 154.2 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.048 -1.032 . . . . 0.0 110.331 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.18 28.74 43.68 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.786 ' HB2' HD12 ' A' ' 30' ' ' ILE . 62.3 m-20 -113.43 103.38 11.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.438 -1.036 . . . . 0.0 110.435 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.64 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -80.29 108.28 13.77 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.186 -0.946 . . . . 0.0 109.295 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.762 ' C ' HD22 ' A' ' 52' ' ' LEU . 51.4 mt -75.4 134.55 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 111.085 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.762 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.5 mm? -119.58 14.04 12.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.505 -0.747 . . . . 0.0 109.81 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 1.3 t 178.02 146.33 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 108.997 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.756 HG21 ' CB ' ' A' ' 70' ' ' ALA . 2.6 m -138.72 125.28 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.985 -1.072 . . . . 0.0 111.186 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' A' ' 78' ' ' VAL . 6.3 m120 59.12 16.08 4.55 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.411 -0.806 . . . . 0.0 111.233 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.9 24.98 7.02 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.481 ' O ' ' CB ' ' A' ' 53' ' ' SER . 2.4 mm-40 -116.26 166.14 12.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -1.163 . . . . 0.0 108.686 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.16 119.57 39.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.058 -1.026 . . . . 0.0 110.062 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.793 HD13 ' HB3' ' A' ' 62' ' ' ALA . 2.0 mm? -101.1 -9.52 21.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 110.693 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -51.64 -28.87 15.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.972 -1.08 . . . . 0.0 110.483 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.9 m -120.65 46.76 1.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.37 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.793 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -135.57 157.2 47.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 110.207 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.682 HG22 ' HB3' ' A' ' 22' ' ' ARG . 33.7 p -87.94 167.79 13.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.398 -0.814 . . . . 0.0 110.34 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.93 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.1 t60 -53.69 -24.51 14.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.181 -0.95 . . . . 0.0 109.622 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.37 -39.99 52.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 109.455 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.571 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 19.3 mm-40 -68.32 -25.87 65.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.482 -0.761 . . . . 0.0 109.623 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.638 ' HA ' HD11 ' A' ' 59' ' ' LEU . . . -79.33 -44.32 21.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.345 -0.847 . . . . 0.0 110.38 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.98 ' CG2' HD11 ' A' ' 18' ' ' ILE . 4.0 t -69.06 -30.49 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.064 -1.022 . . . . 0.0 108.745 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.65 -38.07 71.64 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.484 -0.76 . . . . 0.0 109.236 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.756 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -74.02 -25.87 60.11 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.402 -0.811 . . . . 0.0 109.478 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.751 ' HB3' HG11 ' B' ' 7' ' ' VAL . 3.6 mm? -75.18 -27.86 59.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.408 -0.808 . . . . 0.0 109.893 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -76.61 -42.5 42.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.907 . . . . 0.0 110.162 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -95.16 22.23 6.96 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.246 -0.909 . . . . 0.0 109.965 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.929 ' CG2' HG22 ' A' ' 78' ' ' VAL . 60.2 m -52.91 132.51 37.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 110.518 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.39 178.29 51.65 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.434 ' HG3' ' N ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -52.99 -32.76 48.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.209 -1.171 . . . . 0.0 110.34 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.434 ' N ' ' HG3' ' A' ' 76' ' ' LYS . 9.3 tt0 -101.81 109.0 20.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 108.983 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.929 HG22 ' CG2' ' A' ' 74' ' ' THR . 22.0 t -97.0 82.41 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 0.0 111.052 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.649 ' O ' HD12 ' A' ' 80' ' ' LEU . 3.3 t -78.2 108.48 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.854 HD13 HG12 ' A' ' 78' ' ' VAL . 5.7 mp -118.73 109.09 15.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.025 -1.047 . . . . 0.0 112.508 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 51.2 tt0 -71.04 137.9 49.39 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.983 HG13 ' HB3' ' A' ' 2' ' ' ARG . 2.2 p -139.22 145.64 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.81 -1.181 . . . . 0.0 112.093 -177.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -106.75 88.57 2.79 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.164 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.589 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -55.62 114.78 2.0 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.463 -0.773 . . . . 0.0 111.151 -177.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.408 ' HG3' HD21 ' A' ' 29' ' ' LEU . 2.4 mtt -100.38 50.93 0.89 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 108.992 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.197 -179.406 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 tttt . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.188 0.518 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 47.2 tt0 -153.66 106.46 2.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.322 -0.861 . . . . 0.0 110.065 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.446 ' HB3' HG11 ' A' ' 68' ' ' VAL . 70.3 m -109.01 131.29 55.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.143 -0.973 . . . . 0.0 110.206 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.823 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 0.5 OUTLIER -100.13 96.81 7.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -0.836 . . . . 0.0 110.751 -179.601 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.751 HG11 ' HB3' ' A' ' 71' ' ' LEU . 44.5 t . . . . . 0 N--CA 1.492 1.667 0 O-C-N 120.919 -1.113 . . . . 0.0 110.133 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.442 0.639 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.848 ' CB ' HG13 ' A' ' 82' ' ' VAL . 1.7 mtp85 -153.51 168.17 27.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.409 -0.807 . . . . 0.0 110.187 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -135.57 118.83 16.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 0.0 109.384 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.736 HG11 ' HG ' ' A' ' 45' ' ' LEU . 60.3 t -124.04 128.85 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.004 -1.06 . . . . 0.0 110.691 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.7 m -118.26 118.8 32.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.453 -0.78 . . . . 0.0 109.768 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.897 HG21 HD12 ' A' ' 45' ' ' LEU . 89.7 t -113.73 108.08 24.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.63 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.7 mtm105 . . . . . 0 C--N 1.299 -1.606 0 O-C-N 121.524 -0.735 . . . . 0.0 110.048 -179.481 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.722 HD23 ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.971 0.415 . . . . 0.0 110.756 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.971 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 58.21 83.39 0.05 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.48 HG21 HD22 ' A' ' 14' ' ' LEU . 3.4 tt -175.16 117.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.218 -1.166 . . . . 0.0 110.002 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.409 ' HB2' ' HG ' ' B' ' 6' ' ' LEU . 1.2 t -108.44 106.52 16.66 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.131 -0.981 . . . . 0.0 110.089 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.028 HD11 HG22 ' A' ' 68' ' ' VAL . 20.4 pt -83.65 145.85 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.406 -0.809 . . . . 0.0 110.275 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.463 ' CG ' ' HB2' ' A' ' 31' ' ' SER . 3.2 ptmt -128.61 153.19 47.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.974 -1.079 . . . . 0.0 109.066 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 127.89 -157.65 21.14 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.274 -1.441 . . . . 0.0 110.338 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.45 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 162.22 134.68 1.68 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.42 ' NH2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -58.46 -16.66 16.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -1.08 . . . . 0.0 110.603 -179.727 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -14.74 60.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.736 -1.227 . . . . 0.0 110.246 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.3 28.14 7.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.976 . . . . 0.0 110.006 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HA ' ' NH2' ' A' ' 22' ' ' ARG . 7.0 mmmt 52.48 81.76 0.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.218 -0.926 . . . . 0.0 110.23 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.612 ' HE1' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -160.23 122.46 1.82 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.185 -0.947 . . . . 0.0 110.336 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.699 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 54.3 Cg_endo -72.38 50.95 1.69 Allowed 'Trans proline' 0 N--CA 1.494 1.554 0 O-C-N 123.42 1.221 . . . . 0.0 111.773 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.586 HG21 ' HB1' ' A' ' 67' ' ' ALA . 17.6 mm 42.36 87.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 121.108 -0.995 . . . . 0.0 110.746 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.612 ' CB ' ' HE1' ' A' ' 26' ' ' MET . 5.9 mt -95.28 134.58 37.89 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.822 -1.174 . . . . 0.0 111.849 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.859 HD12 ' HB2' ' A' ' 49' ' ' ASP . 59.5 mt -66.95 138.03 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.218 -0.926 . . . . 0.0 108.831 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.463 ' HB2' ' CG ' ' A' ' 19' ' ' LYS . 47.4 t -120.37 -26.29 5.45 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.975 -1.078 . . . . 0.0 110.941 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.405 ' CB ' ' HB3' ' A' ' 17' ' ' SER . 0.5 OUTLIER -137.84 105.5 5.59 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.069 -1.019 . . . . 0.0 111.019 -179.398 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.76 HD11 HG21 ' A' ' 30' ' ' ILE . 15.3 mm -90.71 96.97 6.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.586 ' HB2' HD13 ' A' ' 37' ' ' LEU . 95.9 m-85 -62.34 134.79 56.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.605 -0.685 . . . . 0.0 110.625 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.588 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -78.17 176.1 9.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.421 -0.8 . . . . 0.0 110.528 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.55 28.62 51.81 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.971 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -136.42 162.69 32.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -1.162 . . . . 0.0 110.65 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.759 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -52.8 -55.21 24.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.582 -0.699 . . . . 0.0 111.916 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.722 ' HB2' HD23 ' A' ' 14' ' ' LEU . . . -56.37 -37.01 69.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.115 -0.99 . . . . 0.0 112.126 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.432 ' HB2' HG22 ' A' ' 33' ' ' ILE . 17.6 t70 -92.77 -6.23 49.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.807 -1.183 . . . . 0.0 111.615 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -106.82 15.7 25.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.807 -1.183 . . . . 0.0 110.525 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.497 HG21 HG22 ' A' ' 6' ' ' VAL . 4.9 t -108.91 14.56 24.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.101 -1.0 . . . . 0.0 110.812 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 45.22 48.41 10.11 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.199 -0.938 . . . . 0.0 111.419 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.653 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -169.15 -46.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 0.0 110.471 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.897 HD12 HG21 ' A' ' 6' ' ' VAL . 2.2 mt -71.66 84.83 0.89 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.812 -1.18 . . . . 0.0 108.568 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.595 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -111.13 151.22 28.39 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.739 -179.198 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.479 ' N ' HG13 ' A' ' 33' ' ' ILE . 98.3 t -50.36 159.14 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.851 -1.156 . . . . 0.0 110.008 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.56 31.11 51.6 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.859 ' HB2' HD12 ' A' ' 30' ' ' ILE . 42.2 m-20 -114.25 104.77 12.42 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.542 -0.975 . . . . 0.0 110.354 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -82.86 110.58 17.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.151 -0.968 . . . . 0.0 109.761 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.811 ' C ' HD22 ' A' ' 52' ' ' LEU . 71.9 mt -77.28 136.89 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.87 . . . . 0.0 110.891 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.811 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.4 mm? -120.43 -0.44 10.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.464 -0.772 . . . . 0.0 110.844 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 2.5 p -178.79 103.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.875 -1.141 . . . . 0.0 109.819 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.892 HG21 ' CB ' ' A' ' 70' ' ' ALA . 17.1 m -92.46 121.38 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.167 -0.958 . . . . 0.0 110.351 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 57.65 34.2 24.21 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.135 -0.978 . . . . 0.0 110.917 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.96 17.62 67.08 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.544 ' O ' HD23 ' A' ' 59' ' ' LEU . 4.8 tt0 -105.01 91.24 3.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.019 -1.283 . . . . 0.0 109.805 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -43.49 99.52 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.523 0.678 . . . . 0.0 111.135 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.88 HD13 ' CB ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -92.54 24.88 3.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -0.796 . . . . 0.0 110.292 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 61' ' ' SER . 52.6 p -73.92 -58.71 3.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.147 -0.971 . . . . 0.0 110.397 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.425 ' N ' ' OG ' ' A' ' 60' ' ' SER . 0.8 OUTLIER -80.47 -19.21 46.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 110.096 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.88 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -57.54 167.54 1.01 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.36 -0.837 . . . . 0.0 110.589 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.5 p -100.72 -166.76 1.35 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.398 -0.814 . . . . 0.0 108.98 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.908 ' O ' HG23 ' A' ' 68' ' ' VAL . 7.3 t60 -75.18 -23.6 57.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.006 -1.059 . . . . 0.0 109.981 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.01 -34.76 61.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.961 . . . . 0.0 109.663 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.487 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 22.6 mm-40 -72.55 -25.55 61.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 109.849 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.586 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -78.91 -38.88 36.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 110.205 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.028 HG22 HD11 ' A' ' 18' ' ' ILE . 2.9 t -75.03 -37.86 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.216 -0.928 . . . . 0.0 108.806 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -55.47 -38.89 69.69 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.443 -0.786 . . . . 0.0 109.965 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.892 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.53 -49.4 48.54 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.112 -0.992 . . . . 0.0 109.107 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.625 ' CB ' HG11 ' B' ' 7' ' ' VAL . 79.1 mt -61.1 -23.94 65.86 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.656 -0.653 . . . . 0.0 109.666 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -76.11 -37.17 58.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.084 -1.01 . . . . 0.0 109.082 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 17.0 ttmt -121.72 51.07 1.35 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.746 ' HB ' HG22 ' A' ' 78' ' ' VAL . 58.8 p -52.44 -85.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 110.615 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.432 ' N ' ' OG1' ' A' ' 74' ' ' THR . . . 147.99 -172.81 28.22 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.412 ' CG ' ' N ' ' A' ' 77' ' ' GLU . 3.7 pttt -49.08 -40.28 31.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.247 -1.149 . . . . 0.0 110.441 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 76' ' ' LYS . 25.8 pt-20 -128.58 129.94 46.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.326 -0.859 . . . . 0.0 109.672 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.848 HG12 HD13 ' A' ' 80' ' ' LEU . 45.2 t -96.8 79.63 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.036 -1.04 . . . . 0.0 111.12 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.643 ' O ' HD12 ' A' ' 80' ' ' LEU . 20.1 t -73.43 112.09 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.848 HD13 HG12 ' A' ' 78' ' ' VAL . 4.8 mp -120.34 110.14 16.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.915 -1.116 . . . . 0.0 111.943 -177.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.1 tp10 -69.32 122.7 19.42 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.848 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.4 p -118.31 146.35 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.092 -1.005 . . . . 0.0 112.19 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -113.18 82.42 1.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.595 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -50.11 127.11 16.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.529 -0.732 . . . . 0.0 111.211 -177.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.3 mtt -121.87 53.78 1.19 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.421 -0.8 . . . . 0.0 109.518 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.494 ' HD2' ' CE2' ' A' ' 84' ' ' TYR . 6.3 mtpp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.287 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.522 ' HG3' ' CE1' ' A' ' 64' ' ' HIS . 3.1 ptmt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.048 0.451 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 19.9 mt-10 -48.82 126.54 12.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.17 -0.956 . . . . 0.0 110.251 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.43 -24.65 10.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.97 -1.081 . . . . 0.0 111.138 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.56 HD21 ' CE1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER 59.06 96.75 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.099 -1.001 . . . . 0.0 110.592 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.644 ' CG2' HG13 ' A' ' 68' ' ' VAL . 44.8 t . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.046 -1.034 . . . . 0.0 110.071 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.259 0.552 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.542 ' CG ' HG13 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -163.59 147.3 10.33 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.21 -0.931 . . . . 0.0 109.728 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.424 ' N ' ' HG3' ' A' ' 2' ' ' ARG . 21.5 ptt180 -125.53 136.65 53.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.112 -0.992 . . . . 0.0 110.041 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.733 HG13 ' CB ' ' A' ' 44' ' ' ALA . 46.6 t -140.42 157.06 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.102 -0.999 . . . . 0.0 110.567 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.449 ' OG1' HG22 ' A' ' 79' ' ' VAL . 40.1 m -144.24 125.69 14.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 110.212 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.038 HG22 HG21 ' A' ' 42' ' ' THR . 87.7 t -117.75 114.4 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.649 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 -179.675 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.636 HD22 HG21 ' A' ' 16' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.131 0.491 . . . . 0.0 110.365 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.504 ' HA3' ' CG ' ' A' ' 37' ' ' LEU . . . 63.38 83.94 0.07 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.636 HG21 HD22 ' A' ' 14' ' ' LEU . 1.1 tt -176.43 120.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -1.175 . . . . 0.0 109.921 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.488 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -111.53 106.1 14.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.89 . . . . 0.0 109.469 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.038 HD11 HG22 ' A' ' 68' ' ' VAL . 22.0 pt -82.41 156.54 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.449 -0.782 . . . . 0.0 111.522 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.459 ' CB ' ' HB2' ' A' ' 31' ' ' SER . 7.9 ttmm -139.73 119.98 13.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.493 -0.755 . . . . 0.0 109.772 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.71 -159.46 28.09 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.445 ' CA ' ' HB2' ' A' ' 64' ' ' HIS . . . 156.88 140.27 2.91 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.499 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.0 OUTLIER -60.88 -14.64 23.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -1.084 . . . . 0.0 110.713 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -72.73 -19.12 61.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.893 -1.129 . . . . 0.0 110.006 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -123.38 28.22 7.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 109.879 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.24 83.91 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.392 -0.817 . . . . 0.0 110.166 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.581 ' HE1' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -167.39 123.13 0.87 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.29 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.847 ' HB3' HD21 ' A' ' 52' ' ' LEU . 55.2 Cg_endo -71.61 52.32 1.63 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 O-C-N 123.39 1.205 . . . . 0.0 111.729 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 64' ' ' HIS . 13.9 mm 42.39 88.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 O-C-N 121.093 -1.005 . . . . 0.0 110.817 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 50' ' ' ALA . 6.0 mt -97.39 131.6 43.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.757 -1.214 . . . . 0.0 111.89 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.657 HG21 HD11 ' A' ' 33' ' ' ILE . 39.6 mt -67.18 132.22 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.284 -0.885 . . . . 0.0 108.74 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.459 ' HB2' ' CB ' ' A' ' 19' ' ' LYS . 6.9 t -119.51 -10.4 9.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.167 -0.958 . . . . 0.0 111.092 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.38 99.4 2.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.987 -1.071 . . . . 0.0 110.707 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.657 HD11 HG21 ' A' ' 30' ' ' ILE . 13.4 mm -89.58 95.92 5.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.318 -0.864 . . . . 0.0 108.682 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.584 ' CZ ' HD13 ' B' ' 6' ' ' LEU . 4.8 m-30 -45.02 137.45 4.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.818 -0.551 . . . . 0.0 110.85 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 37' ' ' LEU . 1.6 tttp -79.98 158.42 26.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.279 -0.888 . . . . 0.0 110.479 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.27 22.31 29.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 35' ' ' LYS . 1.9 mm? -112.01 168.82 9.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -1.111 . . . . 0.0 109.718 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.78 ' O ' HG23 ' A' ' 42' ' ' THR . . . -56.1 -70.46 0.11 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.135 -0.978 . . . . 0.0 111.174 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 14' ' ' LEU . . . -47.1 -24.66 0.7 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.332 -0.855 . . . . 0.0 111.671 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.475 ' HB2' HG22 ' A' ' 33' ' ' ILE . 4.8 t70 -93.91 -31.81 14.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.888 -1.133 . . . . 0.0 110.456 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 1.4 pp0? -87.13 12.0 12.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.062 -1.024 . . . . 0.0 110.491 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 1.038 HG21 HG22 ' A' ' 6' ' ' VAL . 35.3 p -98.88 6.62 46.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.053 -1.029 . . . . 0.0 110.815 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER 49.98 53.83 12.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.864 -1.147 . . . . 0.0 110.818 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.733 ' CB ' HG13 ' A' ' 4' ' ' VAL . . . -177.13 -52.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.134 -0.979 . . . . 0.0 110.547 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.817 HD12 HG21 ' A' ' 6' ' ' VAL . 2.6 mt -69.56 85.96 0.45 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.874 -1.141 . . . . 0.0 108.808 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.606 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -112.59 151.38 30.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.942 -0.474 . . . . 0.0 109.801 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.472 ' HA ' HG22 ' A' ' 30' ' ' ILE . 53.7 t -49.1 162.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 120.903 -1.123 . . . . 0.0 110.127 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.406 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 74.07 32.18 58.86 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.786 -1.725 . . . . 0.0 108.786 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.611 ' HB2' HD12 ' A' ' 30' ' ' ILE . 54.2 m-20 -116.96 104.8 11.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.603 -0.939 . . . . 0.0 110.173 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -81.94 97.04 7.88 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 110.158 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.51 HG21 ' CG1' ' A' ' 54' ' ' VAL . 51.4 mt -62.1 135.07 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 0.0 110.155 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.847 HD21 ' HB3' ' A' ' 27' ' ' PRO . 65.3 mt -132.53 14.0 4.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.465 -0.772 . . . . 0.0 110.217 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 178.96 96.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.505 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.849 HG21 ' CB ' ' A' ' 70' ' ' ALA . 14.5 m -95.46 126.48 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.216 -0.927 . . . . 0.0 110.452 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.2 m120 59.28 24.4 12.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.382 -0.824 . . . . 0.0 110.609 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.6 30.78 17.62 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.1 mm-40 -123.07 95.58 4.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.134 -1.215 . . . . 0.0 109.647 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.6 97.55 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.561 0.696 . . . . 0.0 111.356 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.976 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -80.58 -8.12 59.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.54 -0.725 . . . . 0.0 110.548 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.8 p -54.36 -36.7 64.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.011 -1.055 . . . . 0.0 110.152 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t -95.39 22.33 7.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 110.108 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.976 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -118.76 161.48 20.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 110.281 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 22' ' ' ARG . 55.1 p -91.08 -170.71 2.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 109.926 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.887 ' O ' HG23 ' A' ' 68' ' ' VAL . 10.2 t60 -69.07 -23.57 64.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.031 -1.043 . . . . 0.0 109.806 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -77.42 -39.73 45.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.617 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.753 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 5.7 mm-40 -65.3 -24.72 67.36 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.424 -0.797 . . . . 0.0 109.953 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.49 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -82.83 -41.11 19.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.175 -0.953 . . . . 0.0 110.587 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.038 HG22 HD11 ' A' ' 18' ' ' ILE . 5.4 t -73.45 -28.45 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.141 -0.974 . . . . 0.0 109.398 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -40.33 93.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -0.801 . . . . 0.0 109.81 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.849 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -68.47 -49.3 60.85 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.209 -0.932 . . . . 0.0 108.976 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 80' ' ' LEU . 82.4 mt -58.51 -23.35 57.85 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.641 -0.662 . . . . 0.0 109.362 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -77.54 -40.12 43.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 109.624 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.11 64.82 0.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.403 -0.811 . . . . 0.0 109.364 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.588 ' CB ' HG22 ' A' ' 78' ' ' VAL . 30.4 p -82.23 174.4 11.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.375 -0.828 . . . . 0.0 109.933 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.17 -175.03 34.61 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.67 -37.88 19.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.148 -1.207 . . . . 0.0 110.544 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -117.76 101.9 8.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.397 -0.814 . . . . 0.0 109.894 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.898 HG12 HD13 ' A' ' 80' ' ' LEU . 59.9 t -67.28 73.5 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.0 110.795 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.449 HG22 ' OG1' ' A' ' 5' ' ' THR . 2.0 t -69.53 106.47 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.898 HD13 HG12 ' A' ' 78' ' ' VAL . 3.8 mp -114.0 119.79 38.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.884 -1.135 . . . . 0.0 112.235 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 14.3 tp10 -73.34 133.39 43.82 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.542 HG13 ' CG ' ' A' ' 2' ' ' ARG . 2.2 p -135.16 144.35 34.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.837 -1.164 . . . . 0.0 111.741 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.683 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -107.51 86.57 2.33 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.606 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -54.33 122.86 11.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.472 -0.768 . . . . 0.0 110.662 -177.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -111.78 52.3 0.76 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.636 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.3 pttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.27 -179.762 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.498 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 56.3 tttt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.128 0.489 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.54 87.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.431 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.431 ' N ' ' O ' ' B' ' 3' ' ' LYS . 0.4 OUTLIER -90.86 -163.54 1.04 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 109.865 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.584 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 30.5 tp -163.27 121.49 1.98 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 109.995 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.714 HG11 ' C ' ' A' ' 71' ' ' LEU . 83.1 t . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.082 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.436 0.636 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.834 ' CB ' HG13 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -155.18 168.03 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.409 -0.807 . . . . 0.0 110.692 -179.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -141.55 121.12 13.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.468 -0.77 . . . . 0.0 109.197 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.669 HG13 ' CB ' ' A' ' 44' ' ' ALA . 64.3 t -131.94 139.48 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.931 -1.105 . . . . 0.0 111.05 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.8 m -119.14 116.47 26.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.459 -0.776 . . . . 0.0 109.683 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.667 HG22 HG21 ' A' ' 42' ' ' THR . 90.9 t -103.83 111.57 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 110.207 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.88 131.15 42.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.86 . . . . 0.0 109.916 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 1.6 tttt -61.46 -151.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.369 -0.832 . . . . 0.0 110.387 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 8' ' ' LYS . . . 55.63 -171.21 0.07 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.248 -0.907 . . . . 0.0 110.225 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.594 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 6.9 m-20 58.48 113.28 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.594 -0.691 . . . . 0.0 110.583 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 10' ' ' ASP . . . 67.26 -62.02 0.33 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.353 -0.842 . . . . 0.0 110.595 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 10' ' ' ASP . . . 125.46 -74.9 0.41 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.56 160.87 10.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.4 -16.2 22.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -1.186 . . . . 0.0 110.666 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.882 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 56.0 87.0 0.02 OUTLIER Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.413 HG23 ' HB ' ' B' ' 7' ' ' VAL . 3.3 tt -176.32 118.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.223 -1.163 . . . . 0.0 110.345 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -112.94 101.09 9.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.561 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.124 HD11 HG22 ' A' ' 68' ' ' VAL . 28.4 pt -78.31 151.06 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.95 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' B' ' 3' ' ' LYS . 46.6 tttt -137.83 122.22 18.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.452 -0.78 . . . . 0.0 110.209 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.08 -153.05 24.16 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 160.44 133.85 1.56 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.578 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.2 OUTLIER -60.12 -15.43 23.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.424 -1.045 . . . . 0.0 110.617 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.68 7.07 15.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.719 -1.238 . . . . 0.0 110.487 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.53 23.76 2.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.085 -1.009 . . . . 0.0 109.749 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm 53.88 64.87 1.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.883 . . . . 0.0 110.213 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.523 ' HE3' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -145.51 117.84 5.2 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 110.236 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.745 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 48.3 Cg_endo -69.54 54.34 1.09 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 O-C-N 123.425 1.224 . . . . 0.0 111.653 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 64' ' ' HIS . 16.3 mm 42.33 88.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 O-C-N 121.268 -0.895 . . . . 0.0 110.304 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' A' ' 50' ' ' ALA . 31.8 tp -100.89 125.72 47.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.843 -1.16 . . . . 0.0 111.888 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.864 HD12 ' HB2' ' A' ' 49' ' ' ASP . 57.4 mt -61.82 136.26 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.588 -0.695 . . . . 0.0 110.188 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.3 t -121.98 -11.4 8.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 110.686 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 106.78 3.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.956 -1.09 . . . . 0.0 110.703 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.539 HD11 HG21 ' A' ' 30' ' ' ILE . 11.8 mm -95.6 94.74 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 109.45 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.964 ' CE1' HD13 ' B' ' 6' ' ' LEU . 88.3 m-85 -54.27 141.55 29.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.841 . . . . 0.0 110.26 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.849 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.0 mmmt -86.42 171.57 11.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 110.805 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.58 30.89 73.13 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.882 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.7 OUTLIER -138.28 162.61 33.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -1.196 . . . . 0.0 110.78 -179.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.615 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -46.5 -64.08 0.85 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.514 -0.741 . . . . 0.0 111.63 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.758 ' O ' HG22 ' A' ' 42' ' ' THR . . . -48.6 -53.75 17.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.96 -1.087 . . . . 0.0 111.385 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.448 ' HB2' HG22 ' A' ' 33' ' ' ILE . 16.3 t70 -77.3 -9.26 58.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.86 -1.15 . . . . 0.0 111.891 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.496 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -107.41 10.95 29.41 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.67 -1.268 . . . . 0.0 110.746 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 39' ' ' ALA . 5.4 t -106.82 15.62 25.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.017 -1.052 . . . . 0.0 110.512 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER 47.74 55.31 8.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.117 -0.989 . . . . 0.0 110.991 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.669 ' CB ' HG13 ' A' ' 4' ' ' VAL . . . -176.64 -47.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.083 -1.011 . . . . 0.0 110.524 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -67.93 82.44 0.21 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.973 -1.079 . . . . 0.0 109.154 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.588 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.91 150.01 32.39 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.548 -0.72 . . . . 0.0 109.835 -179.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 48' ' ' GLY . 96.2 t -50.24 167.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.97 -1.081 . . . . 0.0 110.253 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.503 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 70.88 30.21 68.35 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.864 ' HB2' HD12 ' A' ' 30' ' ' ILE . 36.5 m-20 -114.06 99.57 7.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.485 -1.009 . . . . 0.0 110.968 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.779 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -78.43 107.11 10.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 109.518 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.811 ' C ' HD22 ' A' ' 52' ' ' LEU . 61.2 mt -77.46 134.33 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 110.939 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.811 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.0 mm? -120.9 7.3 10.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.488 -0.757 . . . . 0.0 110.003 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 4.8 t -175.76 131.92 0.26 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.148 -0.97 . . . . 0.0 109.871 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.766 HG12 ' HG ' ' A' ' 80' ' ' LEU . 2.0 m -123.9 113.96 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.302 -0.873 . . . . 0.0 109.721 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.6 34.29 20.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.292 -0.88 . . . . 0.0 110.283 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.99 21.02 51.8 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 53' ' ' SER . 3.3 tm-20 -109.51 84.9 2.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.064 -1.257 . . . . 0.0 110.417 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -44.56 97.88 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.432 -0.793 . . . . 0.0 110.947 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.643 HD11 HG22 ' A' ' 54' ' ' VAL . 37.3 mt -79.09 -8.78 59.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.473 -0.767 . . . . 0.0 110.877 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.427 ' O ' ' CZ ' ' A' ' 22' ' ' ARG . 21.7 p -47.01 -36.19 7.58 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.212 -0.93 . . . . 0.0 110.611 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -106.85 29.86 6.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.752 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.634 ' HB1' ' CB ' ' A' ' 66' ' ' GLU . . . -119.72 153.65 35.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.355 -0.841 . . . . 0.0 110.133 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.578 HG22 ' HB3' ' A' ' 22' ' ' ARG . 2.9 p -86.32 171.56 11.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.303 -0.873 . . . . 0.0 110.071 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.909 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.2 t60 -55.29 -24.65 29.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -0.964 . . . . 0.0 109.777 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -77.14 -38.24 52.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.014 . . . . 0.0 109.761 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.634 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 4.1 mm-40 -67.94 -25.89 65.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.832 . . . . 0.0 110.166 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.87 -38.82 24.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 110.416 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.124 HG22 HD11 ' A' ' 18' ' ' ILE . 8.2 t -73.26 -27.38 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.068 -1.02 . . . . 0.0 109.334 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -65.09 -38.16 89.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.363 -0.835 . . . . 0.0 109.767 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.6 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.26 -48.53 56.45 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.15 -0.969 . . . . 0.0 108.726 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.69 ' CD2' HD21 ' A' ' 80' ' ' LEU . 82.7 mt -59.62 -22.49 61.92 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.661 -0.649 . . . . 0.0 109.674 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -80.11 -45.11 18.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.654 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 5.5 tttt -112.74 59.79 0.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.38 -0.825 . . . . 0.0 109.719 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.601 ' HB ' HG22 ' A' ' 78' ' ' VAL . 47.3 p -78.08 174.2 11.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 110.248 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.88 -169.48 29.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -52.11 23.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.017 -1.284 . . . . 0.0 110.448 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 1.8 pt-20 -107.74 117.24 33.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.902 . . . . 0.0 109.778 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.007 HG12 HD13 ' A' ' 80' ' ' LEU . 45.8 t -83.11 78.56 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.938 -1.101 . . . . 0.0 110.781 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.6 ' O ' HD12 ' A' ' 80' ' ' LEU . 16.8 t -68.53 112.53 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.101 -0.999 . . . . 0.0 108.329 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.007 HD13 HG12 ' A' ' 78' ' ' VAL . 4.4 mp -119.94 115.79 24.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.993 -1.067 . . . . 0.0 111.87 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 7.3 tp10 -73.56 128.63 36.02 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.834 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.5 p -127.23 150.27 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.044 -1.035 . . . . 0.0 112.15 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.779 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 34.5 tttp -115.58 85.04 2.2 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.588 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -51.56 130.65 28.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.468 -0.77 . . . . 0.0 111.119 -177.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.4 mtt -115.47 51.74 0.92 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.765 . . . . 0.0 109.451 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.338 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 10.6 tttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.174 0.511 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -121.49 94.34 4.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.154 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.417 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -91.28 -169.52 2.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.394 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.964 HD13 ' CE1' ' A' ' 34' ' ' PHE . 5.1 tp -157.77 94.83 1.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.82 . . . . 0.0 109.883 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 71' ' ' LEU . 94.9 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.088 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.499 0.666 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.48 ' CG ' HG13 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -158.77 146.51 17.9 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.548 -0.72 . . . . 0.0 109.736 -179.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.413 ' N ' ' HG3' ' A' ' 2' ' ' ARG . 0.4 OUTLIER -124.28 129.33 50.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.057 -1.027 . . . . 0.0 110.307 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.735 HG22 ' HB1' ' A' ' 44' ' ' ALA . 93.5 t -128.79 127.53 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.384 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.6 m -114.69 132.57 56.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.737 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.546 HG21 HD12 ' A' ' 45' ' ' LEU . 90.4 t -122.69 109.96 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 110.304 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.12 78.12 0.95 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 109.549 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.49 155.92 0.32 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.314 -0.866 . . . . 0.0 110.786 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.84 -168.27 1.69 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.87 . . . . 0.0 110.199 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.7 -43.64 88.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 110.229 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.8 121.66 1.31 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 110.172 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.0 -78.23 0.04 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.75 165.57 21.15 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.711 HD23 ' HB2' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -109.83 -23.07 11.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -1.194 . . . . 0.0 110.367 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.962 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 56.21 90.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.691 HD12 HD22 ' A' ' 45' ' ' LEU . 1.1 tt -176.33 120.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.203 -1.175 . . . . 0.0 110.525 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.588 ' OG ' HD13 ' B' ' 6' ' ' LEU . 1.3 m -112.46 106.25 14.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.186 -0.947 . . . . 0.0 109.404 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.974 HD11 ' CG2' ' A' ' 68' ' ' VAL . 12.3 pt -82.58 156.64 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.426 -0.796 . . . . 0.0 111.501 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.431 ' CD ' ' CB ' ' A' ' 31' ' ' SER . 10.4 mtpt -136.44 156.92 47.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.578 -0.702 . . . . 0.0 109.833 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 123.05 -156.49 17.44 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.68 133.98 1.57 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.709 ' HB3' HG22 ' A' ' 63' ' ' THR . 1.9 tpm_? -60.71 -15.39 28.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -1.15 . . . . 0.0 110.62 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.412 ' OE2' ' ND2' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -82.03 5.51 19.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.649 -1.282 . . . . 0.0 110.342 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.412 ' ND2' ' OE2' ' A' ' 23' ' ' GLU . 0.7 OUTLIER -140.9 25.75 2.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.091 -1.006 . . . . 0.0 109.446 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.29 90.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 0.0 109.875 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.526 ' HE2' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -170.03 127.01 0.76 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.305 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.743 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 57.0 Cg_endo -75.88 45.5 1.51 Allowed 'Trans proline' 0 N--CA 1.494 1.541 0 O-C-N 123.371 1.195 . . . . 0.0 111.717 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.514 HG21 ' HB1' ' A' ' 67' ' ' ALA . 27.0 mm 47.51 90.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 120.789 -1.194 . . . . 0.0 109.848 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.629 HD13 ' HB2' ' A' ' 50' ' ' ALA . 36.6 tp -103.15 125.05 49.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.812 -1.18 . . . . 0.0 112.051 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.821 HD12 ' HB2' ' A' ' 49' ' ' ASP . 60.9 mt -58.78 139.39 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.568 -0.707 . . . . 0.0 109.85 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.431 ' CB ' ' CD ' ' A' ' 19' ' ' LYS . 33.3 t -124.6 -10.5 7.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 110.969 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' CB ' ' NZ ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -154.81 100.4 2.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.905 -1.122 . . . . 0.0 110.843 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.45 HG13 ' HA ' ' A' ' 46' ' ' PHE . 13.7 mm -86.39 101.26 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.212 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.586 ' HB3' HD13 ' A' ' 37' ' ' LEU . 3.3 m-85 -59.36 135.56 57.69 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.604 -0.685 . . . . 0.0 109.698 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.661 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -83.06 169.47 15.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.117 -0.989 . . . . 0.0 110.851 -179.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.48 30.29 77.15 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.962 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER -138.28 162.1 35.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.112 -1.228 . . . . 0.0 110.955 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -46.22 -69.06 0.14 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.628 -0.67 . . . . 0.0 111.694 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.711 ' HB2' HD23 ' A' ' 14' ' ' LEU . . . -45.01 -39.25 5.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.472 -0.767 . . . . 0.0 111.575 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.419 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 16.5 t70 -93.61 10.62 31.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.057 -1.027 . . . . 0.0 110.758 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -115.44 3.72 14.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.925 -1.109 . . . . 0.0 110.773 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.521 HG21 HG22 ' A' ' 6' ' ' VAL . 10.1 t -108.22 15.16 24.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.93 -1.106 . . . . 0.0 110.893 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.12 60.98 3.24 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.084 -1.01 . . . . 0.0 110.926 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.735 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -175.15 -50.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.2 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.691 HD22 HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -70.31 86.83 0.6 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.959 -1.088 . . . . 0.0 108.705 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.603 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -115.96 153.33 31.81 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.825 -0.547 . . . . 0.0 110.029 -179.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 48' ' ' GLY . 32.5 t -48.12 165.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 120.899 -1.126 . . . . 0.0 110.151 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.449 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 70.77 31.69 67.33 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.821 ' HB2' HD12 ' A' ' 30' ' ' ILE . 44.9 m-20 -116.58 100.28 7.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -1.041 . . . . 0.0 110.997 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.743 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -79.1 108.88 12.93 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.858 . . . . 0.0 109.831 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.819 ' C ' HD22 ' A' ' 52' ' ' LEU . 55.2 mt -75.4 139.94 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.329 -0.857 . . . . 0.0 110.824 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.819 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.2 mm? -125.05 4.63 7.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.255 -0.903 . . . . 0.0 110.916 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 176.96 103.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.832 -1.168 . . . . 0.0 109.75 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.91 HG21 ' CB ' ' A' ' 70' ' ' ALA . 20.5 m -92.49 121.04 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.223 -0.923 . . . . 0.0 110.602 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 59.41 34.16 22.62 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.168 -0.958 . . . . 0.0 110.809 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.99 19.89 62.12 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.8 mt-10 -110.23 91.83 3.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.941 -1.329 . . . . 0.0 109.91 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -41.44 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.574 0.702 . . . . 0.0 111.488 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.889 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -90.39 14.01 14.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.489 -0.757 . . . . 0.0 110.399 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.6 t -68.88 -49.54 57.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 110.724 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.36 18.58 5.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.061 -1.024 . . . . 0.0 110.523 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.889 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -104.21 158.41 16.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -0.927 . . . . 0.0 110.233 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.709 HG22 ' HB3' ' A' ' 22' ' ' ARG . 12.4 p -90.15 176.23 6.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 110.071 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.718 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.5 t60 -58.64 -26.01 63.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.072 -1.018 . . . . 0.0 109.556 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.45 -30.28 59.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.089 -1.007 . . . . 0.0 109.709 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.76 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 7.3 mm-40 -75.62 -27.03 58.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.838 . . . . 0.0 109.952 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.514 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -80.09 -36.68 35.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.368 -0.832 . . . . 0.0 110.502 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.974 ' CG2' HD11 ' A' ' 18' ' ' ILE . 17.5 t -75.5 -32.71 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.047 -1.033 . . . . 0.0 109.549 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -60.97 -38.32 85.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 109.879 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.91 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.98 -50.58 32.77 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.177 -0.952 . . . . 0.0 108.788 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.682 ' O ' HG11 ' B' ' 7' ' ' VAL . 86.7 mt -58.56 -23.59 58.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.619 -0.676 . . . . 0.0 110.01 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -80.69 -36.78 31.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.124 -0.985 . . . . 0.0 109.941 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -119.43 58.21 0.88 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.111 -0.993 . . . . 0.0 109.871 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.498 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 39.4 p -80.96 -170.65 2.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.904 . . . . 0.0 110.003 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.53 -175.05 15.33 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -49.04 -59.88 3.25 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.056 -1.261 . . . . 0.0 110.298 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -88.4 95.44 10.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 109.582 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.885 HG12 HD13 ' A' ' 80' ' ' LEU . 94.8 t -79.86 78.74 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 110.66 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.602 ' O ' HD12 ' A' ' 80' ' ' LEU . 5.0 t -68.66 116.32 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.083 -1.01 . . . . 0.0 108.352 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.885 HD13 HG12 ' A' ' 78' ' ' VAL . 3.4 mp -121.06 100.8 7.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.978 -1.076 . . . . 0.0 111.743 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 20.5 tt0 -64.13 128.89 37.8 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.636 HG11 HG23 ' A' ' 4' ' ' VAL . 2.2 p -131.9 143.93 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 111.799 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.703 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 79.5 tttt -106.67 88.34 2.74 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.603 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -56.0 111.24 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.456 -0.778 . . . . 0.0 111.165 -177.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 mtt -89.21 53.43 2.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 109.198 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.149 -179.535 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.465 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 15.3 tttp . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.157 0.503 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -121.13 90.84 3.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.991 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.413 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -79.9 -161.72 0.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.277 -0.889 . . . . 0.0 110.461 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.588 HD13 ' OG ' ' A' ' 17' ' ' SER . 22.1 tp -171.14 99.88 0.21 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 109.935 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.682 HG11 ' O ' ' A' ' 71' ' ' LEU . 92.5 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.255 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.351 0.596 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.851 ' CB ' HG13 ' A' ' 82' ' ' VAL . 1.7 mtp85 -157.05 167.74 29.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.68 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -138.66 119.01 13.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.497 -0.752 . . . . 0.0 109.189 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.977 HG22 ' HB1' ' A' ' 44' ' ' ALA . 83.2 t -127.63 126.15 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.969 -1.082 . . . . 0.0 110.655 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.5 m -117.29 114.39 23.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.446 -0.784 . . . . 0.0 109.441 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.914 HG21 HD12 ' A' ' 45' ' ' LEU . 98.4 t -102.8 111.04 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.946 . . . . 0.0 109.964 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -71.72 123.68 23.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.436 -0.79 . . . . 0.0 110.044 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -67.61 -70.72 0.24 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 110.2 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 8' ' ' LYS . . . 64.39 -70.61 0.08 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.636 -0.665 . . . . 0.0 110.39 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 8' ' ' LYS . 15.9 m-20 -163.17 117.01 1.62 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.062 -1.024 . . . . 0.0 109.882 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -174.87 126.09 0.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.834 . . . . 0.0 110.015 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -50.91 -64.07 4.04 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.3 -168.1 15.46 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.714 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -113.39 -17.84 12.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.409 -1.053 . . . . 0.0 110.277 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.947 ' CA ' HD22 ' A' ' 37' ' ' LEU . . . 63.86 81.65 0.1 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.628 HG21 HD22 ' A' ' 14' ' ' LEU . 3.9 tt -176.42 117.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.326 -1.102 . . . . 0.0 110.325 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' B' ' 5' ' ' SER . 0.7 OUTLIER -111.8 119.57 39.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.186 -0.946 . . . . 0.0 109.577 179.231 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.014 HD11 HG22 ' A' ' 68' ' ' VAL . 8.8 pt -95.6 148.98 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.98 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HG2' ' CA ' ' B' ' 4' ' ' GLU . 0.2 OUTLIER -132.67 134.72 45.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.812 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 142.17 -159.98 27.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 168.32 136.84 2.12 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.545 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.0 OUTLIER -59.46 -16.1 21.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -1.133 . . . . 0.0 110.598 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.43 -12.38 60.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.826 -1.171 . . . . 0.0 110.233 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.14 27.54 8.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.088 -1.007 . . . . 0.0 110.185 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.69 49.68 19.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.126 -0.984 . . . . 0.0 110.043 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.614 ' HE1' ' HB2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -125.33 122.56 25.11 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 110.365 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.693 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 55.5 Cg_endo -72.66 50.86 1.77 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 O-C-N 123.422 1.222 . . . . 0.0 111.735 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 64' ' ' HIS . 25.4 mm 43.37 88.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 O-C-N 121.053 -1.029 . . . . 0.0 110.706 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.705 HD21 ' HG3' ' A' ' 85' ' ' MET . 5.6 mt -97.74 132.51 43.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.857 -1.152 . . . . 0.0 111.608 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.801 HG21 HD11 ' A' ' 33' ' ' ILE . 56.9 mt -69.2 138.21 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.284 -0.885 . . . . 0.0 108.952 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 42.6 t -119.83 -24.73 6.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.94 -1.1 . . . . 0.0 110.931 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.43 108.3 5.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.016 -1.053 . . . . 0.0 110.666 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.801 HD11 HG21 ' A' ' 30' ' ' ILE . 15.9 mm -94.24 98.44 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.429 -0.794 . . . . 0.0 109.166 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.756 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 92.0 m-85 -57.9 130.83 48.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.608 -0.683 . . . . 0.0 110.362 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.972 ' O ' HD12 ' A' ' 37' ' ' LEU . 7.3 pttt -76.83 171.68 14.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.402 -0.811 . . . . 0.0 110.95 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.57 30.57 65.53 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.972 HD12 ' O ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -138.47 161.96 35.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.076 -1.249 . . . . 0.0 110.903 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.592 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -48.24 -66.73 0.35 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.579 -0.701 . . . . 0.0 111.592 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.714 ' HB2' ' CD2' ' A' ' 14' ' ' LEU . . . -47.57 -33.03 6.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 112.199 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.441 ' HB2' HG22 ' A' ' 33' ' ' ILE . 5.4 t70 -95.77 -19.91 19.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.719 -1.238 . . . . 0.0 111.302 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.494 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -93.78 14.86 17.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.905 -1.122 . . . . 0.0 110.725 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.509 HG21 HG22 ' A' ' 6' ' ' VAL . 8.9 t -107.74 14.07 25.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.013 -1.055 . . . . 0.0 110.843 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 44.79 46.91 8.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.188 -0.945 . . . . 0.0 111.284 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.977 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -165.62 -51.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 110.515 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.914 HD12 HG21 ' A' ' 6' ' ' VAL . 2.8 mt -70.61 83.07 0.6 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.839 -1.163 . . . . 0.0 108.504 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.591 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -110.29 155.07 22.58 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 48' ' ' GLY . 90.6 t -51.02 167.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.813 -1.179 . . . . 0.0 110.29 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.5 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 67.84 32.36 77.49 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.796 ' HB2' HD12 ' A' ' 30' ' ' ILE . 32.6 m-20 -114.05 104.44 12.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.484 -1.009 . . . . 0.0 110.431 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -80.56 105.69 12.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.328 -0.857 . . . . 0.0 109.627 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.793 ' C ' HD22 ' A' ' 52' ' ' LEU . 54.7 mt -76.62 135.97 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.405 -0.809 . . . . 0.0 111.07 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.793 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.4 mm? -120.55 8.21 10.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.488 -0.757 . . . . 0.0 110.214 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 26.0 t -178.68 135.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.103 -0.998 . . . . 0.0 109.704 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.664 HG22 HD11 ' A' ' 59' ' ' LEU . 1.5 m -129.24 114.83 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.309 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.42 ' ND2' ' HB ' ' A' ' 74' ' ' THR . 2.9 m-80 58.75 31.15 20.9 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.262 -0.899 . . . . 0.0 110.76 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.83 21.07 34.72 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.561 ' HB2' HG23 ' A' ' 54' ' ' VAL . 1.3 mm-40 -112.41 88.03 2.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.041 -1.27 . . . . 0.0 110.164 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -46.64 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.276 -0.89 . . . . 0.0 111.004 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.664 HD11 HG22 ' A' ' 54' ' ' VAL . 79.8 mt -81.7 -11.92 58.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.563 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.505 ' HB2' HD12 ' A' ' 52' ' ' LEU . 2.2 t -48.16 -32.41 6.96 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.231 -0.918 . . . . 0.0 110.06 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.9 t -112.06 22.62 14.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.343 -0.848 . . . . 0.0 109.451 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.498 ' HB3' ' HA ' ' A' ' 59' ' ' LEU . . . -113.11 152.57 29.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.425 -0.797 . . . . 0.0 110.143 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.545 HG22 ' HB3' ' A' ' 22' ' ' ARG . 3.1 p -86.9 169.94 12.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 110.053 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.896 ' O ' HG23 ' A' ' 68' ' ' VAL . 3.3 t60 -54.0 -25.74 22.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.929 . . . . 0.0 109.789 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -77.44 -36.26 53.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.062 -1.024 . . . . 0.0 110.034 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.428 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 46.4 mm-40 -73.11 -23.04 60.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.934 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.36 -38.25 24.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 110.417 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.014 HG22 HD11 ' A' ' 18' ' ' ILE . 14.1 t -72.44 -29.21 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.154 -0.966 . . . . 0.0 109.184 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -61.37 -37.2 82.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.335 -0.853 . . . . 0.0 109.813 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.605 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -71.54 -50.31 32.4 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.171 -0.956 . . . . 0.0 108.81 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.472 ' CD2' HD21 ' A' ' 80' ' ' LEU . 86.7 mt -57.68 -23.67 52.75 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.543 -0.723 . . . . 0.0 109.443 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -78.56 -34.91 46.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.678 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -130.79 54.17 1.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.343 -0.848 . . . . 0.0 109.684 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.706 ' CB ' HG22 ' A' ' 78' ' ' VAL . 66.2 p -57.81 -84.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.855 . . . . 0.0 110.502 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.427 ' N ' ' OG1' ' A' ' 74' ' ' THR . . . 154.12 -170.74 32.7 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -47.23 -35.69 7.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.147 -1.208 . . . . 0.0 110.665 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -132.96 130.39 39.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.223 -0.923 . . . . 0.0 109.705 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.875 HG12 HD13 ' A' ' 80' ' ' LEU . 99.4 t -94.64 81.59 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.072 -1.018 . . . . 0.0 111.196 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.678 ' O ' HD12 ' A' ' 80' ' ' LEU . 22.0 t -72.21 116.74 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.875 HD13 HG12 ' A' ' 78' ' ' VAL . 3.8 mp -124.54 108.49 12.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.959 -1.088 . . . . 0.0 112.108 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -70.26 129.15 38.56 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.851 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.8 p -129.02 145.38 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.855 -1.153 . . . . 0.0 112.602 -177.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.73 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 5.4 tttp -111.51 83.77 1.83 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.591 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -49.31 119.39 3.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.469 -0.77 . . . . 0.0 111.645 -177.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.705 ' HG3' HD21 ' A' ' 29' ' ' LEU . 2.8 mmt -101.21 47.32 0.91 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.6 tptt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.318 -179.449 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.544 ' CD ' ' CD2' ' A' ' 64' ' ' HIS . 12.0 mttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.319 0.58 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.466 ' CA ' ' HG2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER 54.92 49.71 17.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.015 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.423 ' O ' ' CB ' ' A' ' 17' ' ' SER . 26.5 t -54.24 -175.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 110.526 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.756 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -149.95 73.31 1.16 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.375 -0.828 . . . . 0.0 110.381 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.463 ' CG2' HG13 ' A' ' 68' ' ' VAL . 59.1 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.168 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.272 0.558 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.828 ' CB ' HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -155.19 162.4 40.95 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.217 -0.927 . . . . 0.0 110.506 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.93 109.92 6.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.438 -0.789 . . . . 0.0 109.295 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.857 HG22 ' HB1' ' A' ' 44' ' ' ALA . 89.6 t -115.49 152.87 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.029 -1.045 . . . . 0.0 110.846 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.6 m -132.79 114.94 14.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 109.564 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.63 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 86.2 t -102.82 118.67 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.086 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.1 mtm180 -88.05 87.81 7.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.934 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.408 ' HG3' HG21 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -49.4 112.32 0.62 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.298 -0.877 . . . . 0.0 110.637 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.87 50.55 1.42 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.35 -0.844 . . . . 0.0 109.907 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.35 26.22 10.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.37 -0.831 . . . . 0.0 109.968 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.95 59.34 0.7 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.369 -0.832 . . . . 0.0 110.511 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.61 36.74 32.33 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.38 -149.13 18.21 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -116.72 -18.92 10.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -1.154 . . . . 0.0 110.717 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.883 ' CA ' HD22 ' A' ' 37' ' ' LEU . . . 57.88 90.17 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 tt -176.78 118.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.204 -1.174 . . . . 0.0 110.226 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' B' ' 5' ' ' SER . 1.1 t -112.4 100.24 8.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.182 -0.949 . . . . 0.0 109.783 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.949 HD11 HG22 ' A' ' 68' ' ' VAL . 9.8 pt -77.63 150.48 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 110.693 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 31' ' ' SER . 58.9 tttt -136.18 123.24 21.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 110.103 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.75 -140.44 8.69 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.444 ' CA ' ' HB2' ' A' ' 64' ' ' HIS . . . 138.99 148.11 5.22 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -61.36 -14.11 24.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -1.08 . . . . 0.0 110.844 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -9.08 57.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.921 -1.112 . . . . 0.0 110.559 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -130.32 26.28 5.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.043 -1.036 . . . . 0.0 110.12 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.5 mttp 54.72 40.88 32.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.312 -0.868 . . . . 0.0 110.157 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.593 ' HE1' ' HB2' ' A' ' 29' ' ' LEU . 6.2 mmm -120.88 124.77 27.33 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.377 -0.827 . . . . 0.0 110.034 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.699 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 49.6 Cg_endo -70.21 52.66 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 O-C-N 123.348 1.183 . . . . 0.0 111.745 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.654 HG21 ' HB1' ' A' ' 67' ' ' ALA . 18.0 mm 43.53 89.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.084 -1.01 . . . . 0.0 110.096 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' A' ' 50' ' ' ALA . 32.7 tp -102.41 126.78 49.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.886 -1.134 . . . . 0.0 112.072 -178.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.9 HD12 ' HB2' ' A' ' 49' ' ' ASP . 56.7 mt -62.08 135.81 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.463 -0.773 . . . . 0.0 109.633 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.432 ' HA ' HG13 ' A' ' 47' ' ' VAL . 8.4 t -121.91 -18.49 7.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 110.963 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.89 106.48 4.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.002 -1.061 . . . . 0.0 110.702 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.697 HD11 HG21 ' A' ' 30' ' ' ILE . 16.8 mm -94.77 109.78 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 0.0 109.265 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.824 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 88.6 m-85 -71.54 128.15 34.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.8 ' O ' HD12 ' A' ' 37' ' ' LEU . 1.8 mttp -73.83 173.08 10.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -0.939 . . . . 0.0 110.666 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.23 29.65 69.13 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.883 HD22 ' CA ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -138.26 159.42 42.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -1.163 . . . . 0.0 110.941 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.63 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -44.44 -62.42 1.18 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.628 -0.67 . . . . 0.0 111.604 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.726 ' O ' HG22 ' A' ' 42' ' ' THR . . . -47.82 -57.76 5.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.179 -0.95 . . . . 0.0 110.99 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.439 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 12.8 t70 -75.47 0.51 16.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.998 -1.064 . . . . 0.0 111.332 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -104.66 -2.44 25.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.75 -1.219 . . . . 0.0 110.865 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 39' ' ' ALA . 9.2 t -98.67 14.82 27.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.842 -1.161 . . . . 0.0 110.662 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 47.62 49.31 16.38 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.11 -0.993 . . . . 0.0 110.649 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.857 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -169.11 -43.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 110.206 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.489 ' CD2' HG11 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -68.17 80.1 0.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 108.83 179.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.586 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.23 153.67 26.75 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.594 -0.692 . . . . 0.0 110.043 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.526 HG12 ' N ' ' A' ' 48' ' ' GLY . 96.1 t -52.66 168.35 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.075 -1.015 . . . . 0.0 110.362 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.526 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 70.85 30.28 68.33 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.9 ' HB2' HD12 ' A' ' 30' ' ' ILE . 45.6 m-20 -114.92 99.9 7.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -1.036 . . . . 0.0 111.059 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -79.07 107.58 11.93 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.092 -1.005 . . . . 0.0 109.718 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.858 ' C ' HD22 ' A' ' 52' ' ' LEU . 52.2 mt -76.49 138.66 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.441 -0.787 . . . . 0.0 110.683 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.858 HD22 ' C ' ' A' ' 51' ' ' ILE . 3.9 mm? -127.35 7.23 6.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.153 -0.967 . . . . 0.0 110.82 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 176.08 99.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.87 -1.144 . . . . 0.0 109.765 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.927 HG21 ' CB ' ' A' ' 70' ' ' ALA . 23.1 m -91.1 121.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.138 -0.976 . . . . 0.0 110.36 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' A' ' 79' ' ' VAL . 3.8 m120 60.37 36.29 20.45 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.096 -1.002 . . . . 0.0 110.274 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.3 11.42 85.34 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.2 tp10 -96.79 92.34 6.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.882 -1.363 . . . . 0.0 109.429 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -40.89 103.96 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.562 0.696 . . . . 0.0 111.31 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.038 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -92.99 -13.53 28.6 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.61 -0.681 . . . . 0.0 110.499 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.2 p -54.9 -37.64 66.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.004 . . . . 0.0 110.135 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 m -96.96 23.42 7.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -0.935 . . . . 0.0 110.264 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 1.038 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -117.59 155.43 29.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 110.171 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.9 p -85.54 172.6 10.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.314 -0.866 . . . . 0.0 110.18 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.805 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.0 t60 -53.62 -25.74 18.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.107 -0.996 . . . . 0.0 109.786 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -75.87 -40.91 53.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.017 -1.052 . . . . 0.0 109.27 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.885 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 19.6 mt-10 -65.25 -22.43 66.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.527 -0.733 . . . . 0.0 109.87 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.654 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -83.98 -40.58 18.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.298 -0.877 . . . . 0.0 110.658 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.949 HG22 HD11 ' A' ' 18' ' ' ILE . 9.4 t -74.49 -28.37 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.205 -0.935 . . . . 0.0 109.26 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -65.54 -37.88 88.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.342 -0.849 . . . . 0.0 110.093 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.927 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.06 -37.28 75.46 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.12 -0.988 . . . . 0.0 109.125 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.8 mt -73.81 -19.95 60.6 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.648 -0.658 . . . . 0.0 109.808 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -80.88 -45.0 17.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.904 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -106.22 30.83 5.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.366 -0.834 . . . . 0.0 109.99 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 1.076 HG21 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -65.64 142.66 57.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.845 . . . . 0.0 109.972 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.86 -179.98 40.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 77' ' ' GLU . 8.2 pttt -49.9 -50.92 44.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.363 -1.081 . . . . 0.0 110.688 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.425 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 81.5 mm-40 -88.86 92.87 9.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.908 -1.12 . . . . 0.0 109.133 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.076 HG13 HG21 ' A' ' 74' ' ' THR . 78.3 t -83.06 78.63 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.189 -0.944 . . . . 0.0 110.903 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.65 ' O ' HD12 ' A' ' 80' ' ' LEU . 11.0 t -66.44 124.01 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.892 HD13 HG12 ' A' ' 78' ' ' VAL . 2.3 mp -124.21 106.14 10.07 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.901 -1.125 . . . . 0.0 111.749 -178.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.9 tt0 -68.2 121.59 16.53 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.828 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.6 p -127.05 147.95 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.069 -1.02 . . . . 0.0 112.683 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 13.9 ttmt -112.45 88.2 2.76 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.586 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -56.28 126.68 27.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 111.157 -177.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.0 mmt -105.89 54.89 0.69 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.344 -0.847 . . . . 0.0 109.226 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.5 tttt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.224 -179.527 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.54 ' CB ' ' CE1' ' A' ' 64' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.234 0.54 . . . . 0.0 110.178 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER 54.29 62.31 2.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -0.862 . . . . 0.0 109.858 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 17' ' ' SER . 3.5 t -73.59 -156.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.241 -0.912 . . . . 0.0 110.62 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.824 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -167.07 89.25 0.34 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.317 -0.864 . . . . 0.0 110.515 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.53 ' CG2' HG13 ' A' ' 68' ' ' VAL . 41.9 t . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.066 -1.021 . . . . 0.0 110.082 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 15.5 mtm-85 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.468 0.652 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.884 ' CB ' HG13 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -148.21 164.36 34.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.397 -0.815 . . . . 0.0 110.195 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.43 117.51 18.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 109.461 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.054 HG22 ' HB1' ' A' ' 44' ' ' ALA . 53.3 t -129.63 126.95 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.05 -1.031 . . . . 0.0 110.521 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.1 m -119.79 130.81 55.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.364 -0.835 . . . . 0.0 109.674 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.54 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 89.2 t -117.21 111.1 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.783 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -72.3 94.46 1.6 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.016 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -61.21 100.18 0.12 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.384 -0.823 . . . . 0.0 110.43 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.37 32.42 2.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 110.156 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 56.91 108.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.527 -0.733 . . . . 0.0 110.595 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -175.34 80.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 110.217 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.31 -62.43 1.81 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.15 -151.77 10.54 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.782 HD23 ' HB2' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -102.7 -19.63 14.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -1.175 . . . . 0.0 110.283 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.46 ' CA ' ' HB2' ' A' ' 34' ' ' PHE . . . 65.23 76.19 0.34 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.925 HD12 HD21 ' A' ' 45' ' ' LEU . 4.2 tt -166.24 117.18 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -1.055 . . . . 0.0 109.698 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 32' ' ' LYS . 1.2 t -107.29 92.31 4.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.09 -1.006 . . . . 0.0 109.933 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.98 HD11 ' CG2' ' A' ' 68' ' ' VAL . 45.2 pt -69.04 146.67 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.199 -0.938 . . . . 0.0 110.886 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' CB ' ' HB2' ' A' ' 31' ' ' SER . 21.5 tttt -135.41 117.32 15.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.495 -0.753 . . . . 0.0 109.728 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.06 -155.37 26.44 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 155.92 135.66 2.03 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -61.5 -14.47 29.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -1.12 . . . . 0.0 110.698 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.7 2.2 34.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.838 -1.164 . . . . 0.0 110.23 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -138.35 26.77 2.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.517 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.07 74.15 0.38 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.0 109.965 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.703 ' HE1' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -161.82 120.43 1.42 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 110.649 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.674 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 53.6 Cg_endo -72.63 52.85 2.14 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 O-C-N 123.508 1.267 . . . . 0.0 111.408 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 64' ' ' HIS . 11.4 mm 43.45 87.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 120.998 -1.064 . . . . 0.0 110.666 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.703 ' CB ' ' HE1' ' A' ' 26' ' ' MET . 6.0 mt -97.33 132.32 43.18 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.672 -1.268 . . . . 0.0 111.663 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.804 HD12 ' HB2' ' A' ' 49' ' ' ASP . 57.4 mt -65.64 137.17 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.248 -0.907 . . . . 0.0 108.628 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.454 ' HB2' ' CB ' ' A' ' 19' ' ' LYS . 3.1 t -119.73 -29.58 4.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.046 -1.034 . . . . 0.0 110.715 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -133.45 101.43 5.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 110.601 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.673 HD11 HG21 ' A' ' 30' ' ' ILE . 10.2 mm -87.69 106.11 15.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.548 ' CE1' HD13 ' B' ' 6' ' ' LEU . 5.3 m-85 -59.24 123.1 15.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.509 -0.745 . . . . 0.0 110.219 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.417 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -75.21 146.18 41.4 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.228 -0.92 . . . . 0.0 110.563 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.422 ' C ' HD22 ' A' ' 37' ' ' LEU . . . 78.74 0.75 81.84 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.532 ' N ' HD22 ' A' ' 37' ' ' LEU . 4.0 mm? -100.7 163.07 12.5 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.942 -1.328 . . . . 0.0 110.26 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.54 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -47.09 -55.5 8.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.364 -0.835 . . . . 0.0 110.775 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 1.044 ' HB1' HD23 ' A' ' 45' ' ' LEU . . . -51.38 -47.67 62.8 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.363 -0.835 . . . . 0.0 111.024 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 13.8 t70 -86.72 3.43 44.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.157 -0.964 . . . . 0.0 111.267 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -103.58 4.56 35.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.815 -1.178 . . . . 0.0 110.783 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 39' ' ' ALA . 4.9 t -107.66 14.65 25.44 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.854 -1.154 . . . . 0.0 110.712 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 45.4 56.79 5.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.263 -0.898 . . . . 0.0 111.068 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 1.054 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -170.57 -48.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.109 -0.994 . . . . 0.0 110.315 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.044 HD23 ' HB1' ' A' ' 39' ' ' ALA . 3.5 tp -70.45 84.58 0.59 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.831 -1.168 . . . . 0.0 108.489 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -111.04 147.44 34.77 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.758 -0.589 . . . . 0.0 110.039 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.504 ' HA ' HG22 ' A' ' 30' ' ' ILE . 52.0 t -47.35 147.47 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.274 -0.891 . . . . 0.0 110.3 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.32 26.85 26.99 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.421 -1.872 . . . . 0.0 108.421 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.804 ' HB2' HD12 ' A' ' 30' ' ' ILE . 58.2 m-20 -110.26 106.82 16.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.524 -0.986 . . . . 0.0 110.384 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.674 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -84.41 108.95 17.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.938 . . . . 0.0 109.593 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.794 ' C ' HD22 ' A' ' 52' ' ' LEU . 63.8 mt -76.57 136.31 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 111.042 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.794 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.2 mm? -124.63 15.5 8.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.476 -0.765 . . . . 0.0 109.886 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 4.6 t 176.81 135.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 108.967 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.88 HG12 HD22 ' A' ' 80' ' ' LEU . 1.2 m -128.68 118.15 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.041 -1.037 . . . . 0.0 110.497 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 54.72 37.91 29.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.332 -0.855 . . . . 0.0 110.554 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.75 26.93 40.07 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.596 ' HB2' HG23 ' A' ' 54' ' ' VAL . 47.7 mt-10 -118.93 93.19 4.01 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.081 -1.247 . . . . 0.0 110.173 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -44.96 111.79 0.36 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.448 -0.783 . . . . 0.0 110.93 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.934 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -101.48 17.18 23.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.508 -0.745 . . . . 0.0 110.658 -179.385 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 t -66.3 -50.37 63.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 0.0 110.29 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.28 36.62 1.57 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.066 -1.021 . . . . 0.0 110.48 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.934 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -116.46 149.44 39.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.957 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.8 p -83.09 171.58 13.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 0.0 110.418 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.916 ' O ' HG23 ' A' ' 68' ' ' VAL . 8.7 t60 -56.61 -23.45 41.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.231 -0.918 . . . . 0.0 109.91 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.91 -42.83 31.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 109.447 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 2.5 mt-10 -65.65 -21.16 66.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.349 -0.844 . . . . 0.0 109.784 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.614 ' CA ' HD11 ' A' ' 59' ' ' LEU . . . -84.5 -45.41 12.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.371 -0.831 . . . . 0.0 110.53 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.98 ' CG2' HD11 ' A' ' 18' ' ' ILE . 6.0 t -67.03 -31.48 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.124 -0.985 . . . . 0.0 109.186 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -42.04 82.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.401 -0.812 . . . . 0.0 109.444 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.681 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -67.93 -46.0 72.74 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.115 -0.991 . . . . 0.0 108.741 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.67 ' HB3' HG11 ' B' ' 7' ' ' VAL . 3.8 mm? -52.88 -29.79 30.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.672 -0.643 . . . . 0.0 109.697 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.599 ' HG2' HG13 ' B' ' 7' ' ' VAL . 7.8 mttm -82.19 -40.15 22.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.242 -0.911 . . . . 0.0 110.24 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -110.59 34.66 3.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 110.117 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.827 ' HB ' HG22 ' A' ' 78' ' ' VAL . 21.3 p -51.97 -79.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 0.0 110.309 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.39 -176.99 25.96 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -50.59 -41.04 54.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.206 -1.173 . . . . 0.0 110.169 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 3.7 pt-20 -117.61 112.64 20.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.852 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.827 HG22 ' HB ' ' A' ' 74' ' ' THR . 53.1 t -84.94 83.66 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.076 -1.015 . . . . 0.0 110.407 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.799 ' O ' HD23 ' A' ' 80' ' ' LEU . 11.1 t -76.1 116.68 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.88 HD22 HG12 ' A' ' 54' ' ' VAL . 14.8 mt -125.06 116.45 22.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.842 -1.161 . . . . 0.0 111.523 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -74.19 122.57 22.99 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.884 HG13 ' CB ' ' A' ' 2' ' ' ARG . 3.1 p -119.21 144.63 27.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.543 -177.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 7.0 tptm -110.15 90.06 3.2 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.58 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -55.21 125.12 19.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.448 -0.783 . . . . 0.0 111.067 -177.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.4 mmm -116.3 51.91 0.95 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.462 -0.774 . . . . 0.0 109.41 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.7 pttt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.256 -179.605 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.469 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 14.9 tttt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.211 0.529 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -112.68 97.88 6.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.215 -0.928 . . . . 0.0 110.02 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 17' ' ' SER . 33.1 m -103.99 133.07 49.57 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.201 -0.937 . . . . 0.0 110.398 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.548 HD13 ' CE1' ' A' ' 34' ' ' PHE . 41.0 tp -105.92 108.35 19.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -0.863 . . . . 0.0 110.207 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.67 HG11 ' HB3' ' A' ' 71' ' ' LEU . 40.2 t . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.053 -1.029 . . . . 0.0 110.203 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.304 0.573 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.872 ' CB ' HG13 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -147.85 158.72 44.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.537 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.7 115.26 16.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.215 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.742 HG13 ' HB3' ' A' ' 44' ' ' ALA . 37.9 t -132.0 139.32 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.07 -1.018 . . . . 0.0 110.689 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.8 m -128.26 126.54 41.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.311 -0.868 . . . . 0.0 110.271 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.093 HG22 HG21 ' A' ' 42' ' ' THR . 98.2 t -106.07 126.37 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.047 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.89 85.03 2.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 110.203 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -80.21 166.69 21.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 110.155 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.41 63.73 1.46 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.943 . . . . 0.0 110.366 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 52.84 23.01 2.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.435 -0.791 . . . . 0.0 110.396 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.13 -58.73 6.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.235 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.15 -73.38 0.08 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.36 143.88 15.18 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.544 ' O ' HD23 ' A' ' 14' ' ' LEU . 1.2 tt -63.23 -17.39 62.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -1.105 . . . . 0.0 110.726 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.494 ' HA3' ' CG ' ' A' ' 37' ' ' LEU . . . 64.86 87.53 0.05 OUTLIER Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -178.8 121.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.113 -1.227 . . . . 0.0 110.28 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.49 109.78 21.55 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.918 HD11 HG22 ' A' ' 68' ' ' VAL . 27.5 pt -92.05 143.08 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -0.89 . . . . 0.0 111.171 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -125.69 170.14 11.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.57 179.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.09 -143.28 15.91 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' CA ' ' HB2' ' A' ' 64' ' ' HIS . . . 138.43 143.04 4.41 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -60.53 -14.56 20.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -1.116 . . . . 0.0 110.99 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.14 -20.35 64.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.934 -1.104 . . . . 0.0 110.106 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.73 24.33 7.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 109.726 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.2 tttt 55.58 82.59 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.41 -0.806 . . . . 0.0 110.218 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.535 ' HE1' ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -159.12 127.89 3.03 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 109.879 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.829 ' HB2' HD11 ' A' ' 52' ' ' LEU . 52.9 Cg_endo -70.28 50.61 0.96 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 O-C-N 123.321 1.169 . . . . 0.0 112.376 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.467 ' N ' ' HE2' ' A' ' 26' ' ' MET . 21.0 mm 38.88 88.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.549 0 O-C-N 121.201 -0.937 . . . . 0.0 111.189 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.619 HD11 ' HG3' ' A' ' 85' ' ' MET . 6.1 mt -96.66 133.23 41.44 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.88 -1.138 . . . . 0.0 111.765 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.842 HD12 ' HB2' ' A' ' 49' ' ' ASP . 67.8 mt -65.74 144.25 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 108.806 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.3 t -123.85 -23.88 4.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.925 -1.11 . . . . 0.0 111.252 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.06 95.26 2.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.97 -1.081 . . . . 0.0 111.04 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.481 HG22 ' HB2' ' A' ' 40' ' ' ASP . 10.7 mm -77.47 100.24 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.36 -0.837 . . . . 0.0 108.831 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.791 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 17.2 m-85 -49.76 137.17 16.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.637 -0.664 . . . . 0.0 110.644 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.615 ' O ' HD23 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -79.29 159.0 27.41 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.177 -0.952 . . . . 0.0 110.487 -179.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.58 21.37 27.97 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 35' ' ' LYS . 2.1 mm? -111.09 167.9 9.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -1.191 . . . . 0.0 109.865 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.889 ' O ' HG23 ' A' ' 42' ' ' THR . . . -51.84 -66.89 0.31 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.139 -0.975 . . . . 0.0 111.164 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 45' ' ' LEU . . . -47.62 -47.25 29.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.253 -0.905 . . . . 0.0 111.108 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.481 ' HB2' HG22 ' A' ' 33' ' ' ILE . 4.8 t70 -71.88 -11.76 60.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.097 -1.002 . . . . 0.0 110.861 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -105.48 15.87 26.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.828 -1.17 . . . . 0.0 110.547 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 1.093 HG21 HG22 ' A' ' 6' ' ' VAL . 48.3 p -106.06 12.81 29.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.027 -1.045 . . . . 0.0 110.73 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 48.24 44.88 20.0 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.056 -1.027 . . . . 0.0 110.538 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.742 ' HB3' HG13 ' A' ' 4' ' ' VAL . . . -174.72 -43.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.551 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.433 HD21 HD12 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -66.83 83.37 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.81 -1.181 . . . . 0.0 109.049 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.585 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -114.24 151.39 32.9 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.579 -0.7 . . . . 0.0 110.094 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 48' ' ' GLY . 24.5 t -47.66 169.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.21 -0.931 . . . . 0.0 110.35 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 66.46 33.77 85.76 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.842 ' HB2' HD12 ' A' ' 30' ' ' ILE . 28.4 m-20 -115.16 106.23 13.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.432 -1.04 . . . . 0.0 110.177 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.951 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -83.76 108.78 17.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.212 -0.93 . . . . 0.0 110.383 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.812 ' C ' HD12 ' A' ' 52' ' ' LEU . 60.1 mt -77.67 134.79 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.413 -0.805 . . . . 0.0 110.379 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.829 HD11 ' HB2' ' A' ' 27' ' ' PRO . 10.0 mp -126.6 10.14 7.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.877 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 176.31 96.97 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.983 -1.073 . . . . 0.0 110.013 179.06 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.969 HG21 ' CB ' ' A' ' 70' ' ' ALA . 33.7 m -86.99 118.32 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.858 . . . . 0.0 110.508 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 55.49 33.96 22.07 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.362 -0.836 . . . . 0.0 111.089 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.11 -11.4 72.03 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.555 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' SER . 0.3 OUTLIER -77.53 90.23 3.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.787 -1.42 . . . . 0.0 109.593 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -41.97 106.51 0.06 Allowed 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.557 0.694 . . . . 0.0 111.075 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.943 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -98.9 -10.32 22.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.546 -0.722 . . . . 0.0 110.92 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.2 p -52.65 -36.53 57.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.02 -1.05 . . . . 0.0 110.296 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 m -113.57 49.34 0.98 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.167 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.943 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -130.74 149.2 52.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.236 -0.915 . . . . 0.0 110.303 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.9 p -72.41 163.01 28.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.369 -0.832 . . . . 0.0 109.882 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.889 ' O ' HG23 ' A' ' 68' ' ' VAL . 7.7 t60 -54.48 -25.16 23.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.004 -1.06 . . . . 0.0 109.729 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -75.17 -43.93 49.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.063 -1.023 . . . . 0.0 108.796 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.724 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -60.38 -28.83 68.52 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.502 -0.749 . . . . 0.0 109.419 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.682 ' CA ' HD11 ' A' ' 59' ' ' LEU . . . -77.51 -49.49 14.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.688 -0.633 . . . . 0.0 110.881 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.918 HG22 HD11 ' A' ' 18' ' ' ILE . 3.0 t -66.56 -30.54 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 119.206 -0.998 . . . . 0.0 108.927 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.58 -36.61 71.93 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.308 -0.87 . . . . 0.0 109.202 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.969 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -72.49 -35.76 68.24 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.245 -0.909 . . . . 0.0 109.302 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.706 ' C ' HG11 ' B' ' 7' ' ' VAL . 4.1 mm? -69.18 -29.08 66.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.698 -0.626 . . . . 0.0 109.918 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -79.1 -37.85 37.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.212 -0.93 . . . . 0.0 109.87 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -104.33 33.52 3.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.423 -0.798 . . . . 0.0 109.591 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.96 HG22 HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -73.39 138.09 45.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.403 -0.811 . . . . 0.0 110.188 -179.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.99 -178.46 52.4 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.429 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 20.7 mtpt -53.31 -62.98 1.3 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -1.126 . . . . 0.0 110.366 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -73.59 90.59 1.78 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.209 -0.932 . . . . 0.0 109.223 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.96 HG22 HG22 ' A' ' 74' ' ' THR . 99.2 t -84.33 83.29 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 110.92 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.966 ' O ' HD23 ' A' ' 80' ' ' LEU . 9.0 t -74.98 124.92 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.966 HD23 ' O ' ' A' ' 79' ' ' VAL . 13.0 mt -130.25 118.67 21.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.744 -1.223 . . . . 0.0 111.71 -178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 35.0 tt0 -76.59 121.47 23.24 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.872 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.7 p -120.28 149.31 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 0.0 112.447 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.951 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -114.54 86.49 2.44 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.611 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.585 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -55.09 118.17 4.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.414 -0.804 . . . . 0.0 111.475 -177.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.619 ' HG3' HD11 ' A' ' 29' ' ' LEU . 4.1 mmt -95.98 51.01 1.21 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.319 -0.863 . . . . 0.0 108.769 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.8 tttt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.302 -179.402 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 64' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.376 0.608 . . . . 0.0 110.523 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 16.8 tt0 -58.5 96.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.468 -0.77 . . . . 0.0 110.593 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 8.2 m -84.22 -162.15 0.63 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.217 -0.927 . . . . 0.0 110.01 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.791 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -161.6 86.3 0.65 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.068 -1.02 . . . . 0.0 110.326 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.706 HG11 ' C ' ' A' ' 71' ' ' LEU . 39.1 t . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.05 -1.031 . . . . 0.0 109.979 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.53 0.681 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.524 ' CG ' HG13 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -158.78 143.47 15.9 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.483 -0.761 . . . . 0.0 109.614 -179.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.9 ptt-85 -122.28 136.56 54.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.121 -0.987 . . . . 0.0 110.115 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.739 HG13 ' CB ' ' A' ' 44' ' ' ALA . 46.6 t -139.31 134.26 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.103 -0.998 . . . . 0.0 110.538 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.7 m -118.04 125.22 49.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.393 -0.817 . . . . 0.0 110.08 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.566 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 83.2 t -118.39 129.14 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.353 -0.842 . . . . 0.0 109.185 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.6 mtm-85 -96.61 85.47 3.87 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.912 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -83.96 176.5 8.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 110.392 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.9 -156.78 0.59 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.891 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -51.13 -53.12 37.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.027 -1.045 . . . . 0.0 110.317 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.45 70.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.27 -0.894 . . . . 0.0 110.293 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.18 33.73 6.08 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.86 143.73 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.91 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -109.82 -16.81 13.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -1.15 . . . . 0.0 110.382 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.887 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 56.48 90.47 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.628 ' CD1' HD22 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -175.04 123.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.175 -1.191 . . . . 0.0 110.826 -178.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.441 ' HB3' ' CB ' ' A' ' 32' ' ' LYS . 29.7 t -111.07 125.04 53.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 109.403 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.934 HD11 ' CG2' ' A' ' 68' ' ' VAL . 42.4 pt -105.0 150.66 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.135 -0.978 . . . . 0.0 110.883 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -133.9 158.97 42.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.377 -0.827 . . . . 0.0 109.848 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.1 -159.86 13.85 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 164.83 148.25 5.4 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.419 ' CB ' ' HA ' ' A' ' 63' ' ' THR . 10.5 ttp85 -60.46 -14.94 22.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -1.085 . . . . 0.0 110.809 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.63 -19.8 54.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.897 -1.127 . . . . 0.0 110.021 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -111.34 23.08 14.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.266 -0.896 . . . . 0.0 109.932 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 tptp 54.49 54.88 8.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.323 -0.86 . . . . 0.0 110.355 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.454 ' CE ' ' HB2' ' A' ' 29' ' ' LEU . 4.9 mmm -138.05 125.66 13.79 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.218 -0.926 . . . . 0.0 110.233 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.764 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 48.3 Cg_endo -69.53 52.33 0.91 Allowed 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.104 1.203 . . . . 0.0 111.882 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 64' ' ' HIS . 13.0 mm 42.96 90.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 121.116 -0.99 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 50' ' ' ALA . 30.4 tp -98.9 124.97 44.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.887 -1.133 . . . . 0.0 111.785 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.836 HD12 ' HB2' ' A' ' 49' ' ' ASP . 56.2 mt -57.27 142.31 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.47 -0.769 . . . . 0.0 109.671 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.3 -25.9 4.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.136 -0.977 . . . . 0.0 110.904 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.441 ' CB ' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -141.11 105.59 4.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.02 -1.05 . . . . 0.0 110.628 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.669 HD11 HG21 ' A' ' 30' ' ' ILE . 15.9 mm -90.38 115.71 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 109.085 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.525 ' HB3' HD13 ' A' ' 37' ' ' LEU . 17.2 m-85 -75.99 136.75 39.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.443 -0.785 . . . . 0.0 109.774 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.668 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -82.68 167.59 18.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.152 -0.968 . . . . 0.0 110.855 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.88 29.01 74.19 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.887 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER -137.47 160.23 39.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -1.157 . . . . 0.0 110.834 -179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -44.11 -69.63 0.13 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.495 -0.753 . . . . 0.0 111.935 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.91 ' HB2' ' CD2' ' A' ' 14' ' ' LEU . . . -45.55 -47.65 14.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.482 -0.761 . . . . 0.0 111.532 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.428 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 13.7 t70 -85.18 4.84 32.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.959 -1.088 . . . . 0.0 110.892 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -106.11 -3.14 21.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.822 -1.174 . . . . 0.0 110.835 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.501 HG21 HG22 ' A' ' 6' ' ' VAL . 8.7 t -99.82 14.71 29.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.922 -1.111 . . . . 0.0 110.643 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 47.43 39.24 8.87 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.043 -1.035 . . . . 0.0 110.904 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.739 ' CB ' HG13 ' A' ' 4' ' ' VAL . . . -152.28 -46.38 0.1 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.152 -0.967 . . . . 0.0 110.428 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.628 HD22 ' CD1' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -71.69 85.62 0.91 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.781 -1.2 . . . . 0.0 108.649 179.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.602 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.82 156.12 23.44 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.655 -179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.497 ' HA ' HG22 ' A' ' 30' ' ' ILE . 89.3 t -52.04 163.37 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.659 -1.275 . . . . 0.0 109.575 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.441 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 75.59 26.17 66.0 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.836 ' HB2' HD12 ' A' ' 30' ' ' ILE . 59.5 m-20 -112.94 101.24 9.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.506 -0.996 . . . . 0.0 110.57 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.764 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -79.4 110.0 14.29 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.369 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 52' ' ' LEU . 42.9 mt -78.28 138.81 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.426 -0.796 . . . . 0.0 110.325 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.644 HD11 ' HB2' ' A' ' 27' ' ' PRO . 3.3 mp -135.34 15.35 3.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.591 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 14.6 t 175.59 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.409 -0.807 . . . . 0.0 109.267 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.092 HG21 ' HB1' ' A' ' 70' ' ' ALA . 33.8 m -100.68 122.23 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.253 -0.904 . . . . 0.0 110.96 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 57.43 28.24 15.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.442 -0.786 . . . . 0.0 111.466 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.26 22.46 32.14 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.585 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 53' ' ' SER . 9.1 mt-10 -115.72 93.22 4.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.97 -1.312 . . . . 0.0 109.539 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.42 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.62 0.724 . . . . 0.0 111.438 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.034 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -87.61 -12.65 44.99 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.607 -0.683 . . . . 0.0 110.622 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.448 ' OG ' HD23 ' A' ' 52' ' ' LEU . 49.3 m -53.09 -31.8 43.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.994 -1.066 . . . . 0.0 110.442 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.61 33.25 3.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.194 -0.941 . . . . 0.0 110.475 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 1.034 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -124.7 144.94 49.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 0.0 110.203 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.419 ' HA ' ' CB ' ' A' ' 22' ' ' ARG . 51.1 p -76.9 166.19 23.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 109.835 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.915 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.6 t60 -51.59 -25.04 6.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.056 -1.028 . . . . 0.0 110.071 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.69 -44.0 35.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.117 -0.989 . . . . 0.0 109.057 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.587 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 15.3 mm-40 -66.59 -22.34 66.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.387 -0.821 . . . . 0.0 109.499 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.795 ' HA ' HD11 ' A' ' 59' ' ' LEU . . . -80.6 -46.91 14.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.388 -0.82 . . . . 0.0 110.44 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.934 ' CG2' HD11 ' A' ' 18' ' ' ILE . 10.4 t -64.73 -29.82 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.99 -31.01 69.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.351 -0.843 . . . . 0.0 109.468 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.092 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -74.25 -33.31 63.27 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.276 -0.89 . . . . 0.0 109.679 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.67 ' HB3' HG11 ' B' ' 7' ' ' VAL . 4.4 mm? -72.02 -26.38 62.19 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.537 -0.727 . . . . 0.0 109.782 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.4 -41.36 24.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.251 -0.906 . . . . 0.0 109.939 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -93.63 23.21 4.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.678 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.788 ' CG2' HG22 ' A' ' 78' ' ' VAL . 74.4 m -54.83 129.86 38.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.394 -0.816 . . . . 0.0 110.16 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.79 176.91 46.32 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.422 ' HG3' ' HG2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -49.82 -46.03 50.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -1.146 . . . . 0.0 110.517 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.422 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 20.1 mm-40 -90.94 106.15 18.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.026 -1.047 . . . . 0.0 109.092 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.892 HG12 HD13 ' A' ' 80' ' ' LEU . 20.3 t -97.5 82.0 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.132 -0.98 . . . . 0.0 111.15 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.499 ' O ' HD12 ' A' ' 80' ' ' LEU . 10.8 t -78.64 108.2 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.892 HD13 HG12 ' A' ' 78' ' ' VAL . 4.4 mp -114.82 112.22 22.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.78 -1.2 . . . . 0.0 112.529 -177.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 32.0 tt0 -74.89 124.48 26.96 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.524 HG13 ' CG ' ' A' ' 2' ' ' ARG . 2.2 p -127.53 147.6 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.949 -1.095 . . . . 0.0 111.768 -177.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 3.4 mttt -107.75 87.4 2.49 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.602 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -59.51 114.08 2.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.505 -0.747 . . . . 0.0 110.788 -177.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 mmm -93.62 59.95 2.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.883 . . . . 0.0 109.756 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.0 tttt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.285 -179.81 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.459 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 8.9 tttt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.236 0.541 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 5.7 tt0 -117.88 86.23 2.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 110.196 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.04 -169.44 2.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.209 -0.932 . . . . 0.0 110.258 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.713 ' O ' HD13 ' B' ' 6' ' ' LEU . 2.5 tm? -160.51 106.75 1.5 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 110.122 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.67 HG11 ' HB3' ' A' ' 71' ' ' LEU . 61.6 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.163 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 121.225 0.536 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.516 ' CG ' HG13 ' A' ' 82' ' ' VAL . 1.6 tpt180 -167.6 143.92 4.17 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.321 -0.862 . . . . 0.0 109.74 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -119.98 136.75 54.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.09 -1.006 . . . . 0.0 110.29 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 44' ' ' ALA . 54.9 t -142.75 159.6 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.968 . . . . 0.0 110.528 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 54.0 m -146.73 143.38 28.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.356 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.628 ' CG2' HD12 ' A' ' 45' ' ' LEU . 80.7 t -130.28 118.03 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.334 -0.854 . . . . 0.0 109.804 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -92.01 95.91 10.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.851 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt -49.76 119.15 3.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.318 -0.864 . . . . 0.0 110.722 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.81 118.68 24.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.839 . . . . 0.0 109.912 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.78 21.47 3.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.908 . . . . 0.0 110.285 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.32 98.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.291 -0.881 . . . . 0.0 110.432 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.13 -84.69 0.25 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.25 -178.18 22.34 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.566 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -122.67 -32.92 3.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.233 -1.157 . . . . 0.0 110.51 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.505 ' HA3' ' HG ' ' A' ' 37' ' ' LEU . . . 66.6 91.71 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.55 HG22 ' OXT' ' B' ' 7' ' ' VAL . 2.2 tt -179.15 119.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.094 -1.239 . . . . 0.0 110.56 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.83 ' HB2' HD12 ' B' ' 6' ' ' LEU . 0.3 OUTLIER -105.71 91.48 3.77 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.24 -0.913 . . . . 0.0 109.177 178.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.059 HD11 HG22 ' A' ' 68' ' ' VAL . 25.2 pt -69.16 155.35 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 111.131 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' CG ' ' HG3' ' B' ' 4' ' ' GLU . 0.7 OUTLIER -136.11 175.2 9.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.089 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.61 -154.97 19.36 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 157.57 134.53 1.76 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.496 ' HB3' HG22 ' A' ' 63' ' ' THR . 7.2 ttp85 -60.07 -15.47 23.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.4 -1.059 . . . . 0.0 110.762 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.61 -15.15 61.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.856 -1.152 . . . . 0.0 109.813 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.93 22.15 11.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.16 -0.962 . . . . 0.0 109.663 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.67 58.16 5.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.888 . . . . 0.0 109.842 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.435 ' HE3' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -138.7 132.59 16.35 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.935 -179.454 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.546 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 46.3 Cg_endo -68.83 132.31 24.57 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 N-CA-C 108.332 -1.449 . . . . 0.0 108.332 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.603 HG13 ' HB2' ' A' ' 67' ' ' ALA . 17.4 mm -48.77 97.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.055 -1.028 . . . . 0.0 109.591 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.621 HD13 ' HB2' ' A' ' 50' ' ' ALA . 39.9 tp -101.24 128.73 47.23 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.438 -0.789 . . . . 0.0 112.149 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.887 HD12 ' HB2' ' A' ' 49' ' ' ASP . 64.0 mt -63.91 139.23 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.601 -0.687 . . . . 0.0 110.18 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.2 t -121.83 -25.3 5.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 110.641 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -137.25 108.83 6.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.088 -1.007 . . . . 0.0 110.501 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.623 HD11 HG21 ' A' ' 30' ' ' ILE . 10.5 mm -94.64 105.55 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.13 -0.981 . . . . 0.0 108.853 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.814 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 4.2 m-85 -56.75 134.41 54.9 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.274 0.559 . . . . 0.0 110.495 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.574 ' O ' HD23 ' A' ' 37' ' ' LEU . 2.2 mptt -80.76 158.64 25.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.184 -0.947 . . . . 0.0 110.36 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.49 19.29 47.31 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 35' ' ' LYS . 2.4 mm? -109.91 167.48 10.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.18 -1.188 . . . . 0.0 109.698 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . . . -56.53 -65.84 0.54 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.013 -1.054 . . . . 0.0 110.96 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.534 ' O ' HG22 ' A' ' 42' ' ' THR . . . -47.58 -37.7 12.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.309 -0.869 . . . . 0.0 111.284 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 9.3 t70 -86.62 -6.78 58.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.038 -1.039 . . . . 0.0 111.047 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -97.85 -1.86 42.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.825 -1.172 . . . . 0.0 110.911 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 39' ' ' ALA . 9.6 t -97.81 13.61 29.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.839 -1.163 . . . . 0.0 110.708 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 45.52 59.18 3.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.316 -0.865 . . . . 0.0 111.141 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.634 ' HB3' HG13 ' A' ' 4' ' ' VAL . . . -174.1 -49.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.153 -0.967 . . . . 0.0 110.128 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.628 HD12 ' CG2' ' A' ' 6' ' ' VAL . 1.7 mt -70.95 84.02 0.68 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.933 -1.104 . . . . 0.0 108.303 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.597 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -111.0 153.13 25.99 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.879 -0.513 . . . . 0.0 110.083 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.464 ' N ' HG13 ' A' ' 33' ' ' ILE . 91.7 t -50.26 152.26 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.833 -1.167 . . . . 0.0 109.767 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.79 26.06 39.46 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.544 -1.823 . . . . 0.0 108.544 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.887 ' HB2' HD12 ' A' ' 30' ' ' ILE . 67.6 m-20 -111.53 100.08 8.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.396 -1.061 . . . . 0.0 110.627 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.67 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -77.9 110.38 12.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.095 -1.003 . . . . 0.0 110.67 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.859 ' C ' HD22 ' A' ' 52' ' ' LEU . 61.6 mt -79.29 134.64 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 110.232 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.859 HD22 ' C ' ' A' ' 51' ' ' ILE . 3.9 mm? -125.64 10.95 7.85 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.258 -0.902 . . . . 0.0 110.439 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 175.99 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.031 -1.043 . . . . 0.0 109.765 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.943 HG21 ' CB ' ' A' ' 70' ' ' ALA . 27.5 m -76.24 126.46 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.365 -0.834 . . . . 0.0 110.847 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.0 p30 37.19 40.45 0.18 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.57 -7.18 63.37 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.565 -1.302 . . . . 0.0 111.142 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.532 ' O ' HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -89.81 91.9 8.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.671 -1.488 . . . . 0.0 109.848 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -44.33 112.16 0.38 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.381 0.61 . . . . 0.0 110.888 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.986 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -101.8 -5.97 24.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.323 -0.86 . . . . 0.0 110.962 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.45 ' OG ' HD12 ' A' ' 52' ' ' LEU . 34.5 m -55.36 -32.65 62.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.875 -1.141 . . . . 0.0 110.287 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.3 m -113.13 35.64 3.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.092 -1.005 . . . . 0.0 110.345 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.986 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -121.5 152.8 38.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.178 -0.951 . . . . 0.0 110.193 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.496 HG22 ' HB3' ' A' ' 22' ' ' ARG . 18.0 p -81.79 165.13 21.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.857 . . . . 0.0 109.87 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.1 t60 -52.55 -26.15 12.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.014 -1.054 . . . . 0.0 109.903 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.63 -45.73 51.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.052 -1.03 . . . . 0.0 108.923 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.554 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 13.0 mt-10 -61.26 -23.01 65.35 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.597 -0.689 . . . . 0.0 109.4 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.603 ' HB2' HG13 ' A' ' 28' ' ' ILE . . . -80.42 -47.22 14.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.788 . . . . 0.0 110.319 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.059 HG22 HD11 ' A' ' 18' ' ' ILE . 2.6 t -66.3 -33.07 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.481 -0.888 . . . . 0.0 108.773 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -56.25 -41.23 75.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.415 -0.803 . . . . 0.0 109.131 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.943 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.91 -26.35 63.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.439 -0.788 . . . . 0.0 109.35 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.767 ' C ' HG11 ' B' ' 7' ' ' VAL . 3.5 mm? -80.6 -34.57 35.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.628 -0.67 . . . . 0.0 110.082 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -75.93 -33.87 59.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.064 -1.023 . . . . 0.0 110.125 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -112.07 36.27 3.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.631 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.84 HG22 HG22 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -71.42 137.65 48.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.391 -0.818 . . . . 0.0 110.077 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.18 -177.95 34.44 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 78' ' ' VAL . 22.5 tttp -55.45 -76.61 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -1.158 . . . . 0.0 110.022 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -63.91 101.56 0.39 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.095 -1.003 . . . . 0.0 109.466 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.84 HG22 HG22 ' A' ' 74' ' ' THR . 94.5 t -96.61 82.78 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 111.32 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.558 ' O ' HD23 ' A' ' 80' ' ' LEU . 35.0 t -80.26 113.73 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.798 HD21 ' CG1' ' A' ' 78' ' ' VAL . 13.0 mt -117.42 125.03 50.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.956 -1.09 . . . . 0.0 111.917 -177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -77.78 125.39 29.28 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.516 HG13 ' CG ' ' A' ' 2' ' ' ARG . 1.8 p -126.03 147.94 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.993 -1.067 . . . . 0.0 111.749 -177.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.67 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -108.2 85.79 2.18 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.597 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -55.62 118.58 4.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.433 -0.792 . . . . 0.0 110.957 -177.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.9 mmm -96.76 49.58 1.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.184 -0.948 . . . . 0.0 109.401 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.8 tptt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.236 -179.669 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.427 ' HB3' ' ND1' ' A' ' 64' ' ' HIS . 32.2 tttt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.282 0.563 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 3.4 tt0 -153.87 138.31 16.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 110.032 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.511 ' OG ' HG11 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -126.59 -163.37 1.23 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.192 -0.942 . . . . 0.0 110.419 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.83 HD12 ' HB2' ' A' ' 17' ' ' SER . 1.4 tp -159.16 56.57 0.41 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.321 -0.862 . . . . 0.0 110.187 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.767 HG11 ' C ' ' A' ' 71' ' ' LEU . 53.4 t . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.048 -1.032 . . . . 0.0 110.255 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.408 ' O ' ' CG ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.317 0.58 . . . . 0.0 110.257 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.839 ' CB ' HG13 ' A' ' 82' ' ' VAL . 3.9 mtp85 -161.94 170.54 19.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 110.408 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' A' ' 3' ' ' ARG . 0.5 OUTLIER -138.88 116.7 11.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.408 -0.808 . . . . 0.0 109.206 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.79 HG22 ' HB1' ' A' ' 44' ' ' ALA . 65.7 t -121.24 136.85 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.992 -1.067 . . . . 0.0 110.841 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.8 m -125.08 126.26 45.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.371 -0.83 . . . . 0.0 109.881 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.83 HG21 HD12 ' A' ' 45' ' ' LEU . 89.3 t -121.79 115.35 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.138 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -87.7 114.87 24.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.127 -0.983 . . . . 0.0 109.871 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -115.51 79.37 1.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 110.662 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.34 -58.32 7.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.903 . . . . 0.0 110.078 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.09 -23.28 65.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 110.252 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.28 46.61 26.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.24 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.85 75.2 0.22 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.18 138.79 0.35 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.76 HD23 ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -102.03 -14.61 17.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -1.116 . . . . 0.0 110.534 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.924 ' CA ' HD22 ' A' ' 37' ' ' LEU . . . 60.61 82.49 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 16' ' ' ILE . 1.1 tt -173.11 120.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.427 -1.043 . . . . 0.0 110.341 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.481 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -112.08 119.38 38.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 109.543 179.152 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.092 HD11 HG22 ' A' ' 68' ' ' VAL . 21.2 pt -100.72 151.66 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.236 -0.915 . . . . 0.0 111.266 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 9.9 pttt -131.04 160.74 33.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 109.643 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.59 -163.78 12.13 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.439 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 160.51 141.0 3.02 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.576 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.0 OUTLIER -60.15 -15.59 25.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -1.091 . . . . 0.0 110.695 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -71.93 -16.86 62.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.886 -1.134 . . . . 0.0 109.796 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -125.66 24.18 7.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.246 -0.908 . . . . 0.0 109.706 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.19 92.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.336 -0.852 . . . . 0.0 110.259 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.512 ' HE2' ' N ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -170.92 128.25 0.71 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.904 . . . . 0.0 110.208 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.71 ' CB ' HD11 ' A' ' 52' ' ' LEU . 55.9 Cg_endo -72.82 46.51 1.07 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 O-C-N 123.448 1.236 . . . . 0.0 112.19 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.637 HD12 ' HA ' ' A' ' 64' ' ' HIS . 12.9 mm 44.33 90.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 120.797 -1.189 . . . . 0.0 110.756 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.828 HD21 ' HG3' ' A' ' 85' ' ' MET . 5.4 mt -97.28 132.84 42.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.799 -1.188 . . . . 0.0 111.613 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.713 HD12 ' HB2' ' A' ' 49' ' ' ASP . 54.8 mt -67.63 136.99 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.868 . . . . 0.0 108.854 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.1 -16.27 8.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.955 -1.091 . . . . 0.0 110.997 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.95 100.47 3.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.995 -1.065 . . . . 0.0 110.682 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.676 HD11 HG21 ' A' ' 30' ' ' ILE . 16.7 mm -86.83 94.12 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.417 -0.802 . . . . 0.0 108.894 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.644 ' HB3' HD13 ' A' ' 37' ' ' LEU . 4.3 m-30 -52.69 137.04 32.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.475 -0.765 . . . . 0.0 110.0 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.826 ' O ' HD12 ' A' ' 37' ' ' LEU . 12.8 tttt -83.75 171.55 13.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.896 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.49 32.4 73.02 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.924 HD22 ' CA ' ' A' ' 15' ' ' GLY . 0.4 OUTLIER -140.44 162.94 34.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.132 -1.216 . . . . 0.0 111.088 -179.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.7 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -50.04 -56.59 10.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.523 -0.735 . . . . 0.0 111.461 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.76 ' HB2' HD23 ' A' ' 14' ' ' LEU . . . -55.67 -35.51 66.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.245 -0.909 . . . . 0.0 112.092 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.532 ' HB2' HG22 ' A' ' 33' ' ' ILE . 22.0 t70 -95.74 -3.11 46.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.916 -1.115 . . . . 0.0 111.474 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.484 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 1.4 pp0? -110.34 16.98 21.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.728 -1.233 . . . . 0.0 110.354 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.523 HG21 HG22 ' A' ' 6' ' ' VAL . 7.4 t -108.47 14.72 24.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.945 . . . . 0.0 110.777 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 45.5 54.38 7.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.197 -0.94 . . . . 0.0 111.343 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.79 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -175.72 -50.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.127 -0.983 . . . . 0.0 110.445 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.83 HD12 HG21 ' A' ' 6' ' ' VAL . 1.4 mt -70.51 84.56 0.6 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.871 -1.143 . . . . 0.0 108.92 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.592 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -112.88 152.28 29.46 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.56 -179.399 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 48' ' ' GLY . 60.3 t -47.74 168.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.028 -1.045 . . . . 0.0 110.607 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.519 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 66.8 37.22 92.15 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.713 ' HB2' HD12 ' A' ' 30' ' ' ILE . 27.8 m-20 -120.89 107.61 12.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.256 -1.143 . . . . 0.0 110.483 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.795 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -84.57 105.12 15.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.835 . . . . 0.0 110.147 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.766 ' O ' HD12 ' A' ' 52' ' ' LEU . 65.0 mt -71.03 135.95 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.363 -0.835 . . . . 0.0 110.854 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 51' ' ' ILE . 6.5 mp -125.63 6.97 7.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.391 -0.818 . . . . 0.0 110.96 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER 176.1 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.97 -1.082 . . . . 0.0 109.978 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.913 HG21 ' CB ' ' A' ' 70' ' ' ALA . 17.5 m -96.53 119.22 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.134 -0.979 . . . . 0.0 110.865 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 54' ' ' VAL . 45.8 m-80 57.06 33.52 23.47 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.53 -0.731 . . . . 0.0 111.573 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.82 12.05 61.07 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.944 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.474 ' O ' HD23 ' A' ' 59' ' ' LEU . 10.1 mt-10 -105.46 90.5 3.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.7 -1.47 . . . . 0.0 109.741 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.33 102.01 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.479 0.656 . . . . 0.0 110.977 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.867 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -94.8 -14.04 25.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.429 -0.794 . . . . 0.0 110.703 -179.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.5 p -50.01 -32.62 15.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.004 -1.06 . . . . 0.0 110.437 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 t -107.75 31.41 5.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 109.987 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.867 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -122.43 163.66 19.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.378 -0.826 . . . . 0.0 110.346 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.576 HG22 ' HB3' ' A' ' 22' ' ' ARG . 12.7 p -85.12 165.07 17.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.399 -0.813 . . . . 0.0 110.375 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.871 ' O ' HG23 ' A' ' 68' ' ' VAL . 3.4 t60 -53.72 -26.17 21.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 109.831 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -73.75 -36.58 65.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.081 -1.012 . . . . 0.0 109.335 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.626 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 1.3 mm-40 -68.86 -22.96 64.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.588 -0.695 . . . . 0.0 109.724 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.417 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -82.83 -41.05 19.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.299 -0.876 . . . . 0.0 110.545 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.092 HG22 HD11 ' A' ' 18' ' ' ILE . 2.9 t -72.85 -32.86 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.152 -0.968 . . . . 0.0 109.372 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -59.65 -38.1 80.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.371 -0.831 . . . . 0.0 109.952 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.913 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.45 -53.1 17.73 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.152 -0.967 . . . . 0.0 108.81 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.563 ' HB3' HG11 ' B' ' 7' ' ' VAL . 96.4 mt -56.78 -22.43 35.89 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.709 -0.619 . . . . 0.0 109.485 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -79.52 -40.42 29.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.859 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 1.5 ttmt -119.11 59.54 0.83 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.405 -0.809 . . . . 0.0 109.869 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.651 ' HB ' HG22 ' A' ' 78' ' ' VAL . 66.4 p -78.06 -175.04 3.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.324 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.06 -171.46 20.13 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -48.57 -48.37 38.92 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.101 -1.235 . . . . 0.0 110.455 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 12.4 pt-20 -108.73 119.88 40.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.328 -0.857 . . . . 0.0 109.863 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.706 ' CG1' HD21 ' A' ' 80' ' ' LEU . 85.6 t -89.42 82.02 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.176 -0.952 . . . . 0.0 110.721 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.459 ' C ' HD23 ' A' ' 80' ' ' LEU . 2.8 t -77.27 107.11 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.706 HD21 ' CG1' ' A' ' 78' ' ' VAL . 14.1 mt -113.34 115.77 28.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.805 -1.184 . . . . 0.0 111.576 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.416 ' HB3' ' OG ' ' A' ' 53' ' ' SER . 5.9 tp10 -67.79 124.59 23.75 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.839 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.4 p -121.74 141.53 41.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.003 -1.06 . . . . 0.0 112.199 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.795 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 40.4 tttm -107.41 81.3 1.51 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.592 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -50.52 122.19 6.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.576 -0.703 . . . . 0.0 111.191 -178.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.828 ' HG3' HD21 ' A' ' 29' ' ' LEU . 6.3 mmt -96.39 49.0 1.1 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.281 -0.887 . . . . 0.0 109.023 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.874 -1.06 . . . . 0.0 110.295 -179.512 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.554 ' CD ' ' CD2' ' A' ' 64' ' ' HIS . 1.6 mttm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.32 0.581 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER 54.19 41.45 32.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 109.679 -179.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.405 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . 1.3 m -57.28 -169.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.359 -0.838 . . . . 0.0 110.783 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.558 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 39.2 tp -156.71 117.58 3.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.387 -0.821 . . . . 0.0 110.086 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.563 HG11 ' HB3' ' A' ' 71' ' ' LEU . 66.2 t . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.157 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.44 0.638 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.522 ' CG ' HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -161.91 146.61 12.83 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.461 -0.774 . . . . 0.0 109.586 -179.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.416 ' N ' ' HG3' ' A' ' 2' ' ' ARG . 1.6 mpp_? -120.59 126.57 50.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 109.927 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.739 HG23 HG11 ' A' ' 82' ' ' VAL . 54.5 t -121.51 153.87 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 110.549 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 84.8 m -139.16 109.69 6.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.514 -0.741 . . . . 0.0 109.513 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.811 HG22 HG21 ' A' ' 42' ' ' THR . 56.6 t -100.53 125.19 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 0.0 109.813 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.9 mtt-85 -99.11 96.91 8.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.933 . . . . 0.0 110.29 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 1.2 mttt -52.33 101.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.343 -0.848 . . . . 0.0 110.117 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.18 119.35 23.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.326 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 53.54 21.61 2.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.28 -0.888 . . . . 0.0 110.514 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.15 84.31 1.82 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 110.245 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.02 -41.65 53.04 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.89 154.92 42.06 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.555 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -105.62 -15.95 14.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.291 -1.123 . . . . 0.0 110.464 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.948 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 56.9 86.72 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.665 HD12 ' CD2' ' A' ' 45' ' ' LEU . 6.2 tt -174.34 115.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.107 -1.231 . . . . 0.0 110.534 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.22 98.18 7.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.937 . . . . 0.0 109.728 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.066 HD11 HG22 ' A' ' 68' ' ' VAL . 44.7 pt -74.55 146.93 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 110.615 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -132.97 116.14 16.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.462 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.11 -160.38 30.78 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 163.17 134.47 1.65 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -60.72 -14.85 23.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.465 -1.021 . . . . 0.0 110.807 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.29 5.53 22.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.984 -1.073 . . . . 0.0 110.138 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -140.94 25.65 2.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.093 -1.004 . . . . 0.0 109.463 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 54.75 83.23 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.333 -0.855 . . . . 0.0 109.62 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.598 ' HE1' ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -169.11 126.92 0.85 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.254 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.893 ' CB ' HD21 ' A' ' 52' ' ' LEU . 56.0 Cg_endo -76.76 45.66 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.459 1.241 . . . . 0.0 111.972 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 19.9 mm 45.07 89.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 O-C-N 120.869 -1.144 . . . . 0.0 110.218 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.604 HD13 ' HB2' ' A' ' 50' ' ' ALA . 36.6 tp -103.7 127.58 51.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.853 -1.155 . . . . 0.0 111.751 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.827 HD12 ' HB2' ' A' ' 49' ' ' ASP . 61.8 mt -62.05 136.2 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.464 -0.772 . . . . 0.0 109.734 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 t -120.5 -18.59 7.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.218 -0.926 . . . . 0.0 110.734 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.5 104.77 4.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.972 -1.08 . . . . 0.0 110.517 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.712 HD11 HG21 ' A' ' 30' ' ' ILE . 10.8 mm -92.56 99.51 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.146 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.648 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 94.7 m-85 -59.64 136.34 57.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.488 -0.758 . . . . 0.0 110.271 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.836 ' O ' HD12 ' A' ' 37' ' ' LEU . 21.4 mtmt -80.37 174.49 11.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 110.649 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.77 28.33 62.91 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.948 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -136.54 160.45 38.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.106 -1.232 . . . . 0.0 110.726 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.743 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -48.43 -57.71 5.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 111.502 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.943 ' HB1' HD23 ' A' ' 45' ' ' LEU . . . -52.04 -45.79 64.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 111.808 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.458 ' HB2' HG22 ' A' ' 33' ' ' ILE . 7.3 t70 -85.01 -17.29 38.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.913 -1.117 . . . . 0.0 111.623 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.493 ' CG ' ' HA ' ' A' ' 38' ' ' ALA . 1.5 pp0? -99.42 13.2 34.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.797 -1.189 . . . . 0.0 110.851 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.811 HG21 HG22 ' A' ' 6' ' ' VAL . 10.0 t -107.84 14.83 25.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.997 -1.064 . . . . 0.0 110.775 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 45.39 49.71 10.32 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.252 -0.905 . . . . 0.0 111.079 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.71 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -167.43 -55.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.585 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.943 HD23 ' HB1' ' A' ' 39' ' ' ALA . 2.4 tp -69.43 84.03 0.4 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.853 -1.154 . . . . 0.0 108.683 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.602 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.58 152.55 28.76 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.86 -0.525 . . . . 0.0 109.665 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.44 ' N ' HG13 ' A' ' 33' ' ' ILE . 65.7 t -49.26 153.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.919 -1.113 . . . . 0.0 110.035 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.427 ' C ' HD11 ' A' ' 29' ' ' LEU . . . 83.76 24.08 50.84 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.827 ' HB2' HD12 ' A' ' 30' ' ' ILE . 69.4 m-20 -109.69 100.38 9.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.398 -1.06 . . . . 0.0 110.675 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.891 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -78.28 102.23 7.55 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.152 -0.968 . . . . 0.0 110.022 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 81' ' ' GLU . 69.4 mt -71.03 138.03 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.428 -0.795 . . . . 0.0 110.702 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.893 HD21 ' CB ' ' A' ' 27' ' ' PRO . 83.0 mt -136.32 9.83 3.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.287 -0.883 . . . . 0.0 111.269 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 179.09 92.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.922 -1.111 . . . . 0.0 109.832 179.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.999 HG21 ' CB ' ' A' ' 70' ' ' ALA . 33.1 m -91.51 121.04 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.287 -0.883 . . . . 0.0 110.156 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 55.69 36.42 27.19 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.495 -0.753 . . . . 0.0 110.838 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.99 -7.35 78.08 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.743 -1.218 . . . . 0.0 110.388 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -78.63 93.81 4.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.741 -1.447 . . . . 0.0 109.513 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.71 102.87 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.525 0.678 . . . . 0.0 111.021 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.878 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.5 OUTLIER -91.0 -4.89 56.07 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.5 -0.75 . . . . 0.0 110.556 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 t -58.54 -43.16 89.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 110.242 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.2 m -102.27 35.25 2.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 110.343 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.878 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -119.29 145.39 46.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 110.274 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.2 p -78.23 168.6 19.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.911 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.881 ' O ' HG23 ' A' ' 68' ' ' VAL . 7.7 t60 -54.51 -24.04 18.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.01 -1.056 . . . . 0.0 109.871 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.25 -43.39 42.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.12 -0.987 . . . . 0.0 109.12 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.622 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 32.9 mm-40 -65.61 -21.49 66.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.586 -0.696 . . . . 0.0 109.648 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.726 ' HA ' HD11 ' A' ' 59' ' ' LEU . . . -83.54 -47.5 11.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 110.583 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.066 HG22 HD11 ' A' ' 18' ' ' ILE . 7.8 t -62.8 -27.14 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.126 -0.983 . . . . 0.0 108.797 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -39.4 81.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.425 -0.797 . . . . 0.0 109.202 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.999 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -62.8 -44.35 96.39 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.355 -0.84 . . . . 0.0 108.849 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.702 ' C ' HG11 ' B' ' 7' ' ' VAL . 3.8 mm? -69.7 -23.39 63.42 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -84.27 -42.04 16.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.977 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -100.79 24.33 9.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.0 109.89 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -64.38 154.23 36.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.916 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.54 -172.01 20.6 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 8' ' ' LYS . 19.2 mttt -48.95 -62.32 1.59 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.061 -1.258 . . . . 0.0 110.389 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -83.62 115.92 22.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.083 -1.011 . . . . 0.0 108.639 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.886 ' CG1' HD21 ' A' ' 80' ' ' LEU . 71.5 t -109.39 89.85 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.072 -1.018 . . . . 0.0 111.154 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.895 ' O ' HD23 ' A' ' 80' ' ' LEU . 48.7 t -76.96 123.46 33.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.895 HD23 ' O ' ' A' ' 79' ' ' VAL . 15.5 mt -128.09 109.33 11.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.822 -1.174 . . . . 0.0 111.64 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 13.6 tp10 -66.29 129.63 40.47 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.739 HG11 HG23 ' A' ' 4' ' ' VAL . 2.4 p -132.68 146.7 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.873 -1.142 . . . . 0.0 112.119 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.891 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 13.5 tttt -107.7 85.09 2.06 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.602 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -55.51 123.53 14.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.741 . . . . 0.0 110.99 -177.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.1 mmt -99.47 51.63 0.94 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.375 -0.828 . . . . 0.0 109.866 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.268 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 64' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.185 0.517 . . . . 0.0 110.355 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 36.2 tt0 54.6 68.89 0.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.883 . . . . 0.0 110.361 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 39.8 t -66.21 -153.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.097 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.648 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -175.81 66.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.115 -0.991 . . . . 0.0 110.328 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.702 HG11 ' C ' ' A' ' 71' ' ' LEU . 46.6 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.236 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.312 0.577 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.854 ' CB ' HG13 ' A' ' 82' ' ' VAL . 1.6 mtp85 -157.15 165.42 36.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.319 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -140.97 112.53 7.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.409 -0.807 . . . . 0.0 109.229 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.629 HG13 ' HB3' ' A' ' 44' ' ' ALA . 37.5 t -124.56 152.85 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.039 -1.038 . . . . 0.0 110.529 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.3 m -139.99 143.57 36.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.365 -0.835 . . . . 0.0 110.124 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.461 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 98.5 t -130.75 109.7 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.919 . . . . 0.0 109.849 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.421 ' HD3' ' N ' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -72.19 113.52 9.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 110.159 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.98 62.04 0.44 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.351 -0.843 . . . . 0.0 110.408 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.5 -60.22 4.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 109.987 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -160.94 113.38 1.92 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.344 -0.848 . . . . 0.0 110.194 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -176.45 126.7 0.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -0.881 . . . . 0.0 110.015 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.92 58.86 3.89 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.29 146.61 4.53 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.842 HD22 HG21 ' A' ' 16' ' ' ILE . 1.4 tt -88.07 -23.98 23.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.255 -1.144 . . . . 0.0 110.215 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.49 ' HA3' ' HG ' ' A' ' 37' ' ' LEU . . . 70.94 79.93 0.35 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.842 HG21 HD22 ' A' ' 14' ' ' LEU . 2.7 tt -176.58 117.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.314 -1.109 . . . . 0.0 109.876 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.416 ' HB3' ' HB3' ' A' ' 32' ' ' LYS . 4.1 t -108.69 114.56 28.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.29 -0.881 . . . . 0.0 110.263 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.01 HD11 HG22 ' A' ' 68' ' ' VAL . 27.2 pt -88.06 153.84 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 110.637 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' B' ' 3' ' ' LYS . 16.4 ttpp -142.83 118.47 10.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.272 -0.893 . . . . 0.0 110.054 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.55 -161.07 32.87 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.448 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 169.12 131.95 1.38 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.607 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.0 OUTLIER -60.31 -15.34 24.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -1.191 . . . . 0.0 110.71 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.95 -14.02 58.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.94 -1.1 . . . . 0.0 109.977 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.87 24.0 11.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.809 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.1 tttt 54.67 78.81 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.995 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.611 ' HE1' ' N ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -161.95 120.77 1.42 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 110.409 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.733 ' HB2' HD11 ' A' ' 52' ' ' LEU . 50.6 Cg_endo -71.35 52.45 1.55 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 O-C-N 123.514 1.271 . . . . 0.0 111.966 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 64' ' ' HIS . 6.9 mm 42.57 89.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 121.09 -1.006 . . . . 0.0 110.574 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.611 ' N ' ' HE1' ' A' ' 26' ' ' MET . 6.0 mt -98.66 132.69 43.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.768 -1.208 . . . . 0.0 111.975 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.593 HD12 ' HB2' ' A' ' 49' ' ' ASP . 49.1 mt -66.52 133.53 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.306 -0.872 . . . . 0.0 108.815 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 t -116.79 -16.53 10.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.066 -1.021 . . . . 0.0 110.888 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -146.02 106.63 4.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.998 -1.064 . . . . 0.0 111.143 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.568 HD11 HG21 ' A' ' 30' ' ' ILE . 12.2 mm -93.32 115.16 31.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.261 -0.899 . . . . 0.0 108.601 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.861 ' CE1' HD13 ' B' ' 6' ' ' LEU . 10.0 m-85 -66.82 134.39 52.02 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.405 -0.809 . . . . 0.0 109.988 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.557 ' O ' HD23 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -79.81 151.88 30.05 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.259 -0.9 . . . . 0.0 110.821 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.16 16.5 60.13 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.557 HD23 ' O ' ' A' ' 35' ' ' LYS . 3.2 mm? -105.4 165.3 11.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -1.164 . . . . 0.0 110.298 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.461 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -48.42 -63.73 1.0 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.22 -0.925 . . . . 0.0 111.036 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.886 ' O ' HG22 ' A' ' 42' ' ' THR . . . -50.45 -53.0 32.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 110.721 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 24.1 t70 -73.09 -4.93 35.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.026 -1.046 . . . . 0.0 111.152 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -97.01 3.54 51.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.773 -1.205 . . . . 0.0 110.899 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 39' ' ' ALA . 7.2 t -107.68 15.17 24.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.805 -1.184 . . . . 0.0 110.781 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 47.31 56.95 6.27 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.12 -0.988 . . . . 0.0 110.954 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.629 ' HB3' HG13 ' A' ' 4' ' ' VAL . . . -173.74 -44.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 110.245 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.544 ' CD1' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -69.09 81.94 0.33 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.975 -1.078 . . . . 0.0 108.687 179.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.587 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -112.21 149.32 32.44 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.601 -0.687 . . . . 0.0 110.231 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 48' ' ' GLY . 84.5 t -49.89 169.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.124 -0.985 . . . . 0.0 110.404 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.534 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 68.61 32.96 75.35 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.597 ' C ' HD23 ' A' ' 29' ' ' LEU . 27.6 m-20 -117.95 108.57 15.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.559 -0.965 . . . . 0.0 110.423 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.648 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -85.8 104.69 15.71 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.465 HG21 ' CG1' ' A' ' 54' ' ' VAL . 30.7 mt -70.36 134.05 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.356 -0.84 . . . . 0.0 110.136 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 27' ' ' PRO . 2.4 mp -132.25 17.69 4.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 110.368 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 174.58 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.214 -0.929 . . . . 0.0 109.967 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.952 HG21 ' CB ' ' A' ' 70' ' ' ALA . 21.2 m -91.08 127.0 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.107 -0.996 . . . . 0.0 109.846 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.3 m120 57.72 38.64 27.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 0.0 110.013 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.83 29.87 70.74 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 53' ' ' SER . 7.4 tt0 -115.81 91.8 3.71 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -1.108 . . . . 0.0 109.579 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -37.91 102.04 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.691 0.758 . . . . 0.0 112.071 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.99 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -91.48 -13.63 31.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.648 -0.658 . . . . 0.0 110.483 179.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.699 ' OG ' HD23 ' A' ' 52' ' ' LEU . 44.1 m -53.52 -37.14 62.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.014 -1.054 . . . . 0.0 110.182 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.9 m -96.86 25.88 4.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 110.035 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.99 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -120.18 157.54 28.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 110.233 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.607 HG22 ' HB3' ' A' ' 22' ' ' ARG . 32.0 p -88.95 164.96 14.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 110.081 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.926 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.1 t60 -52.0 -25.76 9.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.953 . . . . 0.0 109.578 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -73.13 -40.19 65.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.096 -1.003 . . . . 0.0 109.082 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.495 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 1.1 mt-10 -71.06 -25.57 62.69 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.441 -0.787 . . . . 0.0 109.452 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.618 ' O ' HD23 ' A' ' 71' ' ' LEU . . . -76.35 -42.2 45.62 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.445 -0.784 . . . . 0.0 110.0 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.01 HG22 HD11 ' A' ' 18' ' ' ILE . 6.3 t -70.47 -30.63 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.189 -0.944 . . . . 0.0 109.08 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -58.87 -40.27 83.87 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.375 -0.828 . . . . 0.0 109.16 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.952 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -68.68 -46.75 68.23 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.355 -0.841 . . . . 0.0 108.814 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.702 ' C ' HG11 ' B' ' 7' ' ' VAL . 3.0 mm? -56.75 -30.13 63.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.681 -0.637 . . . . 0.0 109.63 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.3 -41.52 22.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.1 -1.0 . . . . 0.0 109.983 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -106.58 55.17 0.67 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.667 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.783 ' HB ' HG22 ' A' ' 78' ' ' VAL . 33.2 p -79.11 149.14 32.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.323 -0.861 . . . . 0.0 109.657 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.04 -177.63 45.88 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -50.94 47.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.253 -1.145 . . . . 0.0 110.122 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -98.35 94.18 6.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -0.87 . . . . 0.0 109.423 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.783 HG22 ' HB ' ' A' ' 74' ' ' THR . 92.8 t -63.72 78.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 111.085 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.948 ' O ' HD23 ' A' ' 80' ' ' LEU . 12.8 t -75.81 123.7 32.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.948 HD23 ' O ' ' A' ' 79' ' ' VAL . 13.0 mt -128.98 117.62 21.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.747 -1.22 . . . . 0.0 111.465 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 20.2 tt0 -73.78 125.21 27.61 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.854 HG13 ' CB ' ' A' ' 2' ' ' ARG . 3.0 p -125.72 145.48 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.052 -1.03 . . . . 0.0 112.206 -177.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.547 ' HB2' HD13 ' A' ' 52' ' ' LEU . 1.0 OUTLIER -112.53 86.41 2.36 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.587 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -52.91 129.46 30.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.572 -0.705 . . . . 0.0 110.959 -178.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.4 mmt -101.29 46.66 0.93 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.292 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.284 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.53 ' HD2' ' CD2' ' A' ' 64' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.29 0.566 . . . . 0.0 110.59 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.8 mt-10 -109.37 -158.89 0.66 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.455 -0.778 . . . . 0.0 109.048 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.595 ' OG ' HG11 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -175.85 -48.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.83 -1.169 . . . . 0.0 110.806 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.861 HD13 ' CE1' ' A' ' 34' ' ' PHE . 13.0 tp 54.6 92.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 109.936 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.702 HG11 ' C ' ' A' ' 71' ' ' LEU . 61.2 t . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.028 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.271 0.558 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.811 ' O ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -122.52 147.35 46.47 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.272 -0.892 . . . . 0.0 109.032 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -105.24 106.49 17.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.054 -1.029 . . . . 0.0 110.058 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.767 HG13 ' HB3' ' A' ' 44' ' ' ALA . 61.1 t -107.48 128.86 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.948 . . . . 0.0 110.266 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.0 m -115.28 111.23 20.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 110.125 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.621 ' CG1' ' HB1' ' A' ' 38' ' ' ALA . 99.0 t -97.09 118.54 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.846 . . . . 0.0 109.823 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.13 110.23 19.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.232 -0.917 . . . . 0.0 110.288 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HE3' HD12 ' A' ' 14' ' ' LEU . 2.4 mmmp? -85.11 90.14 7.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.347 -0.846 . . . . 0.0 110.18 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.11 -74.2 0.43 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.929 . . . . 0.0 110.333 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.7 -19.03 65.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.035 -1.041 . . . . 0.0 110.641 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 52.41 54.62 10.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.051 -1.031 . . . . 0.0 110.239 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -117.38 50.57 0.79 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.36 139.01 10.54 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -96.21 -21.1 18.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -1.183 . . . . 0.0 110.132 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.882 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 58.27 87.46 0.02 OUTLIER Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 45' ' ' LEU . 4.6 tt -176.51 117.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.184 -1.186 . . . . 0.0 110.404 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 32' ' ' LYS . 35.2 t -106.94 117.82 35.06 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.295 -0.878 . . . . 0.0 109.619 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.961 HD11 ' CG2' ' A' ' 68' ' ' VAL . 43.7 pt -94.85 150.26 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 110.817 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' B' ' 3' ' ' LYS . 17.1 tttt -138.49 120.26 15.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 110.183 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.18 -153.43 24.61 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 157.19 134.13 1.71 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -60.69 -14.77 22.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.374 -1.074 . . . . 0.0 110.547 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' OE2' ' ND2' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -80.32 1.88 26.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.949 -1.094 . . . . 0.0 110.469 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.414 ' ND2' ' OE2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -138.07 26.17 2.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.973 -1.08 . . . . 0.0 109.795 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 54.47 66.99 1.08 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 110.113 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.474 ' HE3' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -149.86 115.89 3.52 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.436 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.937 ' HB3' HD21 ' A' ' 52' ' ' LEU . 49.2 Cg_endo -68.2 55.38 0.76 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.321 1.347 . . . . 0.0 111.793 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 64' ' ' HIS . 16.0 mm 41.66 88.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 121.286 -0.884 . . . . 0.0 110.446 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' A' ' 50' ' ' ALA . 34.3 tp -101.88 126.66 48.83 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.831 -1.168 . . . . 0.0 112.121 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.788 HD12 ' HB2' ' A' ' 49' ' ' ASP . 55.6 mt -64.41 140.88 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.686 -0.634 . . . . 0.0 109.953 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.6 t -128.68 4.14 5.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 110.718 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 1.9 ttmt -165.03 99.89 0.75 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.818 -1.176 . . . . 0.0 110.263 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 30' ' ' ILE . 14.4 mm -89.64 111.88 23.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.32 -0.862 . . . . 0.0 109.318 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.663 ' HB3' HD13 ' A' ' 37' ' ' LEU . 16.2 m-85 -74.3 126.83 31.51 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.47 -0.769 . . . . 0.0 109.984 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.863 ' O ' HD12 ' A' ' 37' ' ' LEU . 20.3 mtmt -75.62 170.54 15.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.312 -0.867 . . . . 0.0 110.548 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.52 26.19 71.77 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.882 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -138.99 159.55 41.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -1.19 . . . . 0.0 110.918 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.621 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -42.72 -66.36 0.37 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.648 -0.658 . . . . 0.0 112.128 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.886 ' O ' HG22 ' A' ' 42' ' ' THR . . . -45.83 -59.3 2.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.316 -0.865 . . . . 0.0 111.354 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -71.97 -4.19 27.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.904 -1.123 . . . . 0.0 111.114 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -107.78 11.82 27.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.555 -1.341 . . . . 0.0 110.726 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 39' ' ' ALA . 8.9 t -108.42 15.73 23.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.956 -1.09 . . . . 0.0 110.708 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 47.86 51.08 14.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.07 -1.019 . . . . 0.0 110.846 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.767 ' HB3' HG13 ' A' ' 4' ' ' VAL . . . -172.73 -45.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -0.918 . . . . 0.0 110.017 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.497 ' HG ' ' HB1' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -67.26 81.49 0.14 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.017 -1.052 . . . . 0.0 109.344 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -113.21 152.7 29.42 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.479 -0.763 . . . . 0.0 109.978 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.456 ' N ' HG13 ' A' ' 33' ' ' ILE . 86.4 t -50.94 163.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.783 -1.198 . . . . 0.0 109.98 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.431 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 75.0 28.5 62.36 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.788 ' HB2' HD12 ' A' ' 30' ' ' ILE . 46.3 m-20 -109.81 98.15 7.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.387 -1.066 . . . . 0.0 110.705 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.795 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -75.4 92.61 2.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 0.0 110.282 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 59' ' ' LEU . 51.6 mt -64.13 136.72 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.386 -0.821 . . . . 0.0 110.191 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.937 HD21 ' HB3' ' A' ' 27' ' ' PRO . 10.5 mt -136.11 19.82 3.21 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.375 -0.828 . . . . 0.0 109.591 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 22.6 t 177.72 126.46 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.594 -0.691 . . . . 0.0 109.351 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.042 HG12 HD22 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -124.81 116.68 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.228 -0.92 . . . . 0.0 110.233 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 58.58 31.95 21.62 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.481 -0.762 . . . . 0.0 110.643 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.44 23.92 32.61 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 53' ' ' SER . 4.9 tt0 -115.4 88.23 2.83 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.026 -1.279 . . . . 0.0 110.079 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -44.62 101.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.504 -0.748 . . . . 0.0 111.28 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.703 HD11 HG22 ' A' ' 54' ' ' VAL . 70.5 mt -81.3 -13.04 58.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 110.358 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 t -48.5 -33.45 9.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.16 -0.963 . . . . 0.0 110.284 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.43 27.97 7.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.353 -0.842 . . . . 0.0 109.591 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 66' ' ' GLU . . . -123.81 149.07 46.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.407 -0.808 . . . . 0.0 110.493 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 p -79.86 166.43 21.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.312 -0.868 . . . . 0.0 109.812 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.943 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.4 t60 -55.48 -31.83 62.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.082 -1.011 . . . . 0.0 109.854 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.66 -32.43 65.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.824 -1.173 . . . . 0.0 109.547 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.488 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 1.2 mm-40 -72.65 -28.39 62.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.55 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.427 ' O ' HD23 ' A' ' 71' ' ' LEU . . . -77.08 -41.72 41.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.757 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.961 ' CG2' HD11 ' A' ' 18' ' ' ILE . 7.3 t -63.79 -26.96 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.544 -0.862 . . . . 0.0 108.98 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -36.58 81.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.522 -0.736 . . . . 0.0 109.549 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.763 ' O ' HG23 ' A' ' 74' ' ' THR . . . -72.36 -39.89 67.73 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.169 -0.957 . . . . 0.0 109.262 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.682 ' HB3' HG11 ' B' ' 7' ' ' VAL . 4.0 mm? -60.64 -29.92 69.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.368 -0.832 . . . . 0.0 108.918 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -84.75 -36.77 21.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.853 . . . . 0.0 110.118 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -106.05 27.34 8.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.974 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.763 HG23 ' O ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -67.29 166.58 14.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.133 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -109.19 -176.01 21.4 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -51.78 -63.1 1.24 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.204 -1.174 . . . . 0.0 110.4 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -81.8 88.02 6.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.206 -0.934 . . . . 0.0 109.915 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.774 ' CG1' HD21 ' A' ' 80' ' ' LEU . 53.9 t -80.4 90.35 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.932 . . . . 0.0 110.644 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.661 ' O ' HD23 ' A' ' 80' ' ' LEU . 7.1 t -80.68 117.3 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.042 HD22 HG12 ' A' ' 54' ' ' VAL . 17.3 mt -122.5 116.02 23.2 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.409 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.459 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 0.8 OUTLIER -74.0 133.51 42.98 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 2' ' ' ARG . 4.0 p -129.99 153.68 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.95 -1.093 . . . . 0.0 112.519 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.65 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 2.6 mtpt -115.53 81.55 1.61 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -47.96 121.13 3.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.457 -0.777 . . . . 0.0 111.334 -177.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.3 mtt -116.15 52.21 0.92 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.48 -0.762 . . . . 0.0 109.311 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.396 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.474 ' HG2' ' CD2' ' A' ' 64' ' ' HIS . 6.9 tttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.167 0.508 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.416 ' OE2' ' CE ' ' A' ' 32' ' ' LYS . 1.2 tt0 -113.71 70.31 0.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 109.938 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.6 -176.42 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.265 -0.897 . . . . 0.0 110.73 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.62 HD13 ' CE1' ' A' ' 34' ' ' PHE . 21.8 tp -160.15 90.64 0.91 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.443 -0.785 . . . . 0.0 109.855 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.682 HG11 ' HB3' ' A' ' 71' ' ' LEU . 93.1 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.122 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.267 0.556 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.983 ' HB3' HG13 ' A' ' 82' ' ' VAL . 1.1 ttm-85 -152.83 172.65 16.41 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 0.0 109.939 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.84 135.44 14.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.916 . . . . 0.0 109.349 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.637 HG22 ' HB1' ' A' ' 44' ' ' ALA . 66.6 t -142.19 137.67 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.05 -1.031 . . . . 0.0 110.997 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.9 m -121.08 114.08 20.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.522 -0.736 . . . . 0.0 109.304 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.933 HG22 HG21 ' A' ' 42' ' ' THR . 83.1 t -105.53 119.51 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.123 -0.986 . . . . 0.0 110.826 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.03 123.38 42.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.396 -0.815 . . . . 0.0 109.74 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -131.38 173.03 11.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.136 -0.977 . . . . 0.0 110.468 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -163.92 142.6 7.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 109.947 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 6.8 t0 62.99 133.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.29 -0.881 . . . . 0.0 110.116 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 10' ' ' ASP . . . 61.56 121.88 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.652 -0.655 . . . . 0.0 110.324 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.75 62.73 4.37 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.99 96.96 0.93 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.539 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -92.73 -19.94 21.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -1.142 . . . . 0.0 110.505 -179.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.947 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 57.84 89.78 0.01 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.766 HD12 HD23 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -174.92 120.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.237 -1.155 . . . . 0.0 110.316 -179.043 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.425 ' HB3' ' CB ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -110.56 93.62 4.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.253 -0.904 . . . . 0.0 109.755 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.98 HD11 ' CG2' ' A' ' 68' ' ' VAL . 28.9 pt -73.62 148.67 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.378 -0.826 . . . . 0.0 110.557 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 31' ' ' SER . 2.3 mtpt -136.88 144.46 43.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.01 . . . . 0.0 110.183 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 136.85 -158.34 24.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.456 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 165.89 133.24 1.48 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.682 ' HB3' HG22 ' A' ' 63' ' ' THR . 1.9 ttp85 -59.53 -15.64 19.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -1.13 . . . . 0.0 110.64 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -14.2 60.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.946 -1.096 . . . . 0.0 109.922 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.02 24.36 10.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.189 -0.944 . . . . 0.0 109.704 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.39 73.21 0.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 110.166 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.53 ' HE1' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -150.4 123.96 4.4 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.93 . . . . 0.0 110.317 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.64 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 54.8 Cg_endo -73.04 50.23 1.78 Allowed 'Trans proline' 0 N--CA 1.493 1.448 0 O-C-N 123.35 1.184 . . . . 0.0 111.752 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 64' ' ' HIS . 10.0 mm 43.06 89.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.498 0 O-C-N 121.101 -0.999 . . . . 0.0 110.656 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.614 HD23 ' N ' ' A' ' 50' ' ' ALA . 6.1 mt -96.57 132.87 41.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.88 -1.137 . . . . 0.0 111.723 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.786 HD12 ' HB2' ' A' ' 49' ' ' ASP . 52.3 mt -67.49 135.55 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.451 ' HA ' HG13 ' A' ' 47' ' ' VAL . 10.7 t -116.29 -36.04 4.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.062 -1.024 . . . . 0.0 110.815 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.425 ' CB ' ' HB3' ' A' ' 17' ' ' SER . 0.0 OUTLIER -129.06 105.04 7.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.056 -1.028 . . . . 0.0 110.82 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.707 HD11 HG21 ' A' ' 30' ' ' ILE . 10.1 mm -90.45 97.2 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.198 -0.939 . . . . 0.0 109.139 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.823 ' CZ ' HD11 ' B' ' 6' ' ' LEU . 96.3 m-85 -61.89 133.86 55.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.476 -0.765 . . . . 0.0 110.529 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.793 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.8 ttmt -79.06 175.91 10.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.829 . . . . 0.0 110.432 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.61 25.08 60.51 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.947 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.9 OUTLIER -134.88 159.42 41.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.144 . . . . 0.0 110.386 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.789 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -47.54 -59.06 3.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.382 -0.824 . . . . 0.0 111.17 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.612 ' HB1' HD23 ' A' ' 45' ' ' LEU . . . -48.4 -44.55 34.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.279 -0.888 . . . . 0.0 111.334 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.416 ' HB2' ' CG2' ' A' ' 33' ' ' ILE . 16.4 t70 -95.87 11.13 34.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.052 -1.03 . . . . 0.0 111.092 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -107.12 -4.74 18.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.823 -1.173 . . . . 0.0 110.588 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.933 HG21 HG22 ' A' ' 6' ' ' VAL . 7.2 t -105.56 14.44 28.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.827 -1.171 . . . . 0.0 110.704 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 46.21 53.85 8.97 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.23 -0.919 . . . . 0.0 110.951 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.637 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -160.74 -48.43 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.239 -0.913 . . . . 0.0 110.036 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.766 HD23 HD12 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -72.64 87.63 1.24 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.843 -1.161 . . . . 0.0 108.0 178.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.589 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -113.2 149.57 33.53 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.133 0.492 . . . . 0.0 110.175 -178.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.503 ' HA ' HG22 ' A' ' 30' ' ' ILE . 56.3 t -47.19 154.2 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.048 -1.032 . . . . 0.0 110.331 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.18 28.74 43.68 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.786 ' HB2' HD12 ' A' ' 30' ' ' ILE . 62.3 m-20 -113.43 103.38 11.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.438 -1.036 . . . . 0.0 110.435 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.64 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -80.29 108.28 13.77 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.186 -0.946 . . . . 0.0 109.295 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.762 ' C ' HD22 ' A' ' 52' ' ' LEU . 51.4 mt -75.4 134.55 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 111.085 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.762 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.5 mm? -119.58 14.04 12.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.505 -0.747 . . . . 0.0 109.81 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 1.3 t 178.02 146.33 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 108.997 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.756 HG21 ' CB ' ' A' ' 70' ' ' ALA . 2.6 m -138.72 125.28 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.985 -1.072 . . . . 0.0 111.186 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' A' ' 78' ' ' VAL . 6.3 m120 59.12 16.08 4.55 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.411 -0.806 . . . . 0.0 111.233 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.9 24.98 7.02 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.481 ' O ' ' CB ' ' A' ' 53' ' ' SER . 2.4 mm-40 -116.26 166.14 12.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -1.163 . . . . 0.0 108.686 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.16 119.57 39.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.058 -1.026 . . . . 0.0 110.062 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.793 HD13 ' HB3' ' A' ' 62' ' ' ALA . 2.0 mm? -101.1 -9.52 21.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 110.693 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -51.64 -28.87 15.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.972 -1.08 . . . . 0.0 110.483 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.9 m -120.65 46.76 1.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.37 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.793 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -135.57 157.2 47.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 110.207 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.682 HG22 ' HB3' ' A' ' 22' ' ' ARG . 33.7 p -87.94 167.79 13.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.398 -0.814 . . . . 0.0 110.34 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.93 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.1 t60 -53.69 -24.51 14.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.181 -0.95 . . . . 0.0 109.622 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.37 -39.99 52.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 109.455 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.571 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 19.3 mm-40 -68.32 -25.87 65.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.482 -0.761 . . . . 0.0 109.623 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.638 ' HA ' HD11 ' A' ' 59' ' ' LEU . . . -79.33 -44.32 21.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.345 -0.847 . . . . 0.0 110.38 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.98 ' CG2' HD11 ' A' ' 18' ' ' ILE . 4.0 t -69.06 -30.49 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.064 -1.022 . . . . 0.0 108.745 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.65 -38.07 71.64 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.484 -0.76 . . . . 0.0 109.236 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.756 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -74.02 -25.87 60.11 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.402 -0.811 . . . . 0.0 109.478 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.751 ' HB3' HG11 ' B' ' 7' ' ' VAL . 3.6 mm? -75.18 -27.86 59.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.408 -0.808 . . . . 0.0 109.893 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -76.61 -42.5 42.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.907 . . . . 0.0 110.162 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -95.16 22.23 6.96 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.246 -0.909 . . . . 0.0 109.965 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.929 ' CG2' HG22 ' A' ' 78' ' ' VAL . 60.2 m -52.91 132.51 37.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 110.518 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.39 178.29 51.65 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.434 ' HG3' ' N ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -52.99 -32.76 48.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.209 -1.171 . . . . 0.0 110.34 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.434 ' N ' ' HG3' ' A' ' 76' ' ' LYS . 9.3 tt0 -101.81 109.0 20.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 108.983 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.929 HG22 ' CG2' ' A' ' 74' ' ' THR . 22.0 t -97.0 82.41 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 0.0 111.052 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.649 ' O ' HD12 ' A' ' 80' ' ' LEU . 3.3 t -78.2 108.48 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.854 HD13 HG12 ' A' ' 78' ' ' VAL . 5.7 mp -118.73 109.09 15.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.025 -1.047 . . . . 0.0 112.508 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 51.2 tt0 -71.04 137.9 49.39 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.983 HG13 ' HB3' ' A' ' 2' ' ' ARG . 2.2 p -139.22 145.64 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.81 -1.181 . . . . 0.0 112.093 -177.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -106.75 88.57 2.79 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.164 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.589 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -55.62 114.78 2.0 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.463 -0.773 . . . . 0.0 111.151 -177.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.408 ' HG3' HD21 ' A' ' 29' ' ' LEU . 2.4 mtt -100.38 50.93 0.89 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 108.992 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.197 -179.406 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 tttt . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.188 0.518 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 47.2 tt0 -153.66 106.46 2.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.322 -0.861 . . . . 0.0 110.065 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.446 ' HB3' HG11 ' A' ' 68' ' ' VAL . 70.3 m -109.01 131.29 55.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.143 -0.973 . . . . 0.0 110.206 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.823 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 0.5 OUTLIER -100.13 96.81 7.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -0.836 . . . . 0.0 110.751 -179.601 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.751 HG11 ' HB3' ' A' ' 71' ' ' LEU . 44.5 t . . . . . 0 N--CA 1.492 1.667 0 O-C-N 120.919 -1.113 . . . . 0.0 110.133 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.442 0.639 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.848 ' CB ' HG13 ' A' ' 82' ' ' VAL . 1.7 mtp85 -153.51 168.17 27.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.409 -0.807 . . . . 0.0 110.187 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -135.57 118.83 16.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 0.0 109.384 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.736 HG11 ' HG ' ' A' ' 45' ' ' LEU . 60.3 t -124.04 128.85 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.004 -1.06 . . . . 0.0 110.691 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.7 m -118.26 118.8 32.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.453 -0.78 . . . . 0.0 109.768 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.897 HG21 HD12 ' A' ' 45' ' ' LEU . 89.7 t -113.73 108.08 24.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.63 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.7 mtm105 -65.34 110.78 2.74 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.524 -0.735 . . . . 0.0 110.048 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.919 ' HE2' HD12 ' A' ' 14' ' ' LEU . 2.3 tttp -125.14 149.9 47.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.359 -0.838 . . . . 0.0 110.423 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.58 -158.08 0.64 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.416 -0.803 . . . . 0.0 110.117 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.11 20.81 4.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.167 -0.958 . . . . 0.0 110.377 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.44 118.86 2.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 110.05 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.81 106.84 0.9 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.94 157.46 1.77 Allowed Glycine 0 N--CA 1.495 2.584 0 O-C-N 120.784 -1.421 . . . . 0.0 109.842 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.919 HD12 ' HE2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -93.43 -14.99 26.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.277 -1.131 . . . . 0.0 110.756 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.971 ' N ' HD22 ' A' ' 37' ' ' LEU . . . 58.21 83.39 0.05 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.48 HG21 HD22 ' A' ' 14' ' ' LEU . 3.4 tt -175.16 117.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.218 -1.166 . . . . 0.0 110.002 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.409 ' HB2' ' HG ' ' B' ' 6' ' ' LEU . 1.2 t -108.44 106.52 16.66 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.131 -0.981 . . . . 0.0 110.089 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.028 HD11 HG22 ' A' ' 68' ' ' VAL . 20.4 pt -83.65 145.85 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.406 -0.809 . . . . 0.0 110.275 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' CG ' ' HB2' ' A' ' 31' ' ' SER . 3.2 ptmt -128.61 153.19 47.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.974 -1.079 . . . . 0.0 109.066 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 127.89 -157.65 21.14 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.274 -1.441 . . . . 0.0 110.338 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.45 ' HA2' ' HB2' ' A' ' 64' ' ' HIS . . . 162.22 134.68 1.68 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' NH2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -58.46 -16.66 16.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -1.08 . . . . 0.0 110.603 -179.727 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -14.74 60.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.736 -1.227 . . . . 0.0 110.246 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.3 28.14 7.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.976 . . . . 0.0 110.006 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HA ' ' NH2' ' A' ' 22' ' ' ARG . 7.0 mmmt 52.48 81.76 0.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.218 -0.926 . . . . 0.0 110.23 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.612 ' HE1' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -160.23 122.46 1.82 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.185 -0.947 . . . . 0.0 110.336 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.699 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 54.3 Cg_endo -72.38 50.95 1.69 Allowed 'Trans proline' 0 N--CA 1.494 1.554 0 O-C-N 123.42 1.221 . . . . 0.0 111.773 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.586 HG21 ' HB1' ' A' ' 67' ' ' ALA . 17.6 mm 42.36 87.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 121.108 -0.995 . . . . 0.0 110.746 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.612 ' CB ' ' HE1' ' A' ' 26' ' ' MET . 5.9 mt -95.28 134.58 37.89 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.822 -1.174 . . . . 0.0 111.849 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.859 HD12 ' HB2' ' A' ' 49' ' ' ASP . 59.5 mt -66.95 138.03 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.218 -0.926 . . . . 0.0 108.831 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.463 ' HB2' ' CG ' ' A' ' 19' ' ' LYS . 47.4 t -120.37 -26.29 5.45 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.975 -1.078 . . . . 0.0 110.941 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.405 ' CB ' ' HB3' ' A' ' 17' ' ' SER . 0.5 OUTLIER -137.84 105.5 5.59 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.069 -1.019 . . . . 0.0 111.019 -179.398 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.76 HD11 HG21 ' A' ' 30' ' ' ILE . 15.3 mm -90.71 96.97 6.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.586 ' HB2' HD13 ' A' ' 37' ' ' LEU . 95.9 m-85 -62.34 134.79 56.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.605 -0.685 . . . . 0.0 110.625 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.588 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -78.17 176.1 9.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.421 -0.8 . . . . 0.0 110.528 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.55 28.62 51.81 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.971 HD22 ' N ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -136.42 162.69 32.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -1.162 . . . . 0.0 110.65 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.759 ' HB1' ' CG1' ' A' ' 6' ' ' VAL . . . -52.8 -55.21 24.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.582 -0.699 . . . . 0.0 111.916 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.722 ' HB2' HD23 ' A' ' 14' ' ' LEU . . . -56.37 -37.01 69.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.115 -0.99 . . . . 0.0 112.126 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.432 ' HB2' HG22 ' A' ' 33' ' ' ILE . 17.6 t70 -92.77 -6.23 49.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.807 -1.183 . . . . 0.0 111.615 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -106.82 15.7 25.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.807 -1.183 . . . . 0.0 110.525 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.497 HG21 HG22 ' A' ' 6' ' ' VAL . 4.9 t -108.91 14.56 24.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.101 -1.0 . . . . 0.0 110.812 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 45.22 48.41 10.11 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.199 -0.938 . . . . 0.0 111.419 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.653 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -169.15 -46.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 0.0 110.471 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.897 HD12 HG21 ' A' ' 6' ' ' VAL . 2.2 mt -71.66 84.83 0.89 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.812 -1.18 . . . . 0.0 108.568 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.595 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -111.13 151.22 28.39 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.739 -179.198 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.479 ' N ' HG13 ' A' ' 33' ' ' ILE . 98.3 t -50.36 159.14 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.851 -1.156 . . . . 0.0 110.008 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.56 31.11 51.6 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.859 ' HB2' HD12 ' A' ' 30' ' ' ILE . 42.2 m-20 -114.25 104.77 12.42 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.542 -0.975 . . . . 0.0 110.354 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -82.86 110.58 17.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.151 -0.968 . . . . 0.0 109.761 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.811 ' C ' HD22 ' A' ' 52' ' ' LEU . 71.9 mt -77.28 136.89 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.87 . . . . 0.0 110.891 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.811 HD22 ' C ' ' A' ' 51' ' ' ILE . 4.4 mm? -120.43 -0.44 10.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.464 -0.772 . . . . 0.0 110.844 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 2.5 p -178.79 103.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.875 -1.141 . . . . 0.0 109.819 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.892 HG21 ' CB ' ' A' ' 70' ' ' ALA . 17.1 m -92.46 121.38 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.167 -0.958 . . . . 0.0 110.351 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 57.65 34.2 24.21 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.135 -0.978 . . . . 0.0 110.917 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.96 17.62 67.08 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.544 ' O ' HD23 ' A' ' 59' ' ' LEU . 4.8 tt0 -105.01 91.24 3.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.019 -1.283 . . . . 0.0 109.805 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -43.49 99.52 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.523 0.678 . . . . 0.0 111.135 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.88 HD13 ' CB ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -92.54 24.88 3.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -0.796 . . . . 0.0 110.292 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 61' ' ' SER . 52.6 p -73.92 -58.71 3.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.147 -0.971 . . . . 0.0 110.397 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.425 ' N ' ' OG ' ' A' ' 60' ' ' SER . 0.8 OUTLIER -80.47 -19.21 46.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 110.096 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.88 ' CB ' HD13 ' A' ' 59' ' ' LEU . . . -57.54 167.54 1.01 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.36 -0.837 . . . . 0.0 110.589 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.5 p -100.72 -166.76 1.35 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.398 -0.814 . . . . 0.0 108.98 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.908 ' O ' HG23 ' A' ' 68' ' ' VAL . 7.3 t60 -75.18 -23.6 57.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.006 -1.059 . . . . 0.0 109.981 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.01 -34.76 61.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.961 . . . . 0.0 109.663 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.487 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 22.6 mm-40 -72.55 -25.55 61.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 109.849 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.586 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -78.91 -38.88 36.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 110.205 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.028 HG22 HD11 ' A' ' 18' ' ' ILE . 2.9 t -75.03 -37.86 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.216 -0.928 . . . . 0.0 108.806 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -55.47 -38.89 69.69 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.443 -0.786 . . . . 0.0 109.965 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.892 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -70.53 -49.4 48.54 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.112 -0.992 . . . . 0.0 109.107 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.625 ' CB ' HG11 ' B' ' 7' ' ' VAL . 79.1 mt -61.1 -23.94 65.86 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.656 -0.653 . . . . 0.0 109.666 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -76.11 -37.17 58.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.084 -1.01 . . . . 0.0 109.082 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 17.0 ttmt -121.72 51.07 1.35 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.746 ' HB ' HG22 ' A' ' 78' ' ' VAL . 58.8 p -52.44 -85.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 110.615 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.432 ' N ' ' OG1' ' A' ' 74' ' ' THR . . . 147.99 -172.81 28.22 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.412 ' CG ' ' N ' ' A' ' 77' ' ' GLU . 3.7 pttt -49.08 -40.28 31.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.247 -1.149 . . . . 0.0 110.441 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 76' ' ' LYS . 25.8 pt-20 -128.58 129.94 46.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.326 -0.859 . . . . 0.0 109.672 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.848 HG12 HD13 ' A' ' 80' ' ' LEU . 45.2 t -96.8 79.63 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.036 -1.04 . . . . 0.0 111.12 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.643 ' O ' HD12 ' A' ' 80' ' ' LEU . 20.1 t -73.43 112.09 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.848 HD13 HG12 ' A' ' 78' ' ' VAL . 4.8 mp -120.34 110.14 16.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.915 -1.116 . . . . 0.0 111.943 -177.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.1 tp10 -69.32 122.7 19.42 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.848 HG13 ' CB ' ' A' ' 2' ' ' ARG . 2.4 p -118.31 146.35 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.092 -1.005 . . . . 0.0 112.19 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -113.18 82.42 1.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.595 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -50.11 127.11 16.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.529 -0.732 . . . . 0.0 111.211 -177.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.3 mtt -121.87 53.78 1.19 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.421 -0.8 . . . . 0.0 109.518 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.494 ' HD2' ' CE2' ' A' ' 84' ' ' TYR . 6.3 mtpp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.287 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.522 ' HG3' ' CE1' ' A' ' 64' ' ' HIS . 3.1 ptmt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.048 0.451 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 19.9 mt-10 -48.82 126.54 12.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.17 -0.956 . . . . 0.0 110.251 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.43 -24.65 10.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.97 -1.081 . . . . 0.0 111.138 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.56 HD21 ' CE1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER 59.06 96.75 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.099 -1.001 . . . . 0.0 110.592 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.644 ' CG2' HG13 ' A' ' 68' ' ' VAL . 44.8 t . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.046 -1.034 . . . . 0.0 110.071 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.259 0.552 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.542 ' CG ' HG13 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -163.59 147.3 10.33 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.21 -0.931 . . . . 0.0 109.728 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.424 ' N ' ' HG3' ' A' ' 2' ' ' ARG . 21.5 ptt180 -125.53 136.65 53.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.112 -0.992 . . . . 0.0 110.041 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.733 HG13 ' CB ' ' A' ' 44' ' ' ALA . 46.6 t -140.42 157.06 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.102 -0.999 . . . . 0.0 110.567 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.449 ' OG1' HG22 ' A' ' 79' ' ' VAL . 40.1 m -144.24 125.69 14.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 110.212 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.038 HG22 HG21 ' A' ' 42' ' ' THR . 87.7 t -117.75 114.4 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.649 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -80.27 118.99 22.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.73 105.18 0.1 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.324 -0.86 . . . . 0.0 110.288 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.59 122.79 11.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.943 . . . . 0.0 110.225 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.2 OUTLIER 62.32 128.73 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.374 -0.829 . . . . 0.0 110.403 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 10' ' ' ASP . . . 55.94 92.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.456 -0.778 . . . . 0.0 110.445 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.8 -30.72 15.33 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.53 120.53 11.93 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.636 HD22 HG21 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -72.79 -20.36 61.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -1.15 . . . . 0.0 110.365 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.504 ' HA3' ' CG ' ' A' ' 37' ' ' LEU . . . 63.38 83.94 0.07 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.636 HG21 HD22 ' A' ' 14' ' ' LEU . 1.1 tt -176.43 120.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -1.175 . . . . 0.0 109.921 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.488 ' OG ' ' CE1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -111.53 106.1 14.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.89 . . . . 0.0 109.469 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.038 HD11 HG22 ' A' ' 68' ' ' VAL . 22.0 pt -82.41 156.54 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.449 -0.782 . . . . 0.0 111.522 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.459 ' CB ' ' HB2' ' A' ' 31' ' ' SER . 7.9 ttmm -139.73 119.98 13.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.493 -0.755 . . . . 0.0 109.772 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.71 -159.46 28.09 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.445 ' CA ' ' HB2' ' A' ' 64' ' ' HIS . . . 156.88 140.27 2.91 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.499 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.0 OUTLIER -60.88 -14.64 23.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -1.084 . . . . 0.0 110.713 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -72.73 -19.12 61.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.893 -1.129 . . . . 0.0 110.006 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -123.38 28.22 7.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 109.879 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.24 83.91 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.392 -0.817 . . . . 0.0 110.166 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.581 ' HE1' ' CB ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -167.39 123.13 0.87 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.29 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.847 ' HB3' HD21 ' A' ' 52' ' ' LEU . 55.2 Cg_endo -71.61 52.32 1.63 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 O-C-N 123.39 1.205 . . . . 0.0 111.729 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 64' ' ' HIS . 13.9 mm 42.39 88.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 O-C-N 121.093 -1.005 . . . . 0.0 110.817 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 50' ' ' ALA . 6.0 mt -97.39 131.6 43.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.757 -1.214 . . . . 0.0 111.89 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.657 HG21 HD11 ' A' ' 33' ' ' ILE . 39.6 mt -67.18 132.22 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.284 -0.885 . . . . 0.0 108.74 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.459 ' HB2' ' CB ' ' A' ' 19' ' ' LYS . 6.9 t -119.51 -10.4 9.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.167 -0.958 . . . . 0.0 111.092 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.38 99.4 2.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.987 -1.071 . . . . 0.0 110.707 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.657 HD11 HG21 ' A' ' 30' ' ' ILE . 13.4 mm -89.58 95.92 5.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.318 -0.864 . . . . 0.0 108.682 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.584 ' CZ ' HD13 ' B' ' 6' ' ' LEU . 4.8 m-30 -45.02 137.45 4.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.818 -0.551 . . . . 0.0 110.85 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 37' ' ' LEU . 1.6 tttp -79.98 158.42 26.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.279 -0.888 . . . . 0.0 110.479 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.27 22.31 29.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 35' ' ' LYS . 1.9 mm? -112.01 168.82 9.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -1.111 . . . . 0.0 109.718 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.78 ' O ' HG23 ' A' ' 42' ' ' THR . . . -56.1 -70.46 0.11 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.135 -0.978 . . . . 0.0 111.174 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 14' ' ' LEU . . . -47.1 -24.66 0.7 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.332 -0.855 . . . . 0.0 111.671 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.475 ' HB2' HG22 ' A' ' 33' ' ' ILE . 4.8 t70 -93.91 -31.81 14.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.888 -1.133 . . . . 0.0 110.456 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 1.4 pp0? -87.13 12.0 12.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.062 -1.024 . . . . 0.0 110.491 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 1.038 HG21 HG22 ' A' ' 6' ' ' VAL . 35.3 p -98.88 6.62 46.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.053 -1.029 . . . . 0.0 110.815 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER 49.98 53.83 12.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.864 -1.147 . . . . 0.0 110.818 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.733 ' CB ' HG13 ' A' ' 4' ' ' VAL . . . -177.13 -52.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.134 -0.979 . . . . 0.0 110.547 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.817 HD12 HG21 ' A' ' 6' ' ' VAL . 2.6 mt -69.56 85.96 0.45 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.874 -1.141 . . . . 0.0 108.808 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.606 ' CE1' ' CE2' ' A' ' 84' ' ' TYR . 0.1 OUTLIER -112.59 151.38 30.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.942 -0.474 . . . . 0.0 109.801 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.472 ' HA ' HG22 ' A' ' 30' ' ' ILE . 53.7 t -49.1 162.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 120.903 -1.123 . . . . 0.0 110.127 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.406 ' N ' HG12 ' A' ' 47' ' ' VAL . . . 74.07 32.18 58.86 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.786 -1.725 . . . . 0.0 108.786 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.611 ' HB2' HD12 ' A' ' 30' ' ' ILE . 54.2 m-20 -116.96 104.8 11.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.603 -0.939 . . . . 0.0 110.173 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' A' ' 83' ' ' LYS . . . -81.94 97.04 7.88 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 110.158 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.51 HG21 ' CG1' ' A' ' 54' ' ' VAL . 51.4 mt -62.1 135.07 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 0.0 110.155 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.847 HD21 ' HB3' ' A' ' 27' ' ' PRO . 65.3 mt -132.53 14.0 4.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.465 -0.772 . . . . 0.0 110.217 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER 178.96 96.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.505 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.849 HG21 ' CB ' ' A' ' 70' ' ' ALA . 14.5 m -95.46 126.48 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.216 -0.927 . . . . 0.0 110.452 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.2 m120 59.28 24.4 12.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.382 -0.824 . . . . 0.0 110.609 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.6 30.78 17.62 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 53' ' ' SER . 1.1 mm-40 -123.07 95.58 4.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.134 -1.215 . . . . 0.0 109.647 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.6 97.55 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.561 0.696 . . . . 0.0 111.356 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.976 HD13 ' HB3' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -80.58 -8.12 59.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.54 -0.725 . . . . 0.0 110.548 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.8 p -54.36 -36.7 64.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.011 -1.055 . . . . 0.0 110.152 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t -95.39 22.33 7.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.906 . . . . 0.0 110.108 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.976 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -118.76 161.48 20.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 110.281 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 22' ' ' ARG . 55.1 p -91.08 -170.71 2.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 109.926 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.887 ' O ' HG23 ' A' ' 68' ' ' VAL . 10.2 t60 -69.07 -23.57 64.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.031 -1.043 . . . . 0.0 109.806 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -77.42 -39.73 45.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.617 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.753 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . 5.7 mm-40 -65.3 -24.72 67.36 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.424 -0.797 . . . . 0.0 109.953 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.49 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -82.83 -41.11 19.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.175 -0.953 . . . . 0.0 110.587 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.038 HG22 HD11 ' A' ' 18' ' ' ILE . 5.4 t -73.45 -28.45 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.141 -0.974 . . . . 0.0 109.398 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -40.33 93.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -0.801 . . . . 0.0 109.81 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.849 ' CB ' HG21 ' A' ' 54' ' ' VAL . . . -68.47 -49.3 60.85 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.209 -0.932 . . . . 0.0 108.976 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 80' ' ' LEU . 82.4 mt -58.51 -23.35 57.85 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.641 -0.662 . . . . 0.0 109.362 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -77.54 -40.12 43.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 109.624 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.11 64.82 0.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.403 -0.811 . . . . 0.0 109.364 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.588 ' CB ' HG22 ' A' ' 78' ' ' VAL . 30.4 p -82.23 174.4 11.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.375 -0.828 . . . . 0.0 109.933 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.17 -175.03 34.61 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.67 -37.88 19.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.148 -1.207 . . . . 0.0 110.544 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -117.76 101.9 8.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.397 -0.814 . . . . 0.0 109.894 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.898 HG12 HD13 ' A' ' 80' ' ' LEU . 59.9 t -67.28 73.5 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.0 110.795 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.449 HG22 ' OG1' ' A' ' 5' ' ' THR . 2.0 t -69.53 106.47 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.898 HD13 HG12 ' A' ' 78' ' ' VAL . 3.8 mp -114.0 119.79 38.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.884 -1.135 . . . . 0.0 112.235 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 14.3 tp10 -73.34 133.39 43.82 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.542 HG13 ' CG ' ' A' ' 2' ' ' ARG . 2.2 p -135.16 144.35 34.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.837 -1.164 . . . . 0.0 111.741 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.683 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -107.51 86.57 2.33 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.606 ' CE2' ' CE1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -54.33 122.86 11.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.472 -0.768 . . . . 0.0 110.662 -177.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -111.78 52.3 0.76 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.636 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.3 pttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.27 -179.762 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.498 ' O ' ' CE1' ' A' ' 64' ' ' HIS . 56.3 tttt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.128 0.489 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.54 87.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.431 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.431 ' N ' ' O ' ' B' ' 3' ' ' LYS . 0.4 OUTLIER -90.86 -163.54 1.04 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 109.865 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.584 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 30.5 tp -163.27 121.49 1.98 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 109.995 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.714 HG11 ' C ' ' A' ' 71' ' ' LEU . 83.1 t . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.082 179.804 . . . . . . . . 1 1 . 1 stop_ save_